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Abstract 
The coordination chemistry of twenty chelating heterocyclic ligands, seven of which 
are new, is described. These ligands all contain heterocyclic ring systems that have 
previously received little attention in the literature. The specific ring systems involved are 
benzoxazoles, benzisoxazoles, benzothiazoles, benzotriazoles, 1,2,4- and 1,2,5-
heterodiazoles, and the 1,4,2,5-dioxadiazene systems. 
Many of the complexes synthesised are of ruthenium(II). These include 
monoruthenium complexes of the type [Ru(bPY)2(L)] 2+, homodinuclear complexes 
{[(bPY)2Ru(Jl-BL)Ru(bpY)2]4+ with IJ-BL representing a doubly bidentate bridging ligand} as 
well as heterodinuclear ruthenium/palladium and ruthenium/platinum {[(bPY)2Ru(Jl-
BL )MChf+ with M = PdlPt} complexes. 
Also investigated are the coordination and supramolecular chemistry of many of the 
ligands with palladium(II), silver(I) and copper(II) metal ions. The X-ray crystal structures of 
five ligands and twenty complexes are described. An unexpected, previously unreported, 
heterocyclic transformation mediated by the RU(bPY)22+ cation is also reported. 
A combination of multinuclear NMR, UV-visible spectroscopy, cyclic voltammetry 
and X-ray crystallography has been used to study the nature of the metal-ligand and metal-
metal interactions in the complexes produced. 
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Chapter 1 
Introduction 
Since the preparation of 2,2'-bipyridine (bpy) over 110 years ago, I this versatile 
bidentate chelating ligand has been of great value in coordination, organometallic, analytical 
and, more recently, in metallosupramolecular chemistry. This is because of the stable metal 
complexes it forms with nearly all of the metallic elements of the periodic table.2 
In 1936 Bursta11 first synthesised the tris(2,2 '-bipyridine )ruthenium dication 
[Ru(bPY)l+].3 However, it was not until 1959 that the important properties of Ru(bPY)32+ 
were realised, with the spectroscopic investigation carried out by Paris and Brandt.4 Since 
then RU(bpy)l+ has arguably become the most studied and used coordination complex. A 
unique combination of chemical stability, redox properties, excited state properties and 
luminescence emission have made Ru(bpy)/+ suitable for a wide range of investigations, and 
there has been a tremendous amount of work on the compilation of data on Ru(bpy)l+ and its 
derivatives. 5,6 Ruthenium(II) is a d6 metal ion and has a ground electronic configuration of 
(t2g)6, and in the one-electron oxidised form, [Ru(III)], has the configuration (tzg)5. In these 
oxidation states ruthenium is inert to ligand substitution. Upon excitation by light Ru(bpy)l+ 
has a relatively long-lived excited state and combined with its photo-stability is an ideal 
photocatalyst. There has been particular interest in the use of Ru(bPY)32+ in the photo-
catalytic process of splitting water to oxygen and hydrogen.5 
In the search for better photocatalysts, the differing properties of heterocyclic ligands 
have provided a mechanism for tuning' the physical properties of the complex. That is, by 
changing the donor/acceptor properties of the ligands the properties of the resultant complex 
are altered. The heterocycles most investigated have continued to be 11-deficient six-
membered aromatic heterocycles, the azines. The introduction of substituents into the 
pyridine rings ofbpy can alter the physical and chemical properties, but more dramatic effects 
can result from changing the heterocycles themselves.7 The isomeric diazines, pyridazine, 
pyrimidine and pyrazine have been incorporated into chelating ligands, as have ligands 
containing a benzo-fused azine, eg quinoline and isoquinoline.6,7 Ligands containing a 11-' 
excessive azole have received less attention. The N-heterocyclic pyrazole,7,8 imidazole,7 
1,2,4-triazole1o and tetrazole9 systems have been incorporated into ligands, although these 
have not been studied in as much detail as the azine ligands. Importantly, the azole-
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containing ligands have imparted significantly different properties to complexes, because of 
their very different electronic properties compared to the azines. 
Little effort has been expended in studying other more exotic heterocyclic systems, 
and yet these systems may offer exciting new properties. The aim of this thesis is to 
determine the properties of some previously unexplored N-heterocyclic systems, thereby 
assessing their suitability for use in coordination chemistry, as well as learning about the 
heterocycles themselves. We aimed to do this by incorporating the chosen heterocycles into 
chelating ligands, and examining these ligands in Ru(bpy)l+ complexes. Also, where 
appropriate, their metallosupramolecular chemistry will also be investigated by preparing 
complexes with other metal ions. The heterocyclic systems chosen for investigation in this 
study are shown in Fig. 1.1. 
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benzoxazole benzothiazole 1,2-benzisoxazole benzotriazole 
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1,2,4-oxadiazole 1,2,4-thiadiazole 1,2,5-oxadiazole 1,2,5-thiadiazole 
Fig. 1.1 
A theme throughout this work is the synthesis of N-heterocyclic ligands that also 
contain oxygen or sulfur atoms in the ring. Furthermore, we intend to study some isomers, 
the 1,2,4- and 1,2,5-heterodiazoles, where only the order of the atoms in the rings is changed. 
In Chapters 2 and 3 the benzo-fused systems benzoxazole, benzothiazole, 1,2-benzisoxazole 
and benzotriazole are investigated, while Chapters 4 and 5 deal with the 1,2,4-heterodiazoles 
and the 1,2,5-heterodiazoles, respectively. 
In recent years there has been a tremendous upsurge in the area of supramolecular 
chemistry. A supramolecular species may be defined as a complex assembly consisting of 
molecular components. The 'supermolecule' has definite properties attributable to the 
components, and new properties arising from the incorporation of the components into the 
assembly.lO The construction of metallosupramolecular species is based upon the interactions 
of metal ions with organic ligands, and so far the use of nitrogen donor ligands has dominated 
this field. The range of metal geometries exceeds those of strictly organic components and so 
offers greater diversity in the geometry of the assembly. By the judicious choice of 
components it is possible to assemble metallosupramolecular complexes with desired 
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properties, thus ~ai1or making' molecules, and there have been many impressive examples of 
the construction of metallosupramolecular architectures such as molecular squares, 11 grids,12-
14 helicates,15-17 cylinders,18 a cube, 19 interpenetrating networks,20 and various other 
topology's. 
Upon moving from mononuclear to polynuclear ligand-bridged transition metal 
complexes there is, in addition to metal-ligand interactions, the possibility of metal-metal 
interactions in the form of energy- and electron transfer, magnetic interactions and 
intervalence transfer. 21 These interactions are generally mediated by the bridging aromatic 
heterocycle via the 1t-system of the ligand. Perhaps the most important of these processes are 
those activated by light, as the conversion of solar energy into other useful forms is very 
desirable. By performing useful work functions, these complexes behave as molecular 
machines and have been termed Photochemical Molecular Devices (PMDs). Many of the 
useful processes involve multi-electron catalysis. Therefore the design of multinuclear 
complexes to cope with this requirement is essential. 
From the extensive photochemical investigations of mononuclear ruthenium 
polypyridyl complexes, this unit was a logical choice to use in constructing potential PMDs. 
The design of specific systems offers many possibilities for chemists to explore, and both 
antenna and chain-like systems have been constructed using ligand-bridged ruthenium 
polypyridyl units. Metallodendrimers are also a notable example of such a design motif. The 
construction of these types of metallosupramolecular complex has been based upon 
convergent and divergent syntheses, using the 'complexes as ligands' strategy.22-26 In 
divergent syntheses, each extension is a new generation to the metallodendrimer, and by such 
a methodology a 22-nuclear complex has been successfully synthesised.27 
Currently receiving attention are ligand-bridged dinuclear systems of the form (N-
N)2M-(L-S-L)-M(N-N)2n+, where M = Ru, (N-N) is a terminal ligand such as bpy and L-S-L 
is a doubly bidentate ligand separated by ,a spacer S. With the advent of high-yielding metal-
catalysed coupling procedures, the synthesis of oligopyridines and ligands containing 
extended alkynyl- or phenyl-type spacers have become easily accessible. The bridging ligand 
determines the distance between the metals, and the electronic structure of the ligand plays a 
role in determining the electronic interaction between the metal-based units. In later chapters 
some effort was made to synthesise dinuclear complexes and look at the metal-metal 
interaction. 
A result of bidentate ligand coordination to octahedrally coordinated metal ions is the 
formation of stereoisomers. This aspect 'the stereochemical problem' has been the subject of 
an excellent recent review.28 In octahedral metals, coordination from symmetrical bidentate 
ligands, such as bpy, gives rise to two enantiomeric forms, A and Ll. As the number of metal-
based units containing three bidentate ligands increases so to does the number of 
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stereoisomers. In dinuclear complexes, two stereogenic centres gives rise to a pair of 
diastereoisomers, t:..Il/AA (racemic) and f1AJAt:.. (meso). In contrast to the stereoisomers 
formed with bidentate ligands, octahedral metals with two terdentate ligands, such as 
2,2':6',2"-terpyridine (tpy), give achiral complexes. Thus terdentate ligands have been 
proposed to offer significant advantages over bidentate ligands, especially for the construction 
of rod-like complexes, where linking two tpy ligands in the 4'-positions with a rigid linear 
spacer allows the metals to be in a direct line. However, some authors191 have argued "that 
the successful construction of advanced materials for use as molecular devices will require 
assemblies in more than one dimension and a more subtle selection of molecular building 
blocks. Further, we contend that this diversity can be provided through the diastereo- and 
enantio-isomerism of octahedral complexes derived from bidentate chelating ligands." 
If chirality is to be controlled, a synthesis starting with an enantiomerically pure 
material of known chirality must be used, the alternative being separation of isomers after 
formation. Keene has covered the subject of chromatographic separation in a recent review.29 
Researchers have further addressed the issue of chirality by trying to predetermine the 
chirality of the complex by introducing chiralligands. The chiragen family of ligands, which 
incorporate a ~-pinene group, are perhaps the best-known examples of such chiralligands. 30-35 
Other researchers have incorporated different chiral moieties such as camphor36-38 into 
ligands. 
The ligands used in this work are designed to chelate. However, they are also capable 
of acting as bridges between different metal ions. It is this mode that leads to the construction 
of supramolecular assemblies, drawing upon the information encoded into the components of 
the system to determine the resulting structure. A principle of the method of synthesis of 
these types of metallosupramolecular complexes is based upon the lability of the coordinate 
bond. Whereas in the work with ruthenium the nitrogen-ruthenium bond is inert to ligand 
substitution, the construction of metallo supra molecular complexes with some metals relies on 
the lability of the coordinate bond as well as other factors of solubility, enthalpy and 
entropy.39-41 With labile metal ions, such as copper(I) and silver(I), the metallosupramolecular 
assembly may be able to assemble and disassemble allowing exploration of various 
geometries and binding arrangements, exploring the potential energy surface, until the final 
structure is arrived at. 
The three metals chosen for this purpose in the present work are silver(I), copper(II) 
and palladium(II). This selection is based upon their differing geometrical preferences. 
Silver(I) has a wide range of bonding geometries, although shows a preference to be two-
coordinate (bent or linear) or three-coordinate (T -shaped or trigonal). The use of silver(I) in 
the construction of supramolecular architectures has been discussed in a recent review.42 
Copper(II) also demonstrates flexibility in its coordination modes, ranging from four-
coordinate (square planar) and five-coordinate (square-pyramidal or trigonal bipyramidal) to 
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six-coordinate (tetragonal).241 On the other hand, palladium(II) demonstrates little flexibility 
in its bonding geometry, preferring to be four-coordinate square planar. However, this fact is 
utilised in the construction of systems requiring two cis coordination sites, leading to squares 
or rectangles, or those requiring linear trans coordination, giving chain-like structures. 
The technique of X-ray crystallography is the method of choice for the 
characterisation of metallosupramolecular complexes involving labile metal ions, as it 
provides structural detail that other techniques cannot. Indeed, solution techniques such as 
NMR spectroscopy and mass spectrometry often provide little useful information of 
complexes of labile metal ions. This is in contrast to the solution stability of chelating 
ruthenium complexes, which are well behaved in mass spectrometers giving reliable 
information about nuclearity. Ruthenium complexes can also be fully characterised by NMR 
spectroscopy. 
In summary, this thesis describes the synthesis of a number of chelating heterocyclic 
ligands containing unusual heterocycles and the preparation of their ruthenium complexes. 
Cyclic voltammetry, NMR spectroscopy and UV -visible spectroscopy are then used to study 
these complexes providing information about the metal-ligand and metal-metal interactions. 
Coordination and supramolecular complexes with selected other metals will also be described. 
Chapter 2 
Benzoxazoles, benzisoxazoles and 
benzothiazoles 
2.1 Introduction 
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In this chapter a study of the benzo-fused analogues of oxazole, isoxazole and thiazole 
is presented. These are aromatic heterocycles with a five membered ring containing two 
heteroatoms fused to a benzene ring. The heterocyclic ring systems and ring numbering are 
shown in Fig. 2.l. 
Scr,4 3a 3 
I \N2 
6~ X 
7a 
7 1 
x=o,S 
Fig. 2.1 
The ligands specifically are 2,2 '-bibenzoxazole, (1), 2,2 '-bibenzothiazole, (2), 2,2'-
methylenebisbenzoxazole, (3), 2,2 '-methylenebisbenzothiazole, (4), 3,3 '-bi-1 ,2-benzisoxazole, 
(5), and 3-(2-pyridyl)-1,2-benzisoxazole, (6) (Fig. 2.2). 
~0}-1N~. ~N o.-JV ~S}-1N~ V--N s~ 
1 2 
6~b 60b 
5 6 
Fig. 2.2 
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Firstly, a brief description of the syntheses of the known ligands 1, 2, 3, and 4, from 
literature procedures, is given. Descriptions of attempted syntheses of the ligand 3,3'-
bibenzisoxazole (5) and the successful synthesis of 3-(2-pyridyl)-1 ,2-benzisoxazole (6), are 
then discussed. 
Although ligand 1 has been known for over a century,43 and ligand 2 for more than 
seventy years,44 the preparation and study of ruthenium complexes with these simple ligands 
has not been reported. However, ruthenium complexes of other ligands containing 
benzothiazoles have been studied and reported.45-47 Ligands 1 and 2 are fluorescent and their 
properties have been examined.48,49 Ligands 3 and 4 have been particularly well studied by a 
group of Italian chemists, who have systematically examined the properties of the 
heterocycles together with the acidity of the methylene bridge. 5oa-e However, relatively little 
of their work, other than X-ray crystallographic studies, has been concerned with the 
properties of complexes with these ligands. We felt a study of the parent biheterocycles and 
the methylene-bridged bisheterocycles would provide further information about the electronic 
nature of these heterocyclic systems. 
Further interest was in a comparison of the benzisoxazole ring vs the benzoxazole 
nng. Up to 1991, no literature reports concerning the coordination chemistry of 
benzisoxazole-containing ligands had been published. 51 This chapter also describes some 
coordination chemistry of ligand 6, as well as some aspects of coordination chemistry, with 
metal ions other than ruthenium, for some of the other ligands. 
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2.2 Syntheses of Ligands 
As stated in the introduction to this chapter, 1, 2, 3, and 4 are lmown compounds, 
These ligands were synthesised according to literature procedures involving 
cyc1ocondensations of 2-amino(thio )phenol with the diethyl esters of oxalic or malonic acid 
(n = 0,1) in polyphosphoric acid (PPA), as shown in Scheme 2.1. 
crNH2 I + 
--? XH 
x=o,S 
Scheme 2.1 
By this method 1, 2,52 353 and 452 were prepared in yields of 60%, 8%,54% and 17%, 
respectively. The lower than reported yields for ligands 2 and 4 were subsequently attributed 
to the impure nature of the starting 2-aminothiophenol. The yield of ligand 3 was close to the 
stated literature yield of 52%. 
The X-ray crystal structures of 1 and 2 were carried out in order to determine the 
conformation of the biheterocycles in the solid state. The structures of 1 and 2 are shown in 
Fig. 2.3 and Fig. 2.4, respectively. The asymmetric unit of each contains one half-molecule 
and, by virtue of the centre of inversion within the inter-ring bond, the conformations of the 
biheterocycles are planar and trans. This conformation has been reported for other 
biheterocycles such as 2,2'-bipyridine (bpy).54 Since the completion of this study, Hahn et 
al.55 have published the X-ray crystal structure of 1. 
Ligand 1 crystallises in the monoclinic space group P2 j/c, while ligand 2 crystallises 
in the monoclinic space group P2j/n. The change in space group is simply a change of axis 
for the glide plane. The obvious difference between the two ligands is the large distortion of 
the five-membered ring of the benzothiazole. The reason for this distortion is that the larger 
sulfur atom has considerably longer bonds to the C2 and C7A carbons [Sl-C2 1.741(2), Sl-
C7A 1.730(2)J than does the oxygen of the benzoxazole ring [Ol-C2 1.352(3), 01-C7A 
1.388(2)]. 
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Fig. 2.3 Perspective view, with atom labelling, of 1. Selected bond lengths (A) and angles 
(0): Ol-C7A 1.388(2), C2-N3 1.301(2), N3-C3A 1.396(3), C3A-C7A 1.378(3), C5-C6 
1.391(3), C7A-C7 1.373(3), 01-C2 1.352(3), C2-C2' 1.449(4), C3A-C4 1.399(3), C4-C5 
1.378(3), C6-C7 1.391(3), C7A-OI-C2 103.4(2), N3-C2-01 116.7(2), C2-N3-C3A 103.0(2), 
C3A-C7A-Ol 107.3(2). 
Fig 2.4 Perspective view, with atom labelling, of 2. Selected bond lengths (A) and angles (0): 
Sl-C7 A 1.730(2), C2-N3 1.299(3), N3-C3A 1.390(2), C3A-C7 A 1.408(3), C5-C6 1.401(3), 
C7-C7 A 1.400(3), SI-C2 1.741(2), C2-C2' 1.459(4), C3A-C4 1.397(3), C4-C5 1.375(3), C6-
C7 1.378(3), C7A-SI-C2 88.12(9), N3-C2-S1 117.6(2), C2-N3-C3A 109.2(2), C3A-C7A-Sl 
110.00(14). 
The conformations of these aromatic biheterocycles are subject to forces that govern 
the crystal structure. In the solid state, crystal packing forces such as 1t-1t stacking are 
maximised when the aromatic biheterocycles are planar. In the structure of ligand 2, the 
planar aromatic ligands are stacked at a distance of 3.62(5)A. Also, for reasons of 
conjugation, the aromatic rings prefer to be coplanar. Another crystal packing force in the 
structures of ligands 1 and 2 is an edge to face interaction, which leads to a herringbone array 
(Fig. 2.4b). The closest intermolecular distance for this interaction in the crystal structure of 
ligand 2 is from H6 of one ligand to C5 of another at 2.928(3)A. In these crystal structures, 
the biheterocycles have adopted the trans coplanar conformation. One might expect that the 
lone pairs on the sulfur (or oxygen) and nitrogen atoms would repel each other, and the 
aromatic rings would lie at an angle to each other to minimise this electrostatic interaction. 
With a planar system there are two possible conformations about the inter-ring bond with 
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respect to the heteroatoms, viz 1) where the same heteroatom is on the same side of the inter-
ring bond (cis) or 2) where the same heteroatoms are on different sides of the inter-ring bond 
(trans). Crystal packing forces are, of course, non-existent when the molecules are in 
solution, and for this reason their conformation may be different in solution. 
Fig. 2.4b Perspective view of the herringbone array in the crystal structure of2. 
One possible route to the biheterocyc1e 5 is through a Ni(O).catalysed coupling of a 
suitably halo-substituted benzisoxazole. 3-Ch10ro-1,2-benzisoxazole is known,56 and was 
synthesised according to the reported procedure, starting from the commercially available 
salicylhydroxamic acid, as shown in Scheme 2.2. 
DiN POCl, 
OH 
5 
Scheme 2.2 
The coupling procedure used was based on that described by Iyoda et ai.,57 which had 
previously been found to be the best procedure by other workers in this group. 58 However, 
the NiCOl coupling reaction was unsuccessful, with no biheterocycle isolated. Possibly this is 
due, at least in part, to the sensitive nature ofthe benzisoxazole ring. 
A method that has been used for the preparation ofbenzisoxazole itself, is the reaction 
of hydroxylamine-a-sulfonic acid with 2-hydroxybenzaldehyde.59 We thought it might be 
possible to extend this method to a double cyclisation of the appropriate 2,2'-dihydroxybenzil, 
as shown in Scheme 2.3. This substrate was prepared via a benzoin condensation of 2-
methoxybenzaldehyde, oxidation of the benzoin with copper(II) and deprotection of the 
methoxy groups with boron tribromide. However, an attempted ring closure reaction did not 
give any product that could be positively identifIed as 5. 
OMe 
~CHO 
V 
KCN 
17 
OMe OH () ~(l? U b OMe 
1. X5 H21\OSOjH 
\ \ 
Scheme 2.3 
With both these attempts at synthesising the biheterocyc1e 5 proving unsuccessful, a 
study of the benzisoxazole ring system with a ligand containing only one benzisoxazole ring 
was investigated. The benzisoxazole ring linked to a 2-substituted pyridine ring, viz 6, was 
chosen as the synthetic target. The method used to synthesise 6 is shown in Scheme 2.4. 
I~CHO 
~ ~CI ~~L-i----~ nBuLi tl---
N Sr _78°C 
HO' CI 
Scheme 2.4 
2-Bromopyridine was converted to its 2-lithio derivative by reaction with n-
butyllithium in THF at -78°e. 2-Chlorobenzaldehyde was added and, after work-up, the 
corresponding alcohol was obtained as an oil. This was oxidised to the ketone by Jones 
reagent. Conversion of the ketone to the benzisoxazole was effected by treatment with 
hydroxylamine in concentrated base, as described for the phenyl analogue.6o The overall yield 
for this 5-step sequence was 19%. Characterisation of this new ligand by IH and BC NMR 
spectroscopy, EI mass spectrometry and elemental analysis confinned its structure. 
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2.3 Synthesis and Characterisation of Complexes 
One of the methods of characterisation used in this work is NMR spectroscopy, in 
particular lH NMR spectroscopy. When a ligand forms a coordination complex, differences 
in the NMR spectra of the ligand and the complex are observed. These changes are described 
as coordination induced shifts (CIS = Ocomplex - Oligand). A number of factors have previously 
been identified which contribute to the magnitude and sign of lH NMR CIS values in 
[RU(bPY)2L]2+ complexes. These include ligand-to-metal cr donation, metal-to-ligand 1t back 
donation, chelation imposed conformational changes and inter-ligand through-space ring-
current anisotropy effects.61 -63 By the calculation and interpretation of CIS values for the 
introduced ligand, and by assignment of the other spectral signals, much information about 
the structure and the nature of bonding in the [RU(bPY)2L ]2+ complex can be gleaned. This 
necessitates correct lH NMR assignment. 
When individual signals for the different protons are well separated, assignments are 
generally straightforward and unambiguous, but, in cases where the spectral signals are 
overlapped, the assignment may be difficult, even for two-dimensional techniques such as lH_ 
lH correlation spectroscopy (COSY). This difficulty can be resolved by one-dimensional 
total correlation spectroscopy (l-D TOCSY). The I-D TOCSY experiment can selectively 
irradiate a separated single proton resonance and allow the transfer of magnetisation to the 
other protons in the same spin system.64-66 
An example of I-D TOCSY is shown in Fig. 2.5. The experiment begins with the 
irradiation of a selected resonance, in this case, a H6 proton of a pyridine ring at 8.71 ppm 
(Trace I). With increased mixing times the magnetisation is transferred to other protons in the 
spin system which increase in intensity. In Trace II, the magnetisation has been transferred 
from the H6 proton to the other protons of the ring, and ultimately, in Trace III, the H3 proton 
has received the magnetisation and is the most intense signal. Therefore, each subsequent 
spectrum, with longer mixing times, gives an unambiguous assignment and an accurate 
measure of the chemical shift of the other protons in the spin system. 
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Trace III 
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Fig. 2.5 
2.3.1 Ruthenium Complexes 
Reaction ofligand 1 with bis(2,2'-bipyridine)dichlororuthenium, [Ru(bpY)2Ch], in 3:1 
ethanol/water required,due to the low solubility of 1, a long reflux time. Furthermore, a IH 
NMR spectrum of the material isolated after work-up showed a much more complicated 
spectrum than expected, suggesting a mixture of products. The desired [Ru(bpY)2(1)f+ 
complex, (7), contains a two-fold rotational axis of symmetry. Hence, the 24 aromatic 
protons, 16 from the bipyridine ligands and 8 from 1, should give rise to only 12 signals. One 
chemical shift that is diagnostic in ruthenium complexes such as these is the H6 proton of a 
pyridyl ring that is proximate to a coordinated chloride ion. This proton is heavily deshielded' 
by the chlorine and is shifted downfield. The geometric relationship is demonstrated in Fig. 
2.6. 
Fig. 2.6 
This de shielded proton was evident in the spectrum, and since the chloro-product and 
7 are cations of different charge, chromatography on alumina allowed the separation of the 
two complexes. The IH NMR of the first fraction contained 24 aromatic proton resonances, 
which corresponds to six inequivalent ring systems. 1-D TOCSY spectra identified 4 
different pyridyl rings and two different rings for the ligand 1. Accordingly, the complex was 
formulated as [Ru(bpY)2CI(1)](PF6), (8). The chemical shifts and CIS from 1 and 8 are shown 
in Table 2.1. 
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The proton that has the chemical shift of 5.95 ppm easily distinguishes the coordinated 
ring. This proton is heavily shielded by ring-current anisotropy of the pyridine ring it is 
nearest to, and so is shifted up field giving a very large CIS of -2.04 ppm. This is assigned as 
proton H4 of the coordinated ring. Irradiation of this proton in a 1-D TOCSY experiment 
gave the chemical shifts of the rest of the coordinated ring protons. 
Although all signals for the uncoordinated ring were found by 1-D TOCSY, defmitive 
assignment of the signals to H4'-HT, which would have required a GHSQC experiment, was 
not achieved. This was in part due to ligand dissociation from the complex. Assignment was 
also not possible through coupling constant information as two of the signals were 
considerably broadened, presumably due to slow rotation about the inter-ring bond. The 
chemical shifts of the H4'-HT protons are interesting, as all signals are far upfield of the 
corresponding signals in the free ligand. This is presumably due to the position that the non-
coordinated ring occupies when the ligand is bound in a mono dentate fashion (Fig. 2.7). With 
the coordinated ring aligned with H4 pointing towards the adjacent pyridine ring, the 
uncoordinated ring must point towards another pyridine ring and experiences the effect of 
ring-current anisotropy. 
(PF6l 
8 7 
Fig. 2.7 
Table 2.1 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb of the coordinated 
benzoxazole ring of 8 and chemical shifts of 1. 
H4 H5 H6 H7 
8 5.95 7.25 7.55 7.87 
1 7.99 7.59 7.66 7.89 
CIS -2.04 -0.34 -0.11 -0.02 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex - ~igand). 
The second fraction showed the expected 12 proton resonances for complex 7. The IH 
NMR spectrum of 7 is shown in Figure 2.8, and selected NMR data are given in Table 2.2. 
Assignment of the three individual ring systems was made by 1-D TOCSY. This, however, 
does not distinguish which pyridine ring is cis and which trans to the benzoxazole ligand. A 
1 H nOe experiment, irradiating H4 of the benzoxazole ring, showed enhancement in both H6 
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protons of the bipyridines. Because of this result, complete IH NMR assignment was not 
possible. 
. .. 
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Fig. 2.8 IE NMR spectrum of [Ru(bpY)2(1)] (PF6)2 (7). 
Table 2.2 IHNMR Chemical Shiftsa and Coordination Induced Shiftsb of7 and 1. 
H4 H5 H6 H7 
7 6.03 7.43 7.75 8.01 
1 7.99 7.59 7.66 7.89 
CIS -1.96 -0.16 +0.09 +0.11 
a For deuterated acetonitrile solutions. b CIS = (5complex - Oligand). 
Again the H4 protons show a very large upfield shift, although, interestingly, this shift 
is not quite as large as the CIS of the coordinated ring of the complex 8. This may be 
explained by the angle of coordination. When the ligand is coordinated by only one atom, the 
H4 proton is placed slightly closer to the shielding pyridine ring, resulting in a slightly larger 
CIS. This is also true for the H5 protons that are similarly affected. 
A second method of preparation of ruthenium complexes employed in this work 
involves the use of a silver salt with a non-coordinating anion such as AgBF 4 or AgCI04. The 
silver salt is used to remove chloride from the RU(bPY)2Ch reactant and hence prevent it 
acting as a ligand. The resulting anion was then usually exchanged for hexafluorophosphate 
by metathesis. By this method, complex 7 was produced, selectively, in 64% yield. 
Small crystals of complex 7 were grown by slow evaporation of a dichloromethane 
solution, one of which was used for X-ray diffraction analysis. Complex 7 crystallises in the 
triclinic space group P-I, with the cationic metal complex, two hexafluorophosphate 
counterions and a dichloromethane solvate molecule in the asymmetric unit. A perspective 
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view of the cation is shown in Fig. 2.9, with the counterions and solvate molecule omitted for 
clarity. 
Fig. 2.9 Perspective view, with partial atom labelling, of 7. Selected bond lengths (A) and 
angles (0): Rul-N3 2.112(5), Rul-N3' 2.102(5), Rul-Nll 2.088(5), Rul-N2l 2.029(5), Rul-
N3l2.048(5), Rul-N4l 2.069(5), N3-Rul-N3' 77.6(2), Nll-Rul-N2l 78.6(2), N3l-Rul-N4l 
78.2(2), C2-N3 1.322(8), 01-C2 1.350(7), 01-C7A 1.395(8), N3-C2-0l 115.2(6), C2-N3-
C3A 104.2(5), C3A-C7A-Ol 107.3(6), C2'-N3' 1.314(8), 01 '-C2' 1.351(7), 01 '-C7A' 
1.395(8), N3'-C2'-01' 115.7(6), C2'-N3'-C3A' 104.9(6), C3A'-C7A'-01' 109.4(6) 
The crystal structure of complex 7 proved that the ligand was chelating in a N,N'-
manner. Among the other notable features of this crystal structure is the conformational 
change that the ligand has undergone. In the crystal structure of ligand 1 (Fig. 2.3), the 
orientation of the nitrogens about the inter-ring bond was trans. Upon chelation to the 
Ru(bpy)l+ unit the nitrogens are cis. The bond lengths of the coordinating nitrogens of the 
benzoxazole ligand [2.102(5)A and 2.ll2(5)A] are slightly longer than those of the auxiliary 
bpy ligands [2.029(5)A to 2.088(5)A], probably due to its greater steric demand. Each of the 
chelating ligands is planar, with very little twisting of the rings, although the benzoxazole 
ligand is slightly bowed. The general features of this RU(bPY)2L2+ complex have been noted 
previously for other related complexes.67-7o 
Another quantitative measure that this crystal structure allowed was the distance from 
H4 to the centre of the pyridine ring of the bpy ligand into which it points. The distance of 
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H4 to the bpy ring is 2.848(5)A. This is closer than the distance from the H6 of one bpy to 
the centre of the pyridine ring into which it points [3.188(5)A] and therefore explains the 
large negative CIS value. 
The reaction of ligand 2 with Ru(bpY)2Clz in 3: I ethanol/water gave the complex 
[Ru(bpY)2(2)f+ (9), which was isolated as the hexafluorophosphate salt. Again, due to the 
very low solubility of the ligand, a long reflux time (3 days) was needed in order to obtain a 
reasonable yield of complex (ca. 66%). Because of the insolubility of 2, no IH NMR 
spectrum could be recorded in deuterated acetonitrile. For this reason, the CIS from 2 and 9 
could not be calculated. In the IH NMR spectrum of complex 9, one proton (at 6.28 ppm) 
was considerably up field of the others, as a result of the ring-current anisotropy. 1-D TOCSY 
was used to identify the other protons in this system and the two different spin systems of the 
bpy ligands. 
In this symmetrical complex, it is not immediately obvious which of the protons of the 
benzothiazole rings (H4 or H7) is the upfleld signal at 6.28 ppm, as N,N'- or S,S'-chelation is 
possible. In order to unambiguously assign the IH NMR spectrum of 9 this signal had to be 
assigned to either H4 or H7 .. To accomplish this the use of heteronuclear correlation was 
necessary. 
A l3C NMR spectrum of this complex was obtained with 16 of the possible 17 carbons 
found by a 13C NMR experiment. Comparison with the spectra of related complexes, and with 
benzothiazole,71 did not allow a complete assignment. The comparison did allow for the 
ready assignment of many signals to the bpy ligands, and the assignment of the C3A 
(151.87ppm) and C7A (135.87 ppm) carbons of the benzothiazole ligand based upon 
chemical shift, as well as the realisation that the unrecorded carbon was C2 of the 
bibenzothiazole. However, it did not allow for the distinction of C4 from C7, which was 
needed to confmn the mode of bonding. A GHSQC experiment, which might resolve the 
ambiguities, was performed and is shown in Fig 2.1 O. Importantly, the proton at 6.28 ppm 
correlated to the most upfield carbon at 120.45 ppm. However, this carbon is at a different 
position than is usual for both C4 and C7 carbons of benzothiazole rings and therefore 
distinction could not be made on this basis. The GHSQC spectrum was useful as it did allow 
definite assignment of some carbons to the already differentiated bpy spin-systems, although, 
in the case of the C3's of the bpy ligands, the resolution is not good enough for assignment to 
a specific spin system. Since the upfield proton must be either H4 or H7, a GHMBC 
experiment should be able to correlate it to one of the already identified C3A or C7 A carbons. 
In the GHMBC experiment the IH_13C coupling was set for 3-bond coupling. Therefore H4 
should correlate to C7A and C6, and H7 to C3A and C5 (Fig. 2.11). Indeed, the GHMBC 
spectrum (Fig. 2.10) does give the correlations that enable confirmation of the mode of 
bonding. The up field proton at 6.28 ppm correlates to C7A at 135.87 ppm and to what must 
be C6 at 129.26 ppm. Conversely, the other doublet of the benzothiazole ligand, at 8.32 ppm, 
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correlates with C3A at 151.87 ppm and C5 at 129.55 ppm. This detennined that the ligand 
was chelating through the nitrogen atoms. The GHMBC spectrum also allowed the 
assignment of the quatemarybpy carbons to their respective spin systems. 
F2 11, II lUlL I (ppm) 
~==~.1 
6.5 
7.0 
7.5 
8.0 
~ 
:J 8.5 
1 9.0 
6.6 
7.0 
.... 
7.4 
7.8 
:!I B.2 
..J 
~ 8.6 9.0 
165 
""" <!> 
'" 
'" .., 
<> 
0l 
0 
160 150 140 130 120 110 
I 
I 
155 145 
• , 
135 
F1 (ppm) 
125 115 
Fig. 2.10 GHSQC (top) and GHMBC spectra (bottom) of [RU(bPY)2(2)](PF6)2 (9). 
Fig. 2.11 
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It has been demonstrated that the metal-to-ligand charge-transfer (MLCT) energy of 
[Ru(bpyhL]2+ complexes is an indicator of the HOMO-LlJMO energy gap in such 
complexes.6 The UV-visible spectra of complexes 7 and 9 are shown in Fig. 2.12. 
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Fig. 2.12 UV-visible spectra of a) [Ru(bpyh(1)](PF6)2, (7), and b) [Ru(bpY)2(2)](PF6)2, (9). 
The UV-visible spectrum for complex 7 shows that the lowest energy MLCT is at 485 
nm and this transition is assigned as (M)d-(L)n*. This transition is at longer wavelength 
than that in Ru(bpy)l+ (452 nm), and indicates that the HOMO-LUMO gap is smaller in 7 
than it is in Ru(bpy)l+. The spectrum contains other transitions which are at higher energy; 
the transition at 436 nm can be assigned to (M)d-(bpy)n*, whereas the transition at 357 nm 
is ligand centred (LC). The UV -visible spectrum for complex 9 shows that the lowest energy 
MLCT is at 516 nm, indicating that the energy gap for 9 is smaller than in 7 and in 
RU(bPY)32+. The transition at 431 nm can also be assigned, in a similar manner to 7, as 
(M)d-(bpy)n* and the transitions at 386 and 366 to LC transitions. 
A method that gives a direct measure of the orbital energies in ruthenium complexes is 
cyclic voltammetry. The cyclic voltammograms of complexes 7 and 9 are shown in Fig. 2.13, 
and Table 2.3 gives the absorption maxima and redox potentials for 7 and 9 compared to 
those of Ru(bpy)l+. 
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Fig. 2.13 Cyclic voltarnmograms for [Ru(bpY)2(1)](PF6)2 (7) (top) and [Ru(bpY)2(2)](pF6)2 
(9). 
Table 2.3 Absorption Maximaa with Molar Absorption Coefficientsb and Redox Potentialsc of 
complexes 7 and 9. 
Amax (8) Eox Bredl Bred2 Ered3 11IEm -red] 
RU(bPY)3: 452 (13600) 1.26 -1.33 -1.51 -1.75 "''' 
7 485 (7 300) 1.36 -0.97 -1.55 -1.77 2.33 
9 516 (8 500) 1.32 -0.86 -1.46 -1.73 2.18 
a In nanometers. b M-1cm-1. C In volts vs SCE in acetonitrile. 
Complexes 7 and 9 are both slightly harder to oxidise than Ru(bpy)/+. Since 
oxidations of such complexes are well known to be metal centred, this suggests that the 
ruthenium atom in these complexes is less electron rich than in Ru(bpy)/+. Reductions in 
[RU(bPY)2L]2+ complexes have been shown to be ligand localised.6 The first reductions of 7 
and 9 are ligand based, and 9 is easier to reduce than 7 by 110m V. The second and third 
reductions are in excellent agreement with the corresponding reductions in Ru(bpy)/+ and 
can, on this basis, be ascribed to the auxiliary bpy ligands. The ilEox-redl value for the 
complexes are in agreement with the data from the UV spectra, for which the same orbitals 
are involved [(M)d-(L)rr*]. The HOMO-LUMO [(M)d-(L)rr*J energy gap in the 
complexes is considerably reduced by substitution of a bpy ligand with ligand 1, and further 
reduced by substitution with ligand 2, as evidenced by the LlEox-redl values. This suggests that, 
in the complexes 7 and 9, the rr* orbitals are lower-lying than those in Ru(bpy)/+. 
The effect of benzo-fusion to heterocyclic rings is to lower the energy of the rr* 
orbitals. For example, the rr* orbitals of 2,2'-biquinoline (10) are lower in energy than those 
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of 2l2'-bipyridine (bpy). As a consequence, the ruthenium complexes of 10 have different 
properties to those of Ru(bPY)3z+.72 Ligand 2 is the benzo-fused analogue of the well-studied 
ligand 2,2'-bithiazole (btZ).63,73 Although electrochemical and spectroscopic data for the 
analogous [Ru(bpY)zbtzJz+ complex are not available, the homoleptic complex Ru(btz)l+ has 
been examined electrochemically.74 This allows for a semi-quantitative comparison between 
these two complexes. The oxidation potential for Ru(btz)l+ is 1.33 V, and the authors 
observed that for the substitution of pyridine rings with thiazoles there existed an increase in 
oxidation potential of ca. 0.01 V per thiazole. The oxidation potential for [Ru(bpY)z(2)]z+ is 
1.32 V, which is very similar, and suggests that the effect of benzo-fusion of the ligand is 
small in relation to oxidation of the metal. The reduction potentials are related to the lowest 
lying n* orbitals of individua1ligands. This fact allows for comparison of the first reduction 
potentials of Ru(btz)l+ (-1.08 V) and [Ru(bpY)z(2)]z+ (-0.86 V). Although there exists a 
difference in the other ligands in the complexesl the effect ofbenzo-fusion is clearly to lower 
the energy of the n* orbital. This type of comparison cannot be made for complex 7, as 2,2l_ 
bioxazole is unknown.75 
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The only identifiable productl after chromatography on alumina, from the reaction of 
ligand 3 with Ru(bpY)zClz in 3:1 ethanol/water was the complex [Ru(bpY)2(3-H)](PF6), (11). 
The lH NMR spectrum of the complex gave the expected 12 aromatic signals, and these were 
able to be assigned to individual rings by means of a lH_1H COSY spectrum (Fig. 2.14), but 
the signal for the bridge only integrated for one proton. An attached-proton test (APT) l3C 
NMR experimentl shown in Fig. 2.14, and a high-resolution FAB mass spectrum confirmed 
that the bridge had become deprotonated in the reactionl or when chromatographed on the 
alumina columnl and that the complex exists as the mono-cation 11. 
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Fig. 2.14 13C APT and COSY spectra of [RU(bPY)2(3-)](PF6) (11). 
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When this reaction was repeated using the silver salt method, F ABMS of the crude 
product suggested that the same complex, 11, was formed in the reaction. The material was 
purified by chromatography on alumina, and one dark green fraction (11) was isolated in a 
significantly better yield of 50%. This type of coordination has been observed before for 
ligand 3.50b The chemical shift of 59.99 ppm (CD3CN) for the methine carbon in 11 is in good 
agreement with the value for the methine carbon in the complex Rh(CO)2(3-H) at 61.37 ppm 
(CDCb). 
Table 2.4 gives the IH NMR data for complex 11. The upfield shift of H4 is very 
large and indicates a close proximity to the shielding pyridine rings. This can be explained by 
the fact that this ligand forms a six-membered chelate ring, which places H4 closer to the 
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adjacent pyridine ring than was so in the complex 7, which has a five-membered chelate ring. 
The methine bridge proton has a CIS of +0.47 ppm, which shows it has moved downfield 
upon bridge deprotonation. One H6 proton of the bpy ligands in 11 is at 8.83 ppm, and is 
assigned to the pyridine ring cis to the benzoxazole ligand. This proton generally reflects the 
aromaticity of the ring over which it sits, and in these complexes, it is typically shielded by 
ring-current anisotropy. Clearly it is not shielded in this case but de shielded. It has been 
shown that deprotonation of the bridge in ligand 4 leads to an increase in n-electron density 
on the nitrogen atom,50c and this may explain the de shielded position of this proton. 
Table 2.4 lH J\fMR Chemical Shifts3 and Coordination Induced Shiftsb of3 and 11. 
H4 H5 H6 H7 CH-ICH2 
11 5.20 6.65 6.95 7.28 5.20 
3 7.65 7.42 7.45 7.75 4.73 
CIS -2.45 -0.77 -0.50 -0.47 +0.47 
i bpyH3 bpyH4 bpyH5 bpyH6 
8.52 8.09 7.57 8.83 
8.49 8.05 7.36 8.00 
3 For deuterated acetonitrile solutions. b CIS = (Ocomplex - Oligand). 
The UV -visible spectrum for complex 11 shows a shoulder at 482 nm and an intense 
absorption at 405 nm (8 17 600 M-1cm-1) (Fig. 2.15). As has been postulated,50c the electron 
of the deprotonated bridge is presumably delocalised around the chelate ring of the 
benzoxaz01e ligand. To promote an electron from a metal d orbital to this already electron 
rich environment (MLCT) may be an unfavourable process. 
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Fig. 2.15 UV-visible spectrum of [Ru(bpY)2(3-)](PF6) (11). 
Electrochemically, complex 11 exhibits a reversible one-electron oxidation at + 1.39 V 
and a one-electron irreversible reduction at ·1.04 V, giving ~ox-redl = 2.45 V. The oxidation 
potential of complex 11 suggests that the ruthenium atom is less electron rich, relative to 
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RU(bPY)32+, as the oxidation potential is 130 m V higher. The reduction process is obviously 
that of the benzoxazole ligand, based upon its potential, and, interestingly, it is irreversible. 
The L).Eox-rcdl value is consistent with the (M)d-(L)n* transition being the shoulder at 482 run 
in the UV-visible spectrum of complex 11, leaving the intense transition at 405 run as the 
(M)d-(bpy)n* transition (Fig. 2.15). 
Ligand 4 proved difficult to coordinate to the Ru(bpY)22+ unit in a bidentate chelating 
manner. Reaction of 4 with Ru(bpY)2Ch under the standard conditions gave, on first 
inspection of the lH NMR spectrum (Fig. 2.l6a), a complex with a coordinated chlorine anion 
and presumably the ligand bound in a monodentate fashion [(bpyhRuCl(4)] (PF6), 12, (Fig. 
2.1 7). This was based upon the characteristic downfield H6 proton (10.18 ppm), and the 
presence of an upfield signal at 6.28 ppm. In the usual fashion, further IH NMR assignment 
of this complex was attempted. By the irradiation of the above signals and others in I-D 
TOCSY experiments, five spin systems were identified, including two for the benzothiazole 
ligand. The chemical shifts and assignments for these signals are listed in Table 2.5. 
10.0 9.5 9.0 8.5 B.O 7.5 7.0 6.5 ppm 
Fig.2.16a 
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Fig. 2.17 
Table 2.S IH NMR Chemical shiftsa of the benzothiazole ligand and identified bpy ligands. 
H4 HS H6 H7 H4' HS' H6' H7' 
6.28 7.06 7.38 7.90 7.33 7.22 7.42 7.81 
I bpyH3 • bpyH4 bpyHS . bpyH6 
8.43 8.00 7.40 10.18 
8.91 8.18 7.42 8.26 
I 8.90 8.23 7.14 8.06 
a For deuterated acetonitrile solutions. 
Having identified these rings, further assignment was attempted using IH nOe 
experiments by irradiating the already identified bpy H3 protons. This would hopefully allow 
the identification of the pyridyl partners that make up the bpy ligands. These experiments 
gave unexpected results. Each spectrum showed the presence of large negative nOe's (Fig. 
2.16b). This type of enhancement is evident in molecules undergoing a fluxional process that 
involves chemical exchange. By the selective irradiation of either side of the multiplet at ca. 
8.9 ppm, and using the intensity of the negative nOe obtained, the exchanging partner could 
be ascertained. The assignment was confirmed in one case by the back-irradiation of the 
other isolated H3 at 8.43 ppm. To see if this fluxional process involved the ligand, the up field 
H4 proton was irradiated in a IH nOe experiment, and the resulting spectrum is shown in Fig. 
2.16c. 
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Fig.2.16c 
The expected positive nOe from H4 to H5 on the coordinated ring is seen in the signal 
at 7.06 ppm. Of more interest is the large negative nOe to a doublet at 7.33 ppm, which is the 
signal for H4' in the uncoordinated ring, thereby confirming that the two rings of the ligand 
are interchanging. The exchanging H4' shows a small positive nOe to the H5'proton at 7.22 
ppm. The remaining signal to be assigned is the positive enhancement at 8.26 ppm. This 
signal shows a correlation to a H6 proton of a pyridyl ring identified by the previous I-D 
TOCSY experiments (Table 2.5). Examination of the coupling constant of this signal in the 
lH nOe spectrum confirmed it was a H6 proton. This enhancement is to the pyridyl ring 
adjacent to the coordinated benzothiazole ligand. To further examine the process a variable 
temperature lH NMR study was undertaken with spectra obtained in 10° increments from 23° 
to 63°. However, this study proved inconclusive. In order to encourage chelation, the second 
method of preparation was attempted. Two equivalents of AgBF 4 were stirred with the 
Ru(bpY)2Ch complex in 1: 1 ethanol/acetone to remove the chloride anion and generate the 
adduct Ru(bpyh(acetone)l+ before addition of the ligand. Even with this modification, the 
lH NMR spectrum of the resulting material was the same. 
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The complex was then analysed by electrospray MS, but this did not provide a defmite 
structure of this complex. From the lH NMR evidence, we feel certain that the Ru(bpY)l+ 
unit is intact, and hence it is likely that the ligand has rearranged. The elemental analysis of 
the complex was not supportive of the structure 12. Because of the ambiguity over the 
structure, the mechanism of the fluxional process remains a mystery. 
The complex [Ru(bpY)2(6)](PF6)2 (13) was produced, in excellent yield (94%), by 
reaction of Ru(bpY)2Ch with ligand 6 in 3: 1 ethanol/water. Complex 13 has, because of the 
unsymmetrical nature of the ligand, no internal symmetry. This led to a complicated 1 H NMR 
spectrum with 24 aromatic protons, 20 of which belong to 2-substituted pyridine rings. 
However, both rings of the ligand 6 could be positively identified by the cooperative use of 1-
D TOCSY and IH nOe spectroscopy. The benzisoxazole ring was readily identified, as it 
does not contain a doublet with a smaller coupling constant (a H6 proton of a pyridyl ring), 
and a IH nOe from H4 of the benzisoxazo1e gave the chemical shift of H3' (Fig. 2.18). 
Irradiating H3' in a l-D TOCSY experiment then gave the chemical shifts ofH4', H5' and H6'. 
H3' 84 as 
B.B 8.6 8.4 9.2 8.0 7.B 7.6 7.4 ppm 
Fig. 2.18 IH NMR and IH nOe spectra of [Ru(bpY)2(6)](PF6)2 (13). 
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Table 2.6 IH ]\IT\!IR Chemical Shiftsa and Coordination Induced Shiftsb of 6 and 13. 
H4 HS H6 H7 H3' H4' HS' H6' 
13 8.42 7.73 7.82 7.67 8.79 8.27 7.S9 7.86 
6 8.S8 7.S7 7.73 7.77 8.26 8.01 7.S2 8.86 
CIS -0.16 +0.16 +0.09 -0.10 +0.S3 +0.26 +0.07 -1.00 
a For deuterated acetonitrile solutions. b CIS = (8complex - ~gand). 
For [RU(bPY)2L]2+ complexes negative CIS (upfield shifts) are generally as a result of 
some ring-current anisotropy (shielding) phenomena from other aromatic rings. This is 
demonstrated in complex 13 with the large upfield shift experienced by H6' (CIS -1.00 ppm). 
This shielding is from the pyridyl ring trans to the benzisoxazole (Fig. 2.18). Similarly, a 
shielding of H7 from the pyridyl ring of the bpy ligand that is trans to the pyridine ring of 6 
could be expected. Table 2.6 indeed shows a negative CIS, but, because H7 is further from 
the pyridine ring the effect is much less and this is reflected in the CIS value of -0.10. 
Based upon its upfield shift, it might seem that H4 also experiences some anisotropic 
shielding. Because of the cisoid conformation imposed by chelation, protons H4 and H3' are 
in an environment of high steric compression. To relieve this situation, the rings may be tilted 
relative to one another. In this case, H4 would lie above the pyridine ring and experience a 
small shielding effect from it. However, the H3' proton of the pyridyl ring should also 
experience a similar shielding from the benzene ring of the benzisoxazole. A positive CIS 
(downfield shift) ofH3'to 8.79 ppm implies it does not experience any such shielding. 
To explain this situation, rationalisation of the chemical shifts in the free ligand is 
necessary. This requires an understanding of the conformation of the ligand itself in solution. 
The chemical shift ofH4, in the free ligand, is well downfield at 8.S8 ppm. This information 
implies that proton H4 experiences a deshielding effect, and it is most likely that this is from 
the nitrogen of the pyridine ring (Fig. 2.19). Thus, the conformation of the ligand in solution 
is one where the nitrogens are trans, with respect to the inter-ring bond, and the molecule 
itself is near-planar. Therefore, H4 is not shielded by any ring-current anisotropy in complex 
13, but less de shielded when forced to adopt the cisoid conformation for chelation. This 
explanation is also consistent with the observed CIS of H3', which is shifted downfield (CIS 
+0.S3) upon chelation to ruthenium. 
1'-'::: 
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Fig. 2.19 
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The UV-vis spectrum of complex 13 (Fig. 2.20) shows a Amax at 442 nm with a 
shoulder on the high-energy side at around 420 run. The fonner is probably the (M)d--{L)n* 
transition and the latter (M)d-(bpy)n*. The (M)d--{L )n* transition is at higher energy than 
that of Ru(bpy)/+ (452 run), which suggests that the 6Eox-redl value for 13 should be greater 
than that for RU(bpy)32+. The cyclic voltammogram of complex 13 (Fig. 2.20) shows a 
reversible oxidation at 1.36 V and an irreversible reduction at -1.01 V. The reduction can be 
ascribed to electron transfer to ligand 6, and may result in decomposition of the complex. 
Irreversible reductions of structurally related pyrazole-containing ligands have previously 
been shown to lead to complex decomposition.8,76 The 6Eox-red value for 13 is 2.37 V, which 
is less than that in Ru(bpy)/+ (2.59 V) and very similar to [Ru(bpY)2(I)f+ (7) (2.33 V). 
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Fig. 2.20 UV-visible spectrum and cyclic voltammogram of [RU(bPY)2(6)] (PF6)2 (13). 
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2.3.2 Complexes with other metal ions 
Having studied the mononuclear ruthenium complexes, we thought it might be 
interesting to prepare and study some complexes of other metal ions with these ligands. To 
this end, selected complexes were prepared with Pd(II), Ag(l) and Cu(II). The extreme 
insolubility of ligand 2 was found to thwart any attempts at complex formation. Ligand 4 has 
been particularly well studied with neutral and cationic complexes of divalent transition metal 
ions, such as Ni(II), Cu(II), Zn(II), Co(II) and Hg(II), having been reported.50c 
Palladium Complexes 
When ligand 1 was reacted with 1 equiv. of lithium tetrachloropalladate (LizPdC14) in 
refluxing methanol, a tan complex of 1:1 stoichiometry [1.PdClz], (14), was formed in good 
yield (82%). FABMS indicated the dominant molecular ion was (I)Pd+, and thus, the ligand 
is most probably acting as a N,N-chelating ligand (Fig. 2.21). The complex is soluble in 
strongly solvating solvents such as DMF, DMSO and MeN02 to give red/pink solutions. IH 
NMR of 14 in deuterated DMSO showed no change from that of the free ligand, indicating 
that in DMSO solution the complex dissociates. 
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When ligand 3 was reacted with LizPdC14 in methanol, an immediate precipitate 
developed and was filtered off. F ABMS of the resulting solid suggested a chelating structure, 
as the molecular ion corresponding to (3)PdCl+ was identified. Elemental analysis confirmed 
a 1:1 stoichiometry [3.PdCh.H20], and a monomeric chelating structure, (15), (Fig. 2.22) was 
proposed. The complex showed surprisingly good solubility in deuterated chloroform and a 
IH NMR spectrum was obtained. In six-membered chelate rings containing a methylene 
bridge, there exists the possibility of an agostic interaction between a methylene proton and 
the metal centre when the chelate ring is in a boat conformation.77,78 The protons of the bridge 
are on the mirror plane which relates one half of complex 15 to the other, but they are 
diastereotopic, and hence should give rise to two signals. This was not seen in the IH NMR 
spectrum of 15, and indicates that there is fast interconversion on the NMR timescale of the 
two possible boat forms. The chemical shifts and coordination induced shifts are presented in 
Table 2.7. The order of the ring protons was found by irradiation of the downfield doublet 
(H4) in a I-D TOCSY experiment. The large positive CIS (+1.04) of the H4 protons is 
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testimony to the fact that the proximate chlorine deshields them. The H5 and H6 protons 
show small positive CIS values, and the protons of the methylene group have moved 
downfield 0.49 ppm as a result of the ligand chelating to palladium. 
o~o o -~ N\ h \J\/~ 
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Fig. 2.22 
Table 2.7 Chemical Shiftsa and Coordination Induced Shiftsb of3 and 15. 
H4 H5 H6 H7 CH2 
15 8.56 7.49 7.53 7.58 5.16 
3 7.52 7.35 7.35 7.73 4.67 
CIS +1.04 +0.14 +0.17 -0.15 +0.49 
a For deuterated chloroform solutions. b CIS = (8complex - 8ligand). 
Reaction of ligand 4 with LhPdCl4 in refluxing methanol gave fine golden flakes that 
analysed as [4.PdCb,YzH20], (16). FABMS provided evidence that the ligand was chelating 
with a molecular ion of (4)PdCI+ being identified. The lH NMR spectrum of complex 16 was 
recorded in deuterated acetonitrile, but a spectrum of the ligand itself could not, and so no CIS 
could be calculated from this. A IH NMR spectrum was then recorded in deuterated DMSO, 
and this showed a mixture of free and complexed ligand, indicating an equilibrium between 
the two. The peaks due to the complex were easily distinguished from those of the free ligand 
as the complex has a downfield doublet (H4) brought about by the close proximity of these 
protons to the deshielding chlorine atom. A I-D TOCSY irradiating this downfield doublet 
identified the rest of the ring protons. Again, as in the example of complex 15 above, the IH 
NMR spectrum showed only one signal for the protons of the methylene bridge. The 
chemical shifts and coordination induced shifts are presented in Table 2.8. The H4 
proto~s of this complex are moved downfield as a result of deshielding from the chlorine 
atoms. All other ring protons show small positive CIS values. The methylene protons show a 
strong positive CIS value of +0.80 ppm. 
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Table 2.8 Chemical Shiftsa and Coordination Induced Shiftsb of 4 and 16. 
H4 H5 H6 H7 CH2 
16 8.65 7.65 7.58 8.18 5.90 
4 8.00 7.45 7.53 8.10 5.10 
CIS +0.65 +0.20 +0.05 +0.08 +0.80 
a For deuterated dimethyl sulfoxide solutions. b CIS = (8complex - 8ligand). 
When ligand 6 was reacted with Li2PdC14 in methanol a yellow complex, that analysed 
as [6.PdClz], (17), was formed in high yield (94%). The lH NMR spectrum of the complex 
was recorded in deuterated DMSO, and this showed a mixture of free and complexed ligand. 
The shifts of the complexed ligand were found by the irradiation of two signals at 9.11 ppm 
and 8.66 ppm in l-D TOCSY experiments. The chemical shifts and coordination induced 
shifts are presented in Table 2.9. All the CIS values for this complex are positive, and this 
reflects the change in the adjacent substituent from a shielding pyridine ring in complex 13 to 
a deshielding chlorine atom. This leads to a positive CIS value of H6' (+0.24). Many of the 
other CIS values for 17 are similar to the shifts observed for the ruthenium complex 13, and 
the reasons for these are the same as those discussed previously. 
- () 
C}-0 
\ / 
Pd 
CI/ "CI 
17 
Fig. 2.24 
Table 2.9 lH NMR Chemical Shiftsa and Coordination Induced Shiftsb of 17 and 6. 
H4 H5 H6 H7 H3' H4' H5' H6' 
17 8.66 7.73 7.85 8.11 8.83 8.49 7.95 9.11 
6 8.52 7.51 7.73 7.86 8.22 8.05 7.61 8.87 
CIS +0.14 +0.21 +0.12 +0.25 +0.61 +0.44 +0.34 +0.24 
a For deuterated dimethyl sulfoxide solutions. b CIS = (8complex - 8ligand). 
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Silver Complexes 
A complex with ligand 1 and AgN03 was prepared by adding equimolar amounts of 
ligand 1 in chloroform to a solution of AgN03 in 1:1 chloroform/methanol. The resulting 
micro-crystals were a mauve colour and analysed as [1.(AgN03)2] (18). Thus despite the fact 
that stoichiometric quantities of ligand and metal salt were mixed, the complex has formed 
has a 1:2 ligand:metal stoichiometry. This will be described as a [1 + 2] complex. The 
micro-crystals were too small for an X-ray structure analysis and, despite various attempts at 
recrystallisation, no crystals suitable for a structural investigation were obtained. IH NMR 
spectroscopy and F ABMS were used to further characterise complex 18. However, this and 
other attempts at characterisation of Ag(I) complexes described in this thesis by these 
methods gave no useful information. The Ag(l) ion is labile, and in the 'H NMR spectrum no 
coordination induced shifts were observed, and in F ABMS no molecular ions corresponding 
to any complexed ions were found. 
When AgN03, dissolved in 1: 1 methanol/water, was added to ligand 3 dissolved in 
methanol, the reaction solution immediately darkened. Upon standing, metallic silver was 
deposited around the sides of the vial, and the solution was filtered to remove metallic 
material every 24 hours until no more precipitated, then concentrated to dryness in vacuo. 
TLC showed the presence of two main components, one of which was the starting material. 
An EI mass spectrum identified the second major component as the dimeric product, 1,1 ',2,2 '-
tetra(2-b enzoxazolyl)eth ene, (19), (Fig 2.25). Also identifiable were alcohol and ketone 
oxidation products of the methylene-bridge of the starting ligand. This type of reaction has 
been previously observed for both ligands 3 and 4.50a A possibility is that the silver acts to 
oxidise the methylene bridge in 3 to the corresponding ketone, which reacts via the 
Knoevengel reaction with another molecule of 3 to form the alkene 19. Alternatively, the 
silver ion could act as a one-electron oxidant inducing radical coupling. 
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Fig. 2.25 
Reacting AgN03 and 4 in refluxing methanol gave, after complete evaporation, 
needle-like crystals that analysed as [4.AgN03], (20), and some precipitated silver. The IH 
NMR spectrum of complex 20 in deuterated DMSO showed no difference from that of the 
free ligand, which indicated that the methylene bridge had not been oxidised. 
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Copper Complexes 
Reaction of stoichiometric amounts of ligand 1 with CuCb.2H20 in 
chlorofonnlmethanol gave purple cube-shaped crystals, (21), suitable for X-ray diffraction. 
The structure is shown in Fig. 2.26. 
Fig. 2.26 Perspective view, with atom labelling of the asymmetric unit, of 21. Selected bond 
lengths (A) and angles CO): Cu-N3 1.979(7), Cu-CI 2.261(2), N3-Cu-CI 88.7(2), C2-N3 
1.312(8), N3-C3 1.365(11), C3-C7A 1.414(11), C7A-01 1.355(11), 01-C2 1.346(1l),C2-N3-
C3 104.8(6), C2-01-C7A 104.7(5), C2-C2' 1.471(12), C2'-N3' 1.255(10), N3'-C3' 1.416(10), 
C3'-C7A' 1.417(12), C7A-01' 1.355(11), 01'-C2' 1.350(10) C2'-N3'-C3' 104.4(6), C2'-Ol'-
C7A'102.7(6). 
The complex crystallises in the monoclinic space group P2dc, with the copper atom 
lying on a centre of inversion. The full structure is a [2 + 1] complex, with monodentate 
coordination of the heterocyclic ligands. The geometry about the copper is square planar, 
with the N3-Cu distance being 1.979(7)A and the Cu-CI bond distance 2.261(2)A. The N3-
Cu-CI bond angle of88.7(2)0 defines the square planar environment of the copper. 
Interesting is the conformation of the ligand in this complex. The ligand is essentially 
planar, although slightly bowed, with a mean deviation from the plane of 0.086(1)A. The 
nitrogens of the coordinated and uncoordinated benzoxazole rings are cis, even though the 
ligand is only bound in a monodentate fashion. This is in contrast to the structure of the free 
ligand where the nitrogens are trans (see Fig. 2.3).55 The Cu-N3' distance of 3.082(7)A is 
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considered to be too long for a bonding interaction. Perhaps the reason for this confonnation 
is an attractive interaction between N3' of one ligand and H4 of the other, as the distance of 
2.806(7)A is indicative of a weak hydrogen bond. The reason the ligand is not chelating may 
be based upon a steric argument, where the ligand may be too large to satisfactorily arrange in 
a trans fashion around the copper. This would be due to a steric interaction between the H4 
protons that would result from this arrangement (Fig. 2.27). When two bpy ligands are in a 
trans arrangement around a metal atom, the ligands are significantly distorted from planarity, 
due to the interaction between their H6 protons. 79,80 As ligand 1 is larger than bpy, the H4 
protons would be placed even closer, and would not allow two chelate rings to fonn. 
Fig. 2.27 
The reaction of stoichiometric amounts of ligand 6 with CU(N03)2.3H20 in methanol 
gave large green block-shaped crystals, (22), one of which was cut and used for X-ray 
analysis. The structure is shown in Figure 2.28. 
Fig. 2.28 Perspective view, with atom labelling of the asymmetric unit, of 22. Selected bond 
lengths (A) and angles (0): NI-Cul 2.035(2), N2-Cu1 2.020(2), N1-Cu1-N2 78.8(1), 01-N2 
1.391(2), N2-C2 1.318(2), Ol-N2-C3 109.6(1), N2-01-C7A 106.2(1), N1-Cul-Ol1 85.16(6), 
N2-Cul-Ol1 82.34(6). 
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The structure is another [2 + 1J complex, and has crystallised in the triclinic space 
group P-l. By virtue of the centre of inversion about CuI, the rings of each ligand are trans 
with respect to each other in the complex. The ligand is chelating through N1 of the pyridine 
ring and N2 of the benzisoxazole, and is essentially planar, with a mean deviation from the 
plane of O.080(3)A. This supports the conclusion reached for complex 13 where the rings of 
the ligand are not tilted with respect to each other due to a steric interaction between H3' and 
H4. The bond lengths of the coordinating nitrogens are Nl-Cul 2.035(2)A and N2-Cul 
2.020(2}A with a bite angle N1-Cu1-N2 of 78.8(1)°. Two nitrate counter ions, each bound 
via an oxygen atom, complete the Jahn-Teller tetragonally distorted coordination sphere. 
A search of the Cambridge Crystallographic Database revealed that this is the fIrst 
reported X-ray crystal structure of a benzisoxazole-containing coordination complex. 
Structurally, this complex is very similar to one published in 1994 by Battaglia et ai. 81 with 
the related ligand 4-(2-pyridyl)-1,2,3-triazolo[1,5-aJpyridine. A pictorial representation of 
this complex is shown in Fig. 2.29. 
Fig. 2.29 
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2.4 Summary 
In this chapter, four new ruthenium complexes were synthesised and investigated by a 
combination of IH NMR, !3e NMR, UV-visible spectroscopy, cyclic voltammetry and X-ray 
crystallography. The results of these investigations proved that the heteroaromatic 
benzoxazole, benzisoxazole and benzothiazole rings lead to different properties for the 
Ru(bpYhL2+ complexes when compared to Ru(bpY)32+, Electrochemically, the benzoxazole 
and benzothiazole rings have a much lower reduction potential than bipyridine in the 
ruthenium complexes prepared. The irreversible first reduction of [Ru(bpyh(6)](PF6h (13) 
may indicate that the N-O bond in ligand 6 is electrochemically unstable. However, 6 was 
shown to be a useful chelating ligand, in what appears to be the first investigation of a ligand 
containing a 1,2-benzisoxazole component. 
The ligands 2,2'-methylenebisbenzoxazole (3) and 2,2'-methylenebisbenzothiazole (4) 
have acidic methylene bridges due to the electron-withdrawing nature of the heterocyclic 
rings, This was evidenced by the conversion of ligand 3 to its deprotonated fonn when 
chelated to the ruthenium centre. This phenomenon has potential uses in the pH control over 
properties of complexes. This has been accomplished with other acidic hydrogens attached to 
nitrogen in pyrazole,46 imidazole,82 triazole,83,84 and tetrazole rings.9 
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Chapter 3 
Benzotriazoles 
3.1 Introduction 
In this chapter, the complexity of the heterocyclic ring system being examined has 
increased. Benzotriazole has a five-membered ring containing three heteroatoms, all of which 
are nitrogen, fused to a benzene ring. The ring system and ring numbering for benzotriazole 
itself are shown in Fig. 3.1. The coordination chemistry ofbenzotriazole and its deprotonated 
form, the benzotriazolate anion, has been thoroughly explored and reviewed. 85 A notable 
feature of both the protonated and deprotonated forms is their ability to coordinate to more 
than one metal ion. For example, the benzotriazolate anion has been shown to be able to 
coordinate to three metal centres via its three nitrogen atoms,85 as depicted schematically in 
Fig. 3.2. 
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Benzotriazole-containing ligands can be substituted in the 1- or the 2-position of the 
triazole ring. The coordination chemistry of I-substituted benzotriazoles has also been 
explored and, in particular, I-methylbenzotriazole has been examined in some detail by a 
group of Greek chemists.86a-e In general, the results of these investigations show that the N3 
nitrogen atom of I-methylbenzotriazole is the preferred, although by no means exclusive, 
nitrogen for coordination. 
45 
There has been some study of mononuclear iron87 and ruthenium88 complexes with 
benzotriazole, and more recently the electronic properties of a dinuclear ruthenium complex 
containing a benzotriazolate bridge has been examined.89,90 The focus of this study is 
multidentate ligands, containing benzotriazoles substituted in the I-position, that are capable 
of a chelating coordination mode. Ligands of this type have been little studied. However, the 
benzotriazolylborates represent a class of ligands that have been used in coordination 
chemistry. A molybdenum complex containing a tripodal tridentate tris(benzotriazol-I-
yl)borate ligand has been characterised crystallographically,91 and a pictorial representation of 
the complex is shown in Fig. 3.4a. The coordination chemistry of a bis(benzotriazol-I-
yl)borate ligand has been investigated with ruthenium(II)92 and more recently with 
rhodium(I).93 The authors found that this ligand could bind in a chelating fashion through the 
N2 nitrogen atoms, as shown in Fig. 3 Ab. It is instructive to note that a chelating relationship 
is impossible with the I-substituted benzotriazole ligands for the present study when 
coordination occurs through the N3 atom. If this type of coordination occurred, the ligand is 
acting in a divergent manner, and would act as a bridge between different metal ions (Fig. 
3.5). 
Fig.3.4a Fig.3.4b 
Fig. 3.5 
One of the ligands in this study, I, I '-bibenzotriazole, (23), has a structural similarity to 
I, I '-biisoquinioline (biq). Upon chelation, biq is non-planar, due to the steric interaction 
between the H8 and H8' protons (Fig. 3.6). As a result, the coordinated ligand becomes 
chiral. In crystal structures of metal complexes involving this ligand, the rings of the ligand 
are splayed at ca. 37°,94,95 In RU(bPY)22+ and Os(bpY)l+ complexes, where because of the 
existing chirality, the resultant complexes with biq are diastereoisomeric. Furthermore, due to 
the fact that NMR differentiates the diastereomers, their existence was seen in 1 H NMR 
spectra, and the mechanism of interconversion between the diastereomeric forms was 
determined.96-98 We wondered if this type of steric interaction between the H7 and HT 
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protons would exist for 23 upon N2,N2 '-chelation. It was also decided to prepare the hybrid' 
ligand 1-(1-isoquino1y1)benzotriazole, (29), and explore its potential for this interaction. 
23 biq 29 
Fig. 3.6 
The present study concerns the synthesis, characterisation, and electronic properties of 
a group of mononuclear ruthenium complexes bearing benzotriazole-containing ligands. Also 
investigated is the supramolecular chemistry of the ligands with copper(II), silver(I) and 
palladium(II) . 
3.2 Syntheses of Ligands 
1,1 '-Bibenzotriazole (23) was prepared in two steps, following reported literature 
preparations, which are summarised in Scheme 3.1. 
23 
Scheme 3.1 
1,2-Diaminobenzene was oxidised to 2,2'-diaminoazobenzene via the method of 
Carboni et al. 99 and that of Ortiz et al.; 100 however, the workup was changed in either case to 
that described by Skrabel et al. lOl Diazotisation of 2,2 '-diaminoazobenzene by sodium nitrite 
in dilute hydrochloric acid, followed by reductive cyclisation using S02, as described by 
Harder et al., 102 gave 23 in 40% yield from this reaction. 
In the lH NMR spectrum of ligand 23 it was noticed that one of the two doublets was 
considerably upfield, at a chemical shift of 7.33 ppm. This signal was proposed to be due to 
the H7 protons, and this was confirmed by a GHSQC experiment. It seemed that the 
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benzotriazole rings of the biheterocycle were mutually shielding the H7 proton of the other 
ring. It was therefore of interest to study the conformation of this molecule in the solid state 
by single crystal X-ray crystallography. Crystals suitable for a structural study were grown 
by slow evaporation from an ethyl acetate solution of the compound. The structure is shown 
in Fig. 3.7. 
Fig. 3.7 Perspective view, with atom labelling of the contents of the asymmetric unit, of 23. 
Selected bond lengths (A) and angles (0): NI-N2 1.368(4), N2-N3 1.306(4), NI-N2-N3 
107.1(3), C3A-C7A 1.397(5), C7A-NI 1.379(4), N2-NI-C7A 127.9(3), NI-NI' 1.366(4), 
NI'-N2' 1.392(4), N2'-N3' 1.294(4), NI'-N2'-N3' 107.5(3), C3A'- C7A' 1.389(5), C7A'-NI' 
1.378(4). 
The ligand crystallises in the chiral orthorhombic space group P21212t, with the 
asymmetric unit containing one full molecule. The bond lengths and bond angles of the rings 
are all within the range found previously for a I-substituted benzotriazole. 103,104 Of interest is 
the NI-NI' bond length in this molecule as this distance has not been determined previously. 
From the X-ray analysis the value of 1.366(4)A has been determined. Both rings of the ligand 
are planar (mean deviations from the plane of 0.005(1)A for both rings), and are very nearly 
orthogonal to each other [84.5(1)°] (Fig. 3.Th). Surprisingly, the ligand has not adopted the 
trans coplanar conformation (Fig. 3.8), where there are two attractive intramolecular 
hydrogens bonds from the N2 nitrogens to the H7 hydrogens of the other ring. Also this 
conformation would maximise conjugation over the molecule. 
Fig.3.7b 
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Fig. 3.8 
This molecule demonstrates interesting molecular packing in the crystal structure, 
with 7t-7t stacking along each of the three axis of the unit cell, as well as intermolecular 
hydrogens bonds from within a sheet. For example, along the a-axis the planar aromatic rings 
of the ligand stack in a head to tail manner, with the closest distance between the stacks being 
3.475(5)A. A perspective view along the a-axis is shown in Fig. 3.7c, which also shows the 
intermolecular hydrogen bond between the H6 proton of one benzotriazole and the N3 
nitrogen of a different ligand within the same sheet [2.463(3)A]. A reason that the molecule 
has not adopted the coplanar conformation of Fig. 3.8 may be that the effect of the extended 
7t-7t stacking outweighs the stability of conjugation gained by coplanarity. 
Fig. 3.7c View ofthe molecular packing along the a-axis in the crystal structure of23. 
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1,1 '-Methylenebisbenzotriazole (24) was synthesised via a phase-transfer catalysed 
(PTC) reaction. Benzotriazole and diiodomethane were refluxed in a mixture of benzene and 
40% aqueous NaOH, with tetrabutylammonium hydroxide as catalyst, as shown in Scheme 
3.2. 
TetrabutylammoniwII hydroxide Q~ 
40% aq. NoOH _ N{ ~N . 
Benzene 
-------- N" ~N-JN {/ ~ N _ 
24 
Scheme 3.2 
This reaction produced a 6:4:1 ratio of isomers 24, 1,2'-methylenebisbenzotriazole 
(25) and 2,2'-methylenebisbenzotriazole (26), respectively (Fig. 3.9). Ligand 24 had 
previously been prepared via a PTC reaction described by Avila et ai., 105 who also obtained a 
similar product ratio. Recrystallisation from toluenelhexane gave pure 24 in 27% yield. 
·9 ~N J? II :-, I N-N N-N ) ) Nt I (XN (XN\ ~N\N_l-N ~ I ~~ ~ I ~/N ~ "'d 
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Fig. 3.9 
Some ligands containing only one benzotriazole ring were also prepared, viz 1-(2-
pyridyl)benzotriazole, (27), 1-[(2-pyridyl)methylJbenzotriazole, (28), and 1-(1-
isoquinolyl)benzotriazole, (29) (Fig. 3.10). 
9- ~ cy. (XN (XN\ (XN\ ~ I ~r ~ I ~/ ~ I N'/N 
27 28 29 
Fig. 3.10 
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1-(2-Pyridyl)benzotriazole (27) was synthesised following the method of Katritzky,106 
except that 2-chloropyridine was used in place of 2-bromopyridine (Scheme 3.3). This 
resulted in a lower yield (67%) than that obtained with the bromopyridine (99%). 
Toluene 
Scheme 3.3 
1-[(2-Pyridyl)methyl]benzotriazole (28) was synthesised via a PTC reaction, with 
identical conditions to that described above for ligand 26, as shown in Scheme 3.4. 
Tetrabutylammonium hydroxide 
40%aq.NaOH 
~ Benzene ~~CI--------
.HCI 
Scheme 3.4 
A 1 H NMR spectrum of the crude reaction mixture revealed a 10: 1 ratio of products 
28 and 2-[(2-pyridyl)methyl]benzotriazole, (30). Recrystallisation from toluene gave pure 28 
in 45% yield. Ligand 28 has previously been made by other methods. 107 
The synthesis of l-(1-isoquinolyl)benzotriazole (29) was based on the method used to 
produce 27, as shown in Scheme 3.5. 
Toluene 
29 
Scheme 3.5 
l-Chloroisoquinoline was synthesised from isoquinoline by hydrogen peroxide 
oxidation in acetic acid, followed by chlorination in refluxing phosphorus oxychloride. The 
reaction of benzotriazole with l-chloroisoquinoline in refluxing toluene produced the new 
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ligand 29 in 70% yield after recrystallisation. Ligand 29 was characterised by melting point, 
IH and BC NMR spectroscopy, EI mass spectrometry and elemental analysis. 
NMR assignment of29. 
A large part of the work described in this thesis involves the detailed analysis of IH 
NMR spectra of ruthenium complexes, particularly the changes in chemical shifts that 
coordination induces. To record the coordination induced shifts due to complexation, it is 
crucial that the signals of the ligand are correctly assigned. For this reason, it was important 
to assign totally the IHNMR spectrum of29. 
To a fIrst approximation, the IH NMR spectrum of 29 contains 10 different signals for 
the 10 different protons in the molecule, comprising 6 doublets and 4 triplets. The IH NMR 
spectrum of 29 is shown in Fig. 3.11. Nine different signals are observed in the spectrum. 
One signal, at ca. 7.8 ppm, can be recognised as the overlap of one doublet and one triplet. 
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Fig. 3.11 IH NMR spectrum of29. 
The fIrst step in the IH NMR assignment was to separate the protons into their 
respective spin systems. This was done by 1-D TOCSY. Two four-spin systems were found 
with the expected doublet, triplet, triplet, doublet splitting pattern of 1 ,2-disubstituted benzene 
rings. These are at 8.21, 7.49, 7.61, 8.08 and 7.99, 7.81, 7.71, 8.60 ppm, which left two 
doublet signals at 8.58 and 7.82 ppm which must be H3' and H4' of the isoquinoline ring. 1-D 
TOCSY only gives an order around the ring, it does not allow the full assignment unless prior 
information, such as chemical shift or coupling constants, can positively identify one of the 
protons. What remained was to resolve which system belonged to the benzotriazole and 
which belonged to the isoqumoline, as well as obtaining the correct order around the rings. 
To accomplish this, one positive assignment for each system identifIed was needed. The 
benzotriazole ring system has a distinctive chemical shift for the C7 carbon at ca. 110 ppm. 
The identification of the proton signal belonging to C7 would allow the distinction of the 
benzotriazo1e vs isoquinoline four-spin proton system, and then allow for the correct 
assignment ofthe order around the benzotriazole ring from the I-D TOCSY. 
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A l3C NMR experiment was performed, with all 15 signals recorded. The signal of 
C7 was at 112.89 ppm, well separated from other signals in the spectrum. The next step was 
to correlate the protons to their respective carrier carbons by means of a GHSQC experiment. 
In the GHSQC spectrum, shown in Fig. 3.12, a correlation from the C7 carbon signal to the 
signal at 8.08 ppm in F2 identified H7 of the benzotriazole system, and so, the order and 
assignment of this ring was complete. The signals for the protons of the benzene isoquinoline 
ring are at 7.99, 7.81, 7.71 and 8.60 ppm. It seemed likely that the signal at 8.60 ppm was 
that of H8', based upon it being de shielded by the lone pair on N2 of the benzotriazole, 
implying the conformation was trans about the inter-ring bond with respect to N2 and N2' 
(Fig. 3.13). Based upon this assumption, the order around the isoquinoline ring was 
determined. 
Fig. 3.13 
Since the GHSQC spectrum allowed the assignment of all protonated carbons, the 
only other carbons to be assigned were quaternary. Comparison of the l3C NMR spectrum of 
29 with similar molecules allowed assignments of the quaternary carbons based upon 
chemical shift. For instance, C4A' (138.87 ppm) and C8A' (122.84 ppm) of the isoquinoline 
ring and C7A (133.37 ppm) of the benzotriazole were identified by comparison with 
isoquinoline108 and with 27. The only ambiguities which remained were the assignment of 
C l' and C3A to the remaining signals at 145.93 and 148.18 ppm. To resolve these, a 
GHMBC experiment was performed, and this was also used to confirm many of the 
assignments already made, particularly for H8', where in the GHMBC spectrum it should 
correlate to C4A'. 
In the GHMBC spectrum, shown in Fig. 3.12, the signal from 8.60 ppm in F2 
correlates to the C4 A' carbon at 138.87, thereby confirming the proposal that this signal is H8. 
The ambiguity over C 1 ' and C3A is also resolved from the correlations from the identified H7 
and H5 protons to C3A, and the correlations from H3' and H8'to Cl'. 
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Fig. 3.12 GHSQC (top) and GHMBC spectra (bottom) of29. 
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Fig. 3.14 I3 C (and IH NMR) chemical shifts for 29 in deuterated chlorofonn solutions. 
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3.3 Ruthenium Complexes 
3.3.1 Synthesis and 1 H NMR 
The reaction ofligand 23 with Ru(bpY)2Ch in 3:1 ethanol/water gave a dark coloured 
complex, in good yield, that was isolated as a hexafluorophosphate salt. This complex was 
found, by FABMS, to contain a coordinated chloride anion, as well as the ligand, and so was 
fonnulated as [Ru(bpY)2(23)Cl](PF6), (31) (Fig. 3.15). Characterisation of this complex by IH 
NMR was aided by some easily identified signals in the spectrum (Fig 3.16). The proximate 
chlorine relationship described in Chapter 2 (Fig 2.15) was identified by the chemical shift of 
the bpy H6 at 10.18 ppm. Other signals that were recognised by their chemical shift were a 
downfie1d benzotriazole H4 at 9.12 ppm, which is also de shielded by the proximate chlorine, 
and another downfie1d bpy H6 at 9.04 ppm, which was assigned to the bpy H6 that resides 
over the coordinated benzotriazole ring (Fig 3.15). These signals provided an excellent 
starting point for characterisation by 1 H NMR, and allowed some detennination of the 
confonnation of the ligand in the complex. Irradiation of these and other signals in 1-D 
TOCSY experiments provided the chemical shifts of all the protons in the spectrum. As the 
bpy H3 signals are well separated in the spectrum, it was possible, by IH nOe experiments, to 
find the partner H3 proton of each bpy. In this manner, it was possible to assign totally the IH 
NMR spectrum of 31. 
Fig. 3.15 
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Fig. 3.16 IH NMR spectrum of [Ru(bpY)2(23)CI](PF6) (31). 
The chemical shifts and coordination induced shifts for complex 31 are given in Table 
3.1. The only proton that experiences a significant CIS is H4 of the coordinated 
b enzotriazo Ie. For H4 to experience such a large positive CIS (+0.78 ppm), the coordinated 
benzotriazole ring must lie as shown in Fig. 3.15, where H4 is proximate to the chlorine atom. 
Importantly, the benzotriazole is postulated to be coordinated via the N3 nitrogen. If it were 
coordinated via N2, some of the signals of the uncoordinated ring would be expected to 
experience larger CIS, as was the case in the example in Chapter 2, viz complex 
[Ru(bpY)2(1)Cl](PF6) (8). The complex 31 is converted to [Ru(bpY)2CI(CH3CN)](PF6)2 in 
acetonitrile solution, and some of the signals for this complex are seen in the above spectrum 
as the small signals present. 
Table 3.1 1H NMR Chemical ShiftsB and Coordination Induced Shiftsb for 31 and 23. 
H4 H5 H6 H7 H4' H5' H6' H7' 
31 9.12 7.65 7.78 7.57 8.36 7.70 7.80 7.53 
23c 8.34 7.70 7.78 7.53 
CIS +0.78 -0.05 0 +0.04 +0.02 0 +0.02 0 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex - Origand). C The free ligand in solution 
has 2-fold symmetry; hence H4= H4' etc. 
The 3: 1 ethanol/water conditions were also used in the reaction of ligand 24 with 
RU(bPY)2Clz. Again, a dark hexafluorophospate salt was obtained, in remarkably similar yield 
(82%) to complex 31, and this was shown also by FABMS to contain a coordinated chlorine 
and was formulated as [Ru(bpy)z(24)Cl](PF6), (32). In the same manner as for the previous 
complex, the IH NMR spectrum of complex 32 could be totally assigned by I-D TOCSY and 
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IH nOe spectroscopy. The chemical shifts and coordination induced shifts for complex 32 are 
listed in Table 3.2. 
Table 3.2 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 32 and 25. 
H4 H5 H6 H7 H4' H5' H6' H7' CH2 
32 8.88 7.47 7.71 8.07 8.10 7.45 7.68 7.78 7.57 
25c 8.05 7.46 7.67 8.00 7.43 
CIS +0.83 +0.01 +0.04 +0.07 +0.05 -0.01 +0.01 -0.22 +0.14 
a For deuterated acetonitrile solutions. b CIS = (8complex - 8ligand). c The free ligand in solution 
has 2-fold symmetry; hence H4= H4' etc. 
As was the case in the previous example, the ligand again acts in a mono dentate 
fashion. The coordinated benzotriazole H4 experiences a similar CIS (+0.83) to that of 
complex 31 (+0.78), and thus, the ligand was assumed to be acting in the same mode ofN3 
coordination. The only other notable CIS value is that ofH7'. The CIS of -0.22 ppm suggests 
that somehow H7' experiences some shielding. This shielding is most likely due to ring-
current anisotropy. However, exactly which ring is shielding H7' was unable to be 
determined. A IH nOe experiment irradiating H7' gave an enhancement of H6', as expected, 
but no enhancement of any other protons in the complex. A possibility is that the shielding is 
from the benzene ring of the other benzotriazole, where the uncoordinated benzotriazole ring 
has 'folded under' the coordinated ring (Fig. 3.17). 
Fig. 3.17 
Since complexes containing chelating benzotriazole ligands were desired, the reaction 
conditions were altered to encourage chelation. The RU(bPY)2Ch complex was treated with 
two equivalents of AgBF4 in acetone/ethanol before addition of the ligands 23 and 24. Now, 
the corresponding reaction solutions were bright orange, instead of the dark purple colour of 
the ethanol/water reactions. Thus, it was hoped that the chelating complexes 
[Ru(bpY)2(23)](BF4b (33), and [Ru(bpY)2(24)](BF4)2, (34), (Fig. 3.18) had been formed. 
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Fig. 3.18 
Characterisation was attempted by IH NMR spectroscopy, in deuterated acetonitrile, 
for the product from the reaction with ligand 23. The IH NMR spectrum of the complex 
showed changes when the complex was left in solution for a short time, indicating that ligand 
substitution was taking place, presumably with acetonitrile solvent replacing another ligand in 
the complex. IH NMR characterisation was then attempted in deuterated dichloromethane, a 
less nucleophilic solvent. The resulting IH NMR spectrum showed the presence of some 
monodentate impurity. However, some signals due to the chelating complex 33 could be 
assigned, including those of the bibenzotriazole ligand. The signals of the ligand were found 
via I-D TOCSY and recognised by the absence of a bpy H6, with its characteristic small 3-
bond coupling constant. The chemical shifts and coordination induced shifts detennined for 
complex 33 are listed in Table 3.3. 
Table 3.3 IH NMR Chemical Shifts a and Coordination Induced Shiftsb for 33 and 23. 
H4 H5 H6 H7 
33 7.87 7.70 7.70 7.23 
23 8.34 7.70 7.78 7.53 
CIS -0.47 0 -0.08 -0.30 
a For deuterated dichloromethane solutions. b CIS = (8complex - 81igand). 
Proton H4 shows the effect of ring-current anisotropy from the adjacent pyridine ring, 
as expected, with the CIS value of -0.47. The explanation for the negative CIS ofH7 and H6 
is also as a result of ring-current anisotropy, this time not from a pyridyl ring, but from the 
other benzene ring of the bibenzotriazole. Due to the cisoid nature of N2,N2 '-chelation, the 
H7 protons are brought into an environment where they undergo a mutual steric interaction. 
To alleviate this steric interaction the rings of the ligand do not lie in the same plane, rather, 
they lie over one-another. As a result, the H6 and more so the H7 proton of each ring is 
shielded by ring-current anisotropy from the other benzene ring, and this is reflected in the 
larger negative CIS value of H7 relative to H6. As mentioned previously, this phenomenon 
has been reported for complexes of I, I '-biisoquinoline. 94-98 
F ABMS showed that the mono dentate impurity was most likely the mono aqua 
complex [Ru(bpY)z(23)OHzJ(BF4)z, as molecular ions were identified in the mass spectrum 
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for [RU(bPY)2(23)OH2](BF4t and [RU(bPY)2(23)OHt. This complex, of course, could be 
formed in the reaction or from the chelating complex 33, as a result of ligand labilisation with 
subsequent substitution by adventitious water from the solvent. This result may, however, 
explain the result of the .IH NMR in deuterated acetonitrile, where the above monoaqua 
complex is converted to the complex [RU(bPY)2(OH2)(CH3CN)] (BF4)2. No attempts were 
made at stringent exclusion of water from the reaction conditions or NMR solvents, and 
further efforts at separation and purification of the reaction products proved futile. 
[RU(bPY)2(24)] (BF4)2, (34), was able to be separated and purified by column 
chromatography on alumina, albeit with some loss, after the AgBF4 method, and was able to 
be characterised by FABMS, elemental analysis and lH NMR spectroscopy. Complex 34 is 
2-fold symmetric, and thus only gives rise to 12 aromatic signals in the IH NMR spectrum, 
corresponding to the three different aromatic rings. In the IH NMR spectrum, the protons of 
the methylene bridge appear as a singlet, implying that there is rapid interconversion between 
boat conformers on the NMR timescale. The three different aromatic rings were identified by 
l-D TOCSY, and that of the benzotriazole-containing ligand was distinguished as it does not 
contain the doublet of smaller coupling constant (bpy H6). One of the pyridine rings in 34 
has its H6 further downfield than the other (8.27 ppm vs 7.84 ppm) and this was postulated to 
be the H6 proton that lies over the benzotriazole ring. The reason for this assignment was that 
the triazole ring being less aromatic than pyridine would shield this H6 proton less, and that 
the down field position of the H6 proton would reflect this decrease in ring-current anisotropy. 
Confirmation that this downfield proton was over the benzotriazole was provided by a IH nOe 
experiment irradiating the signal for the methylene bridge. This experiment also provided 
information about the order around the benzotriazole ring. The relevant 'H NMR data are 
listed in Table 3.4, and show that proton H4 experiences a small effect of ring-current 
anisotropy from the adjacent pyridine ring, and moves upfield upon chelation (CIS -0.21). 
Table 3.4 IHNMR Chemical Shiftsa and Coordination Induced Shiftsb for 34 and 24. 
H4 H5 H6 H7 Cll2 
34 7.84 7.51 7.76 8.04 7.43 
24 8.05 7.47 7.67 8.00 7.57 
CIS -0.21 +0.04 +0.09 +0.04 -0.14 
a For deuterated dichloromethane solutions. b CIS = (Ocomplex - Oligand). 
The results thus far indicated that the N3 nitrogen atom of the benzotriazole was the 
stronger donor in the l,l-substituted ligands 23 and 24, as it was coordinating preferentially. 
Only by eliminating the chloride ion were the ligands encouraged to act in a chelating 
manner. 
It was hoped that the influence of the pyridine and isoquinoline nitrogens would 
encourage chelation with the ligands 27, 28, and 29. This was shown to be so by the relative 
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ease of synthesis of chelating mononuclear ruthenium complexes with these ligands. Using 
the 3: 1 ethanol/water method, and only relatively short reflux times, chelating mononuclear 
ruthenium complexes [RU(bPY)2(27)](PF6b (35), [RU(bPY)2(28)] (PF6)2, (36), and 
[RU(bPY)2(29)](PF6)2, (37), (Fig. 3.19) were formed in good yields (Table 3.5). FABMS and 
elemental analyses were correct for each of these complexes. 
Table 3.5 
I Reflux Time (Rrs) Yield (%) 
[RU(bPY)2(27)](PF6)2 (35) I 4 88 
[RU(bPY)2(28)](PF6)2 (36) . 5 77 
[Ru(bpy)z(29)](PF6)2 (37) I 15 87 
Fig. 3.19 
Each of these chelating complexes has, because of the unsymmetrical nature of the 
benzotriazole-containing ligand, no internal symmetry. This meant that the IH NMR spectra 
of complexes 35 and 36 would contain 24 different aromatic protons signals, while complex 
37 would contain two more, giving 26 different aromatic proton signals in the IH NMR 
spectrum. Despite this complexity, the signals due to the benzotriazole-containing ligand 
were unambiguously assigned for 35 and 36. Complex 37 provided a particularly challenging 
example for characterisation by IH NMR and total assignment was accomplished using 1- and 
2-D NlVIR techniques. The following describes the NMR characterisation and interpretation 
of these complexes. 
The situation faced for identifying the signals due to the ligand in complex 35 are the 
same as those described for complex 13 in Chapter 2. The IH NMR spectrum for complex 35 
contains 24 different aromatic proton signals, 20 of which are due to 2-substituted pyridyl 
rings. However, fortunately, the same strategy of identifying the non-pyridyl ring in the 
complex and, by IH nOe, identifying the H3 proton of the pyridyl ring of the benzotriazole-
containing ligand, was successful. The chemical shifts and coordination induced shifts are 
listed in Table 3.6. Further assignment of the bpy ligands was not attempted, because the 
signals for these were highly overlapped in the spectrum. 
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Table 3.6 lH NMR Chemical Shifts3 and Coordination Induced Shiftsb for 35 and 27. 
H4 HS H6 H7 H3' H4' HS' H6' 
35 8.0S 7.71 7.91 8.40 8.S7 8.32 7.S1 7.84 
27 8.16 7.S6 7.72 8.69 8.30 8.09 7.47 8.68 
CIS -0.11 +O.IS +0.19 -0.29 +0.27 +0.23 +0.04 -0.84 
a For deuterated acetonitrile solutions. b CIS = (bcomplex - bligand). 
Rationalisation of the CIS values of complex 35 are again based upon shielding 
arguments and a combination of a-donation and back-bonding effects. The H6' and H4 
protons are shielded by their respective adjacent pyridine rings of different bpy ligands, 
although H6' is shielded much more as it is closer. The chemical shift of H7 in the free ligand 
(8.69 ppm) suggests that the pyridine nitrogen is deshielding it. Upon chelation, the 
coordination induced confOlmational change of the ligand places H7 in a less deshielded 
environment, and the proton moves upfield (CIS -0.29 ppm). This is consistent with the CIS 
of H3', which moves downfield upon chelation. Proton H4' shows a positive CIS, which 
reflects a mixture of the a-donation of the pyridine to the metal, which shifts the proton 
downfield, and the back-bonding ability of the ring, which accepts electron density from the 
metal, moving the proton upfield. It is this trade-off which determines the CIS of the H4 
proton in ruthenium complexes, and typically, the CIS is +0.2 - +0.3. Interestingly the 
chemical shifts of HS and H6 show smaller positive CIS, which perhaps indicates that the 
benzotriazole ring is accepting electron density from the metal. 
In the reaction of ligand 28 with RU(bPY)2Ch some monodentate product, 
[Ru(bpY)2(28)Cl](PF6), (38), (Fig. 3.20), was also formed in low yield (14%). This was 
separated by chromatography, and identified by lH NMR to be coordinated via N3 of the 
benzotriazole. This assignment is based on the CIS value (Table 3.7) of the benzotriazole H4 
and the pyridyl H3', which are both similar to those observed for the H4 and HT protons, 
respectively, of the complex [Ru(bpY)2(25)CI] (PF6) (33). As was the case for the 
mono dentate complexes 31 and 32, all the protons of complex 38 could be assigned to spin 
systems by way of I-D TOCSY. Also, since there exists sufficient separation in the chemical 
shifts of the bpy H3 's, 1 H nOe experiments allowed the complete 1 H NMR assignment of 
complex 38. 
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Table 3.7 IH NMR Chemical Shifts a and Coordination Induced Shiftsb for 38 and 28. 
H4 H5 H6 H7 H3' H4' H5' H6' CH2 
38 8.84 7.40 7.57 7.72 6.97 7.72 7.32 8.42 5.72 
28 8.08 7.37 7.45 7.57 7.25 7.62 7.23 8.53 6.04 
CIS +0.76 +0.03 +0.12 +0.15 -0.28 +0.10 +0.09 -0.11 -0.32 
bpyH3 bpyH4 bpyH5 bpyH6 
8.28 8.01 7.71 10.19 
8.14 7.72 7.11 7.87 
8042 7.86 7.23 7.79 
8.53 8.09 7.56 8.90 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex - Oligand). 
The IH NMR spectrum of [Ru(bpY)2(28)](PF6)2' (36), is shown in Fig. 3.21. Of note 
is the appearance of the methylene bridge. In this unsymmetrical complex, the protons of the 
bridge are non-equivalent and close in chemical shift, and so split to form an AB-quartet. 
This was used to advantage for further IH NMR assignment. Irradiation of these signals in IH 
nOe experiments allowed the identification of the H3' and H7 protons of the ligand, which, 
coincidentally, both occur at the same chemical shift of 8.00 ppm. These experiments also 
identified the pyridine ring that is close to the axial proton of the bridge (Fig. 3.21). 
Furthermore, from the nOe's obtained, the axial and equatorial protons could be distinguished. 
Fortunately, in this chelating complex, the bpy H3 signals were sufficiently isolated to allow 
for IH nOe experiments to identify the pyridyl partners that make up the bpy ligands giving a 
complete assignment. The IH NMR data for 36 are listed in Table 3.8. 
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Fig. 3.21 IH NMR and IH nDe spectra of [Ru(bpY)2(28)](PF6)2 (36). 
Table 3.8 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 36 and 28. 
H4 H5 H6 H7 H3' H4' H5' H6' CH2 
36 7.80 7.51 7.71 8.00 8.00 7.97 7.25 7.70 5.91/6.13 
28 8.08 7.37 7.45 7.57 7.25 7.62 7.23 8.53 6.04 
CIS -0.28 +0.14 +0.26 +0.43 +0.75 +0.35 +0.02 -0.83 -0.13/+0.10 
bpyH3 bpyH4 bpyH5 bpyH6 
8.50 8.19 7.64 8.58 
8.40 8.05 7.43 7.77 
8.66 8.20 7.49 7.96 
8.62 7.97 7.25 7.70 
a For deuterated acetonitrile solutions. b CIS = (Ocornplex - Oligand). 
The negative CIS values of H4 and H6' are a result of shielding from the adjacent 
pyridine rings, again as H6' is closer it has a larger value. Proton H4' has a CIS value of 
+0.35, which suggests either a larger amount of cr-donation or a smaller amount of back-
bonding to this ring than is usual. Also the benzotriazole shows significant positive CIS 
values for H6 and H5. This seemed to indicate that there might be a synergistic effect 
between the rings of the ligand. If the pyridine ring was accepting a smaller amount of back-
bonding then perhaps this was because the benzotriazole was accepting more. The large 
positive CIS values for H3' and H7 are as a result of the coordination induced conformational 
change of the ligand. These two protons have been brought close together upon the ligand 
chelating to the ruthenium atom and are mutually deshielded. 
Potentially, complexes of ligand 29 are capable of atropisomerism. When the ligand 
is chelating through the isoquinoline nitrogen and the N2 nitrogen of the benzotriazole, the 
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H7 and H8' protons are placed in an environment of high steric compression and, because of 
this, the rings may lie over one-another. In order to ascertain whether the rings of the ligand, 
in the complex 37, were lying over one-another the identification of the signals due to the 
ligand was essential. 
The signals due to H7 and H8' should be the most sensitive to the effects of 
atropisomerism. If the rings lie over one-another these protons should be shielded, whereas if 
the rings are coplanar they should be mutually deshielded. The lH N1VIR spectrum of 
complex 37 is shown in Fig. 3.22. The first thing of note is that there is no evidence of 
diastereoisomers in the spectrum, as two discrete sets of signals would be observed. This 
indicates that any such isomers must undergo rapid interconversion on the NMR timescale. 
In the approach taken for most of the ruthenium complexes, I-D TOCSY was used to 
distinguish signals to as many different ring systems as possible. The identification of five 
1,2-disubstituted rings and the identification of the two doublets (H3' and H4) of the 
isoquinoline was accomplished from l-D TOCSY. A number of the rings could be easily 
assigned to the pyridyl rings of the bpy ligands, as they contained a doublet of smaller 
coupling constant. One, however, did not contain the doublet of smaller coupling constant, 
and so was either the benzotriazole or the isoquinoline. To identify this ring, the same 
strategy of correlating the H7 proton of the benzotriazole to its carrier carbon was used. The 
GHSQC spectrum of complex 37 is also shown in Fig. 3.22. The C7 carbon at 113.91 ppm 
gives a correlation to a signal at 8.07 ppm, which is one of the non bpy ring protons found via 
1-D TOCSY, and so the benzotriazole ring was identified and assigned. This left only the 
protons of the isoquinoline four-spin system to be assigned. The chemical shift of proton H5' 
(8.25 ppm) was identified by irradiation of H4' in a IH nOe experiment. This signal is 
partially overlapped with a signal from a bpy H4 (c.o.m. 8.22 ppm), yet by selective 
irradiation of H5' and cancellation of the previously identified bpy ring, the signals due to the 
isoquinoline ring were definitively assigned. 
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Fig. 3.22 IH NMR and GHSQC spectra of [RU(bPY)2(29)](PF6)2 (37). 
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Table 3.9 IHNMR Chemical Shiftsa and Coordination Induced Shiftsb for 37 and 29. 
H4 H5 H6 H7 H3' H4' H5' H6' H7' H8' 
37 8.04 7.70 7.81 8.07 7.60 7.94 8.25 8.10 8.08 8.58 
29 8.24 7.60 7.71 8.03 8.62 8.05 8.17 7.94 7.79 8.39 
CIS -0.20 +0.10 +0.10 +0.04 -1.02 -0.11 +0.07 +0.16 +0.29 +0.19 
bpyH3 bpyH4 bpyH5 bpyH6 
8.57 8.12 7.34 7.90 
8.56 8.10 7.37 8.03 
8.58 8.19 7.50 7.82 
8.62 8.22 7.55 7.88 
a For deuterated acetonitrile solutions. b CIS = (8cornplex - 8 ligand). 
The CIS values of 37 can again be rationalised in a combination of through-space 
ring-current anisotropy and cr-donationln back-bonding effects. The H4 and H3' protons are 
moved upfield as a result of ring-current anisotropy from their respective adj acent pyridine 
rings. As before, the CIS value ofH4 is less than that observed for the other shielded proton, 
as it is further removed from the shielding pyridine. The H5 and H6 protons show small 
positive CIS values (+0.10). However, the most interesting CIS value of the benzotriazole 
ring is that of H7. If the rings of the ligand were coplanar, then the signal for this proton 
would be expected to be shifted downfield, resulting in a strong positive CIS value. As the 
CIS value for H7 is only small, this suggests that the ligand is in a non-planar confonnation. 
Although H8 has a larger CIS value (+0.19), it is not strongly shifted and is therefore 
consistent with the above proposaL 
The effect of attaching the five-membered benzotriazole ring to the I-position of the 
isoquinoline is to reduce slightly the bite-angle of the resulting ligand relative to biq. This 
results in further separating the H71H8' protons in ligand 29 relative to the H81H8' protons of 
the biq ligand upon chelation. This obviously reduces the steric interaction, and is likely to 
lead to a reduction in the energy required to pass each other. Perhaps this is one reason why 
the existence ofthe diastereoisomers is not seen in the spectrum of37. 
To further investigate the nature of the benzotriazole-containing ligands, it was 
decided to prepare a homoleptic complex. Based upon the results thus far, it seemed that 
ligand 28 would provide the best chance of fonning a homoleptic complex. Therefore 28 was 
reacted with tetrakis(DMSO)dichlororuthenium [Ru(DMSO)4Clz] in 3: I ethanol/water. Over 
a two hour time period the colour of the solution changed from yellow to orange and to a dark 
red before becoming bright orange. At this time a solid started to fOlm in the reaction mixture 
and so the reaction was stopped. The usual work-up procedure was followed, and the 
solvents were first removed in vacuo before attempting to redissolve the bright orange solid in 
water. However, the solid showed little solubility, indicating that some type of polymeric 
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complex had formed. The solid could be dissolved in DMSO and a IH NMR spectrum was 
recorded in deuterated solvent. The spectrum showed only signals corresponding to the free 
ligand, and this too was taken as further evidence of the formation of some complex other 
than the desired homoleptic complex. 
3.3.2 UV -Visible Spectroscopy and Electrochemical Studies 
Each of the complexes where the ligands acted in a mono dentate fashion was studied 
by UV -visible spectroscopy. The results of the study are summarised in Table 3.10, while a 
representative UV-visible spectrum, for complex 38, is shown in Fig. 3.23. In these chloro-
containing complexes a MLCT occurs around 470-490 nm with other, possibly MLCT or 
MC, absorptions at 355-360 nm. No electrochemical measurements were made on these 
complexes. 
Table 3.10 Absorption Maximaa with Molar Extinction Coefficientsb for 31,32 and 38. 
Amax (8) Az (8) 
[Ru(bpY)z(23)Cl](PF6) (31) 479 (8 650) 356 (7 800) 
[Ru(bpY)z(24)CI](PF6) (32) 471 (7000) 361 ( 6500) 
[Ru(bpY)2(28)CI](PF6) (38) 494 (5600) 360 (7 000) 
2.0-rr-------------------, 
Abs 
1.5 
0.5 
0.0 -+-r-,.--,-r-r-r""T'"T""T"T""1-.-r-r-r-r-r-r-r-r..,--,--r-r-r""T'"T""T"T""1---r-r.,-rl 
300.0 350.0 400.0 450.0 500.0 550.0 600.0 650.0 
Fig. 3.23 UV-visible spectrum for [Ru(bpY)z(28)](PF6)z (38) 
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34 
Fig. 3.24 
UV -visible spectroscopy and cyclic voltammetry were used to investigate the 
chelating complex [Ru(bpY)2(25)](BF4)2 (34), The UV spectrum of 34 shows Amax at 368 run 
(c: 9 800 M'lcm'l) with a shoulder around 420 nm. These transitions are ascribed to the 
(M)d-(L)n* and (M)d-(bpy)n* transitions, respectively. Importantly, this suggested that 
the bisbenzotriazole ligand would be harder to reduce than the auxiliary bpy ligands. 
Electrochemically, complex 34 exhibits a one-electron reversible redox couple at + 1.50 V and 
two reversible one-electron reductions at -1.45 V and -1.60 V, which are both ascribed to the 
reductions of the bpy ligands. No reduction process was seen for the benzotriazole-containing 
ligand in the potential window examined (-2.00 V). Thus the electrochemistry and UV-
visible data are consistent. 
The three unsymmetrical chelating benzotriazole-containing complexes were 
investigated by UV-visible spectroscopy. The UV-visible spectrum for 35 is shown in Fig. 
3.25, and is typical of the three complexes, with shoulders appearing on the high-energy side. 
The results of these investigations for 35, 36 and 37 are summarised in Table 3.11, along 
with, for the sake of comparison, Ru(bPY)32+ and RU(bPY)2(biq)2+.109 
3,0-,-----------------, 
Abs j 
2,5i 
2.01 
1~~ 
,.ol \ 
0.5 
0.0 -h-,.,---r.,-.--,-,-,-r"'"""T""T-r""T.,....,.,r-r-r.,...,.....,--;-;rr-r.,,--.-~ 
325.0 350.0 375.0 400.0 425.0 450,0 475.0 500,0 
Fig. 3.25 UV-visible spectrum of [Ru(bpy)2C27)] (PF6)2 (35). 
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Table 3.11 Absorption Maximaa with Molar Extinction Coefficientsb for 35, 36 and 37. 
"'max (0) 
Ru(bpY)32+ 452 (13 600) 
[Ru(bpY)2(27)](PF6)2 (35) 422 (16 300) 
[Ru(bpyh(28)](PF6)2 (36) 426 (11 300) 
Ru(bpY)2(biq)2+ 518(7500) 
[RU(bPY)2(29)](PF6)2 (37) 429 (16 200) 
a In nanometers. b M-1cm-1. 
The "'max for the complexes 35 and 36 are at shorter wavelength than that of 
Ru(bpY)32+. This would suggest that the ~Eox-redl value, that is the HOMO-LUMO energy 
gap, will be larger in 35 and 36 than in Ru(bpY)32+. Similarly, the "'max for the complex 37 is 
at shorter wavelength than the corresponding Ru(bpY)2(biq)2+ complex. 
The cyclic voltammograms of 35 and 36 are shown in Fig. 3.26, while the 
electrochemical studies for complexes 35, 36 and 37 are summarised in Table 3.12, along 
with the redox potentials of RU(bPY)32+. As suggested by the UV-visible spectra, these 
complexes all show greater ~Eox-redl values than Ru(bpy)l+. However, the reasons for this 
appear to differ between the various complexes. 
35 36 37 
Table 3.12 Redox Potentialsa of 35, 36 and 37. 
Eox Eredl Ered2 Ered3 ~Eox-redl 
RU(bPY)32+ 1.26 -1.33 -1.51 -1.77 2.59 
[RU(bPY)2(27)](PF6)2 (35) 1.53 -1.39 -1.60 - 2.92 
[Ru(bpY)2(28)](PF6)2 (36) 1.30 -1.43 -1.64 _2.00b 2.73 
[RU(bPY)2(29)](PF6)2 (37)C 1.47 -1.34 -1. 72b -1.93b 2.81 
a In volts vs SCE in acetonitrile. b Irreversible reduction. C In volts vs SCE in dichloromethane. 
The effect that the ligand 27 has had on complex 35 is to lower the electron density on 
the metal, thus making it harder to oxidise relative to Ru(bpy)l+. There is a reasonable 
correlation of the first and second reduction potentials between complex 34 and RU(bPY)32+, 
and this would suggest that the reductions observed are most likely of the bpy ligands. No 
further reduction processes were observed in the potential range examined. 
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Interesting is the result for complex 36, where the aromatic rings are separated by a 
methylene bridge. This complex has a much lower oxidation potential compared to the 
complexes 35 and 37, where the heterocycles are directly linked, and therefore conjugated. 
The first two reductions are again most likely to be of the bpy ligands, with the third 
irreversible reduction at -2.00 V being that of the benzotriazole-containing ligand. 
The introduction of the benzotriazole ring into the ligands 27 and 28 has dramatically 
affected the properties of the complexes compared to Ru(bpY)l+, and indicates the difference 
in nature between benzotrifizole and pyridine. The complexes 35 and 36 are harder to oxidise, 
which means the metal is less electron rich in each case, while the electron-rich triazole 
ligands are harder to reduce than the bpy ligands. These two features give rise to the larger 
Eox-redl values shown in Table 3.12. 
-1 V OV +IV 
Ov +IV 
Fig. 3.26 Cyclic voltammograms of [RU(bpY)2(27)] (PF6)2 (35) (top) and [RU(bpY)2(28)](PF6)2 
(36). 
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The electrochemistry of [Ru(bpY)2(29)](PF6)2 (37) was first examined in acetonitrile. 
Two closely spaced waves upon oxidation seemed to suggest that the complex was 
undergoing an eCe mechanism. An eCe mechanism is simply explained by having an 
intervening chemical step between a redox process. Different scan rates (Fig. 3.27) were used 
to probe this process. At the scan rate of20 mVs-1, the chemical step competes with the rate 
of the electrochemical measurement, and hence the redox wave is shifted to the left, 
indicating that the resulting complex formed after the chemical step has a redox potential less 
than that of 37. At the scan rate of 500 mVs-1, the elect1;ochemical measurement is now faster 
than the chemical process and the true redox wave is observed. The mechanism was 
tentatively proposed to be that the benzotriazole ring of the ligand was released from the 
ruthenium upon oxidation, with an acetonitrile taking its place, and upon reversing the current 
the acetonitrile-containing complex was being reduced. No further investigation of this 
process was made. To possibly alleviate this problem, the electrochemistry was carried out in 
dichloromethane solution. This proved much more satisfactory, as the spurious redox wave 
was reduced considerably. 
Scan Rate 
2OmVs-1 
Scan Rate 
500mVs-1 
Fig. 3.27 Voltammograms for the oxidation of [RU(bPY)2(29)] (PF6)2 (37) 
The oxidation potential of this complex is much higher than in RU(bPY)32+, indicating 
the metal atom is again less electron rich. The first two reduction waves of complex 37 are 
most likely of the bpy ligands, with the third irreversible reduction that of ligand 29. This 
seems to indicate that the isoquinoline ring has helped make the reduction of the 
benzotriazole-containing ligand at a less negative potential relative to the complex 35, where 
no reduction was observed for the benzotriazole-containing ligand. This is consistent with the 
concept introduced in Chapter 2 where the effect of benzo-fusion is to lower the energy of the 
n* orbital of the ligand. 
71 
The common element to the metal-based oxidations of 35, 36 and 37 is the raised 
oxidation potential of these complexes, relative to RU(bpy)/+. This is, of course, due to the 
benzotriazole-containing ligand. The electron density on the metal may be reduced primarily 
in one of two ways. It may do so by the ligand being a poorer donor, relative to bpy, thus 
placing less electron density on the metal, or alternatively, the ligand may be better at back-
bonding, that is accepting electron density from the metal. Having identified that the 
benzotriazole N3 is the more basic nitrogen perhaps the first suggestion is consistent with the 
observed chemistry. 
3.4 Other Coordination Complexes 
The aim of this section was to structurally characterise, by X-ray crystallography, 
some other complexes with the ligands used in this study. In particular, it was sought to 
confirm the postulation of preferential N3 coordination of benzotriazole. Complexes of all 
ligands were made with Cu(II), Ag(l) and Pd(lI) salts, which are the three metal ions used 
throughout the work described in this thesis, for reasons already explained. 
Ligand 23 was reacted with CuC}z.2H20, AgBF4 and PdClz to give complexes with 
1:1 stoichiometries [23.CuCh.2H20], (39), [23.AgBF4.lhH20], (40), and [23.PdClz], (41), 
respectively, as determined from elemental analyses. However, no information was gained 
from F ABMS that would suggest discrete complexes, and, despite attempts at 
recrystallisation, crystals suitable for X-ray crystallography were unable to be grown for any 
of these complexes. 
Green crystals were formed by slow evaporation from the methanolic reaction mixture 
of24 and CuC}z.2H20. These analysed as [24.CuClz], (42), and were of suitable quality for 
an X-ray structural investigation. The asymmetric unit of the structure is shown in Fig. 3.28a. 
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Fig. 3.28a Perspective view, with atom labelling of the contents of the asymmetric unit, of 42. 
Selected bond lengths (A) and angles (0): Cul-N3 2.000(2), CulA-N3' 2.021(3), Cul-C12 
2.2137(9), Cul-Cll 2.2335(9), NI-N2 1.340(3), N2-N3 1.305(4), N3-C3A 1.377(4), NI-Cl 
1.452(4), N3-Cul-Cll 91.39(8), N3-Cul-CI2 94.72(8), CI2-Cul-Cll 150.66(4), N2-N3-C3A 
110.0(2), Nl-Cl-N1' 108.8(3). 
The structure is a metallopolymer and has crystallised in the space group P-l. The 
asymmetric unit contains one copper dichloride unit and one ligand. In the metallopolymer, 
the ligand adopts a conformation where the meanplanes of each benzotriazo1e are at an angle 
of 98.5(4)° to each other, and with the methylene bridge being tetrahedral [108.8(3)°]. The 
ligand acts as a bridge separating the copper atoms in the chain by 9.250(1)A. Each 
benzotriazole unit is coordinated via N3, with the Cul-N3 bond length of 2.000(2)A being 
slightly shorter than the CulA-N3' bond length [2.021 (2)A]. The geometry of the copper 
itself is perhaps best described as highly distorted tetrahedral. The angle across the copper to 
the coordinating N3's [149.31(12)°] and the Cll-Cu-C12 bond angle of 150.66(4)° result in a 
'flattened' tetrahedron, while the angles from N3 to the chloride anions are 91.39(8)° (N3-
Cu1-Cll) and 94.72(8)° (N3-Cu1-CI2). The extended structure of 42 (Fig. 3.28b) shows that 
the polymeric chains pack with a weak, complementary, inter-chain interaction, [Cu-Cl 
3.782(5)A], between a coordinated chloride of one chain and the copper ion of another. This 
results in pairs of chains packing together, giving a 2-D ladder-like structure, and may be 
responsible for the 'flattened' tetrahedral arrangement around the copper. 
Fig. 3.28b Perspective view of the extended structure of 42. 
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When ligand 24 was reacted with AgN03 in methanol, a complex precipitated from 
the reaction mixture almost immediately, which after recrystallisation from acetonitrile gave 
colourless crystals, (43), that were suitable for an X-ray diffraction analysis. The crystal 
structure is a one-dimensional metallopolymer, the asymmetric unit of which is shown in Fig. 
3.29a, with the nitrate counterion omitted for clarity. 
Fig. 3.29a Perspective view, with atom labelling of the contents of the asymmetric unit, of 43 
with the non-coordinated nitrate counterion omitted. Selected bond lengths (A) and angles CO): 
Agl-N3 2.255(2), AgIA-N3' 2.311(2), Ag1-N4 2.288(2), N1-N2 1.355(2), N2-N3 1.301(3), 
N3-N2-N1107.8(2), N2-N3-C3A 109.4(2), N1-C11.452(3), N3-Ag1-N4 117.84(8), N3-Ag1-
N3'A 124.93(7), N1-C1-N1' 110.2(2), N1 '-N2' 1.355(2), N2'-N3' 1.300(3), N1 '-C1 1.447(3), 
C3A'-C7A'-Nl' 112.7(2), N2'-N3'-C3A' 109.1(2). 
Fig. 3.29b Perspective view of the extended structure of 43. 
The confonnation of the ligand in complex 43 is very similar to that in the previous 
crystal structure. The meanplanes of the benzotriazole units in the ligand subtend an angle of 
84.1(5)° to each other, with the methylene bridge being close to tetrahedral [11O.2(2tJ. 
Again the ligand is acting as a bridge between two metal ions, with each benzotriazole 
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coordinated via N3 to silver atoms [AgI-N3 2.255(2)A and AgIA-N3' 2.315(2)A]. A 
coordinated acetonitrile molecule completes the coordination sphere of the silver, and is 
essentially linear [N4-C2-C3 179.1(3)oJ with a AgI-N4 bond length of 2.288(2)A. The 
nitrate counterion is not coordinated. The angle across the silver to the coordinating N3 's is 
124.93(7)°, which is smaller than that observed for the copper structure, perhaps because 
there are no inter-chain interactions present. The extended structure is simply a linear chain, 
comprised of silver atoms separated by V-shaped ligand spacers, [Agl'''AgIA 9.212(1)A]. 
A complex with PdClz was also prepared. Ligand 24 was added to a solution of PdClz 
dissolved in hot aqueous 2M HCl to give a tan solid, in high yield, which analysed as 
[23.PdClz], (44). Despite attempts to grow crystals for an X-ray analysis all efforts failed. IH 
NMR in deuterated DMSO gave no CIS, and FABMS was unable to find any discrete 
molecular ions. With this information, and the results of the previous crystal structures, the 
most likely structure for 44 is a metallopolymer (Fig 3.30). 
Fig. 3.30 
The crystal structures of 42 and 43 with ligand 24 are dominated by the ligand 
conformation, and preferential N3 coordination disposes it to act as a V -shaped bridging 
ligand, with metallopolymers resulting. Based on these results, the complexes with ligand 23 
(38, 39 and 40) may also be metallopolymers with similar N3 coordination. 
Large green single crystals, (45), grew from the methanolic reaction mixture of ligand 
27 with Cu(N03)2.3H20. The structure of the resulting complex is shown in Fig. 3.31. 
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Fig. 3.31 Perspective view, with atom labelling of the contents of the asymmetric unit, of 45 
with the non-coordinating nitrate counterions omitted. Selected bond lengths (A) and angles 
(0): Cu1-N1' 2.033(2), Cu1-N2 2.047(2), Cu1-0lO 2.298(2), N1-N2 1.369(3), N2-N3 
1.303(3), N1-C2' 1.430(3), N1'-Cul-N2 78.91(7), N1'-Cul-OlO 90.23(8), N2-Cu1-0lO 
91.71(8), N2-N1-C2' 117.1(2). 
The structure is a [2 + 1] complex, which crystallises in the monoclinic space group 
P 2/n. In the complex, a crystallographic centre of inversion at CuI relates the ligands, and so 
the arrangement around the copper is trans. Although the bulk sample analyses as 
[(27)2.Cu(N03)2.MeOH.H20], refinement of the occupancy of the methanol CH3 group 
converged to a value close to 1.0. Thus, the crystal used appears to have the stoichiometry 
[(27)2.Cu(N03)2.2MeOH], as shown in Fig. 3.31, with the two non-coordinating nitrate 
counterions omitted. The ligand is chelating through N2 [Cu1-N2 2.047(2)A] of the 
benzotriazole and NI' [Cul-NI' 2.033(2)A] of the pyridine ring giving a bite angle NI'-CuI-
N20f78.91(7)0. 
This complex is structurally similar to the complex described in Chapter 2 with ligand 
6 and copper(U) nitrate, viz 22, and to that published by Battaglia et aI.8] The differences are 
that in this complex the apical positions are occupied by methanol solvate molecules whereas 
in complex 22 the nitrate counterions are in the apical positions and in the structure reported 
by Battaglia et aI. the apical positions are occupied by water molecules. 
Ligand 27 was also reacted with AgN03 in methanol to give colourless crystals, (46), 
that analysed as [(27).AgN03], suitable for X-ray diffraction. The complex is a symmetrical 
I2-membered [2 + 2] metallomacrocycle, which crystallises in the space group P-I, around a 
centre of inversion in the central cavity of the metallomacrocycle. Perspective views of the 
metallomacrocycle are shown in Fig. 3.32. 
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Fig. 3.32 Perspective views, with selected atom labelling, of 46. Selected bond lengths (A) 
and angles (0): Agl-N3 2.251(2), Agl-Nl'A 2.291(2), Agl-012 2.592(2), Nl-N2 1.367(3), 
N2-N3 1.309(3), Nl-C2' 1.435(3), N3-Agl-Nl'A 143.37(7), N3-Agl-012 98.10(7), Nl'A-
Agl-012 114.04(7), N2-Nl-C2' 118.6(2). 
In this structure, the pyridine nitrogen (Nl ') and the benzotriazole N3 act as the donor 
atoms from the same ligand to two different silver ions. Thus, the ligand is acting in a 
bridging mode. The silver is tricoordinate, with a pyridine nitrogen coordinated from one 
ligand [2.29l(2)AJ and a benzotriazole N3 from the other [2.25l(2)AJ. The coordination of 
the silver atom is completed with a mono dentate nitrate anion [2.592(2)AJ. The geometry 
about the silver can be described as a distorted T shape, with the N3-Agl-Nl 'A bond angle of 
143.37(7)° differing significantly from linearity. The two rings of the ligand are inclined at 
an angle of 33.5(3)° to each other. The N3-Agl-Nl 'A angle at the silver and the angle 
between the planes of the two rings, define a rhombic cavity (Fig 3.32), with the silver atoms 
separated at a distance of 4.600(1 )A. 
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The palladium complex with 27 was also prepared in the same manner as that 
described for previous palladium complexes, and analysed as [27.PdChYM20 ], (47). 
However, no useful infonnation from IH NMR or FABMS could be gained for 47, and all 
efforts at recrystallisation failed to give crystals suitable for a structural analysis. 
The greenlblue crystals, which were recovered, by filtration, from the reaction of 
stoichiometric amounts of ligand 28 with Cu(CI04)2.6H20 in methanol, analysed in the 
intriguing ratio [(28)3.Cu2(CI04)4.H20]. F AB mass spectrometry gave molecular ions, in a 
1:1 ratio, corresponding to [(28)2Cu(CI04)t and [(28)2Cu2(CI04)t Together, these pieces of 
infonnation suggested the fonnation of [2 + 1] and [2 + 2] complexes which had co-
crystallised. Fractional recrystallisation from DMF afforded beautiful blue diamond-shaped 
crystals, (48), one of which was used for a structural investigation. The structure found by 
crystallography is of the [2 + 1] complex, as shown in Fig. 3.33. 
Fig. 3.33 Perspective view, with atom labelling of the contents of the asymmetric unit, of 48 
with the non-coordinating perchlorate counterions and solvate molecules omitted. Selected 
bond lengths (A) and angles (0): Cu1-N2 2.011(3), Cu1-Nl' 2.034(4), Cul-01 2.369(4), Nl'-
Cu1-N2 87.5(1), N2-Cu1-01 87.9(1), N1-N2 1.350(5), N2-N3 1.304(5), N1-Cl' 1.461(5), 
C1'-C2' 1.507(5),N1-C1'-C2' 111.7(3). 
Complex 48 is a [2 + 1] complex and has crystallised in the triclinic space group P-l. 
The asymmetric unit contains a copper atom, lying on a crystallographic centre of inversion, 
coordinated to a chelating ligand and a water, as well as a non-coordinating perchlorate 
counterion and DMF solvate molecule. The chelating benzotriazole-containing ligands being 
related through inversion are in a trans arrangement around the copper atom. The six-
membered chelate ring of the ligand is in a boat confonnation, providing a bite angle at the 
copper atom [Nl'-Cu1-N2] of87.5(1)O, 
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The reaction of ligand 28 with AgN03 in methanol gave a precipitate, which was 
filtered off and recrystallised from acetonitrile to produce colourless crystals, (49), of 
sufficient quality for an X-ray diffraction analysis. The structure is shown in Fig. 3.34. 
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Fig. 3.34 Perspective view, with selected atom labelling, of 49. Selected bond lengths (A) 
and angles (0): Agl-N3 2.222(2), AgIA-NI' 2.228(2), AgI-Oll 2.527(2), NI-N2 1.345(3), 
N2-N3 1.308, Nl-Cl' 1.462(3), Cl'-C2' 1.511(3), N3-Agl-Nl'A 152.96(8), N3-AgI-011 
92.11(7), Nl'A-Agl-01l114.87(7), Nl-Cl'-C2' 111.2(2), N3-N2-Nll07.9(2). 
The complex is a [2 + 2] metallomacrocycle, similar to the complex 46. This time, 
because ofthe methylene bridge, the metallomacrocycle is l4-membered. The introduction of 
the tetrahedral methylene group also results in a large change to the central cavity, with the 
silver-silver distance increasing to 4.942(1)A relative to 46 [4.600(1)A]. However, the 
geometry about the silver is remarkably similar to that found for the previous [2 + 2] 
structure, with the same number and type of donor atoms, with similar angles around the 
silver. In addition to the strong interactions between the silver atom and N3, NIA' and 011, 
the silver makes weaker contacts with N2A [2.922(3) A] and 012 [3.060(2) A]. 
Ligand 28 dissolved in methanol was added to a solution of PdCb dissolved in hot 
aqueous 2M HCI. A yellow precipitate formed immediately and was collected by filtration. 
F ABMS of the solid gave a molecular ion of (28)2Pd2Ch +, which suggested the formation of 
another [2 + 2] metallomacrocycle. Crystals, (50), suitable for X-ray diffraction were grown 
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by vapour-diffusion of methanol into a DMF solution of the complex. The structure is shown 
in Fig 3.35a. 
Cl3 
Fig. 3.35a Perspective view, with selected atom labelling, of 50 with the methanol solvate 
molecule omitted. Selected bond lengths (A) and angles (0): Pdl-N3A 2.050(7), Pdl-NI'B 
2.071(8), Pdl-Cll 2.313(3), Pdl-C12 2.308(3), N3A-Pdl-Nl'B 87.8(3), Pd2-N3B 2.052(8), 
Pd2-Nl'A 2.056(8), Pd2-C13 2.299(2), Pd2-C14 2.300(3), Nl'A-Pd2-N3B 88.8(3), NIA-CIA-
C2'A 109.3(7), NIB-CIB-C2'B 110.6(8) 
This complex crystallises in the space group P2dc, and contains in the asymmetric 
unit one [2 + 2] metallomacrocyc1e and a methanol solvate molecule, which has been omitted 
for clarity. The metallomacrocyc1e is 14-membered, the same as for the previous structure 
49, but because of the different geometric preference of palladium compared to silver, a very 
different topology results. Each palladium atom is square planar, with the chlorine atoms 
being cis at each metal centre. The angle to the coordinating benzotriazole N3 and pyridine 
Nl atoms, N3A-Pdl-Nl'B 87.8(3)° and Nl'A-Pd2-N3B 88.8(3)°, is significantly smaller than 
for the silver structure and has much to do with the different conformation of the 
metallomacrocyc1e. The methylene groups are tetrahedral and the torsional angle N2B-N I B-
CIB-C2'B differs from the torsional angle N2A-NIA-CIA-C2'A. The benzotriazole rings of 
each ligand lie approximately orthogonal to each other, while the pyridine rings are almost 
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parallel. The influence of the metal geometry has increased the metal-metal separation, as the 
palladium-palladium distance of 6.739(1)A is significantly larger than the silver-silver 
distance in the previous [2 + 2] structure [4.942(1) A]. 
Interestingly, the chlorine atoms coordinated to each palladium do not share two-fold 
symmetry, and this results in the complex 50 being axially chiraL This structure also has an 
interesting conformation. The complex can be described as being in an 'armchair' 
arrangement (Fig. 3.35b), with the benzotriazolerings acting as the back and seat ofthe chair 
and the pyridyl rings providing the legs. 
Fig.3.35b 
A copper complex with ligand 29 was prepared by adding a solution of CuClz.2HzO, 
dissolved in 1: I chloroform/methanol, to 29 dissolved in chloroform. After 1 day a tan solid 
had developed in the vial and this was filtered off. Vapour diffusion of diethyl ether into the 
filtrate precipitated more of the tan solid, resulting in a total yield of 89%. Elemental analysis 
of the solid confirmed a 1: 1 stoichiometry, [29.CuClz] (51), but no information about the 
nuclearity of the complex was gained by F ABMS. Recrystallisation from nitromethane gave 
thin orange plate-like crystals, and one of these was used for an X-ray diffraction study. Due 
to the thin crystal, the quality ofthe X-ray data was poor, and the refinement was only able to 
reduce the R-factor to 12%. However, the structure of the complex, shown in Fig. 3.36, could 
be determined unambiguously and is worthy of some discussion. 
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Fig. 3.36 Perspective view, with partial atom labelling of the asymmetric unit, of 51. The 
hydrogen atoms and solvate molecules have been omitted for clarity. 
The complex crystallises in the monoclinic space group C2/c, with eight molecules in 
the unit cell. Contained in the asymmetric unit is one full [4 + 4] metal complex as well as 
disordered nitromethane and water molecules, all of which have been omitted for clarity in 
Fig. 3.36. The complex contains a central Cll4CI6 cluster encapsulating an oxo anion. Each of 
the four heterocyclic ligands in the complex coordinate in a mono dentate fashion through the 
N3 nitrogen atom of the benzotriazole to a copper. The isoquinoline ring is not involved in 
the coordination. Each of the ligands has a trans arrangement with, respect to the 
heteroatoms about the inter-ring bond, and each possesses different angles between the 
meanplanes of their constituent aromatic rings ranging from 17° to 58°. 
This is a surprisingly common type of cluster, as a search of the Cambridge 
Crystallographic Database found many structures containing the CU4Cl60 core. Many 
contained simple appended ligands such as acetonitrile,l1O DMF, III DMSO,112 pyridine, 113 
and triphenylphosphine oxide.1l4 One complex that has a similarity to the complex 51 is that 
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synthesised by Tosik et aI. Il5 where the central cluster has a benzimidazole bound via its N3 
atom as the appended ligand. 
Attempts to prepare a silver nitrate complex with ligand 29 were unsuccessful. 
Instead, AgBF4 dissolved in methanol/chloroform was added to 29 dissolved in chloroform, 
and the resulting solution stored in the dark whereupon a white powder formed. Elemental 
analysis of this powder determined that the complex formed had a 1:1 stoichiometry, 
[29.AgBF4.'lS.H20], (52), yet despite various efforts to recrystallise complex 52 no crystals 
suitable for a structural study were obtained. 
A palladium complex with ligand 29 was prepared by adding a methanolic solution of 
LizPdCl4 to 29 dissolved in boiling methanol. The resulting yellow solid was filtered off and 
recrystallised from nitromethane to give a yellow microcrystalline solid (53). FABMS of 52 
provided a molecular ion that corresponded to (29)2Pd2CI/, and so the formation of another 
[2 + 2] metallomacrocycle is proposed. A IH NMR spectrum recorded in deuterated DMSO 
showed no change from that of the ligand itself in the aromatic region, indicating that in 
DMSO solution the complex dissociates. A satisfactory elemental analysis of this complex 
was not obtained and this is attributed to an unknown exact composition of nitromethane 
(observed in the IH NMR spectrum) and water in the complex. 
The results of this structural study are summarised in Table 3.13, and show that [2 + 
I] structures were only found for the reactions with copper(II), where coordination is through 
the N2 nitrogen. Table 3.13 shows a prevalence of [2 + 2] metallomacrocycles, even for 
palladium(lI) which, because of its preferred square planar coordination, was expected to give 
the best .chance of chelating structures with these ligands. Unfortunately, some of the 
complexes were unable to be characterised by anything more than an elemental analysis, 
which is only able to determine the stoichiometry of the complex and not the structure. 
Table 3.13 
Ligand Cu(II) Pd(IJ) Ag(I) 
27 [2 + 1] - [2 +2] 
28 [2 + 1] / [2 + 2] [2 + 2] [2 + 2] 
29 [4+4] cluster [2 + 2] -
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3.5 Summary 
Monodentate, che1ating and bridging coordination modes have been found for the 
ligands 23 and 24. This has demonstrated the diversity of coordination modes that these 
ligands possess. The main feature of this study of these benzotriazo1e-containing ligands has 
been that they coordinate preferentially through the N3 nitrogen atom. This disposes 1-
substituted benzotriazo1es towards bridging ligands, rather than che1ating ligands, upon 
coordination. The bibenzotriazoles, however, can be made to chelate and hence become 
N,N'-bidentate ligands; this was demonstrated in the ruthenium complexes, although this 
required more stringent reaction conditions. 
The benzotriazole-containing ligands 27, 28 and 29 displayed monodentate, bidentate 
and bridging coordinating properties. They acted as N,N'-bidentate ligands in the work with 
ruthenium. However, when complexes with other metal ions were made, with no restrictions 
on the coordination modes available, non-chelating structures were also found. 
The inclusion of a benzotriazo1e ring into ligands 27, 28 and 29 significantly altered 
the physicochemical properties of the ruthenium complexes prepared. The effect of the 
benzotriazole component was to reduce the electron density on the metal atom. This was 
postulated to be so in the IH NMR analysis of the complexes prepared, and verified by the 
electrochemical measurements. For example, in the complex [Ru(bpY)2(27)](PF6)2 (35), 
which contains five pyridine rings and one benzotriazole, the oxidation potential was 1.53 V, 
which is 270 mVhigher than that of Ru(bpy)l+. 
The interesting results of the benzotriazo1e-containing ligands reflect the geometrical 
arrangement of the ligands. With two strong donor atoms, namely the benzotriazole N3 and 
the pyridine or isoquinoline nitrogen, in geometric positions that make a chelating 
relationship between them impossible, the ligands act as components in metallomacrocycle 
formation. 
In conclusion, the benzotriazole ring has' been shown for the first time to be a useful 
component for incorporation into multidentate organic ligands, for use in coordination and 
metallosupramolecular chemistry. 
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Chapter 4 
1,2,4-Heterodiazoles 
4.1 Introduction 
For Chapters 4 and 5, the emphasis is moved away from benzo-fused systems. The 
heterocyclic systems that will be investigated in Chapters 4 and 5 are two of the isomers of 
the heterodiazoles. Heterodiazoles are five-membered heterocycles containing 3 heteroatoms 
- two of which are nitrogen and the other either oxygen or sulfur, named oxadiazoles or 
thiadiazoles, respectively. There exist four possible substitution patterns in a five-membered 
ring with three such heteroatoms. These are shown with the ring numbering for each 
substitution pattern in Fig. 4.1. 
3 4 3 4 
3 N 4 3 N4 n N-N 11]\ 
,-') 5 2f( ')5 2 N..... 5 2 2 N N 5 X=O,S 
X ..... X ..... X,... X 
1 
1,2,3- 1,2,4- 1,2,5- 1,3,4-
Fig. 4.1 
Simple 1,2,3-oxadiazoles are unknown,116 with the closest ring system being the 
zwitterionic sydnones (Fig. 4.2). 1,2,3-Thiadiazoles are, on the other hand, well-known. The 
usual method of synthesis of this heterocyclic system has been via the Hurd-Mori 
procedure. 117,118 By this method, the biheterocycle 4,4'-bi-1,2,3-thiadiazole (54) was recently 
synthesised, starting from butane dione, as shown in Scheme 4.1. 119 
Fig. 4.2 
+ 2 H2N-NHC02Et 
54 
Scheme 4.1 
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Only one Xray crystal structure has been reported120 for a coordination complex 
containing a 1,2,3-heterodiazole ligand. This complex, shown in Fig. 4.3a, contains a 1,2,3-
thiadiazole as the heterocyclic ligand. Indeed, very little coordination chemistry has been 
explored with any of these heterocyclic ring systems. The 1,3 ,4-system has been by far the 
most investigated,121-124 undoubtedly due to the ease of synthesis of this ring system 
compared to the others. The ring can be constructed starting from readily available materials, 
such as esters or acid chlorides and hydrazine, with subsequent ring closure using a 
dehydrating reagent. The appropriate choice of dehydrating agent can also be used to 
introduce the oxygen or sulfur into the ring. For example, 5,5'-diphenyl-2,2'-bi-1,3,4-
oxadiazole12s (55) and 5,5'-diphenyl-2,2'-bi-1,3,4-thiadiazoleI26 (56) (Scheme 4.2) can both be 
synthesised from the same precursor by treatment with diphosphorus pentoxide (P20S) and 
diphosphorus pentasulfide (P2SS), respectively. Of particular relevance to the present study 
was the preparation and study of a Ru(bpy)l+ complex containing a 2,2'-bi-l,3,4-thiadiazole 
ligand (Fig. 4.3b). 127 The authors found that the thiadiazole ligand acted to withdraw electron 
density from the metal, and postulated that the presence of the sulfur atoms causes a strong 
enhancement of 'It back-bonding. In part, because of the coordination chemistry already 
reported for the 1,3 ,4-systems, these were not chosen for investigation in the present study. 
Scheme 4.2 
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The purpose of the present study was, firstly, to examme the effect that such 
heterocyclic systems had on mononuclear ruthenium complexes and, secondly, to study the 
interactions between ruthenium centres bridged by a heterodiazole ring. Therefore the design 
of chelating ligands that would al10w a systematic study of mono- and dinuclear ruthenium 
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complexes was necessary. It seemed a natural approach to attach other heterodiazoles, or 
pyridine rings, to the unsubstituted positions of the heterodiazole ring. In this fashion, a range 
of ligands could be synthesised that would allow control over the nuclearity of the complex 
through the available sites of chelation. The coordination chemistry of the 1,2,4- and 1,2,5-
heterodiazoles was chosen for study, as they seemed to be the most well-suited to the 
construction of complexes of higher nUc1earity. In this Chapter, the 1,2,4-heterodiazole 
systems are investigated, while Chapter 5 deals with the 1,2,5-systems. 
Unlike the 1,3,4-systems, the 1,2,4-systems are unsymmetrical and hence isomers are 
possible with monosubstitution of the ring. We thought it would be interesting to see what 
effect, if any, this would have on the electrochemical properties of ruthenium complexes with 
such ligands. To this end, the preparation and study of some isomeric 1,2,4-heterodiazole-
containing ligands was attempted. 
With ligands containing a 3,3'-biheterodiazole core, as in 3,3'-bi-1,2,4-oxadiazole (57), 
there exist three possibilities for chelation of a single metal ion (Fig. 4.4). This ambidentate 
feature is an interesting aspect of the coordination chemistry of this system. Ligands 
containing the 3,3 '-biheterodiazole core are also potentially able to bridge two metals, in one 
of the two modes shown in Fig. 4.4. 
N N 
f,H" ~ O-N N~O 
"M/ 
__ N N-O 
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O'N N~ 
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O~N N-O 
l'H'cJ N N 
" / M 
N4,N4' 
N2,N4':N4,N2' N2,N2':N4,N4' 
Fig. 4.4 Possible coordination modes of 57. 
This bisbidentate type of coordination is similar to the coordination mode 
demonstrated by a 2,2'-biimidazolate (Fig. 4.5), or 2,2'-bibenzimidazolate bridge. Of course, 
an oxadiazole ring does not contain the acidic NH proton of an imidazole and hence the 
ligand would bridge as a neutral, rather than anionic, species. Dinuc1ear complexes 
containing the biimidazolate bridge have been shown to exhibit strong metal-metal 
interactions. 128 Upon dinuc1eation, the metal-metal distance is only ca. 5.6 A, and this is 
postulated to facilitate metal-metal interactions by direct orbital overlap of the two metals. 
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Fig. 4.5 
The ligands selected for the present study are shown in Fig. 4.6. They are 3,3 '-bi-
1,2,4-oxadiazole (57), 5,5'-dimethyl-3,3 '-bi-I,2,4-oxadiazole (58), 5,5'-diphenyl-3,3 '-bi-I,2,4-
oxadiazole (59), 5,5'-di(2-pyridyl)-3,3 '-bi-I,2,4-oxadiazole (60), 5,5'-bi-I,2,4-oxadiazole (61), 
3,3 '-di(2-pyridyl)-5,5 '-bi-l ,2,4-oxadiazole (62), 2-(1,2,4-oxadiazol-3-yl)pyridine (63), 2-
(l,2,4-oxadiazol-5-yl)pyridine (64), 2-(1,2,4-thiadiazol-5-yl)pyridine (65), 3,5-di(2-pyridyl)-
I ,2,4-oxadiazole (66) and 3,5-di(2-pyridyl)-1,2,4-thiadiazole (67). 
57 
61 
63 64 65 
66 67 
Fig. 4.6 
A search of the Cambridge Crystallographic Database revealed only one crystal 
structure of a coordination complex containing a I ,2,4-heterodiazole, 129 and indicates the 
scarcity of use of these systems as ligands. The ligand is structurally related to 2,2':6',2"-
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terpyridine and acted as a tridentate ligand. A pictorial representation of this complex is 
shown in Fig. 4.7. 
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Fig. 4.7 
There have been some reports of ruthenium complexes with l,2,4-heterodiazole 
ligands. Orellana et al.130 attempted to prepare a homoleptic ruthenium complex with the 
ligand 2-(1,2,4-oxadiazol-3-yl)pyridine (63), with a notable lack of success. However, these 
authors did successfully prepare a homoleptic ruthenium complex with the ligand 2-(1,2,4-
thiadiazol-5-yl)pyridine (65),130 which they also examined electrochemically. 131 The 
Ru(bpy)l+ complex with ligand 65 has not been prepared, and this complex is important to 
the present study as it provides a basis for comparison of possible dinuclear RU(bPY)22+ 
complexes containing a 1,2,4-thiadiazole moiety. This is particularly relevant to any 
dinuclear ruthenium complex with ligand 67. 
In contrast to the few studies of the 1,2,4-heterodiazoles, 1,2,4-triazoles have been 
well studied.132-135 Of relevance to the present study are the investigations into the dinuclear 
complexes of several related ligands. For instance, 3,5-di(2-pyridyl)-l,2,4-triazole (68), (Fig. 
4.8), and 5,5'-di(2-pyridyl)-3,3'-bi-l,2,4-triazole (69), (Fig. 4.9), have structural similarities to 
the ligands 66/67 and 60/62, respectively. Ligand 68 has been well-studied, with many 
dinuclear complexes having been prepared and investigated by a variety of techniques. 136-144 
The triazole ring contains an acidic proton and in dinuclear complexes of 68 bridges in the 
fashion shown in Fig. 4.8, where the triazole is anionic and coordination occurs in the less 
sterically demanding NI,N4 manner. This is similar to the only mode in which N,N'-
chelating dinuclear complexes involving ligands 66/67 can bridge two metals (Fig. 4.8), 
although the heterodiazole ligands would not bridge as anionic species. 
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Fig. 4.8 
The ligand 5,5 '-di(2-pyridyl)-3,3 '-bi-l ,2,4-triazole (69) has recently been shown to be 
able to form trinuclear complexes with three chelating Ru(bpy)l+ units (Fig. 4.9).145 Given 
this successful polynuclear construction there was particular interest in the synthesis of 
ligands 60 and 62. 
Fig. 4.9 
In work with ruthenium complexes 1,2,4-triazoles have been shown to be good (J-
donors and poor 1t-acceptors. This results in a lowering of the oxidation potential of the 
complex, but the electron-rich triazole ligands themselves are harder to reduce than bpy 
ligands. No such work has been reported for l,2,4-heterodiazoles and the present study aims 
to explore the electronic nature and properties of these heterocyclic systems in chelating 
ligands. 
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4.2 Syntheses of Ligands 
For the ligands containing a 3,3'-bi-l,2,4-oxadiazole core, oxamidoximel46 proved a 
valuable starting material, as did 2-picolylamidoximel47 for the oxadiazole ligands with 
appended pyridine rings. These molecules were synthesised according to the reported 
procedures and are shown in Fig. 4.10. 
Fig. 4.10 
Ligand 57 was synthesised via the method of Adrianov et at.,148 which involves a 
boron trifluoride promoted double cyclisation of oxamidoxime in hot triethyl orthoformate, as 
shown in Scheme 4.3. By this method ligand 57 was produced in 76% yield. 
Scheme 4.3 
5,5'-Dimethyl-3,3 '-bi-l,2,4-oxadiazole (58) and 5,5'-diphenyl-3,3'-bi-l,2,4-oxadiazole 
(59) are both known molecules, having been first synthesised over 100 years ago. 149 The 
methods described by Zinkeisen,149 summarised in Schemes 4.4 and 4.5, were followed to 
produce 58 and 59, respectively. In both cases, oxamidoxime is reacted with an excess of 
reactant (acetic anhydride and benzoyl chloride) which also acts as a dehydrating agent. The 
reactions required long reflux times, and the yields were rather low (20-40%). 
In line with our interest in the solid state structures of the biheterocycles produced in 
this work, the crystal structure of 59 was determined, and is shown in Fig. 4.11. 
o 0 
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Scheme 4.4 
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Scheme 4.5 
Fig. 4.11 Perspective view, with atom labelling of the contents of the asymmetric unit, of 59. 
Selected bond lengths (A) and angles (0): 01-N2 1.415(3), N2-C3 1.308(3), C3-N4, 1.369(4), 
N4-C5 1.306(4), C5-C1" 1.447(4), C5-01 1.356(3), C3-C3' 1.462(6), C5-01-N2 106.7(2), 
C3-N2-01 102.3(2), N2-C3-N4 116.0(3), N2-C3-C3' 121.0(3), N4-C3-C3' 123.0(3), N4-C5-
C1' 129.0(3), C5-N4-C3 102.4(2), 01-C5-C1' 118.4(3). 
Ligand 59 crystallises in the monoclinic space group P21/c, with a centre of inversion 
located in the middle of the inter-ring bond separating the oxadiazo1e rings. The ligand is 
perfectly planar, with a mean deviation from the plane of only 0.043(1)A. Each phenyl ring 
may be encouraged to lie in the plane of the oxadiazole ring to which it is bonded, by the two 
attractive hydrogen bonding interactions of the ortho hydrogens of the phenyl rings with the 
Oland N4 heteroatoms. Also, the bioxadiazole core is in a trans coplanar confonnation, 
again maximising conjugation. The distances and angles around the oxadiazo1e ring are 
similar to the distances found for other molecules containing a 1,2,4-oxadiazole ring.150-152 As 
this molecule crystallises in the space group P21/c, it packs with the characteristic herringbone 
array (Fig. 4.1lb), with the distance separating the planar aromatic molecules being 3.49(7)A. 
Fig. 4.11b Perspective view of the herringbone array. 
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In an attempt to prepare 5,5'-di(2-pyridyl)-3,3'-bi-l,2,4-oxadiazole (60), oxamidoxime 
was heated in an excess of ethyl picolinate (Scheme 4.6). After 30 minutes the solution had 
become discoloured and a solid had formed in the reaction mixture, so the reaction was 
stopped and analysed by TLC and IH NMR. These both showed no sign of any product that 
could be identified as 60. Attempted catalysis of this reaction by boron trifluoride or 
triethylamine did not aid the formation of ligand 60. As,it was desirable to retain 
oxamidoxime, which provides the 3,3'-bioxadiazole core, the reaction partner was changed to 
be more reactive. Picolinic acid was converted into its acid chloride by reaction with thionyl 
chloride, and reacted with oxamidoxime (Scheme 4.6). The product of this reaction was the 
imino ester, where the two oxime oxygen atoms have acted as nucleophiles. The first attempt 
to cyclise the imino ester was by heating at 250°C, but the only product recovered from this 
reaction was picolinic acid. Cyclisation was then attempted in polyphosphoric acid (PP A). 
The IH NMR spectrum of the material isolated showed only one pyridine ring in the product, 
and signals consistent with an amidoxime. F ABMS indicated that the molecular formula was 
CSH7NSO, and so the product was formulated as shown in Scheme 4.6, where cyclisation of 
one ring had occurred but the other had cleaved to generate an amidoxime. As a simple 
synthesis was not found, it was decided not to pursue the preparation of 60 any further. 
Scheme 4.6 
A synthesis of the ligand 5,5'-bi-l,2,4-oxadiazole (61) has not been reported.7s A 
possible synthesis of this biheterocycle is the reaction of diethyl oxalate with formamidoxime 
(Scheme 4.7). 
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Scheme 4.7 
Two equivalents of the amidoxime were suspended in diethyl oxalate, containing a 
catalytic amount of boron trifluoride, and gently heated until the amidoxime dissolved (ca. 
50DC). At this point a violent reaction ensued, with almost all of the contents of the reaction 
flask being lost out the top of the attached reflux condenser. The reaction was repeated while 
maintaining the temperature below 50DC, and at no point was there a clear solution, yet the 
colour changed from a white to a yellow suspension, and thus it was hoped that at least some 
reaction had taken place. A lH NMR spectrum of the crude material showed no evidence for 
double cyclisation to produce any of the desired biheterocycle 61, or that possible mono- or 
uncyclised intermediates (Fig. 4.12) were present. ElMS of the crude material also found no 
molecular ions that corresponded to any of the anticipated products, and so this synthesis was 
abandoned. 
o 0 
H 
N-O OEt H-f 
NH2 
Fig. 4.12 Some possible products from the reaction of formamidoxime with diethyl oxalate. 
The synthesis of 3,3 '-di(2-pyridyl)-5,5 '-bi-l ,2,4-oxadiazole (62) was also based upon a 
double cyclisation reaction, involving 2-picolylamidoxime with diethyl oxalate (Scheme 4.8). 
Two equivalents of the amidoxime were added to diethyl oxalate heated to 160°C in the 
presence of a catalytic amount of boron trifluoride. From this reaction, the new ligand 62 was 
isolated in 26% yield, along with 3 ,5-di(2-pyridyl)-1 ,2,4-oxadiazole (66) in 25% yield. 
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Scheme 4.8 
2-(1,2,4-0xadiazol-3-yl)pyridine (63) has previously been prepared by Paudler et 
al. 153 This is an important ligand for the present study, and so was synthesised for use in this 
work. In view of the excellent boron trifluoride promoted cyc1isation to give ligand 57, 2-
picolylamidoxime was heated in an excess of triethyl orthoformate in the presence of a 
catalytic amount of boron trifluoride (Scheme 4.9). From this reaction, 63 was isolated in 
82% yield, a considerably better yield than that obtained by Paudler et al. (39%), who did not 
use boron trifluoride. 
HC(OEth 
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Scheme 4.9 
Synthesis of the isomeric ligand, 2-(1,2,4-oxadiazol-5-yl)pyridine (64), was also 
attempted. The method of synthesis was based upon a general procedure for 5-
monosubstituted 1,2,4-oxadiazoles, developed by Lin et al. 154 A reaction scheme for the 
synthesis is shown in Scheme 4.10. Picolinamide was heated in a slight excess of N,N'-
dimethylformamide dimethyl acetal to generate an acyl amidine intermediate, which was 
reacted in situ with acidic aqueous hydroxylamine. This 'one-pot' reaction gave the 
intermediate 70 in 69% yield after recrystallisation. The procedure for the cyc1isation step 
was to heat the intermediate 70 in a mixture of acetic acid and dioxane. However, the 
colourless crystalline solid collected from the reaction mixture was not the expected ligand 
64. The IH NIYIR spectrum of the material (shown in Fig. 4.13) has no signal for the proton 
of the oxadiazole ring, and a number of broad signals are observed that are consistent with 
hydrogens attached to nitrogen or oxygen. The chemical shifts are also different from those 
of the starting material, also shown in Fig. 4.13, and another indicator that a reaction had 
occurred was the change in melting point. These pieces of information indicated that a 
molecular rearrangement had taken place. To determine the molecular constitution, the 
elemental analysis and mass spectrum of the molecule were obtained. These both determined 
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that the molecular constitution of the molecule was unchanged, but that the mass spectrum 
was considerably different. 
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Fig. 4.13 1 H NMR spectra for 70 (bottom) and the rearrangement product. 
The mass spectrum of 70 shows the fragmentations depicted schematically in Fig. 
4.14. For the rearranged product the molecular ion at 165 a.m.u. does not have the cleavage 
path that would suggest the loss of the oxime (31 a.m.u.), but instead loses 16 a.m.u., which 
could be an oxygen atom or an NH2 group. Also observed are the fragment ions that 
correspond to the picolinamide ion (122 a.m.u.), the pyridyl carbonyl species (106 a.m.u.), 
and the pyridyl cation (78 a.m.u.). 
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The IR spectrum also revealed that the rearrangement product contained two carbonyl 
groups, one similar to that of the starting material. Based upon all the experimental 
information we feel that the molecule that best fits all the experimental data is one containing 
a urea functionality (Fig. 4.15). Surprisingly, there has been little published work on 
pyridylureas with the only literature being a patene55 and a recently published series of papers 
by Masiero et al. 156 Fortunately, Masiero et al synthesised the urea-containing molecule in 
Fig. 4.15 by an unrelated route. By the comparison with the IH NMR data provided an 
identical match was found, confirming the structure of the product from the reaction of 70 and 
acetic acid. 
~l NH2 ~~~N---{ 
o 
Fig. 4.15 
Another possible synthesis of ligand 64 is the reaction of formamidoxime with the 
ethyl ester of picolinic acid (Scheme 4.11). This reaction was first attempted by simply 
heating the amidoxime in neat ester, and was monitored by TLC. The TLC plate showed no 
change of the reaction mixture, even after 16 hours at reflux. The reaction was repeated with 
the addition of boron trifluoride, which had been so successful previously, but still no product 
was seen by TLC or in IH NMR spectra. The reaction conditions were varied to include 
different solvents (ethanol, toluene, and xylene), with or without catalysts (boron trifluoride 
and triethylamine), all with no success. 
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Scheme 4.11 
3,5-Di(2-pyridyl)-I,2,4-oxadiazole (66) has previously been prepared by Liete et 
al.,lS? and was also isolated as a by-product in the synthesis of3,3'-di(2-pyridyl)-5,5'-bi-l,2,4-
oxadiazole (62) above. The method of synthesis employed by Liete et al. ls7 was the reaction 
of 2-picolylamidoxime with acetic acid. From this reaction, 2-(5-methyl-1,2,4-oxadiazo-3-
lyl)pyridine, the ligand 66, and an unidentified component were isolated (Scheme 4.13). 
Symmetrical 3,5-diaryl-l,2,4-oxadiazoles can also be prepared by simply heating the 
corresponding arylamidoxime alone,158 and this was the method used to synthesise 66 in the 
present work. 2-Picolylamidoxime was heated neat at 210°C for 30 minutes and 66 was 
obtained as the only product in 50% yield after recrysta1lisation. 
+ 
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Scheme 4.13 
As mentioned in the introduction, 2-(1,2,4-thiadiazol-5-yl)pyridine (65) is a known 
molecule. l3l The paperl3l reporting the synthesis of 65 was extremely light on experimental 
detail, quoting only a yield (35%) and reference to a general procedure followed. 159 
Interestingly, in this paper by Lin et al. l59 the 3- and 4-substituted thiadiazolylpyridines were 
synthesised, but the 2-substituted isomer was not. An outline of the reaction scheme used, 
adapted for the present case, is shown in Scheme 4.12. Thiopicolinamide is reacted with 
N,N'-dimethylformamide dimethyl acetal to give the thioacyl amidine 71, which is converted 
to the desired 1,2,4-thiadiazole by treatment with hydroxylamine-O-sulfonic acid in an 
alcoholic medium containing pyridine. 
Scheme 4.12 
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Accordingly, thiopicolinamide160 was combined with N,N'-dimethylformamide 
dimethyl acetal in a vial and left (accidentally) over a long weekend. A IH NMR spectrum of 
the material isolated, in 54% yield after workup, is shown in Fig. 4.16. Clearly, this is not the 
expected thioacyl amidine 71, as no singlet for the formamidine proton is observed in the 
spectrum. The spectrum does contain the expected splitting pattern for a 1,2-disubstituted 
ring. However, two noticeable features of this spectrum suggested that this ring was no 
longer a pyridine. The position of these signals were much further upfield (ca. 1 ppm) than is 
usual for pyridine rings, and the usual coupling constant of a pyridine H6 (5.6 Hz) was 
missing. Thus, it seemed likely that another molecular rearrangement had taken place. Also 
in the spectrum are two signals in the methyl region, in a 6:3 ratio at 2.87 ppm and 2.38 ppm, 
respectively. The signal at 2.87 ppm was assumed to be the dimethyl amino moiety that had 
been retained in the product. 
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Fig. 4.16 IH NMR spectrum of rearrangement product. 
To identify this product, an EI mass spectrum was first obtained. This gave a 
molecular ion at 207.1 a.m.u., and was identified by a high-resolution measurement as 
CIOH13N3S. With this information, the formation of a novel product, 72 (Fig. 4.17), with an 
imidazo[I,5-aJpyridine heterocyclic system, was proposed. Conformation of this proposal 
was by the complete IH and I3C NMR assignments of this molecule (Fig. 4.17), and by 
comparison of these with the NMR spectra of a similar molecule containing an imidazo[I,5-
a]pyridine system. 1 61 
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Fig. 4.17 I3C NMR (and IH) chemical shifts of72 in deuterated chloroform. 
The reaction was repeated, on a much smaller scale, and followed by IH NMR. Fig. 
4.19 shows the aromatic region of the spectrum over the time period 0-2 hours. In Trace I a 
spectrum of the starting thioamide is shown. In Trace II, taken after 35 minutes, it is clearly 
seen that all the starting thioamide has been consumed, and that only one product, presumably 
the thioacyl ami dine 71, is present. Certainly this is consistent with the observed signal at 
8.70 ppm for the proton of the amidine carbon. After 2 hours (Trace Ill), a considerable 
amount of cyclised product is formed. Clearly, the thioacyl ami dine 71 forms then cyclises, 
and this led to a proposed mechanism for the formation of 72 (Fig. 4.18). The first step is the 
formation of 71, the pyridine nitrogen then acts as an intramolecular nucleophile to the 
ami dine carbon, with subsequent electron rearrangement. Subsequent proton transfer results 
in the formation of a thiol. In the initial condensation methanol is produced, and the thiol is 
methylated to give 72. The imidazo[1,5-aJpyridine system has previously been constructed 
using intramolecular cyclisations involving a pyridine ring. 162 
71 
Fig. 4.18 Proposed mechanism for the fonnation of 72. 
: ~ i " 
100 
TRACE III 
TRACE II 
TRACE I 
'--' 
../ ~ 
i I , i , , i , I I i i I I I I i I , I I i I I I , i I I I 
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 ppm 
Fig. 4.19 IHNMR spectra of the reaction ofN, N'-dimethylfonnamide dimethyl acetal with 
thiopicolinamide. 
In order to circumvent the fonnation of 72, it seemed appropriate to combine the two 
steps of the synthesis into a 'one-pot' procedure. Thiopicolinamide and N,N'-
dimethylfonnamide dimethyl acetal were combined and allowed to stand for 30 minutes 
before hydroxylamine-O-sulfonic acid, in a mixture of methanol/ethanol, and pyridine were 
added and the resulting mixture allowed to stir at room temperature for 5 hours. By this 
method 65 was obtained in 75% yield after purification, a considerable improvement over the 
previously quoted yield of35%. 
3,5-Diaryl-l,2,4-thiadiazoles are conveniently prepared by the oxidation of 
arylthioamides. 163 Meltzer et al. 164 have prepared the 3- and 4-substituted dipyridyl-l,2,4-
thiadiazoles but curiously not the 2-substituted isomer. The method of Meltzer was used in an 
attempt to prepare 3,5-di(2-pyridyl)-1,2,4-thiadiazole (67), starting from the previously 
prepared precursor thiopicolinamide, as shown in Scheme 4.14. 
Scheme 4.14 
The IH NMR spectrum of the material isolated after workup is shown in Fig. 4.20. 
Clearly, the product contains three pyridyl rings and two NH type peaks. Thus in the reaction 
the thioamide has not cyc10dimerised to give the thiadiazole, but has cyc1otrimerised. A high-
resolution EI mass spectrum provided the molecular fonnula ClsH14N6 for this product. In an 
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attempt to identify exactly what this product was, we turned to X-ray crystallography. Small 
single crystals were grown by the slow evaporation of an acetone solution of the compound. 
The crystal structure revealed that the molecule had a central 1,3,5-triazine core with the 2-
substituted pyridine rings appended in the 2, 4, and 6 positions. Unfortunately, however, the 
crystal structure could not fully elucidate the placement of the two NH protons, and hence the 
tautomer present. 2,4,6-Tris(2-pyridyl)-1,3,5-triazine (Fig. 4.21) is a known and well-used 
ligand,165-168 and is conveniently prepared by trirnerisation of 2-cyanopyridine.169 It seems 
likely that the product of the thiopicolinarnide reaction is one of the tautomers of the 
corresponding dihydrotriazine. 
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4.20 IH NMR spectrum of the trirnerisation product. 
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Fig. 4.21 
With the iodine method proving unsuccessful, some other oxidising agents that have 
been used with success for the oxidation ofthioarnides to 1,2,4-thiadiazoles were tried. These 
attempts included hydrogen peroxide in pyridine solution,170 and sodium nitrite in acetic 
acid. l7l However, in each case, none of the desired 1,2,4-thiadiazole could be identified in 
TLC or IH NMR spectra. 
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To avoid an oxidation procedure, an alternative method of synthesis of 67 was tried. 
The generation of nitrile sulfides, by thermal decarboxylation of aryl(1,3,4-oxathiazol-2-
ones), in the presence of nitriles has been shown to lead to the formation of diaryl-l,2,4-
thiadiazoles, by intermolecular [3 + 2] cyc1oaddition (Scheme 4.15).172 
PhCN 
Scheme 4.15 
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To prepare the appropriate 5-(2-pyridyl)-1,3,4-oxathiazol-2-one, picolinamide was 
reacted with chlorocarbonyl sulfenyl chloride in chloroform, following the general method 
described by Muhlbauer et ai. 173 This reaction gave the desired oxathiazolyl-2-one in only 
12% yield (Scheme 4.16). The oxathiazolyl-2-one was then added in small portions to an 
excess of redistilled 2-cyanopyridine heated to 200°C. However, although a new small 
component could be identified in the reaction mixture by TLC this could not be isolated after 
chromatography. Thus the synthesis of 67 was fmally abandoned. 
0---<0 /, .. ~ N NHz 
Scheme 4.16 
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4.3 Metal Complexes 
The first goal of the investigation into the coordination chemistry of 1,2,4-systems 
was to ascertain which mode of bonding the ligands containing a 3,3'-bi-l,2,4-oxadiazole core 
would adopt when chelating to a single metal ion. The three possible modes are shown in 
Fig. 4.22. Two of the modes are symmetrical (N2,N2' and N4,N4) and the other is 
unsymmetrical (N2,N4). It was originally anticipated that the N2,N2' mode might be 
preferred, given that it possesses an oc-diimine arrangement so common for chelating 
biheterocycles, and might also be favoured for steric reasons. 
N2,N2'- N2,N4~ N4,N4'-
Fig. 4.22 
Palladium(II) adopts a square planar geometry almost exclusively, and readily chelates 
to biheterocycles. For this reason, palladium(II) was chosen as the first metal ion to be used 
for this investigation. Ligand 57 was reacted with one equivalent of PdClz dissolved in hot 
aqueous 2M HCI. Yellow plates, suitable for X-ray diffraction, grew from the reaction 
mixture. The structure contained some disorder, which could not be satisfactorily modelled, 
and the structure as a whole could not be refmed to an acceptable level. However, the ligands 
bound to the metal could be determined unambiguously. A pictorial representation of the 
complex (73) is shown in Fig. 4.23, and shows that the complex contains a chelating ligand 
and two coordinated chlorine atoms. One ring of the ligand has ring-opened, regenerating an 
amidoxime, which coordinates to the metal through the oxime nitrogen, and importantly, the 
unopened ring is coordinated via the N4 nitrogen atom. This suggested that perhaps N4,N4' 
chelation would be the preferred mode of chelation by 57. 
74 
Fig. 4.23 
The lH NMR spectrum of the complex was recorded in deuterated acetonitrile and, by 
the selective monocyclisation of oxamidoxime,148 the free ligand, (74), was produced and a 
lH NMR spectrum recorded, allowing the calculation of the CIS values (Table 4.1). The 
oxadiazole H5 shows a positive CIS, consistent with its proximity to the chlorine atom. 
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Table 4.1 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 73 and 74. 
H5 NH2 OB I 
73 9.65 6.85 c 
74 9.06 5.80 8.58 
CIS +0.59 +1.05 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex - Oligand). C Not recorded. 
Moussebios et al. 174 have shown that 1,2,4-oxadiazoles are converted to amidoximes 
upon treatment with acid. So instead of the acidic conditions of the previous reaction, a 
methanolic solution of LbPdC14 was added to a methanolic solution of ligand 57. Again, the 
reaction mixture furnished crystals, (75), suitable for crystallography, and one of these was 
used for X-ray analysis. The structure is shown in Fig. 4.24. 
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Fig. 4.24 Perspective view, with atom labelling of the contents of the asymmetric unit, of 75. 
Selected bond lengths (A) and angles (0): Pdl-N4 2.031(3), Pdl-N4' 2.046(3), Pdl-Cll 
2.270(1), Pdl-C12 2.276(1), N4-Pdl-N4' 79.8(1), Cll-Pdl-C12 92.82(4), 01-C5 1.334(4), 
01 '-C5 1 1.335(4), 01-N2 1.417(4), 01'-N2' 1.423(4), N2-C3 1.295(4), N2'-C3' 1.290(5), C3-
N4 1.371(5), C3'-N4' 1.386(4), N4-C5 1.289(4), N4'-C5' 1.297(5), C5-0l-N2 107.5(3), C5'-
01'-N2' 107.3(3), C3-N2-0l 102.0(3), C3'-N2'-01' 102.3(3), N2-C3-N4 115.0(3), N2'-C3'-
N4' 115.3(3), C3-N4-C5 103.5(3), C3'-N4'-C5' 102.6(3), N4-C5-0l 112.0(3), N4'-C5'-01' 
112.5(3). 
The complex crystallises in the orthorhombic space group Pnma, with a full molecule 
in the asymmetric unit. This structure unambiguously determined the mode of coordination 
as N4,N4'. The values for the bond lengths and angles for the 1,2,4-oxadiazole rings in this 
complex are similar to those found for the other coordination complex containing a 1,2,4-
oxadiazole. 129 
Ligand 57 was also reacted with an excess of LhPdCk in the hope of forming a 
dinuclear complex. However, the complex that formed in this attempt, as determined by 
elemental analysis, was the above mononuclear complex 75. 
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Given that 57 is a multi dentate ligand, and is potentially capable of coordinating to 
more than one metal at a time, it was decided to explore 57 in the context of 
metallosupramolecular chemistry. To this end, the coordination chemistry of ligand 57 was 
investigated with AgN03. A complex of 1:1 stoichiometry [57.AgN03], (76), was prepared 
by mixing methanolic solutions of AgN03 and ligand 57. Recrystallisation of the resulting 
complex from acetonitrile gave colourless single crystals suitable for an X-ray diffraction 
study. The asymmetric unit of the structure is shown in Fig. 4.25a. 
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Fig. 4.25a Perspective view, with atom labelling of the contents of the asymmetric unit, of 76. 
Selected distances (A) and angles (0): Ag1-N4 2.384(2), Ag1-011 2.370(3), 01-N2 1.417(3), 
N2-C3 1.309(3), C3-N4 1.384(3), N4-C5 1.301(3), C3-C3' 1.478(5), 011-Ag1-N4 111.33(5), 
N4-AgI-N4' 131.82(9), C5-01-N2 106.6(2), C3-N2-01 102.6(2), N2-C3-N4 115.2(2), C3-
N4-C5 102.0(2), N4-C5-01 113.6(2). 
Fig. 4.25b Perspective view of the extended structure of76. 
The asymmetric unit contains one half ligand, coordinated to the silver atom via its N4 
nitrogen, and a nitrate anion coordinated via an oxygen atom to the silver. The silver atom 
and the four atoms of the nitrate anion all lie on a mirror plane and the occupancy of these 
atoms is Yz. The silver atom is tricoordinate, and the geometry of the coordination can be 
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described as a distorted T -shape. The angle around the silver for the coordinating N4 atoms 
of different ligands [N4-Agl-N4' 131.82(9)°] results in the coordination being far from linear. 
By virtue of the centre of inversion in the centre of the inter-ring bond, the rings of the ligand 
are strictly coplanar and trans. The two symmetry elements provide this one-dimensional 
metallopolymer with a central axis, about which the nitrate anions oscillate with the polymer 
itself weaving about in a wave-like fashion (Fig. 4.25b). 
Having determined that the N4,N4'-mode was preferred for ligand 57, it was of 
interest to examine the bonding of the ligand 58, where the preferred N4 nitrogen of the 
oxadiazole is crowded by the neighbouring methyl group. This might result in a N2,N2' 
chelate, and would represent an example of steric control over the regioselectivity of complex 
formation. One equivalent of PdClz dissolved in hot aqueous 2M HCl was added to ligand 58 
dissolved in methanol, and the resultant solution left to stand. Fine golden rods, that analysed 
as [58.PdClz], (77), formed in the next few days, but unfortunately these crystals were too 
small for an analysis by X-ray diffraction. hnportantly, there was no evidence for a ring-
opened product in the IH NMR spectrum. However, as the chemical shift of the methyl 
groups in the complex was close to that of the free ligand, the spectrum proved inconclusive, 
indicating either that ligand· dissociation had occurred or that N2,N2 '-chelation had very little 
effect on the chemical shift of the methyl groups. N4 coordination would place the protons 
of the methyl groups considerably closer to the chlorine atom than would the H5 protons of 
ligand 57 (Fig. 4.26). Thus they would be much more sensitive to the effects of shielding by 
the chlorine atom, and only a large positive CIS in one or both groups would be evidence to 
suggest N4 coordination. 
N2,N2' N2,N4' N4,N4' 
Fig. 4.26 
To determine how other ligands containing a 1,2,4-heterodiazole would chelate, some 
coordination complexes were prepared with 2-(l,2,4-oxadiazol-3-yl)pyridine (63) and 2-
(l,2,4-thiadiazol-5-yl)pyridine (65) (Fig. 4.27). Both 63 and 65 are capable of two modes of 
chelation. For ligand 63, Nl,N2'- or Nl,N4'-chelation is possible, while for ligand 65, Nl,S l' 
and Nl,N4' are the possible modes of chelation. Several features could be ascertained by the 
formation and characterisation of chelating complexes with these simple ligands, and these 
features could be used to predict the coordination of complexes of higher nuclearity with the 
extended ligands. Accordingly, palladium(II) and copper(II) complexes were prepared with 
both of these ligands. 
107 
63 65 
Fig. 4.27 
When ligand 63 was reacted with LizPdC4 in methanol, a yellow complex precipitated 
from solution in high yield (95%), and analysed as [63.PdCh], (78). The complex was 
recrystallised from nitromethane, and the golden yellow needle-like crystals formed were 
filtered off. Unfortunately, the crystals were not large enough for crystallography, so lH 
NMR spectroscopy was employed as a tool in characterisation. The mode of chelation 
(Nl ,N2' or Nl ,N4) (Fig. 4.28) could be most easily distinguished by the chemical shift of the 
oxadiazole H5' proton. In the NI ,N4' mode, the oxadiazole proton points toward the adjacent 
chlorine atom, and would be expected to be deshielded by this electronegative element, giving 
a strong positive CIS. Alternatively, the H5' proton in the Nl,N2'mode points away from the 
chlorine atom and would be expected to experience no such deshielding effect. Thus it would 
be expected to have only a small CIS value. 
NI,N2'- Nl,N4'-
Fig. 4.28 
The chemical shifts and coordination induced shifts for 78 are shown in Table 4.2. 
From the shifts, particularly the strong CIS value of H5', chelation is deduced to be through 
the Nl,N4'-mode. 
Table 4.2 lH NMR Chemical Shifts a and Coordination Induced Shiftsb for 78 and 63. 
H3 H4 H5 H6 H5' 
78 8.41 8.41 7.96 9.08 10.73 
63 8.12 8.04 7.62 8.77 9.77 
CIS +0.29 +0.37 I +0.34 +0.31 +0.86 
a For deuterated dimethyl sulfoxide solutions. b CIS = (Ocomplex - OUgend). 
To prepare the copper complex two equivalents of ligand 63 was reacted with 
CU(N03)2.3H20 in methanol and after a few days crystals, (79), suitable for a structural study 
were obtained directly from the reaction solution. The structure is shown in Fig. 4.29. 
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Fig. 4.29 Perspective view, with atom labelling of the contents of the asymmetric unit, of 79. 
Selected distances (A) and angles (0): Cul-NI 2.020(2), Cul-N2 2.012(2), NI-Cul-N2 
80.9(1), Cul-02 2.561(3), CI-N2 1.280(3), CI-OI 1.327(3), CI-C2 1.488(3), Ol-CIO 
1.451(3). 
Complex 79 crystallises in the space group P-I, with a centre of inversion located at 
Cu 1. This results in a trans arrangement of the ligands in the complex, as well as relating the 
non-coordinated nitrate counterions through the centre of inversion. The structure shows that 
the ligand has rearranged, with the oxadiazole ring being cleaved, and that an imino ester has 
formed. Eloy et aI.175 have shown that, upon standing, 3-substituted 1,2,4-oxadiazoles 
decompose to the corresponding nitrile. It seems that this process has occurred, and that the 
solvent has reacted with the nitrile to produce the iminoester, which has then chelated to the 
copper. This rearrangement once again demonstrates the instability of the 1,2,4-oxadiazole 
ring. 
Reacting CuCb.2H20 with ligand 63 in methanol gave another copper complex. 
Immediately, a light lime green precipitate formed, in quantitative yield, and this was 
collected by filtration. Elemental analysis of the complex determined a 1: 1 stoichiometry 
[62.CuCb], (80). Unfortunately, no crystals suitable for a crystallographic study could be 
grown. 
A palladium(II) complex with ligand 65 was prepared and purified in the same manner 
as the palladium(II) complex for ligand 63 described above. The golden needle-like crystals, 
(81), obtained from the nitromethane recrystallisation analysed as [65.PdCb], but were not 
suitable for X-ray crystallography. Again, 1H NMR spectroscopy was employed as a 
characterisation tool. The mode of chelation (NI ,S l' or NI ,N4') (Fig. 4.30) could, as before, 
be most easily distinguished by the chemical shift of the proton on the heterodiazole ring. In 
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one mode (N1,N4j, the thiadiazo1e proton points toward the deshie1ding chlorine atom, 
whereas in the other mode (N1,Sl), it points away from the chlorine atom. On the basis of 
the CIS value the mode of coordination could potentially be distinguished. 
N1,N4'- N1,Sl'-
Fig. 4.30 
The IH NMR spectrum of the complex 81 was recorded in deuterated DMSO, and it 
showed a mixture of free and complexed ligand. In comparison with the spectrum of the free 
ligand, the signals due to the complex were identified. The chemical shifts and coordination 
induced shifts are given in Table 4.3. The H4, H5 and H6 protons of the pyridine ring in 
complex 81 show similar CIS values to the previous palladium complex 78. The CIS value of 
H3 is more than twice that of the CIS of H3 in the previous complex 78, and this was 
assumed to be because this proton was close to the large sulfur atom - indicating N1,N4'-
chelation. 
Table 4.3 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 81 and 65. 
H3 H4 H5 H6 H3' 
81 8.78 8.43 7.95 9.03 9.14 
65 8.17 8.08 7.65 8.72 9.02 
CIS +0.61 +0.35 +0.30 +0.31 +0.12 
a For deuterated dimethyl sulfoxide solutions. b CIS = (Ocomplex - Oligand). 
A copper complex was prepared by reacting ligand 65 with CuCh.2H20 in methanol. 
This gave an immediate precipitate of a light green complex in quantitative yield, and the 
elemental analysis of this complex determined a 1: 1 stoichiometry, [65.CuCh], (82). 
Recrystallisation by vapour diffusion of diethyl ether into a methanollDMSO solution of the 
complex provided crystals suitable for X-ray crystallography. The structure is shown in Fig. 
4.3l. 
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Fig. 4.31 Perspective view with atom labelling of 82. 
This complex crystallises in the monoclinic space group C2/c, and has a chelating 
ligand and two chlorines coordinated to a copper atom in a square planar coordination 
environment. The ligand is coordinating through the pyridine nitrogen and N4' of the 1,2,4-
thiadiazole ring. In this structure, there was evidence of some disorder with respect to the 
orientation of the ligand. The ligand as a whole was found to exist also in the opposite 
orientation within the crystal, and this was foUnd to be so about 15% of the time. Attempted 
modelling of this disorder was unsuccessful, and also due to the presence of diffuse solvent 
the structure could only be refined to an R-factor around 8.5%. Nevertheless, this study 
proved that chelation was through the Nl,N4'-mode for this complex. The molecular packing 
for this structure indicated that the molecules pack in sheets, with weak Cu-Cu interactions 
[ca. 3.8A] between the sheets, and interaction between the chlorine atoms of one complex to 
the sulfur atom of another within the sheet. A search of the Cambridge Crystallographic 
database revealed no X-ray crystal structures of 1,2,4-thiadiazole-containing coordination 
complexes. Indeed, very few X-ray crystal structures of molecules containing this 
heterocyclic ring have been reported.176-179 
These results suggest that there might exist some predictive control over the 
coordination modes that the extended ligands would have upon formation of complexes of 
higher nuclearity. For example, it was expected that the ligand 3,3'-di(2-pyridyl)-5,5'-bi-
1,2,4-oxadiazole (62) would form dinuclear complexes in the form ofN4,Nl"-~-N4',Nl"', as 
shown in Fig. 4.32. 
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Fig. 4.32 
In order to gain some insight into the exact nature of the metal-ligand interactions in 
complexes of these ligands, a study of their coordination chemistry with ruthenium(II) was 
undertaken. The first ruthenium complex prepared was with ligand 57. Using the standard 
3: 1 ethanol/water reaction conditions, RU(bPY)2Ch was first refluxed for an hour before 
addition of the ligand. Reflux was continued for another hour before the reaction was stopped 
and the cationic products isolated as hexafluorophosphate salts. A 1 H NMR spectrum of the 
material obtained after workup was very confusing. No singlet corresponding to the 
oxadiazole H5 proton was immediately obvious, and the spectrum defmitely indicated the 
presence of more than one complex. Interestingly, there were also signals corresponding to 
ethoxy groups. F ABMS of the material was unable to identify any ions that corresponded to 
the desired [Ru(bpY)2(57)](PF6)2 complex (Fig. 4.33) and so further purification and 
identification of the products was not attempted. 
It seemed that the ligand had again undergone rearrangement. To test whether the 
rearrangement was metal-catalysed, the ligand was refluxed alone in 3: 1 ethanol/water. A IH 
NMR spectrum of the resulting products showed a mixture of starting material and products 
containing the ethoxy-type peaks seen in the IH NMR spectrum of the ruthenium complex. 
This proved that the ligand was unstable to the refluxing 3: 1 ethanol/water reaction 
conditions. Hence, the alternative procedure, using AgBF4 as the silver saIt, was attempted. 
Analysis by FABMS and IH NMR spectroscopy of the crude material obtained from this 
reaction again provided no evidence for the formation of the desired complex 
[Ru(bpY)2( 57) ](BF 4)2. 
Fig. 4.33 
At this time we interpreted the results obtained for ligand 57 as suggestive that 
monosubstituted 1,2,4-oxadiazoles may be unstable to such reaction conditions. It was hoped 
that the disubstituted ligand 59 would be more stable. Due to the low solubility of ligand 59, 
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a long reflux time was required in the reaction with RU(bPY)2Ch. A low yield (45%) of 
complex was obtained, and this was purified by chromatography on alumina. The IH NMR 
spectrum of this complex is shown in Fig. 4.34. From the appearance of the spectrum, it is 
obvious that a symmetrical chelating complex has formed. Of note is the existence of a broad 
signal at 10.8 ppm, which is typical of the chemical shifts of oxime protons found in this 
work, and so it seemed that the oxadiazole rings had again ring-opened. To get an idea of the 
molecular constitution of the complex, a high-resolution F AB mass spectrum was obtained. 
The dominant molecular ion was at 707.1 a.m.u. corresponding to C36H29Ns02Ru+, with the 
only higher cluster at 853.1 a.m.u., which corresponds to the addition of HPF6. As the 
Ru(bpyh2+ unit is intact, this leaves C16H14N40Z as the molecular formula for the ligand, 
which represents the addition of 4 hydrogen atoms. In light of the molecular formula 
obtained, and the presence of an acidic hydrogen in the IH NMR spectrum, two possible 
products were considered (Fig. 4.35). In one product, an oxime functional group is present, 
while the other contains an acyl ami dine. Exactly which of these is present in the complex is 
unknown, but the favoured possibility is the ami dine as no singlet signal can be seen for a 
proton attached to the carbon of an imine in the IH NMR spectrum. Also, the N-O bond in 
oxadiazoles is the most susceptible to cleavage and breakage at this point would give the 
amidine product. 
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Fig. 4.34 IH NMR spectrum of the rearrangement product from the reaction ofRu(bpyh2+ 
and ligand 59. 
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It was at this stage that the precursors oxamidoxime, (OAO), and 2-pico1y1amidoxime, 
(PAO), (Fig. 4.10), were reacted with Ru(bpy)zClz and Ru(dmb)zClz, respectively, under the 
standard 3: I ethanol/water reaction conditions. This was done to study their behaviour under 
F ABMS conditions, and to get an idea of the chemical shifts of the oxime and amine protons 
in the IH NMR spectrum. From the IH NMR spectra and from the elemental analyses of 
these complexes it was detennined that che1ating complexes had fonned, and that they were 
both bis(hexafluorophosphate) salts. In the IH NMR spectra of both complexes, the oxime 
proton was not observed, which is in contrast to the spectra seen thus far. This was taken as 
more evidence that the downfie1d proton may be an amidine proton and not that of an oxime. 
Under the FAB mass spectral conditions the complex [Ru(bpY)z(OAO)](PF6)z gave the 
dominant molecular ion of CZ2H21N80zRu + ([Ru(bpY)2(OAO)t minus a proton) with again 
the only higher cluster being the addition of HPF6• This is consistent with losing PF6- then 
HPF6 from the neutral complex. The complex [Ru(dmb)z(pAO)](PF6)2 also underwent the 
same loss of PF6" then HPF6 in the mass spectrometer. Thus the behaviour of these 
complexes simulated that found for the ring opened products, lending support to the 
molecular fonnu1a determination above. 
It was with some trepidation that the reactions with the other 1,2,4-oxadiazole ligands 
in the 3: 1 ethanol/water reaction conditions were performed. The results of the reactions for 
ligands 62 and 63 in ethanol/water are conveniently and concisely summarised in Scheme 
4.17. Neither of the 1,2,4-oxadiazo1e ligands was unchanged in these reactions. The 
decomposition products were characterised, and the technique of F ABMS proved particularly 
useful for this purpose. The decomposition product of the ligands in these reactions was the 
same. The alternative reaction conditions were then used for the reaction of ligand 63. 
However, IH NMR and FABMS showed the presence of the same decomposition product. 
The alternative conditions using the silver salt in acetone/ethanol were unsuitable for the 
reaction with 62 as this molecule has very low solubility in these solvents. As a last attempt, 
the conditions that had been used for the preparation of ruthenium complexes with the 
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triazo1e-based ligand 69 145 (Fig. 4.9) were used for ligand 62. This was unsuccessful as 1H 
NNIR spectroscopy and F ABMS again identified the amidine decomposition product. 
2 2 (PF6h N ~ XS NH4PF6 /N ~ RU(bPYhCI2 + (bpYhRu N;/' N \~ N NH2 
'o--.lJ H 
2 N ~ 2 (PF6h N;/' N XS NH4PF6 /N /5-2 RU(bPYbCI2 + 'o~ . (bpYbRu \~ 
_N N NH2 
o,~ H 
N \ ~ 
Scheme 4.17 
The results for the reaction of Ru( dmb )2Ch with ligand 66 in ethanol/water were 
slightly more interesting in. that the ligand had only ring-opened and not cleaved (Scheme 
4.18). The reaction was repeated using the silver reaction conditions, and again 1H NMR and 
F ABMS identified that the same product had formed. Perhaps some stabilisation would be 
offered by dinucleation of the ligand, and therefore ligand 66 was reacted with two 
equivalents of Ru(bpY)2Ch in refluxing 3: 1 ethanol/water. The product of this reaction, 
isolated as a hexafluorophosphate salt, was shown by F ABMS to contain two Ru(bpy)l+ units 
and was postulated to be the dinuclear complex shown in Scheme 4.18. The 1H NMR 
spectrum of this material was very complicated. However, one piece of information could be 
gleaned from the spectrum; the presence of two signals in the downfie1d region corresponding 
to the NH protons is consistent with the formation of diastereoisomers. 
2 RU(bPYbCI2 
Scheme 4.18 
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The first ruthenium complex prepared with the thiadiazo1e ligand (65) was with 
Ru(dmb)2Ch in the 3:1 ethanol/water conditions. Pleasingly, characterisation by FABMS and 
elemental analysis revealed that a che1ating complex, (83), had formed in an excellent yield of 
96%. From the CIS values (Table 4.4), particularly the large upfie1d shift of H3', it was 
deduced that the thiadiazo1e ligand was che1ating through N1,N4', as shown in Fig. 4.36. Of 
further note is the small positive CIS ofH4. As the CIS of this proton reflects the (J~donor 11-
back-bonding trade off, the value of +0.10 would seem to indicate one of two things: either 
the pyridine is donating less to the metal or is accepting an unusually large amount of n-back 
donation. 
Table 4.4 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 83 and 65. 
H3 ! H4 H5 ! H6 H3' i 
83 8.59 8.14 7.55 7.85 8.28 
65 8.23 8.04 7.59 8.73 8.84 
CIS +0.36 +0.10 -0.04 -0.88 -0.56 
a For deuterated acetonitrile solutions. b CIS =0 (Ocomplcx - Oligand). 
83 
CH3 
Fig. 4.36 
The complex [RU(bPY)2(65)] (PF6)2, (84), was prepared in the same manner as above 
and was characterised by F ABMS and elemental analysis. The IH NMR spectrum of 84 is 
shown in Fig. 4.37. In previous complexes, viz. 13 and 35, the cooperative use of 1-D 
TOCSY and IH nOe spectroscopy allowed the positive identification of the ligand of interest 
in the complexes. Because the thiadiazo1e proton points away from the pyridine ring of the 
ligand (Fig. 4.36), the strategy used previously is inappropriate. This only left the comparison 
of the CIS values of complex 83 to identify the pyridine ring of the thiadiazo1e-containing 
ligand in 84. This made the identification of all the protons of the complex 84 important. 
Unfortunately, none of the identified spin systems in complex 83 gave a sufficiently good 
correlation to that of the pyridine ring of the thiadiazo1e ligand in complex 83 to be able to be 
assigned with certainty. 
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Fig. 4.37 lH NMR spectrum of [Ru(bpY)2(65)](PF6)2 (84). 
UV -visible spectroscopy and cyclic voltammetry were then used to investigate 
complexes 83 and 84. The UV-visible spectrum and cyclic voltammogram of84 are shown in 
Fig. 4.38, while the results ofthese studies are summarised in Table 4.5. 
Table 4.5 Absorption Maximaa and Redox Potentialsb of complexes 83 and 84. 
Amax Eox Eredl Ered2 Ered3 ilEox-redl 
Ru(bpy)l+ 452 +1.26 -1.33 -1.51 -1.75 2.59 
83 494 +1.18 -1.08 -1.69 -1.88 2.26 
84 487 +1.29 -1.02 -1.58 -1.92 2.31 
a In nanometers for acetonitrile solutions. b In volts vs SeE in acetonitrile. 
When compared to Ru(bpy)l+, the substitution of a single pyridine ring with a 1,2,4-
thiadiazole has significantly changed the redox and electronic properties of the resulting 
complex. The thiadiazole-containing complexes 83 and 84 have their Amax at longer 
wavelength, and the HOMO-LUMO energy gap has been considerably reduced, as evidenced 
by the smaller Eox-redl values for these complexes, as compared to Ru(bpy)l+. The complex 
83 is easier to oxidise than complex 84 by 110 mY. This is attributable to the well-known 
effect of replacement of bpy with dmb. l80 The electron donating effect from the methyl 
groups of the dmb ligands adds electron density to the metal, and this allows for easier 
oxidation (the removal of an electron) of the metal. The effect of adding a methyl group is to 
lower the oxidation potential by approximately 25 m V per group, and this is seen in 
complexes 83 and 84 as the complex 83 possesses 4 methyl groups (2 for each dmb ligand) 
and the oxidation potential is lowered by 11 0 m V. 
Abs 
2.5 
2.0 
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Fig. 4.38 UV -visible spectrum and cyclic voltammogram of [Ru(bpY)2(65)](PF6)2 (84). 
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Given the disappointing results of the 1,2,4-oxadiazoles, it was decided to investigate 
another unexplored heterocyclic system. 1,4,2,5-Dioxadiazines have not been used as 
ligands. Despite being such an exotic ring system, 1,4,2,5-dioxadiazines are surprisingly 
easily constructed. De Sarlo181 has synthesised 3,6-diaryl-l,4,2,5-dioxadiazines, in high 
yields, by the pyridine catalysed dimerisation of nitrile oxides. Given the interesting 
properties of dinuclear complexes containing 2,5-di(2-pyridyl)pyrazine, (85), and 3,6-di(2-
pyridyl)tetrazine, 182-188 (86), we thought that by the replacement of CH by Nand 0, using a 
1,4,2,5-dioxadiazine as the central six-membered ring (Fig. 4.39), this study could be 
systematically extended by employing the new ligand 87. 
0--<~-N\~_;;~ 
~~I\~-O~ 
Fig. 4.39 
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To synthesise the desired ligand, the appropriate precursor needed to be prepared 
(Scheme 4.19). 2-Pyridinecarboxaldehyde was converted into the corresponding oxime by 
reaction with hydroxylamine, and treatment ofthe oxime with chlorine in chloroform solution 
gave the hydroximinolyl chloride as the hydrochloride salt in quantitative yield. Two 
equivalents of triethylamine and an excess of pyridine (4-5 equiv.) were added to an ethanolic 
solution of the hydrochloride salt. After work-up two products were identified in TLC, 
separated by chromatography and assigned by IH NMR. In subsequent preparations, 
separation and purification was achieved by simple recrystallisation to produce ligand 87 in 
modest yields of 55-60%. Characterisation of this new ligand was by melting point, IH and 
l3C NMR spectroscopy, ElMS and elemental analysis. 
+ 
87 
Scheme 4.19 
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As the dinuclear Ru(bpY)l+ complex with this ligand would only contain 2-substituted 
pyridine rings, ligand 87 was reacted with two equivalents of Ru( dmb )2Ch under the standard 
3: 1 ethanol/water conditions. This would hopefully allow the ready identification of the 
pyridine rings of the ligand in the IH NMR spectrum. The cationic products of the reaction 
were collected as hexafluorophosphate salts and purified by chromatography on alumina. 
Two bands were separated on the column, and were analysed by IH NMR spectroscopy. This 
ascertained that they were different mononuclear complexes each containing five different 
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pyridine rings. In the first band, the sixth coordination site was lH NMR silent, while the 
second complex had a broad signal at ca. 6.5 ppm reminiscent of a NH2 peale seen for the 
complexes isolated previously. The samples were then positively identified by FABMS as 
complexes containing picolinate and picolinamide (Scheme 4.20). 
2"'-:::: N ~ 
N:/" ° 
+ 
°01 ~~ 
':::::'N I~ 
RU(dmb)2Cb 
(36%) (37%) 
Scheme 4.20 
In an attempt to see if this ligand was able to bridge two metal ions, ligand 87 was 
reacted with two equivalents of CuCh.2H20 in methanol. Upon addition, an immediate 
precipitate formed leaving a green solution, indicating that complete uptake of the metal ion 
was not achieved. The elemental analysis of the complex was not consistent with either a [1 
+ 1] or a [1 + 2] stoichiometry, but something in between, suggesting a mixture of the two 
complexes. 
A silver nitrate complex was prepared in the same manner as previous silver 
complexes. The colourless complex analysed as [87.AgN03], (89), and formed in an 
excellent yield of 96%. Despite various attempts to recrystallise this complex to gain crystals 
suitable for an X-ray analysis no such crystals were grown. 
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4.4 Summary 
In this chapter, the synthesis of a new 1,2,4-oxadiazole-containing ligand (62) was 
described, as well as improved syntheses of three previously reported ligands (63, 65 and 66). 
Other attempts at the syntheses of desired ligands led to the discovery of a novel fused 
heterocyclic compound containing an imidazo[1,5-aJpyridine ring (72), and the formation of 
an unexpected 1,3,5-triazine-containing product from the reaction of thiopicolinamide and 
iodine. Other unsuccessful attempts at ligand preparations were also discussed. 
The characterisation of the chelating palladium complexes prepared confirmed the 
preference for coordination of the N4 nitrogen over the N2 nitrogen in 3-substituted 1,2,4-
oxadiazoles. Also the polymeric structure of the silver nitrate complex with 3,3'-bi-1,2,4-
oxadiazole (57) was determined by X-ray crystallography. This structure too had 
coordination to the metal from the N4 atom. 
Despite the favourable features that the 1,2,4-oxadiazole heterocyclic system offers, in 
retrospect it was an unfortunate choice, as it proved unsuitable for the construction of 
ruthenium complexes by the methods used in this work. Also, a number of complexes formed 
and characterised arose from decomposition of the 1,2,4-oxadiazole rings in the ligands. 
These included an acid induced ring opening and a product where, after decomposition, a 
subsequent reaction with solvent provided a chelating ligand. These both demonstrate the 
instability of this heterocyclic system. On the other hand, the 1,2,4-thiadiazole system, 
although more synthetically challenging, proved to be much more stable. A preliminary 
investigation into this system proved interesting. Electrochemically, the 1 ,2,4-thiadiazole ring 
brought the n* energy level of ligand 65 to lower energy relative to bpy, resulting in a lower 
reduction potential of the ligand in the complex. Thus, in contrast to the unstable 1,2,4-
oxadiazole system, the 1,2,4-thiadiazole ring is a useful component for incorporation into 
chelating ligands and has a significant effect upon the electronic properties of the resulting 
complexes. 
A new, novel, 1,4,2,5-dioxadiazine ligand was successfully synthesised. 
Disappointingly, the brief exploration into the coordination chemistry of this system proved 
fruitless, with no crystal structures to determine if the dioxadiazine ring participates in 
coordination, and with the ligand cleaving under the 3: 1 ethanol/water reaction conditions in 
the attempted preparation of a dinuclear ruthenium complex. 
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Chapter 5 
1,2,5-Heterodiazoles 
5.1 Introduction 
This chapter deals with another isomer of the heterodiazoles. Again the ligands 
contain a five membered ring with three heteroatoms two of which are nitrogen and the 
other either oxygen or sulfur. The ring system and ring numbering for a 1,2,5-system are 
sho¥.'ll in Fig. 5.1. 
3 4 
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2 N N 5 X 0, S 
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Fig. 5.1 
The first point of consideration was, again, the rational design of chelating ligands 
containing these heterocycles that would allow a systematic study of mononuclear and 
dinuclear complexes. As in Chapter 4, linking other heterodiazoles or pyridines to the 
unsubstituted positions of a heterodiazole ring was chosen as the approach. The ligands for 
this study are 2-(1,2,5-oxadiazol-3-yl)pyridine (90), 3,4-di(2-pyridyl)-1,2,5-oxadiazole (91), 
4,4'-di(2-pyridyl)-3,3'-bi-l,2,5-oxadiazole (92), 2-(1,2,5-thiadiazol-3-yl)pyridine (93), 3,4-
di(2-pyridyl)-1,2,5-thiadiazole (94) and 4,4'-di(2-pyridyl)-3,3 '-bi-l,2,5-thiadiazole (95) (Fig. 
5.2). 
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Fig. 5.2 
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Ligands 90 and 93 are the building blocks for these families of oxadiazoles and 
thiadiazoles, Extension tluough the 4-position of the heterodiazole, in each case by a 
pyridine, gives 91 and 94, whereas 92 and 95 are the 'dimer' ligands of 90 and 93, The 
preparation of mononuclear ruthenium complexes with 90 - 95 would provide a basis for 
comparison of the properties of the dinuclear complexes, 
Ligands 91 and 94 have a structural similarity to 2,3-di(2-pyridyl)pyrazine, (96), and 
4,6-di(2-pyridyl)pyrimidine, (97), (Fig, 5.3), both of which have been very well studied. 10,1B9 
In dinuclear complexes involving ligand 96, the pyridine rings of the ligand are kilted with 
respect to the central pyrazine ring because of the steric clash between the H3 protons of the 
pyridyl rings, This leads to disruption of overlap of the n-systems within the ligand. Even so, 
dinuclear ruthenium complexes of 96 exhibit metal-metal interactions (LlEp 170 m V). 190 
Ligand 97 is a sterically less demanding ligand than 96. The pyridyl rings of the ligand are 
further separated, leading to reduced steric interaction, which is much better for the stability 
of dinuclear complexes, Ligand 97 also has a shorter metal-metal distance than 96 but, 
despite these favourable features, the metal-metal interaction in dinuclear ruthenium 
complexes of 97 is slightly less (LlEp 160 m V).191 
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Replacing the central six-membered diazine rings with a five-membered heterodiazole 
has some important consequences geometrically and electronically. Firstly, the angle across a 
five-membered ring is greater than that in a six-membered ring (72° vs 60°), and this fact 
should help reduce the steric interaction for the dinuclear complexes of 91 and 94 relative to 
those encountered in the dinuclear complexes with ligand 96. Another favourable outcome of 
replacing the central six-membered ring with a five-membered ring is that the distance across 
the five-membered ring is less: This will result in the metal-metal distance being decreased 
relative to dinuclear complexes containing 96 and comparable to those containing 97. 
Electronically, the diazines and the heterodiazoles are very different. The diazines are a class 
of n-deficient heterocycles while the heterodiazoles are n-excessive. This electronic 
difference is expected to impart significantly different properties to the dinuclear complexes 
of91 and 94 relative to those of96 and 97. 
In a similar fashion, binuclear complexes of 92 and 95 can be compared to the 
binuclear complexes of2,2':4',4":2",2"'-quaterpyridine, (98) (Fig. 5.3), a ligand that facilitates 
weak, but detectable, metal-metal interactions.76,192 
Previous studies of the coordination chemistry of 1,2,5-heterodiazoles have been 
mainly restricted to 2,1,3-benzothiadiazoles193,194 and simple derivatives of them.195,196 The 
studies of Munakata et al. 194 were investigations into potential metallopolymeric networks 
with simple 2,1,3-benzothiadiazoles and eu(II) salts. A study by Kaim et al. 197 examined the 
properties of dinuclear molybdenum pentacarbonyl complexes bridged by 2,1,3-
benzothiadiazole and 2,1 ,3-benzoselenadiazole rings. 
2,1,3-benzothiadiazole 
The coordination chemistry of 1,2,5-oxadiazoles has been even less well investigated 
with on1y one report in the literature. 198 To summarise, all of the reported studies on the 
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1,2,5-heterodiazole systems have been of simple mono cyclic ligands and not those capable of 
a chelating coordination mode. This is in contrast to the present study, where the aim was to 
study the electronic properties of these heterocycles in new chelating heterocyclic ligands. 
This chapter describes the preparation and characterisation of four new ligands, as 
well as the attempted preparations of two other ligands. Also described is a 
metallosupramolecular complex with one of the ligand precursors, as well as an interesting, 
new, ring-opening ring-closing (RORC) reaction. Mononuclear ruthenium complexes, 
homodinuclear ruthenium complexes, heterodinuclear ruthenium-palladium and 
heterodinuclear ruthenium-platinum complexes are prepared, characterised and examined 
electrochemically. 
5.2 Syntheses of Ligands 
Two established methods for the synthesis of 1,2,5-oxadiazoles are the 
cyclodehydration of a-dioximes and the deoxygenation of 1,2,5-oxadiazole-2-oxides (Scheme 
5.1 ).199 Both of these synthetic procedures were employed in the syntheses of the 1,2,5-
oxadiazole-containing ligands. 
OH 
J 
N Nv"OH 
H 
R R 
Scheme 5.1 
~O, 
N N g 
R R 
~O, 
N N g 
R R 
To produce the ligand 90, 2-acetylpyridine was first oximated by amyl nitrite in 
sodium ethoxide solution to give the desired oxime, and this was then reacted with 
hydroxylamine, based on a procedure for the phenyl analogue,200 to give the a-dioxime in 
17% overall yield for these two steps. Unfortunately, the a-dioxime was not cyclised with 
one equivalent of acetic anhydride as has been reported for the phenyl analogue.201 
Or amyl nitrite I NaOEt ...-:: 0 -----"" N ~ I ~ N N : "OH ~ 
OH 
Scheme 5.2 
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Ligand 91 was produced in two steps starting from the commercially available 2,2'-
pyridil, as shown in Scheme 5.3. An a-dioxime was prepared by reacting the diketone with 
an excess of aqueous hydroxylamine, and heating the dioxime at 185°e for 7 hours in a sealed 
tube effected cyclisation. The yields of the two reactions were 42% and 33%, respectively, 
giving an overall yield for the two steps of 14%. This new 1,2,5-oxadiazole-containing ligand 
was characterised by melting point, lH and l3e NMR spectroscopy, EI mass spectrometry and 
elemental analysis. 
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A closely related molecule to 91 was also synthesised, originally with the intention of 
subsequent deoxygenation to give 91. 3,4-Di(2-pyridyl)-1,2,5-oxadiazole-2-oxide, (99), is a 
known molecule202 and was prepared by the literature procedure as shown in Scheme 5.4. 
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Scheme 5.4 
Ligand 99 is also potentially capable of forming dinuclear complexes. It must, 
however, do so using two different donor sets, as shown in Figure 5.4. The chelate ring sizes 
would also be different in dinuclear complexes containing 99. The N5-N111 chelate is five-
membered, while the 02-N1' is six-membered. Complexes of this type have been little-
studied, perhaps due to their intrinsically more complex nature. In this study, the 
mononuclear ruthenium complex of ligand 99 could be compared to the mononuclear 
complex of 91, perhaps allowing some rationalisations about the nature of the 1,2,5-
oxadiazole-2-oxide ring compared to the 1,2,5-oxadiazole ring. 
126 
Fig. 5.4 
Preparation of ligand 92 was based upon a procedure used for the diphenyl 
analogue,203 and the method is summarised in Scheme S.S. Bis(2-pyridoyl)-1,2,S-oxadiazole-
2-oxide, (100), was synthesised according to the reported literature procedure starting from 2-
acetylpyridine.204 In the paper by Ponzi0203 a tin reduction was used to deoxygenate the 
1,2,S-oxadiazole-2-oxide ring. This was found to be unsatisfactory for the present case, as 
only picolinic acid was recovered from the reaction. Deoxgenation of 1,2,S-oxadiazole-2-
oxides has been accomplished by reaction with phosphites,205,206,226 and this type of reaction 
was attempted for 100. However, suitable conditions for this reaction were not found. When 
100 was stirred in benzene at room temperature with one equivalent of triethyl phosphite 
under an atmosphere of nitrogen, the reaction solution turned dark brown. Analysis of the 
reaction mixture by TLC and lH NNIR showed no sign of any change that would indicate the 
formation of a new product.· When the reaction conditions were changed to refluxing benzene 
still no reaction occurred. This suggested that the reaction would need more forcing 
conditions. Deoxgenation of unstrained 1,2,S-oxadiazole-2-oxides has been effected by 
heating them in a neat solution of the phosphite,207,208 and so 100 was refluxed in an excess of 
triethyl phosphite. This time TLC showed that all the starting material had been consumed in 
the reaction. However, no deoxygenated product could be isolated from the reaction mixture. 
One of the drawbacks of using an excess of phosphite is that further deoxygenation can occur. 
For instance, 1,2,S-oxadiazole-2-oxides can be converted to nitriles,z26 No further attempts 
were made to synthesise 92. 
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1,2,5-Thiadiazoles are available via several methods of synthesis.209 The most general 
of these has been the action of disulfur dichloride (S2Ch) on a-diamines or dioximes.210 
Rees et al.2ll have recently provided a new method for the synthesis of 1,2,5-thiadiazoles 
based on reactions of the inorganic heterocycle trithiazyl trichloride (S3N3Ch) with alkenes 
and alkynes. This reaction is, as they have shown, applicable to a range of substrates.212,213 
Retrosynthetic analysis of the desired thiadiazole-containing ligands in Fig. 5.2 provided 
some easily accessible substrates (Fig. 5.5) for use in this type of reaction. 
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Fig. 5.5 
The first substrate, 2-vinylpyridine (101) is commercially available and was purchased 
from Aldrich. 1,2-Di(2-pyridyl)ethene (102) was prepared by refluxing 2-methylpyridine 
with pyridine-2-carboxaldehyde in the presence of acetic anhydride as described by 
Newkome et al. 214 1,4-Di(2-pyridyl)buta-l,3-diyne (103) is a known compound,215 and was 
prepared, in this work, by a three-step sequence starting from 2-vinylpyridine. 2-
Vinylpyridine was brominated then dehydrobrominated following a literature procedure,216 to 
produce 2-ethynylpyridine, which was oxidatively coupled using CuCl!02 in acetone via the 
method described by Har17 to give 103 in 66% yield. 
The reactions of 101 - 103 with S3N3Ch218,219 were performed by a general method. 
S3N3Ch was suspended or dissolved in dry toluene and added dropwise with stirring to the 
unsaturated substrate dissolved in a mixture of dry pyridine and dry toluene. The solutions 
turned green (dark red in the case of 2-vinylpyridine) and a precipitate generally formed. The 
mixture was set to reflux for a time before the reaction was stopped and the product isolated. 
Table 5.1 gives the reaction times and yields for these reactions. 
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Table 5.1 
Substrate S3N3Cha Reflux timeb Product Yield(%) 
101 1 4 93 43 
102 1 18 94 49 
103 2.5 7 95 17 
a Molar equivalents. b In hours. 
The yields of the thiadiazoles are only modest, but are comparable to the yields 
obtained by this method for similar substrates. As examples, N-vinylphthalimide reacts with 
S3N3Ch to give 3-phthalimido-1,2,5-thiadiazole in 35% yield, 1,2-diphenylethene gave a 28% 
yield of thiadiazole and 1,4-diphenylbuta-1,3-diyne a 70% yield of bithiadiazole. However, 
this one-step procedure has significant advantages over alternative synthetic approaches to the 
ligands. No attempts at optimising these reactions were made. These new 1,2,5-thiadiazole-
containing ligands were characterised by melting point, IH and l3C NMR spectroscopy, EI 
mass spectrometry and elemental analysis. 
As ligand 95 contains a bi-l,2,5-thiadiazol-3-yl subunit, we decided to study the 
conformation of this molecule in the solid state by X-ray diffraction, thereby extending the 
small study of the biheterocyclic species produced in the course of this work. Suitable 
crystals were grown for this study by slow evaporation of an ethanol solution of the 
compound. The structure is shown in Fig. 5.6a. 
Fig. 5.6a Perspective view, with atom labelling ofthe contents ofthe asymmetric unit, of95. 
Although a full set of data was collected the refinement did not converge to an 
acceptable R-factor (10.5%). Subsequently, it was found that the data collected for this 
structure was affected by a fault in the CCD area detector. A crystal will be resubjected to a 
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structural analysis when the area detector is restored to full working order. For the time 
being, a discussion of the structure is given without analysis of the bond length parameters. 
The ligand crystallises in the tric1inic space group P-l, with one full molecule in the 
asymmetric unit. Interestingly, the 1,2,5-thiadiazole rings are approximately orthogonal to 
each other [84.6°], leading to the ligand being split into two different halves at the inter-ring 
bond separating these rings. For one half, the thiadiazole (SI-N5) and its pyridine ring (NI "-
C6") are coplanar, while for the other half there exists a twist of the pyridine away from the 
plane of the thiadiazole [17.8°] (Fig. 5.6b). The conformation of each thiadiazole ring and its 
pyridine is trans with respect to the nitrogen atoms. This is perhaps as a result of an 
intramolecular hydrogen-bonding interaction between the H3 proton of the pyridine ring and 
N5 of the thiadiazole. There is conjugation of the n-systems over each coplanar unit, but this 
does not extend over the whole molecule, due to the non-planarity of the central 
biheterocyclic subunit. The angle of 84.6° between the thiadiazole rings is reminiscent of the 
angle between the benzotriazole rings [84.5(5)°] found in the crystallographic study of 1,1 '-
bibenzotriazole (23) (Fig. 3.6a-c). 
Fig.S.6b 
As an aside, it was realised that 103 had not been previously used as a ligand. 
However, its isomer 1 ,4-di( 4-pyridyl)buta-1 ,3-diyne has been well studied. It displays 
interesting coordination chemistry having been used in the construction of molecular 
frameworks, such as criss-cross grids220 and molecular ladders,221 where it acts as a linear 
bridge between metal centres separating them by ca. 17 A. 
It was therefore decided to explore the coordination chemistry of ligand 103 with 
AgN03• Reaction of 103 with AgN03 in methanol gave a fawn coloured solid, in good yield 
(83%), that analysed as [103.AgN03], (104). In order to distinguish between various cyclic or 
polymeric structures that are possible with this stoichiometry, an X-ray structure analysis was 
carried out. Crystals suitable for an investigation were grown by slow evaporation of an 
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acetonitrile solution of this complex. The asymmetric unit and a view of the extended 
structure are shown in Fig. 5.7a and 5.7b, respectively. 
Fig. 5.7a Perspective view, with atom labelling of the contents of the asymmetric unit, of 104. 
Selected bond lengths (A) and angles (0): Ag1-N1' 2.246(2), Agl-N1" 2.203(2), Ag1-011 
2.642(2), Ag1-012 2.570(2), N1'-Ag1-N1" 146.17(6), C2'-C1 1.438(3), Cl-C2 1.202(3), C2-
C2A 1.386(4), C2'-C1-C2 176.5(2), C1-C2-C2A 178.4(3), C2"-C4 1.429(3), C4-C3 1.207(3), 
C3-C3A 1.364(4), C2"-C4-C3 172.4(2), C4-C3-C3A 178.4(3). 
The asymmetric unit comprises a silver atom coordinated to two different half ligands 
and a weakly chelating nitrate anion. The geometry of one of the ligands is very similar to 
that of the free ligand,222 while the other deviates from linearity at C4 [C2"-C4-C3 172.4(2tJ. 
By virtue of the crystallographic centres of inversion, the two pyridine rings of each ligand 
are strictly coplanar and have the nitrogens disposed in a transoid conformation. Within this 
structure the two independent ligands bridge silver atoms with separations of 8.832(1) and 
8.666(1)A, distances approximately half of those found with the isomeric ligand 1,4-di(4-
pyridyl)buta-1,3-diyne. The whole structural motifbears a close resemblance to that recently 
described for a silver(I) complex of 2,2'-dicyanodiphenylacetylene.223 
Fig. 5.7b Perspective view of the extended structure of 104. 
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5.3 Mononuclear Complexes 
The focus of this study is to examine the properties of complexes containing a 1,2,5-
heterodiazole ligand and also to study dinuclear complexes containing ruthenium polypyridyl 
units bridged by a 1,2,5-heterodiazole ring. The properties of dinuclear complexes are best 
detennined by comparison with their mononuclear complexes. It is, therefore, important to 
study the mononuclear complexes, and understand their properties before attempting to study 
and rationalise the interactions in dinuclear complexes. To this end, mononuclear complexes 
with 93, 91, and 94 were first prepared and examined. 
Ligand 93 and one equivalent of Ru(bpY)2Clz were reacted in refluxing 3:1 
ethanol/water and the cationic products isolated as hexafluorophosphate salts. Purification of 
the resulting dark red product, by chromatography on alumina, separated a small head band 
before a larger reddy-brown fraction. F ABMS continned the small head band was a complex 
containing a chloride anion and the ligand, and so, was fonnulated as [Ru(bpY)2Cl(93)](PF6) 
(107). Characterisation of this complex by IH NMR was attempted, but the complex 
underwent decomposition in solution with the ligand undergoing dissociation. Some 
infonnation about the nature of the complex was able to be detennined before decomposition. 
The signal for the thiadiazole proton was easily recognised in the spectrum by its chemical 
shift and singlet appearance. Interestingly, it appeared at 8.69 ppm in the spectrum, a CIS 
value (CIS = Ocomplex - Oligand) of -0.67 ppm, meaning it has shifted upfie1d upon 
complexation. The most likely explanation for this observed CIS is that H4' is experiencing 
some shielding from ring-current anisotropy. Coordination via N5 of the thiadiazole, with the 
H4'proton facing towards a neighbouring pyridine, would have this effect (Fig. 5.8). 
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Fig. 5.8 
The second fraction collected was the desired [Ru(bpY)2(93)](PF6)2 complex (108). 
The IH NMR spectrum of 108 is shown in Fig. 5.9. The H4' of the ligand is easily assigned to 
the singlet at 9.55 ppm, giving a CIS (CIS = Ocomplex - Oligand) of +0.29 ppm, meaning it has 
moved downfield upon complexation. However, this is the only signal easily assigned as the 
other spectral signals are highly overlapped, with the only separation in chemical shifts being 
the H6's of the pyrldyl rings at around 7.8 ppm. Even then, some of these signals are partially 
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overlapped or not very well separated. Nevertheless, usmg careful I-D TOCSY the 
assignment of signals to 4 of the 5 different pyridyl rings in this complex was achieved. This 
example nicely demonstrates the true power of the I-D TOCSY experiment. With a spectrum 
such as this, a technique such as 1H_1H COSY would have been almost useless, as the mass of 
overlapped signals would have made the extraction of information from a spectrum very 
difficult indeed. 
In previous examples (viz. 13 and 35), the cooperative use of 1-D TOCSY and 1H nOe 
spectroscopy allowed the positive identification of the signals due to the pyridine ring of the 
ligand of interest. This strategy was again used in this case. A 1H nOe experiment irradiating 
H4' was performed and an enhancement found at 8.61 ppm. However, two H3 protons, 
previously identified by the I-D TOCSY, were found to be at the same chemical shift as this 
enhancement. With this result, the positive identification of the signals due to the pyridine 
ring of the thiadiazole ligand was not possible. 
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Fig. 5.9 1H NMR spectrum of [Ru(bpY)2(93)](PF6)2 (108). 
Ligand 91 and one equivalent of Ru(bPY)2Ch were reacted in 3:1 ethanol/water to give 
an orange complex, (109), in high yield (92%), which was isolated as the 
hexafluorophosphate salt. The lH NMR spectrum of complex 109 is shown in Fig. 5.10. By 
I-D TOCSY six different rings were identified in the complex, and it was deduced that the 
ligand is chelating through the nitrogen of a pyridine ring and N2 of the oxadiazole. Hence, 
the ligand has an uncoordinated pyridine ring (Fig. 5.11). Unlike the other H6 protons, the 
H6 of the uncoordinated ring (H6') experiences no ring-current anisotropy effects and is very 
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much downfield of the others at the chemical shift of 9.03 ppm. The other distinctive proton 
in the spectrum is at 9.86 ppm and is assigned as H3 of the coordinated pyridine ring of the 
oxadiazole-containing Ugand. This assignment was based upon the assumption that the 
pyridine nitrogen of the uncoordinated ring de shields this proton. Therefore, the 
conformation in solution is one where the uncoordinated ring lies in the same plane as the 
chelate ring with the nitrogen atom pointing towards H3 of the coordinated ring (Fig. 5.11). 
Confirmation that these were indeed the rings of the oxadiazole-containing ligand was by the 
preparation of the analogous [Ru(dmb)2(91)](PF6)2 complex, (110). The chemical shifts and 
coordination induced shifts for 109 and 110 are Hsted in Table 5.2. Both of these complexes 
were also characterised by F ABMS and elemental analysis. 
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Fig. 5.10 IH NMR spectrum of [Ru(bpY)2(91)](PF6)2 (109). 
Fig. 5.11 
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Table 5.2 IH NMR Chemical Shifts a and Coordination Induced Shiftsb of91, 109 and 110 . 
H3 H4 H5 H6 H3' H4' H5' H6' • 
109 9.86 8.22 7.59 7.88 8.27 8.16 7.76 9.03 
91c 7.91 7.97 7.53 8.60 
CIS +1.95 +0.25 +0.06 -0.72 +0.36 +0.19 +0.24 +0.43 
110 9.80 8.17 7.56 7.85 8.25 8.18 7.76 9.02 
91c 7.91 7.97 7.53 8.60 
CIS +1.89 +0.20 +0.03 -0.75 +0.34 +0.21 +0.23 +0.42 
a For deuterated acetonitrile solutions. b CIS = (Dcomplex - OJigand). c The free ligand in solution 
shows 2-fold symmetry; hence H3 = H3' etc. 
[Ru(bpY)2(94)](pF6)2, (111), was prepared, in high yield (87%), by reaction of ligand 
94 with one equivalent of Ru(bpY)2Ch, as described for the previous complexes. Again by 1-
D TOCSY, identification and assignment of the six different rings was possible. Those of the 
thiadiazole-containing ligand were easily assigned by the now recognisable chemical shifts of 
the H6'proton of the uncoordinated ring and the deshielded H3 of the coordinated ring. The 
1 H NMR data for this complex are shown in Table 5.3. 
Table 5.3 IH NMR Chemical Shifts3 and Coordination Induced Shiftsb of 94 and 111. 
H3 H4 H5 H6 H3' H4' H5' H6' 
111 9.02 8.03 7.49 7.86 8.09 8.12 7.74 8.90 
94c 7.82 7.91 7.43 8.47 
CIS +1.20 +0.12 +0.06 -0.61 +0.27 +0.21 +0.31 +0.43 
3 For deuterated acetonitrile solutions. b CIS = (Ocomplex - Oligand). c The free ligand in solution 
shows 2-fold symmetry; hence H3 := H3' etc. 
The UV-visible spectra of 109 (Fig. 5.12) and 110 were, as expected, very similar in 
appearance. The A.mllx for each of these complexes is centred at ca. 435 nm with shoulders on 
the high energy side around 400 nm. 
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Fig. 5.12 UV-visible spectrum of [Ru(bpY)2(91)](PF6)2 (109). 
Each of the mononuclear complexes 108 - 111 were investigated by cyclic 
voltammetry, and the results of these investigations are summarised in Table 5.4, while Fig. 
5.13 shows the cyclic voltammograms of complex 109 and complex 111. Table 5.4 also 
includes the redox potentials and absorption maxima of the 2,3-di(2-pyridyl )pyrazine (96) and 
4,6-di(2-pyridyl)pyrirnidine (97) Ru(bpy)l+ complexes for the sake of comparison. 
-1 V OV +1 V 
ov +1 V 
Fig. 5.13 Cyclic voltammograms of [Ru(bpY)2(91)](PF6)2 (109) (top) and 
[RU(bpY)2(94)](PF6)2 (111). 
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Table 5.4 Absorption Maximaa and Redox Potentialsb of 108, 109, 110 and 111. 
"-max Eox Eredl Ered2 Ered3 Eox-redl 
Ru(bpY)2(91)2+ (109) 435 1.51 -0.97c - - 2.48 
Ru(dmb)2(91i+ (110) 434 1.40 -1.08c - - 2.48 
Ru(bpy)(93i+ (108) 455 1.36 -1.19 -1.55 c - 2.55 
RU(bPY)2(94i+ (111) 454 1.37 -1.18 -1.53 c - 2.55 
RU(bPY)2(96)2+ 492 1.28 -1.03 -1.55 -1.76 2.31 
RU(bPY)2(97i+ 475 1.31 -1.06 -1.55 -1.74 2.37 
a In nanometers. b In volts vs SCE in acetonitrile. c Irreversible reduction. 
The oxadiazole-containing complexes 109 and 110 show an excellent correlation 
between the UV -visible spectroscopy and the electrochemistry. The reason for the higher 
oxidation potential of the complex 109, compared to the oxidation potential of complex 110, 
is the well-documented effect of replacement of bpy with dmb as discussed in Chapter 4. 180 
However, even with this difference the ~Eox-redl value is the same for each complex, which is 
consistent with the "-max values. Both 109 and 110 have an: irreversible first reduction which, 
based upon the potential, is assigned to the oxadiazole ligand. 
Comparison of the UV -visible and electrochemical properties of the thiadiazole-
containing complexes 108 and 111, reveals that replacement of ligand 93, which is 
unsubstituted at the 4-position of the thiadiazole, with the ligand 94 has little or no effect on 
the UV-visible or electrochemical properties of the complex. Again, the UV-visible and 
electrochemical data are totally consistent. 
The heterodiazole-containing complexes 108, 109, 110 and 111 have larger HOMO-
LUMO gaps than the pyrazine- and pyrimidine-containing complexes. This mainly arises 
because the heterodiazole complexes are harder to oxidise. The electronegative oxygen atom 
in complexes 109 and 110 acts to reduce the electron density of the ruthenium atom, raising 
the oxidation potential of the complex. The explanation for the lower oxidation potential for 
complexes 108 and 111 is that the sulfur is not as electronegative as oxygen, and does not 
reduce the electron density of the metal as much, and so these complexes are easier to oxidise. 
An important electrochemical difference between the 1,2,5-systems is the reversibility 
of the first reductions. We thought the difference might possibly lie in the molecular orbitals 
concerned for the different systems. It was thought that some explanation might be forwarded 
by the examination of the heterodiazole systems, as they were assumed to be primarily 
responsible for the observed properties of the complexes. In an attempt to understand this 
problem, the use of ab initio calculations was turned to. As a first approximation Extended 
Huckel Molecular Orbital (EHMO) calculations224 were performed for the parent heterocyclic 
systems. The results indicated that the HOMO of the 1,2,5-oxadiazole ring is a a-bonding 
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orbital and the LUMO an antibonding n orbital (Fig. S.14). Reduction of the 1,2,S-oxadiazole 
ring involves adding an electron to this antibonding orbital, which perhaps explains the 
irreversibility of this system. It is natural to then ask why the reductions are reversible for the 
1,2,S-thiadiazole system. The ERMO calculations for this ring indicate that the HOMO is 
again a-bonding and the LUMO n-antibonding but, importantly, the LUM.o resides almost 
totally on the sulfur atom alone (Fig. S.lS). Possibly, the electrochemically added electron 
resides principally upon the sulfur atom, and can be reversibly removed from it in these 
complexes. 
Fig. 5.14 HOMO (top) and LUMO (bottom) molecular orbitals of the parent 1,2,S-oxadiazole 
nng. 
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Fig. 5.15 HOMO (top) and LUMO (bottom) molecular orbitals of the parent 1,2,5-thiadiazole 
ring. 
There have been few ab initio studies on these types of compounds. A recent study225 
determined that the 1,2,5-oxadiazole system was the least delocalised of the isomeric 
oxadiazoles, and postulated that the electronegative oxygen atom prevents the electrons in its 
pz orbital from interacting effectively with the rest of the 1t electron system of the ring. Thus, 
it seems the 1,2,5-oxadiazole system has a high diene character. Perhaps it can be expected 
that the thiadiazoles are more 'aromatic' than oxadiazoles, in the same way that thiophene is 
more aromatic than furan. 
At this point, it seemed appropriate to prepare homoleptic ruthenium complexes using 
ligands 91 and 94. This might allow for more insight into the electronic nature of the 
heterocycles. With three symmetrical bidentate ligands coordinated to a single metal ion, 
there exists only two enantiomeric forms, A and 1.1. When the ligand is unsymmetrical, the 
formation of meridional (mer) and facial (fac) diastereoisomers are possible. This is shown in 
Fig. 5.16 where A and B represent different ends of the same ligand. Typically, in the 
preparation of homoleptic complexes with unsymmetrical ligands, the mer- and fac- isomers 
form in a statistical ratio of 3: 1. 
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Fig. 5.16 
Ligands 91 and 94 were reacted with Ru(DMSO)4Clz in 3: 1 ethanol/water. The 
desired homoleptic complexes, [Ru(94)3] (PF6)2, (112) and [Ru(91)3](PF6)2, (113), were 
isolated and purified via the usual procedures. The lH NMR spectrum of 112 is shown in Fig. 
5.17, and, from the appearance ofthe two separated H6 signals at 7.86 ppm and 8.00 ppm, the 
isomers have not formed in the 3: 1 ratio. No attempts to assign the spectrum were made. As 
the H3 protons of the coordinated pyridine rings are downfield (ca. 8.9 ppm) it seems that the 
same phenomenon of deshielding that was evidenced in the lH NMR identification of 
[Ru(bPY)2(94)](PF6)2 (111) is also present for each ofthe ligands in the complex 112. Thus it 
exists in solution in the conformation shown in Fig. 5.18. Complex 112 was further 
characterised by FABMS and elemental analysis. The lH NMR spectrum of 113 was too 
complicated to assign totally, but it did have some signals that indicated the formation of the 
mer- and fac- isomers in a 3:1 ratio. These signals were from the deshielded H3 protons of 
the coordinated pyridine rings. Complex 113 was also characterised by F ABMS. 
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Fig. 5.17 lH NMR spectrum of [Ru(94)3] (PF6)2 (112). 
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To probe the nature of the metal-ligand interactions in these homoleptic ruthenium 
complexes, UV-visible spectra were obtained. These proved enlightening when used in 
comparison with the UV-visible spectra of the corresponding heteroleptic [RU(bPY)2L]2+ (L = 
91 and 94) complexes. The UV-visible spectrum of [Ru(94)3](PF6)2 (112) is shown along 
with the UV-visible spectrum of [Ru(bpY)2(94)](PF6)2 (111) in Fig. 5.19. For complex 111 
the spectrum consists of a. MLCT at 454 nm with a shoulder on the high-energy side at 
approximately 420 nm. In the spectrum of 112, the shoulder of the heteroleptic complex 
corresponds well with the I"max for complex 112 at 435 nm. This seemed to suggest that in 
complex 111 the MLCT [(M)d-(L}n:*] was at 420 nm and that the (M)d-(bpy}n:* transition 
was at the longer wavelength of 455 urn. Similarly, for the complexes [Ru(bpy)z(91)](pF6)z 
(109) and [Ru(91)3](PF6)z (113) (Fig. 5.20), the II-max for the homoleptic complex corresponds 
well to the shoulder of the heteroleptic complex, indicating the shoulder at approximately 400 
nm for complex 109 is the (M)d--(L}n:* transition, and that the (M)d-(bpY)1t* transition was 
at the longer wavelength of 435 nm. 
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Fig. 5.19 UV-visible spectra of a) [Ru(bpY)2(94)](PF6)z (111) and b) [Ru(94)3](PF6)z (112). 
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Fig. 5.20 UV-visible spectra of a) [Ru(bpyh(91)](PF6)2 (109) and b) [Ru(91)3](PF6)2 (113). 
Electrochemical measurements were also made on these homoleptic complexes and 
provided more interesting results. No oxidation process of the ruthenium was observed for 
either 112 or 113 in the potential range examined (+2.1 V), highlighting the electron deficient 
nature of the ruthenium atom in these complexes. Upon scanning to negative potentials, the 
complexes each undergo one irreversible redox process. For complex 112 an irreversible 
reduction occurs at -0.73 V, while complex 113 is reduced at -0.41 V. 
Thus, the effects of the heterodiazole-containing ligands are clear. They are poor 
donors of electron density to the metal, resulting in the raised oxidation potentials of the 
ruthenium complexes and by virtue of the incorporated heterocyclic oxygen or sulfur atoms, 
electron defIcient. This behaviour is in direct contrast to the effects of heterocyclic rings 
incorporating nitrogen heteroatoms only. With these types of heterocyclic systems the effect 
upon the metal atom is to increase the electron density upon it, therefore lowering the 
oxidation potential whilst the electron rich heterocycles are harder to reduce than the 
bipyridine ligands. Thus the incorporated oxygen and sulfur atoms have inverted the 
reactivity demonstrating that, by structural modification of heterocyclic structure, in this case 
molecular replacement, properties of complexes can be dramatically altered. 
The molecule di(2-pyridyl)-1,2,5-oxadiazole-2-oxide (99) was also reacted with 
RU(bPY)2Ch under the standard refluxing 3:1 ethanol/water conditions. The expected product 
from this reaction, after workup, was [Ru(bpY)2(99)](PF6)2 (Fig. 5.21), (114), where 
coordination is through N5 of the oxadiazole and the pyridine nitrogen to form a five-
membered chelate. Furthennore, it seemed logical to expect that the conformation of the 
ligand would be similar to that of the corresponding 1,2,5-oxadiazole (Fig. 5.11), and that the 
IH NMR spectrum would resemble that of complex 109 (Fig. 5.9). Some slight changes to 
the spectrum were expected. For instance, the N-oxide group of the 1,2,5-oxadiazole-2-oxide 
(Fig. 5.21) might influence the ill' proton of the uncoordinated ring. 
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Fig. 5.21 
However, the complex isolated, in 90% yield, has the IH NMR spectrum shown in 
Fig. 5.22. The important difference is that the signal for H6' is not in the expected position 
(ca. 9 ppm). However, there did seem to be the expected downfield H3 signal at 9.55 ppm. 
By l-D TOCSY six different four-proton spin systems were identified. One of the rings 
identified differed from the others in that it did not show the usual coupling constant of a 
pyridine H6. The proton of this ring is visibly different from the other H6's at the chemical 
shift of 7.34 ppm. It seemed likely that the ligand had rearranged, so that this ring was no 
longer a pyridine. To test that it was indeed the ligand rearranging, the reaction was repeated 
with the Ru( dmb )2Ch precursor, to produce the complex 116. Importantly, all dmb auxiliary 
ligands were unaffected, and excellent agreements of the chemical shifts for the ligand in each 
complex were obtained (Table 5.6, pg 145). FABMS of complexes 115 and 116 also 
provided an important result; the molecular ion suggested that the ligand had retained its 
molecular constitution. So, in the rearrangement, the ligand had not lost or gained 3f1Y atoms. 
To determine the structure of the complex an X-ray crystal structure investigation was 
conducted. Small single crystals suitable for X-ray diffraction were grown by slow 
evaporation of a CH2Ch solution of complex 115. Figure 5.23 shows the structure of the 
rearranged product. 
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Fig. 5.22 IH NMR spectrum of 115. 
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Fig. 5.23 Perspective view, with selected atom labelling, of the complex 115 without the 
counterions and solvate molecules. 
The complex crystallises in the monoclinic space group C2/c, with one cationic 
complex, two hexafluorophosphate counterions and water and dichloromethane solvate 
molecules in the asymmetric unit. For clarity, the counterions and solvate molecules are not 
shown in Fig. 5.23. Due to the small crystal, the data set collected was weak, and also the 
structure contains some diffuse solvent, and both of these factors contributed to an 
unsatisfactory refmement converging to an R-factor of 7.4%. However, the crystallographic 
study has succeeded in unambiguously identifying the rearranged ligand. The ligand has 
rearranged from 3,4-di(2-pyridyl)-1,2,5-oxadiazole-2-oxide to 2-(2-pyridyl)-3-nitro-
pyrazolo[1,5-a]pyridine. Perhaps the simplest explanation for the fonnation of this product is 
shown in Fig. 5.24. 
Fig. 5.24 
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The N5-Ol bond is broken heterolytic ally, with the electrons moving to the more 
electronegative element oxygen. The generated intennediate is then attacked by the 
nucleophilic nitrogen atom of the pyridine attached to what was fonnally C3 of the 1,2,5-
oxadiazole-2-oxide ring. Rearrangement of the electron skeleton, as shown, leads to the 
pyrazolo[1,5-a]pyridine system. This mechanism is a ring-opening ring-closing (RORC) 
sequence. 1,2,5-Oxadiazole-2-oxides have a rich history of involvement in many different 
heterocyclic ring transfonnations. 199,226 However, this seems to be the flrst reported 
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rearrangement mediated by a transition metal. Thermal and photochemical isomerisations of 
1,2,5-oxadiazole-2-oxides involve breakage of the 01-N2 bond, and this has been assumed to 
give dinitroso intermediates. Under forcing thermal conditions, 1,2,5-oxadiazole-2-oxides 
undergo retro-1,3-dipolar cycloaddition, which involves not only breakage at the 01-N2 bond 
but also the C3-C4 bond. 199,226 Recently there has been a theoretical and experimental study 
on the rearrangements of nitrobenzofuroxans (nitrobenzo-l ,2,5-oxadiazole-2-oxides )?27 This 
process also involves Ol-N5 bond rupture, similar to that proposed for the above process. 
The RORC sequence reported here is also a previously unreported synthesis of 
pyrazolo[l,5-a]pyridines, which have previously been constructed in several different 
ways.228 The methods that pertain to the present case are those that effect ring closure 
between the heteroatoms. These methods include the oxidation of pyridylethy1amine by 
potassium fenicyanide,229 which gives the parent heterocyclic system. The generation of 
nitrenes, by reaction of phosphites with nitr0230 and nitros0231 containing compounds, in the 
presence of a suitably disposed pyridine ring, also leads to ring closure between the 
heteroatoms. These two methods most closely resemble the proposal forwarded above. A 
method that offers considerable versatility is the reaction ofN-amino(2-methyl)pyridines with 
acid derivatives or synthetiC equivalents.232 The dual electrophilic/nucleophilic character of 
hydroxylamine-O-sulfonicacid has also been utilised in the construction of the pyrazolo[1,5-
a]pyridine ring.233 These procedures are potentially adaptable for a possible synthesis of the 
ligand in complexes 115 and 116 (Scheme 5.6). In some cases, the 3-position of the ring 
requires subsequent nitration to produce the desired ligand, and this is readily achievable for 
this system using mild nitrating conditions.228 There has been some investigation in the field 
of medicinal chemistry of molecules containing the pyrazolo[1,5-a]pyridine moeity,234 as they 
have receptor binding activity for adenosine.235 
~o~? 
o 0 
oOC 
Scheme 5.6 
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The structural identification of the ligand allowed the assignment of the IH NMR 
spectra for the complexes. The chemical shifts for the resulting rearranged ligand in the 
complexes are given in Table 5.6. The proton that did not share the H6 coupling constant is 
H7' of the pyrazolo[1,5-a]pyridine ring, and this proton is shielded in the complexes 115 and 
116 by the adjacent pyridyl ring. The H6 protons are also shielded, and occur at the positions 
expected for pyridyl H6's in these types of ruthenium complexes. The reason for the 
downfield position of the H3 proton is the deshielding it experiences from the neighbouring 
nitro group (See Fig. 5.23). 
Table 5.6 IH NMR Chemical Shiftsa for the ligand in complexes 115 and 116. 
H4' H5' H6' H7' H3 H4 H5 H6 
115 8.57 7.91 7.16 7.34 9.55 8.23 7.50 7.84 
116 8.57 7.91 7.18 7.37 9.53 8.20 7.48 7.83 
II For deuterated acetonitrile solutions. 
Possibly the RORC process was thermodynamically controllable, and so, the reaction 
was repeated using milder reaction conditions with a silver salt, a lower temperature (35-
40°C) and a shorter reaction time. After purification, the IH NMR spectrum (Figure 5.25) 
showed that two products had formed in a ratio of 4:1, with the major product being the 
already identified RORC product 115. The minor product has the chemical shifts that are 
reminiscent of the complexes 109 and 110, where the H6 proton of the uncoordinated ring at 
9.00 ppm is now evident, as is a H3 proton at a downfield position (9.29 ppm) which could 
well be H3 of the coordinated ring. These were both irradiated in l-D TOCSY experiments 
and found to have similar chemical shifts to the oxadiazole ligand in complex 109. With this 
information, it seems entirely reasonable to propose that complex 114 (Figure 5.21) is formed 
in the reaction, but undergoes irreversible rearrangement to the pyrazolo[1,5-a]pyridine. 
Evidence that this is a facile process, is the high conversion to the rearranged product (ca. 
80%) even with the mild conditions of35-40°C. 
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Fig. 5.25 
To test that the rearrangement was metal-catalysed, ligand 99 was refluxed alone in 
3:1 ethanol/water. The material was then analysed by recording its lH NMR spectrum, and 
this showed no change from that of the starting material, indicating that the process was 
metal-catalysed. As a further investigation, the ligand was refluxed in combination with 
another metal salt (nickel perchlorate), before the organic component was analysed by lH 
NMR. Although the resulting spectrum was a little broadened, perhaps due to the presence of 
some paramagnetic Ni(II), it was clear that the ligand had not rearranged. 
Having serendipitously prepared these complexes it was decided to study them further 
by performing UV-visible spectroscopic and electrochemical measurements. Table 5.7 
summarises both the UV-visible and electrochemical studies, and the UV-visible spectrum 
and cyclic voltammogram of complex 115 is shown in Fig. 5.26. 
Table 5.7 Absorption Maximaa with Molar Absorption Coefficientsb and Redox PotentialsC of 
115 and 116. 
!-max (E) Eox Bred Eox-red 
115 443 (15 900) +1.28 -0.97 2.25 
116 438 (15 500) + 1.18 -1.00 2.18 
a 0 -1 -1 C In nanometers. M em . In volts vs SCE III acetomtnle. 
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Fig. 5.26 UV -visible spectrum and cyclic voltammogram of 115. 
The complexes undergo redox couples at +1.28 and +1.18 V for 115 and 116, 
respectively. This difference is again a result of the electron donating effect from the dmb 
ligands as discussed previously. I 80 Each complex has a fully reversible one-electron reduction 
at -0.97 and -1.00 V, respectively, that is attributable to the pyrazolo[I,5-aJpyridine ligand. 
Further multiple electron reductions are evident in the cyclic voltammograms of both 
complexes, but assignment of the redox waves is difficult, as there is considerable overlap. A 
possibility is that the nitro group in the ligand is also participating in the electrochemistry. 
Complexes containing benzo-fused systems have been much studied,236-240 and have 
been shown to possess different properties to the unfused analogues. However, ligands 
containing other fused systems, such as the pyrazolo[I,5-aJpyridine ring, have been little 
studied and yet offer a wide range and scope as ligands for study. The results obtained 
suggested that ligand 99 might display other interesting coordination chemistry. Accordingly, 
coordination complexes with PdCb, CuCb.2H20, and AgNO) were prepared. 
Five and six membered ring chelates are common with palladium(II) complexes. 
With ligand 99 there is the possibility, as mentioned previously, to form either a six-
membered chelate via 02 and NI', or a five-membered chelate via N5 and NI" (Fig. 5.27). It 
was anticipated that the H6' and H6" protons of the molecule could be used diagnostically to 
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identify which of the chelates had formed. For example, in either case, only one of H6' or 
H6" would be deshielded by the proximate chlorine in the IH NMR spectrum, with the other 
changing little in chemical shift. Irradiation of the de shielded H6 in a l-D TOCSY 
experiment would determine the chemical shifts of the other protons in the ring. A GHMBC 
experiment could then correlate the H3 proton to the appropriate quaternary carbon (C3 or 
C4) of the 1,2,5-oxadiazole-2-oxide, which show a separation in chemical shift. This was the 
anticipated method by which the distinction of the chelate could be made. 
N5,Nl" 02,Nl' 
Fig. 5.27 
When LhPdC4 was reacted with ligand 99 in methanol a yellow complex, (117), was 
fonned in high yield (95%); that analysed as [99.PdCb]. FABMS provided a molecular ion 
of (99)PdCl+, which indicated that the complex was monomeric. IH NMR of the complex in 
deuterated DMSO gave an unexpected spectrum, shown in Fig. 5.28, where both the H6' and 
H6" protons are de shielded, indicating that both pyridine rings of the ligand are coordinated to 
palladium. This suggested that another mode of coordination was taking place. The one that 
seemed most likely, given the F ABMS result, was the formation of a seven-membered 
metallocyc1e (Fig. 5.29) with Nl ',Nl" coordination. 
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9.4 9.29.0 8.88.68.4 8.2 8.07.87.6 ppm 
Fig. 5.28 IH NMR spectrum of 117. 
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Nl',Nl" 
Fig. 5.29 
By l-D TOCSY the signals due to each spin system in the complex were identified by 
irradiation of the isolated H5 protons at the chemical shifts of 7.82 ppm and 7.90 ppm. The 
chemical shifts and coordination induced shifts for 117 are shown in Table 5.8, and were 
assigned by assuming that the most downfie1d H6 proton in the free ligand is also the most 
downfield H6 proton in the complex. The small broad peaks that are apparent in the spectrum 
are due to the presence of some dissociated free ligand. 
Table 5.8 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb of 99 and 117. 
H3 H4 H5 H6 H3' I H4' H5' H6' 
117 8.03 8.27 7.82 9.14 8.07 8.28 7.90 9.18 
99 7.91 8.01 7.51 8.55 7.87 8.01 7.56 8.56 
CIS +0.12 +0.26 +0.31 +0.59 +0.20 +0.27 +0.34 +0.62 
a For deuterated dimethyl sulfoxide solutions. b CIS = (8complex - 8ligand). 
The CIS values are very similar for the two rings, although it should be noted that the 
CIS values for H3'-H6' are all slightly larger than the corresponding values for H3-H6. The 
H6 and H6' protons are deshielded by their proximity to the chlorine atoms attached to the 
palladium, resulting in the large positive CIS values. The values for H41H4' and H51H5' are 
significant and indicate a-donation to the metal. 
When ligand 99 and CuCh.2H20 are mixed in methanol, green crystals, (118), that 
analyse as [99.CuCh] are fonned. To unambiguously detennine the structure a crystal was 
subjected to an X-ray crystal structure analysis. The asymmetric unit of the structure is 
shown in Fig. 5.30a. 
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Fig. S.30a Perspective view, with atom labelling of the contents of the asymmetric unit, of 
118. Selected bond lengths (A) and angles (0): NI'-CuI 2.023(3), Nl"-Cul 2.047(3), Cll-
CuI 2.332(1), C12-Cul 2.583(1), Nl'-Cul-Nl" 87.2(1), Nl'-Cul-Cll 167.4(1), Nl'-Cul-C12 
85.1(1), Cll-Cul-C12 93.81(4), 01-N2 1.436(4), 01-N5 1.375(4), N5-02 1.740(10), N2-C3 
1.331(4), C3-C4 1.422(4), N5-C4 1.328(4), N5-01-N2 108.8(3). 
The most notable feature of this structure is the formation of the seven-membered 
chelate ring, as proposed above for the palladium complex. The chelate ring is puckered, with 
the planes of the coordinated pyridine rings making an angle of 69.6(5)° between each other. 
Because of the tilt of the pyridine rings, the copper atom lies well below the plane defined by 
the 1,2,5-oxadiazole-2-oxide ring [2.13 1 (4)A]. The seven-membered chelate ring provides a 
bite angle at the copper (Nl'-Cul-Nl") of 87.2(1)°. There is some disorder of the 1,2,5-
oxadiazole-2-oxide ring, with 02 having partial occupancies on N2 and N5. This disorder 
was successfully modelled and the partial occupancy was found to be around 15%. The full 
structure is a chIoro-bridged [2 + 2] dimer (Fig. 5.30b), by virtue of the centre of inversion in 
the centre of the four-membered CU2Ch ring. Such cyclic dimers are common for copper(II) 
chloride complexes.241 The coordination geometry of the copper itself can be described as 
square pyramidal with the ~-chIoro occupying the apical position. 
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Fig. 5.30b Perspective view of the dimeric structure of 118. 
When ligand 99 and AgN03 are mixed in methanol a colourless complex is formed, in 
high yield (86%), which analyses as [99.AgN03J, (119). The lH NMR spectrum of the 
complex was obtained in deuterated acetonitrile, and this proved that the ligand had not 
undergone any rearrangement. However, crystals suitable for a structural characterisation 
were unable to be grown. 
It is interesting that in the coordination complexes of 99 with copper and palladium, 
the 1,2,5-oxadiazole-2-oxide ring has played no part in the coordination. In both structures 
the ligand is coordinated to the metal ion through the pyridine donors, with the formation of a 
seven-membered ring, rather than the formation of a smaller chelate. To test if this was a 
general phenomenon some other complexes were synthesised and investigated with ligands 
91 and 93 and 94. 
A palladium(II) complex was prepared by reacting ligand 93 with Li2PdCl4 in 
methanol, giving a yellow complex, (120), in high yield (91 %). The lH NMR spectrum of the 
complex showed a mixture of free and complexed ligand, indicating an equilibrium between 
the two. The signals for the complex were determined after comparison with the spectrum of 
the free ligand. The CIS values (Table 5.9) show that the H6 proton of the pyridine ring 
shows a small positive value consistent with it being deshielded by the adjacent chlorine. The 
CIS value (+0.42) of H4 of the pyridine ring indicates the a-donation effect from the pyridine 
to the metal. The thiadiazole ring proton (H4) has moved downfield upon complexation and 
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this is likely to be both a deshielding effect due to its proximity to H3 and an electronic effect. 
The CIS value for this proton in the complex [Ru(bpY)2(93)](PF6)2 108 was +0.29 ppm. 
Table 5.9 IHNMR Chemical Shiftsa and Coordination Induced Shiftsb for 120 and 93. 
I H3 H4 H5 H6 H4' 
120 8.57 8.44 7.88 8.93 9.76 
93 8.16 8.02 7.55 8.74 9.43 
CIS I +0.41 +0.42 +0.33 +0.19 +0.33 
a For deuterated dimethyl sulfoxide solutions. b CIS = (Ocomplex - Oligand). 
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Fig. 5.31 
A palladium complex was prepared in the above manner using ligand 91. A yellow 
complex, (121), formed in high yield (95%), and analysed in a 1:1 stoichiometry [91.PdCb]. 
The IH NMR spectrum was recorded in deuterated dimethyl sulfoxide and showed the 
presence of a deshielded H6 proton and another signal for a H6 proton at a chemical shift very 
close to that of the free ligand. The integration of these signals was the same, and this left 
some doubt about the nature of the bonding in the complex, as this situation is consistent with 
either a five-membered chelate or an equilibrium between a seven-membered chelate and 
dissociated free ligand. Two pieces of information led to the assignment that the seven-
membered chelate had formed. The first was the large CIS value (Table 5.10) of the 
deshielded H6 (+0.56). This is only consistent with the formation of the seven-membered 
ring, as it places the H6 protons of the pyridine rings closer to the chlorine atoms attached to 
the palladium. If the five-membered chelate had formed then the CIS would not be as large 
(for example, see the CIS of H6 in the previous complex). Also there is no desheilding effect 
from the pyridine nitrogen of the uncoordinated ring upon the H3 proton of the coordinated 
ring, as was seen for previous five-membered chelates with this ligand. Thus, the fact that the 
signals had such a close integration appears to be merely a coincidence. The chemical shifts 
and coordination induced shifts for all signals are given in Table 5.10. The CIS values for 
121 show the same general features as the values found for the seven-membered chelate with 
ligand 99, viz. complex 117, and the reasons for these are the same as those proposed for 117. 
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Table 5.10 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 121 and 91. 
H3 H4 H5 H6 
121 8.05 8.26 7.86 9.15 
91 7.89 8.00 7.56 8.59 
CIS +0.16 +0.26 +0.30 +0.56 
a For deuterated dimethyl sulfoxide solutions. b CIS =' (Ocomplex - Oligand). 
121 
Fig. 5.32 
A palladium complex with ligand 94 was prepared in the same fashion as above, and 
the yellow complex, (122), analysed as [94.PdCh]. The IH NMR spectrum was recorded in 
deuterated dimethyl sulfoxide and again showed a mixture of free and complexed ligand, but 
integration of the signals due to each were not the same and so the ,formation of the seven-
membered chelate was again evident. The coordination induced shifts for complex 122 are 
given in Table 5.11, and show similar features to those of complex 121 for exactly the same 
reasons. However, the CIS values are all less positive that the corresponding values for 121. 
Table 5.11 1H NMR Chemical Shifts a and Coordination Induced Shiftsb for 122 and 94. 
H3 H4 H5 H6 
122 8.93 8.19 7.79 9.08 
94 7.91 8.10 7.55 8.72 
CIS +0.16 +0.09 +0.24 +0.36 
a For deuterated dimethyl sulfoxide solutions. b CIS = (Ocomplex - Oligand). 
A platinum complex was prepared by adding a nitromethane solution of bis(dimethyl 
sulfoxide)dichloroplatinum [(DMSO)2PtCh] to ligand 94 dissolved in nitromethane. The 
yellow micro-crystals, (123), which were recovered by filtration, in high yield (91%), 
analysed as [94.PtChJ. Recording the IH NlVIR spectrum of this complex was attempted in 
deuterated dimethyl sulfoxide, but this only succeeded in precipitated the (!it-DMSO)2PtCh 
complex and liberating the ligand. 
In an attempt to synthesise a dinuclear complex, ligand 94 was reacted with two 
equivalents of copper(II) nitrate in methanol. Sky blue crystals, (124), suitable for 
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crystallography were afforded directly from the reaction mixture. The structure is shown in 
Fig. 5.33. 
04 
Fig. 5.33 Perspective view, with atom labelling, of 124. Selected bond lengths (A) and angles 
(0). Cul-Nl' 2.002(2), Cul-Nl" 1.979(2), Nl '-Cul-Nl II 93.74(6), Cul-05 2.413(2), Cul-06 
2.014(1), 05-Cul-06 58.02(5), Ol-Cul-03 58.03(6), Cul-Ol 2.373(2), Cul-03 2.028(1), 
Sl-N2 1.633(2), Sl-N5 1.629(2), N2-C3 1.330(3), C3-C4 1.446(3), C4-N5 1.327(3). 
The crystal structure revealed that a mononuclear complex with a seven-membered 
chelate ring had fonned. The ligand is coordinating to the copper by the pyridine nitro gens 
[Cul-Nl' 2.002(2)A and Cul-Nl II 1.979(2)A], making a large bite angle [93.74(6)°] at the 
metal atom. The two nitrate anions are chelating, with one of the coordinating oxygens of 
each nitrate bonded more strongly than the other, and complete the pseudo-octahedral 
coordination of the copper atom. The structural confonnation of the ligand is remarkably 
similar to the structure found earlier with ligand 99 and copper(II) chloride, viz, 118. The 
seven-membered chelate again provides a similar angle between the pyridines [66.3(5)°], and 
the copper atom lies below the plane of the thiadiazole ring [1.997(3)A] 
The results of the palladium and copper complexes with ligands 91 and 94 indicated 
that the heterodiazole rings were not participating in coordination, and that, as with ligand 99, 
the fonnation of the seven-membered chelate was favoured over the fonnation of a smaller 
chelate. Of interest was an investigation into the coordination chemistry of these ligands with 
silver(I), where there is a very different geometric preference. To this end, ligand 94 and 
AgN03 were reacted in methanol. The resulting precipitated material was recrystallised from 
acetonitrile to give colourless crystals, (125), one of which was used for an X-ray analysis. A 
155 
perspective view of the asymmetric unit is shown in Fig. 5.34a, while the extended structure 
is shown in Fig. 5.34b. 
Fig. 5.34a Perspective view, with atom labelling, of 125. Selected bond lengths (A) and 
angles (D). Agl-N1' 2.305(2), Agl-Nl"A 2.235(2), Nl '-Ag1-N1"A 136.54(8), Agl-013 
2.412(3), 013-Ag1-Nl' 81.48(8), S1-N2 1.633(2), Sl-N5 1.633(2), N2-S1-N5 98.6(1), N2-C3 
1.333(4), Sl-N2-C3 107.6(2), C3-C4 1.434(4), N2-C3-C4 113.2(2), C4-N5 1.334(4), C3-C4-
N5 112.9(3), C4-N5-Sl 107.7(2), C3-C2' 1.493(4), C4-C2" 1.478(4). 
The complex is a one-dimensional metallopolymer, and has crystallised in the 
monoclinic space group P2]/n. The asymmetric unit contains a silver atom, bonded to a 
mono dentate nitrate anion, and one ligand coordinated to the silver via a pyridine nitrogen. 
The ligand is coordinated to the silver by the pyridine nitrogen only, with the thiadiazole ring 
again not participating in coordination. The ligand acts in a bridging fashion through each of 
its pyridine nitrogens, separating two silver atoms in the polymeric chain by 7.401 (l)A. The 
confonnation of the ligand can be defined by the angles between each of the meanplanes of 
the three planar aromatic rings. The two pyridine rings are of a similar pitch relative to the 
central 1,2,5-thiadiazole ring [45.9(4)° and 31.3(4t], but have the nitrogens in the opposite 
orientation, leading to the metallopolymer having an undulating character. The silver atom is 
tricoordinate with the angle between the coordinating nitrogens l36.54(8t. The angle at 
silver between the nitrate anion and Nl' is 81.48(8)°, and this is considerably smaller than the 
Nl "A-Agl-Ol3 angle [141.77(8t], which gives the silver a geometry that is neither trigonal 
planar nor distorted T -shape. 
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Fig. 5.34b Perspective view of the extended structure of 125. 
5.4 Dinuclear Ruthenium Complexes 
Having prepared. and examined mononuclear ruthenium complexes, some 
homodinuclear complexes of ruthenium with ligands 91, 94, and 95 were prepared. ill 
dinuclear complexes containing two octahedral metal centres there exists the possibility of 
diastereoisomerism between racemic, (M / ~~), and meso, (M), forms (Fig. 5.35). Each of 
the diastereoisomers contains a 2-fold element of symmetry, with the racemic diastereomer 
having a 2-fold rotational axis, whereas the meso contains an internal mirror plane. The meso 
and racemic forms are diastereoisomeric, and are therefore potentially distinguishable by 
NMR. 
AA/M 
(N liN ~ represents bpy or dmb 
n n 
L i;---L L represents a bridging bidentate ligand 
Fig. 5.35 
ill anticipation that the lH NMR spectrum of the dinuclear complexes of ligands 91 
and 94 with RU(bPY)2Cb would be difficult to assign, the first complex prepared was with the 
4,4 '-dimethyl derivative Ru( dmb )2Cb. This perhaps would at least allow identification of the 
pyridine rings of the bridging ligand. The dinuclear complex [(dmb)2Ru(91)Ru(dmb)2](PF6)4, 
(126), was prepared by reacting ligand 91 with an excess of Ru( dmb )2Cb in refluxing 3: 1 
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ethanolJwater, with conversion to the hexafluorophosphate salt during work-up. In the 
reaction, the mononuclear complex 110 was also formed and this was separated from the 
desired dinuclear complex 126 by chromatography on alumina using 100: 1 CH2ChIMeOH as 
eluant. After purification by vapour-diffusion recrystallisation of diethyl ether into an 
acetonitrile solution of the complex, complex 126 was characterised by F ABMS which 
confirmed a dinuclear complex. 
In the IH 1'lMR spectrum of complex 126, the pyridine rings of the thiadiazole-
containing ligand were found by I-D TOCSY by irradiation of the most downfield signal at 
8.96 ppm. From this signal two pyridine rings were identified, consistent with the formation 
of diastereoisomers. The only difference in the chemical shifts between the diastereoisomers 
is in the H6 protons. Integration of these separated resonances revealed that the 
diastereoisomeric complexes had formed in a 6:5 ratio. However, they could not be 
specifically assigned to either the meso or racemic forms. The chemical shifts and 
coordination induced shifts for complex 126 are presented in Table 5.12. 
Table 5.12 1 H NMR Chemical Shiftsa and Coordination Induced Shiftsb of 126 and 91. 
H3 H4 H5 H6 
126 8.96 8.33 7.66 7.90 
7.98 
91 7.91 7.97 7.53 8.60 
CIS +1.05 +0.36 +0.13 -0.70 
-0.62 
The CIS values show a large positive shift of the H3 protons for each complex of 
+ 1.05 ppm. This is a chelation-induced change in chemical shift. The dinucleation by the 
ligand has forced all three rings of the ligand to be coplanar, or very nearly so, which has 
brought the H3 protons of the ligand to be close together in space (Fig. 5.36), and in this 
confoffilation the rings deshield each other. The CIS value of +0.36 for the H4 protons is 
indicative of one of the effects of cr-donation or 1t back-bonding dominating the other. The 
usual upfield CIS is seen for the H6 protons. 
126 
Fig. 5.36 
The dinuclear complexes [(bpY)2Ru(91)Ru(bpY)2] (BF4)4, (127), and 
[(bPY)2Ru(94)Ru(bpY)2](PF6)4, (128), (Fig. 5.37) were also prepared and purified in the same 
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manner as complex 126. The reaction times and yields for these three complexes are shown 
in Table 5.13. The formation of the dinuclear complexes required a longer reflux time (ca. 24 
hrs) than the corresponding mononuclear complexes (ca. 4 hrs). F ABMS and elemental 
analyses were correct for the dinuclear complexes 127 and 128. 
127 128 
Fig. 5.37 
Table 5.13 
Complex Reflux Time (hrs) % Yield 
126 24 35 
127 24 31 
128 24 47 
In the same manner as for complex 126, the rings of the ligand were found for 
complex 127 by the irradiation of the most downfield multiplet in a l-D TOCSY experiment. 
The signals for each diastereoisomer were resolved in the experiment, although cannot be 
assigned to a specific isomer. No further IH NMR assignment of this complex was attempted 
due to the complicated nature of the spectrum. Keene et al.242,243 have separated such 
diastereoisomers by ion-exchange chromatography. Separation may have considerably aided 
further 1 H NMR identification in this case, but, as the signals due to the oxadiazole ligand 
were clearly found, this was not deemed to be necessary. The relevant NNIR data are 
presented in Table 5.14. Not surprisingly, the CIS values are very similar to complex 126, 
and the reasons for these are the same. 
Table 5.14 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb of 127 and 91. 
H3 H4 H5 H6 
127 8.96 8.35 7.69 7.99 
8.95 7.67 7.91 
91 7.91 7.97 7.53 8.60 
CIS +1.05 +0.38 +0.16 -0.61 
+1.04 +0.14 -0.69 
a For deuterated acetonitrile solutions. b CIS = (8complex - ~igand). 
It is not unreasonable to expect that the meso and racemic diastereoisomers may form 
in a 1: 1 ratio. However, in the case of complex 128, there exists a 3: 1 ratio of 
diastereoisomers. Each complex contains 40 protons, related by 2-fold symmetry, and so the 
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spectrum has 40 different proton signals. Because of the large diastereoisomeric excess, and 
the highly symmetrical nature of the spectrum (Fig. 5.38), the individual IH NMR spectrum 
of the diastereoisomers could be distinguished and assigned to either the major or minor form. 
Table 5.15 gives the chemical shifts and coordination induced shifts for the major, 128a, and 
minor, 128b, diastereoisomers . 
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Fig. 5.38 
Table 5.15 IHNMR Chemical Shiftsa and Coordination Induced Shiftsb of 94 and 128a/128b. 
H3 H4 H5 H6 
128a 9.00 8.30 7.66 7.95 
94 7.82 7.91 7.43 8.47 
CIS 1.18 0.39 0.23 -0.52 
H3 H4 H5 H6 
128b 8.98 8.27 7.62 7.92 
94 7.82 7.91 7.43 8.47 
CIS 1.16 0.36 0.18 -0.49 
a For deuterated acetonitrile solutions. b CIS = (bcomplex - ~gand). 
The UV-visible spectra of complexes 126, 127 and 128 show the effect of chelation of 
a second Ru(bpy)l+ unit, with the lowest energy MLCT being red-shifted in each complex 
relative to the corresponding mononuclear complex. As an example, the ""max for complex 
127 is at 497 nm, whereas in the mononuclear complex 109 it was at 435 nm. This 
corresponds to a lowering of the LUMO in dinuclear complexes compared to mononuclear 
complexes. The UV-visible spectra of [(bpY)2Ru(91)Ru(bpY)2] (PF6)4 (127) and 
[(bPY)2Ru(94)Ru(bpY)2](PF6)4 (128) are shown in Fig. 5.39 and some important UV-visible 
data for all three dinuclear complexes are presented in Table 5.16. 
Table 5.16 UV-visible parametersa for 126,127 and 128. 
Amax (c:)b A2(C:) 
126 498 (15 000) 409 (18700) 
127 497 (11 600) 405 (18200) 
128 531 (16000) 420 (17 800) 
a In acetonitrile solutions. b M- l cm-l • 
Fig. 5.39 UV-visible spectra of a) [(bPY)2Ru(91)Ru(bpY)2](BF4)4 (127) and b) 
[(bPY)2Ru(94)Ru(bpY)2](PF6)4 (128). 
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The UV-visible spectrum of 127 consists of two distinct peaks at 405 nm 
[(M)d-(bpy)rt*] and 497 nm [(M)d-(L)rt*], the latter, which is less intense, also having a 
broad low intensity shoulder at longer wavelength. The UV-visible spectrum for 128 has the 
same general features, with the (M)d-(bpy)rt* transition occurring at 420 nm, and the 
(M)d-(L)rt* transition at 531 nm also with a broad low intensity shoulder at longer 
wavelength. 
The dinuclear complexes were each examined by cyclic voltammetry, and the cyclic 
voltammograms of complex 127 and 128 are shown in Fig. 5.40, while the data for all three 
complexes are shown in Table 5.17. 
-1 V ov +1 V 
ov +1 V 
Fig. 5.40 Cyclic voltarnmograms for [(bPY)2Ru(91)Ru(bpY)2](BF4)4 (127) (top) and 
[(bpY)2Ru(94)Ru(bpY)2](PF6)4 (128). 
Table 5.17 Redox Potentialsa of complexes 127, 126, and 128. 
Eox! Eox2 Eredl Ered2 Eoxl-redl 
127 +1.48 +1.82 -0.53b - 2.01 
126 +1.42 +1.80 -0.58 - 2.00 
128 +1.41 +1.67 -0.62 -1.08b 2.03 
a 1n volts vs SCE in acetonitrile. b Irreversible reduction. 
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Electrochemically, complex 127 exhibits two one-electron oxidations at 1.48 and 1.82 
V, a peak separation of 340 mV (~Ep == 340 mY). This indicates a large metal-metal 
interaction when compared to the dinuclear complexes [(bpY)zRu(96)Ru(bpY)zt+ (~Ep = 170 
mV)45,183 and [(bpY)2Ru(97)Ru(bpY)2t+ (~Ep = 160 mV/9l and indicates the stability of the 
mixed valence [Ru(II)-Ru(III)] complex. A measure of stability is the comproportionation 
constant Kc, given by the formula Kc = exp[~1/2(mV)/25.69 mY] for which complex 127 
has a value of 5.6 x 105. Examination in the negative potential region revealed a single 
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irreversible reduction process at -0.53 V for the complex 127 and this is assigned to the 
bridging ligand. 
The electrochemical examination of 128 revealed the complex undergoes two one-
electron reversible oxidations at 1.41 V and 1.67 V, which is a smaller peak separation (AEp 
= 260 mY) than was seen for 127. The comproportion constant for complex 128 is 2.5 x 104. 
The first reduction at -0.62 V is fully reversible and is centred on the bridging ligand. The 
second reduction at -1.08 V is irreversible and is also bridging ligand based. The 
electrochemistry of complex 128 became somewhat complicated by adsorption processes at 
the electrode surface. This has been encountered before in work with sulfur-containing 
ligands.45 However, further 2-electron reduction processes were found at -1.60 V and -1.86 V, 
and by analysis of peak heights and peak-to-peak separations, were assigned as the 
simultaneous one-electron reductions of the auxiliary bpy ligands. 
Some of the important factors governing metal-metal interactions are the metal-metal 
distance, the electron density of the LUMO at the coordinating centres,188,244 and of course, 
the nature of the bridge. With short internuc1ear metal-metal separations, it has been 
proposed that electron transfer may be through the direct orbital overlap of the metal d 
orbitals (Fig. 5.41). This point has been particularly made for dinuc1ear complexes containing 
a 2,2'_bipyrimidine188,245 or 2,2 '-biimidazolate bridge.128 In other bridging ligands the 
geometry is such that direct metal d orbital overlap is not possible, so that communication 
must be mediated through the n-system of the bridging ligand, and this is the case with the 
present examples. The metal-metal interactions of the homodinuc1ear complexes just 
described are of a strong nature, with ~Ep = 340 m V for 127 and ~Ep = 260 m V for 128, 
which indicates good communication of the metals through the bridging ligand. Molecular 
models suggested a distance of ca. 6.oA for the dinuc1ear complexes 126, 127 and 128. 
BL represents a bidentate bridging 
ligand, such as 2,2 '-bipyrimidine or 
2,2 '-biimidazolate. 
Fig. 5.41 
As mentioned in the introduction to this chapter, the ligands 91 and 94 have a 
structural similarity to 96 and 97. However, the replacement of the central diazine rings with 
a heterodiazole would alter the distance between the metals (more so in the case of 96), and 
importantly the electronic nature of the bridge. The degree of aromaticity of the bridge has 
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been postulated to facilitate interaction between the metals. As was mentioned previously, 
the l,2,5-oxadiazoles are only 'aromatic' in that they contain 6 n electrons, with the oxygen 
atom contributing little of its electron density into the ring,225 and the heterocyclic 1,2,5-
oxamazole system is perhaps better described as being diene-like. The thiadiazoles may be, 
because of the greater polarisability of the larger sulfur atom, a more delocalised system. 
However, this being the case, the low aromatic character of the bridge has not restricted the 
electronic communication between the metals. In fact, on the basis of the electrochemical 
results obtained, the low aromatic character has served to facilitate the interaction! 
Two dinuclear ruthenium complexes were also prepared using ligand 95. Refluxing 
95 with 3-4 equivalents of Ru( dmb )2Ch or RU(bPY)2Ch gave the dinuclear complexes 
[(dmb)2Ru(95)Ru(dmb)2t+, (129), and [(bPY)2Ru(95)Ru(bpy)2t+, (130), respectively, which 
were isolated as the hexafluorophosphate salts. None of the possible trinuclear ruthenium 
complexes were formed. This is perhaps indicative of a transoid or orthogonal conformation 
between the thiadiazole rings, due to the free rotation about the 3,3'-inter-ring bond. The 
dinuclear complexes exist as shown in Fig 5.42. Both complexes were formed in excellent 
yields by the standard 3: 1 ethanol/water method (Table 5.18). 
(PFS)4 
I"': 
~ 
N \ '\:N 
I N I (bpY12Ru- -s 
130 
Fig. 5.42 
Table 5.18 
Complex Reflux time (Hrs) I Yield (%) I 
129 18 95 
130 18 I 96 I 
The aromatic region of the IH NMR spectrum of complex 129 is shown in Fig. 5.43. 
By irradiation of the most downfield doublet at 8.12 ppm in a I-D TOCSY experiment, only 
one ring for the ligand was identified in the spectrum. This indicates that if the meso and 
racemic diastereoisomers have formed, they must have the same influence upon the rings of 
the ligand. The chemical shifts and coordination induced shifts for 129 and 95 are listed in 
Table 5.19. Due to the unusually highfield position of the pyridine H6 protons in the ligand 
95, the CIS of the H6 protons in the complex 129 is smaller than that usually observed for 
such ruthenium complexes. The H4 protons of the complex also show a smaller than usual 
shift, and this is again due to one of the effects of n back donation or cr donation dominating 
the other. 
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Table 5.19 IH NMR Chemical Shifts a and Coordination Induced Shiftsb for 129 and 95. 
H3 H4 H5 H6 
129 8.12 7.92 7.51 7.86 
95 7.97 7.74 7.20 8.10 
CIS 0.15 0.18 0.31 -0.24 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex - Oligand). 
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Fig. 5.43 IH NMR spectrum of [(bPY)2Ru(95)Ru(bpY)2](PF6)4 (129). 
The IH NMR spectrum of complex 130 was too difficult to assign. The IH J'JMR 
spectrum effectively contains ten different 2-substituted pyridine rings, five for each 
diastereoisomer, all of the signals of which appear to be overlapped in the spectrum. To 
determine which of these signals were due to the thiadiazole-containing ligand was not 
possible. It is reasonable to expect that the chemical shifts in 130 would be similar to those of 
129. One technique that has been used with success in cases such as this, is the replacement 
ofbpy with ds-bpy. The drawbacks of this technique are the high cost of ds-bpy and the loss 
of information that other protons in the spectrum carry. Characterisation of 130 was by 
FABMS and elemental analysis, both of which confIrmed a dinuclear complex. 
The UV-visible spectrum of 129 (Fig. 5.44) shows a A.max at 471 nm whereas in the 
mononuclear complex it is at 454 nm. This suggests that the metal-metal interaction is 
smaller in complex 129 than in the complex 126, for which the A.max was 531 nm. The 
(M)d-(bpy)n* transition is also evident at 420 nm and is less intense than the MLCT 
transition into the bridging ligand. 
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Fig. 5.44 UV-visible spectrum of [(bpY)2Ru(95)Ru(bpyh](PF6)4 (129). 
165 
The electrochemical investigations of complexes 129 and 130 are summarised in 
Table 5.20, while the cyclic voltammogram for complex 130 is shown in Fig. 5.45. Both 
complexes undergo simultaneous two-electron oxidations, meaning the metal-metal 
interaction is small. In the negative potential region, the first two reduction waves are closely 
spaced, and are assigned to the bridging ligand 95 in each complex. Perhaps the first added 
electron has the effect of influencing the second, making the latter slightly harder to add to the 
bridging ligand. The complexes then undergo a third reduction process, most likely a two-
electron reduction, that is irreversible, and at which point adsorption processes at the 
electrode surface are encountered, as evidenced by the stripping curve in the voltammogram. 
The complex 129 has a lower oxidation potential, which is again attributable to the 
electron donating methyl groups of the auxiliary dmb ligands. This difference is primarily 
responsible for the smaller Eox-redl value of 129 compared to 130. As the distance between the 
two metals has increased, the metal-metal interaction has decreased. This result has been seen 
for many dinuclear ruthenium complexes, including those of 2,2':4',4":2",2"'-quaterpyridine 
(98),76,192 where the metal-metal interaction is diminished relative to those containing the 
bridging ligands 96 and 97, which have smaller internuclear distances. Also, the metal-metal 
interaction may be decreased as a result of rotation about the 3,3 '-inter-ring bond, which 
disrupts a planar 7C system of the ligand, precluding mediation via the bridging ligand. 
Table 5.20 Redox Potentials3 of complexes 129 and 130. 
Eox Ered! Ered2 Ered3 Eox-redl 
129 + 1.31 b -1.02 -1.14 -1.75c 2.33 
130 +l.4lb -0.98 -1.10 -1.62c 2.39 
a In volts vs SeE in acetonitrile. b Two-electron process. C Irreversible reduction. 
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Fig. 5.45 Cyclic voltammogram of [(bpY)zRu(95)Ru(bpy)z] (PF6)4 (130). 
5.5 Heterodinuc1ear Complexes 
The mononuclear complexes 109, 110 and 111 are amenable for the construction of 
heterodinuc1ear complexes. As a further investigation, some heterodinuc1ear 
ruthenium/palladium and ruthenium/platinum complexes were prepared and examined. 
The first attempt at preparing a dinuc1ear ruthenium-palladium complex was by 
adding a methanolic solution of LizPdC14 to complex 111 dissolved in hot acetone/ethanol. 
An immediate precipitate formed and was collected by filtration. F ABMS showed that the 
precipitated complex was the chloride salt, (131), formed by the reaction shown below. 
Complex 131 is sparingly soluble in acetonitrile, and a IH NMR spectrum was 
recorded in deuterated solvent. The spectrum of 131 is shown in Fig. 5.46, and the relevant 
NMR data for 131 are shown in Table 5.26. The appearance and position (9.38 ppm) of a 
pyridine H6 proton (H6') easily distinguished the pyridine ring of the thiadiazole-containing 
ligand coordinated to palladium. The chemical shifts of the other protons of this ring were 
found by 1-D TOCSY from the irradiation of this signal. Interestingly, the H3 proton of this 
ring (H3') was more upfield than expected. Irradiation of another isolated signal in the 
spectrum, at 7.68 ppm, provided the other ring of the ligand. This ring too had a signal for H3 
that was at unusually high field. With both H3 protons of the complex being shielded, the 
pyridine rings of the ligand were proposed to be providing the ring-current anisotropy 
shielding the H3 proton of the other ring (Fig. 5.47). 
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Fig. 5.46 IH NMR spectrum of [(bPY)2Ru(94)PdCh]Ch (131). 
Table 5.26 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 94 and 131. 
H3 H4 HS H6 H3' H4' HS' H6' 
131 7.68 7.86 7.46 7.93 7.87 8.21 7.79 9.35 
94c 7.82 7.91 7.43 8.47 
CIS -0.14 -0.05 +0.03 -0.54 +0.05 +0.30 +0.36 +0.88 
a For deuterated acetonitrile solutions. b CIS = (8complex-Otigand). c The free ligand in solution 
shows 2-fold symmetry; hence H3 = H3'. 
(Cl)z 
131 
Fig. 5.47 
By the preparation and IH NMR characterisation of the ruthenium-palladium complex, 
[(dmb)2Ru(91)PdC12]Clz (132), starting with the 4,4'-dimethyl-2,2'-hipyridine precursor 110, 
the signals assigned to the rings of the thiadiazole ligand in complex 131 were confirmed by 
comparison. The relevant IH NMR data for complex 132 is given in Table 5.27. Importantly, 
the CIS values show a good correlation to those found above. 
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Table 5.27 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 91 and 132. 
H3 H4 H5 H6 H3' H4' H5' H6' 
132 7.88 7.93 7.52 7.88 8.06 8.26 7.85 9.33 
91c 7.91 7.97 7.53 8.60 
CIS -0.03 -0.04 -0.01 -0.72 +0.15 +0.39 +0.32 +0.73 
a For deuterated acetonitrile solutions. b CIS = (Ocomplex-Oligand). c The free ligand in solution 
shows 2-fold symmetry; hence H3 = H3 '. 
In order to perform electrochemical measurements the chloride anion needed to be 
exchanged for a non-redox active counterion, and this was attempted using a metathesis 
reaction. The chloride salt was suspended in water, containing an excess of J\lli4PF6, and 
stirred for two days. However, F ABMS indicated the presence of chloride counterions and no 
satisfactory elemental analyses were obtained. To alleviate this problem a different method of 
synthesis was used. 
When an equimolar amount of bis(benzonitrile )dichloropalladium [(PhCN)2PdClz] in 
chloroform was added to mononuclear ruthenium complex 111 dissolved in dichloromethane 
at room temperature, a product precipitated out of solution in near quantitative yield. F ABMS 
of the resulting solid gave a molecular ion that suggested the complex contained a PdClz 
fragment as well as a coordinated benzonitrile and so was formulated as 
[(bPY)2Ru(94)Pd(PhCN)Clz] (PF6)2, (133). A IH NMR spectrum in deuterated acetonitrile 
showed that 133 had some very similar chemical shifts compared to the precursor ruthenium 
complex. In particular, the H6 of the uncoordinated ring and the H3 of the coordinated ring 
had both changed very little in chemical shift. Therefore the resulting complex was proposed 
as shown in Fig. 5.48, where the palladium has coordinated to the N5 of the thiadiazole in a 
mono dentate fashion. Importantly, the complex still contains an uncoordinated pyridyl ring, 
which is consistent with the chemical shifts observed. 
P;fJh N:;-' \ N :--/ / \ (bpyhRu- N N CI 
"s'/ "'--. / Pd 
CI/ "----NCPh 
133 
Fig. 5.48 
When the reaction conditions are changed to refluxing acetone/ethanol the desired 
chelating complex, 134, is formed. Also, the complex 133 could be converted to the 134 by 
the same conditions (Scheme 5.7). 
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111 133 
Refluxing EtOH / acetone 
Refluxing EtOH / acetone 
134 
Scheme 5.7 
A ruthenium-platinum complex was prepared by reacting equimolar amounts of the 
mononuclear ruthenium complex 111 with (DMSO)2PtCb in acetone/nitromethane at room 
temperature (Scheme 5.8). Careful inspection of the IH NMR spectrum revealed that a 
downfield H6 proton was close in chemical shift to the ruthenium precursor, and this 
indicated that the complex formed contained an uncoordinated pyridine ring of the ligand. 
This proton was irradiated in a 1-D TOCSY experiment and the chemical shifts of all protons 
of the ring did not suggest coordination. Also, the presence of DMSO was observed in the 
spectrum. The F AB mass spectrum of this complex indicated coordinated DMSO and 
elemental analysis confirmed this. As above it seemed the metal fragment was coordinated to 
the thiadiazole N5 in a monodentate fashion. The complex was then heated at reflux in 
ethanol/nitromethane, in the hope of converting it to the desired chelating complex. However, 
F ABMS again indicated the presence of coordinated DMSO. Accordingly, the complex was 
formulated as [(bPY)2Ru(94)PtCb(DMSO)](PF6)2 (136). The H6 proton of the pyridyl ring 
coordinated to the platinum was identified in the spectrum by its appearance and downfield 
position (9.07 ppm). This proton had changed in chemical shift and suggested another mode 
of coordination. Irradiation of this signal gave the chemical shifts of the other protons of the 
ring. From the CIS values of this ring (Table 5.22), in particular H4', it was deduced that the 
platinum fragment was now coordinated to the pyridine ring. The proton signals for the other 
pyridine ring of the thiadiazole-containing ligand was found by irradiation of a downfield 
signal at 8.86 ppm in a I-D TOCSY experiment. In general, the signals for the bpy ligands 
were grouped together in the IH NMR spectrum with considerable overlap. No attempts to 
. assign any of the individual bpy ring systems were therefore made. 
Acetone / nitromethane RT 
111 135 
+ (DMSO)2PtC12 Refluxing EtOH / nitromethane 
Refluxing EtOH / nitromethane 
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Ru 
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Scheme 5.8 
Table 5.22 IH NMR Chemical Shiftsa and Coordination Induced Shiftsb for 94 and 136. 
H3 H4 H5 H6 H3' H4' H5' H6' 
136 8.86 8.25 7.62 7.95 8.76 8.50 7.83 9.07 
94c 7.82 7.91 7.43 8.47 
CIS +1.04 +0.34 +0.19 -0.52 +0.94 +0.59 +0.40 +0.60 
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a For deuterated acetonitrile solutions. b CIS = (bcomplex-bligand). c The free ligand in solution 
shows 2-fold symmetry; hence H3 = H3'. 
Both H3 and H3' show the effect of being de shielded and are moved downfie1d. This 
may be as a result of the pyridine coordinated to the platinum existing in the conformation 
shown in Scheme 5.8. The CIS value ofH4'reflects the strong effect ofcr-donation, when the 
metal does not participate in back-bonding. This difference is illustrated in the comparison of 
the CIS values ofH4 with H4'. The CIS value of the H4 proton is tempered with the effect of 
back-bonding, resulting in a smaller CIS value of +0.34. Complex 136 was also prepared 
directly from 111, as shown in Scheme 5.8. 
The incorporation of the PtClz(DMSO) fragment has a marked effect on the UV-
visible spectrum of the complex. The UV-visible spectrum (Fig. 5.46) of 136 shows three 
MLCT transitions. The transitions occur at 514 nm, 458 nm and 423 nm and are assigned, 
based on previous complexes, to the (M)d-(L) n*, (M)d-(bpy)n* and (M)d-(L) n* 
transitions, respectively. The influence of the platinum is to induce another MLCT transition 
at lower energy. As this transition is at 514 nm, this suggested that the electrochemistry 
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would show a first reduction of the bridging ligand at a potential close to that of the 
homodinuc1ear ruthenium complex 128 (Amax 531 nm). 
4.0,...,----------------, 
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Fig. 5.46 UV -visible spectrum and cyclic voltammogram of 
[(bPY)2Ru(94)PtClz(DMSO)](PF6)2 (136). 
Indeed, the cyclic voltammogram of complex 136 (Fig. 5.46) did show an irreversible 
first reduction of the bridging thiadiazole-containing ligand (-0.60 V) at a potential close to 
that of the homodinuc1ear ruthenium complex (-0.62 V). The platinum atom undergoes a 
two-electron oxidation at + 1.41 V, and surprisingly this is a reversible process. For a related 
heterodinuclear ruthenium/platinum complex, with 96 as the bridging ligand, this redox 
process is irreversible.246 The oxidation potential of the ruthenium atom is at + 1.67 V, which 
is similar to the second oxidation potential of the homodinuc1ear ruthenium complex 128. 
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5.6 Summary 
This chapter has included the syntheses of four new ligands, 3,4-di(2-pyridyl)-1,2,5-
oxadiazole 91, (1,2,5-thiadiazol-3-yl)pyridine 93, 3,4-di(2-pyridyl)-1,2,5-thiadiazole 94, and 
4,4'-di(2-pyridyl)-3,3'-bi-I,2,5-thiadiazole 95. Also the attempted preparations of two other 
1,2,5-oxadiazole-containing ligands were discussed. The three thiadiazoles were synthesised 
following a procedure recently described by Rees et ai., thereby extending this method. 
Ligand 95 was also studied in the solid state by X-ray diffraction and was found to exist with 
an approximately orthogonal relationship between the 1 ,2,5-thiadiazole rings. A silver nitrate 
complex was prepared with one of the ligand precursors - 1,4-di(2-pyridyl)buta-1,3-diyne 
103, and characterised crystallographically, resulting in the discovery of a metallopolymeric 
structure. This is the ftrst example of a metal complex using this molecule as a ligand. 
Also incorporated into this study was the known molecule 3,4-di(2-pyridyl)-1,2,5-
oxadiazole-2-oxide 99. This ligand was found to undergo a new RORe reaction mediated by 
the Ru(bpy)l+lRu(dmb)l+ cations, which resulted in the formation of complexes containing a 
pyrazolo[1,5-a]pyridine ligand. The resulting complexes were studied and the pyrazolo[1,5-
a ]pyridine system was found to lower the first reduction potential of the ligand in the 
complexes when compared to Ru(bpy)l+. Presently, we are unaware of any other complexes 
containing this ring system having been studied. Palladium and copper complexes were 
subsequently prepared with 99 and, by a combination of IH NMR and X-ray crystallography, 
were found to form seven-membered che1ates in preference to a possible five-membered 
chelate. By the preparation of palladium and copper complexes with structurally related 
ligands (91 and 94) this was found to be a general phenomenon. 
The ligands 91, 93 and 94 were shown to be able to form five-membered chelates in 
the work with the Ru(bpy)l+ cation and for Pd(II) with 93. The results for the Ru(bpy)l+ 
cation are in no doubt related to the steric requirements placed upon complex formation by 
the existing metal complex. The seven-membered chelate, with its large bite-angle at the 
metal atom, is simply unable to fit into the space available. The UV-visible spectroscopy and 
electrochemical measurements provided insight into the electronic nature of the heterocyclic 
systems and the ruthenium complexes. For these complexes, the oxidation potential is raised 
considerably by the incorporation of just one heterodiazole ring. For example, the complex 
[Ru(bpY)2(91)](PF6)2 109 undergoes metal-based oxidation at +1.53 V, which is 270 mV 
higher than in Ru(bpy)l+ (+1.26 V). The heterodiazole ligands are also more easily reduced 
than bpy in the complexes, highlighting their electron deficient nature. 
A factor previously considered important for electronic communication in dinuclear 
complexes is the aromaticity of the bridge. Although ab initio22S studies suggest the 1,2,5-
oxadiazole ring contains little aromatic character, the dinuclear ruthenium complexes bridged 
173 
by a 1,2,5-oxadiazole ring were found to allow good electronic connnunication, as evidenced 
by the AEp values. An important electrochemical difference in some of the ruthenium 
complexes prepared, was the reversibility of the reductions of the heterodiazole ligands. In 
particular, strict irreversibility of the 1,2,5-oxadiazoles and the sometimes reversible 
behaviour of the 1,2,5-thiadiazoles were observed. An attempt to explain this behaviour was 
made by preliminary ab initio calculations. 
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hapter 
Conclusions and Prospects 
The work described in this thesis involved previously little-studied heterocyclic 
systems contained in chelating multidentate ligands. The aim of this work was to gain insight 
into the nature of these heterocyclic systems by the preparation and study of their metal 
complexes. The effects of the Ru(bpy)l+ unit are well understood, and this moiety was used 
as a template in this work, serving as a basis for comparison and examination. By the 
preparation of complexes with other metal ions, having different geometrical preferences, the 
metallosupramolecular chemistry with many ligands was also investigated. 
IH NMR spectroscopy proved a useful tool in the characterisation of the many 
ruthenium and palladium complexes produced in this work. The use of IH nOe and I-D 
TOCSY experiments was crucial for determination of the structures of such complexes. From 
the calculation and subsequent interpretation of proton CIS values, which required 
unambiguous assignment of IH NMR spectra, the nature of the metal-ligand interaction was 
probed. The electronic nature of the metal-ligand interaction in the ruthenium complexes was 
further investigated with UV -visible spectroscopy and cyclic voltametric measurements. The 
technique of X-ray crystallography was able to provide direct structural assignment for twenty 
complexes, and was also used to study the solid state conformations of molecules containing a 
biheterocyclic unit or subunit. 
As the heterocyclic systems investigated in Chapters 2 and 3 are sufficiently different 
from the heterodiazoles of Chapters 4 and 5, conclusions about them will be drawn separately. 
In Chapter 2, the benzo-fused benzoxazole, benzisoxazole, and benzothiazole systems were 
studied for a combination of new and known ligands. We felt a study of the parent 
biheterocyclic ligands, when chelated to Ru(bpY)l+, would provide the effects due solely to 
the heterocyclic systems. The studies of the benzoxazole and benzothiazole biheterocycles 
proved successful, and the effects due to the heterocyclic systems were determined, and were 
found to have significantly different properties from those of bpy. This now allows ligands 
containing these heterocyclic systems to be designed with these properties in mind. 
We were also interested in a comparison of the benzoxazole ring with the 1,2-
benzisoxazole ring. Although the biheterocycle 3,3'-bi-l,2-benzisoxazole (5) could not be 
synthesised, some feeling about the nature of the isomeric ring systems was gained from the 
synthesis and study of 3-(2-pyridyl)-1 ,2-benzisoxazole (6). The important differences were 
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that the 1,2-benzisoxazole-containing ligand raised the oxidation potential of the ruthenium 
complex more than the benzoxazole-containing ligand and also proved to be 
electrochemically unstable. Notable by its absence was any investigation into the 1,2-
benzisothiazole system in this study, and this area remains unexplored. Also there has been 
little study of ruthenium complexes involving isoxazoles or isothiazoles and together these 
still represent a gap in the literature. 
The benzotriazole system was examined in Chapter 3, with the investigations of five 
I-substituted benzotriazole-containing ligands. The main feature from this study was that the 
3-position of the triazole ring was the preferred nitrogen for coordination. This disposed the 
ligands to act in bridging fashions, rather than the desired chelating mode. However, ligands 
containing the benzotriazole system were able to be forced to chelate, and the study of these 
complexes provided an insight into the electronic nature of the I-substituted benzotriazole 
ring. Ligands containing a 2-substituted benzotriazole have received little attention. A study 
of such ligands would provide an interesting comparison between the 1- and 2-substituted 
benzotriazole ring. This is an opportune area for further study. 
An interesting comparison between Chapters 2 and 3 is that of 3-(2-pyridyl)-1,2-
benzisoxazole (6) and 1-(2-pyridyl)benzotriazole (27). These ligands are isoelectronic, but 
analysis of their respective electrochemical properties (Table 6.1) of their ruthenium 
complexes, 13 and 35, (Fig. 6.1) reveals very different behaviour. 
13 35 
Fig. 6.1 
Table 6.1 Redox PotentialsU of 13 and 35. 
Eox Eredl Ered2 Bred3 I LlEox-redl 
RU(bPY)32+ +1.26 -1.33 -1.51 -1.75 2.59 
Ru(bPY)2(6)2+ (13) +1.36 -1.01 b - -
• 
2.37 
Ru(bpy)z(27)2+ (35) +1.53 -1.39 -1.60 - I 2.92 
a In volts vs SCE in acetonitrile. b Irreversible reduction. 
The effect of both heterocyclic systems is to reduce electron density on the ruthenium 
atom, and therefore raise the oxidation potential of the respective complexes, relative to 
Ru(bpy)/+. Interestingly, the triazole has done so more than the isoxazole. With regards to 
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the reductions of the ligands 6 and 27 in the complexes, the difference is even more 
pronounced. The first reduction of complex 13 is attributed to that of ligand 6, while no 
reduction was attributed to the ligand 27 in complex 35, as the two observed reductions are 
assigned to the bpy ligands. The combined result of these effects is manifested in the ~Eox-red1 
values. As the metal atom is less electron-rich and the benzotriazole-ligand harder to reduce, 
complex 35 has a very large ~Eox-red1 value 2.92; and although the incorporation of the 1,2-
benzisoxazole ring has raised the oxidation potential of the complex, the 1,2-benzisoxazole-
containing ligand is much more easily reduced than bpy, giving the smaller ~Eox-redl value, 
relative to Ru(bpy)/+, of 2.37. These examples demonstrate how one can control the 
physicochemical properties of such complexes. 
The latter half of this work focused on two isomers of the heterodiazoles - the 1,2,4-
systems and the 1,2,5-systems. The aims for these chapters were twofold; firstly, to study the 
effects due to the heterocyclic systems in mononuclear complexes and, secondly, to examine 
metal-metal interactions in dinudear complexes containing these types of ligands. Very little 
previous study has been conducted on complexes with heterodiazole-containing ligands. 
Accordingly, they are currently not well understood. 
The study of Chapter 4 found that the 1,2,4-oxadiazole ring is not robust, and is 
therefore not suitable for the construction of polynuclear ruthenium complexes. Indications 
of a preference for N4 coordination were seen for the 1,2,4-oxadiazole ring. In contrast, the 
1,2,4-thiadiazole ring proved to be much more stable, and was found to impart significantly 
different properties to complexes relative to bpy. Thus, it is a useful component for 
incorporation into chelating ligands. 
A complex studied in Chapter 4, [Ru(bpY)2(65)](PF6)2 (S4), can be compared to a 
complex studied in Chapter 5, [Ru(bPY)2(93)](PF6)2 (lOS), both of these complexes are shown 
in Fig. 6.2, and their respective electrochemistry summarised in Table 6.2. These complexes 
differ only in the transposition of CH and S subunits. 
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Table 6.2 Redox Potentialsa of 84 and 108. 
Ered2 Ered3 ilEox-redl 
-1.51 -1.75 2.59 
-1.02 -1.58 -1.92 
-1.19 -1.55 
a In volts vs SCE in acetonitrile. 
Clearly, the introduction of these heterocyclic systems has had a dramatic effect 
electrochemically. The incorporation of just one heterodiazole ring into the complexes has 
altered the properties of the resulting complex relative to Ru(bpy)l+. The metal atoms in 84 
and 108 are less electron-rich than in Ru(bpy)l+, as the oxidation potential is higher in each 
case, and in turn, the metal atom in 108 is significantly less electron rich than in 84. 
Somehow the 1,2,5-thiadiazole has reduced the electron density on the metal more than the 
1,2,4-thiadiazole. At this time we suspect this effect is primarily due to the donor strength of 
the coordinating nitrogen, and therefore may show a correlation to pKb measurements. As 
reductions in such complexes have been shown to be ligand localised, this allows a 
comparison of the reduction potential due to the thiadiazole ligand in each complex. The 
reduction potentials show that it is easier to add an electron to the 1,2,4-thiadiazole ligand (-
1.02 V) than it is to the 1,2,5-thiadiazole (-1.19 V). Obviously, the arrangement of the 
heteroatoms plays a role in determining the properties of the complex. Thus, this work has 
demonstrated that subtle variation in ligand structure can result in pronounced changes in 
physical properties of complexes. To aid the determination of factors responsible for these 
changes, the preparation of the Ru(bpy)l+ complexes with the isomeric ligands 2-(1,2,3-
thiadiazol-4-yl)pyridine247 and 2-(1,3,4-thiadiazol-2-yl)pyridine would be valuable. 
For a statistical analysis of the complexes produced in this work, a plot of Eox-redl vs 
Amax was drawn. The values for a dataset of sixty mononuclear ruthenium complexes were 
taken from the literature5,6 and a least-squares regression line fitted to this data, resulting in a 
modest correlation coefficient of 0.71. The 17 mononuclear complexes synthesised and 
studied in this work are plotted as the triangular points and were not included in the regression 
analysis. 
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Many of the complexes produced fit nicely to the line of best fit, and inspection of 
these data points revealed these complexes were of the benzoxazoles and benzothiazoles of 
Chapter 2, the 1,2,4-thiadiazoles of Chapter 4 and the 1,2,5-thiadiazoles of Chapter 5. At 
shorter wavelength values (420-430 nm) are the group of three benzotriazole-containing 
complexes, 35, 36 and 37, which also conform reasonably welL The complex having the 
largest Eox-redl value is the complex 34, which contains the chelating 1,1 '-
methylenebisbenzotriazole ligand, and this complex too shows a reasonable correlation to the 
projected line. 
More interesting, however, are the points that lie well below the line. Clearly these 
complexes do not conform welL These five data points relate to the l,2-benzisoxazole-
containing complex, 13, of Chapter 2, the l,2,5-oxadiazole-containing complexes, 109 and 
110, and the pyrazolo[1,5-aJpyridine-containing complexes, 115 and 116, of Chapter 5. 
Three of these five complexes contain a nitrogen-oxygen bond in the heterocyclic ligand and, 
all of these complexes have an irreversible reduction of the ligand. Obviously, the presence 
of this N-O moiety in the ligands changes considerably the properties of the complexes. A 
useful comparison would be with isoxazoles, but, as noted above, there is a complete lack of 
data concerning isoxazole-containing ruthenium complexes in the literature. The 
pyrazolo[l ,5-a Jpyridine complexes, 115 and 116, lie farthest from the regression line, 
representing the largest deviation from the norm. Interestingly the two closest points to these 
complexes are two other complexes containing pyrazole ligands. This perhaps indicates the 
unique properties associated with these kinds of heterocyclic systems. 
The new dinuclear complexes, 127 and 128, produced in this work showed large 
metal-metal interactions, indicating efficient coupling between the metal centres. Although 
the l,2,5-oxadiazole system has little aromaticcharacter225 it mediated strong electronic 
coupling (~Ep 340 mY) in the dinuclear complex 127. The l,2,5-thiadiazole system also 
mediated electronic coupling of the metal centres, although not as well as the 1,2,5-oxadiazole 
179 
(./llip 260 mV for complex 128). We postulated that the 1,2,5-thiadiazoles are more aromatic 
in the same way that thiophene is more aromatic than furan. This might suggest that 
aromaticity is not as important as previously thought. Perhaps, the oxygen and sulfur 
heteroatoms, in disrupting the aromaticity, enforce the bridge to behave as a diene, facilitating 
electronic communication via this pathway. From this work, it is clear that disubstituted 
1,2,5-heterodiazole ligands are useful components to add to the ever-expanding pool of 
heterocyclic ligands. 
The study of Chapter 5 could be extended to include other heterocyclic systems, which 
retain the desirable structural characteristics of ligands 91 and 94. 4,5-Di(2-
pyridyl)imidazole, 4,5-di(2-pyridyl)-1,2,3-triazole, and 4,5-di(2-pyridyl)-2, 1 ,3-selenodiazole 
(Fig. 6.3) would be new, interesting, ligands for such a study. As the ab initio study by 
Bean225 revealed, the incorporation of more nitrogen atoms into a five-membered ring induces 
more delocalisation; ie. 1,2,3-triazoles are more delocalised than pyrazoles, which is the 
opposite to what happens in the oxoles due to electronegativity of the oxygen atom. One 
might expect that the imidazole- and 1,2,3-triazole-containing ligands would show reduction 
at more negative potentials than the heterodiazoles examined in the present study, while the 
selenodiazole may be expected to exhibit redox behaviour similar to the heterodiazoles. 
~ /; OJJ~ N- N 
HN, .-;,N 
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Fig. 6.3 
In summary, this study has demonstrated that all the examined heterocyclic systems 
have imparted different properties to the Ru(bpy)zL2+ complexes, relative to Ru(bpy)l+. 
Some of the examined systems seem to be unique, as they are do not conform to the Eox-redl vs 
Amax relationship found for previously studied complexes. The reasons for this are not 
immediately obvious, as the heterocyclic systems investigated have had no previous study of 
this type and, as always in this circumstance, there is no existing model for comparison with 
experimental results. The use of computational methods, like those described in this work, 
may provide an important link for systems that are little-studied and hence not well 
understood. 
There are a great many still unexplored heterocyclic systems, and combinations of 
systems, available for the type of investigation that has been conducted in this study. As the 
study of the more common heterocycles become exhausted, chemists will surely tum to the 
more exotic types of systems, similar to those examined here, in search of complexes 
containing new interesting properties. Thus by the compilation of data on such complexes, 
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chemists are offered a more diverse choice of molecular components available for 
incorporation into coordination complexes and supramolecular assemblies. 
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Chapter 7 
Experimental 
General Experimental 
NMR spectra were recorded on Varian XL 300 or Varian Unity 300 spectrometers 
with a 3 mm probe and operating at 300 MHz and 75 MHz for IH and 13C, respectively. IH 
NMR spectra recorded in CDCh were referenced relative to the internal standard Me4Si and 
those recorded in deuterated dimethyl sulfoxide and acetonitrile were referenced against the 
solvent signals at 2.5 and 2.0 ppm, respectively. l3C NMR spectra recorded in CDCh were 
referenced against the solvent signal at 77.0 ppm and those recorded in dimethyl sulfoxide 
and acetonitrile were referenced against the solvent signals at 36.8 and 117.7 ppm, 
respectively. When required, IH nOe, 1-D TOCSY, COSY, GHSQC and GHMBC 
experiments were performed using the standard pulse sequences available with the Unity 300 
system. Unless otherwise stated the value for the chemical shift is given to the centre of the 
multiplet. 
UV-visible spectra were recorded on a GBC spectrophotometer for ca. 0.1 mmol 
solutions in acetonitrile .. Cyclic voltametric measurements were made on a PAR Model 175 
Universal Programmer coupled to a PAR Model 173 potentiostat. Measurements were made 
of acetonitrile solutions containing ca. 1 mmol of complex and 0.1 M tetrabutylammonium 
hexafluorophosphate as the supporting electrolyte, using a scan rate of 100 mVs-1 and a glassy 
carbon electrode (area 0.07 cm-2), with a platinum wire as the auxiliary electrode. Ferrocene 
was used as an internal standard and potentials are given vs the saturated calomel electrode 
[EO(Fc/Fc +) = 0.31 V vs SCE]. 
Mass spectra (El and F AB) were recorded using a KratDs MS80RF A mass 
spectrometer with a Mach 3 data system. Electron Impact (El) spectra were obtained at 70 eV 
with a source temperature of 250°C. Fast Atom Bombardment (F AB) spectra were acquired 
in a nitrobenzyl alcohol matrix using an Iontech ZN11NF FAB gun operated at 8 KV and 2 
rnA. Electrospray mass spectra were recorded using a Micromass LCT TOF mass 
spectrometer, with a probe operating at 3200 V and cone voltage of 30 V. Samples were 
dissolved in 1: 1 acetonitrile/water, and spectra acquired using source and desolvation 
temperatures of 80°C and 150°C, respectively. 
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Infrared spectra were recorded as a solution in CDCh using a Shimadzu FTIR-8201PC 
spectrophotometer. Melting points were determined using an Electrothermal melting point 
apparatus and are uncorrected. The Chemistry Department, University of Otago, Dunedin 
performed elemental analyses. 
EHMO calculations were performed on a Power Macintosh 6100/600 personal 
computer with the CAChe Extended Huckel Program from the personal CAChe suite of 
programs, CAChe Scientific, Oxford molecular group, 1995. 
Unless otherwise stated reagents were obtained from commercial sources and used as 
received. The following compounds were prepared using literature procedures: 3-
chlorobenzisoxazole,56 silver(II) oxide,248 bis(2,2' -bipyridine )dichlororuthenium,249 
tetrakis(DMSO)dichlororuthenium,250 bis(benzonitrile)dichloropalladium,251 2,2'-
diaminoazobenzene,99-101 3,3 '-bi-1 ,2,4-oxadiazole (57),148 5,5'-dimethyl-3,3 '-bi-1 ,2,4-
oxadiazole (58) and 5,5'-diphenyl-3,3'-bi-1,2,4-oxadiazole (59)/49 bis(2-pyridolyl)furoxan 
(100),204 2-picolylamidoxime,147 2-ethynylpyridine,216 1,2-di(2-pyridyl)ethene (102),214 
trithiazyl trichloride218,219 and oxamidoxime.146 
Preparation of Ligands 
2,2'-Bibenzoxazole (1) 
P20 S (12 g) and H3P04 (5 ml) were combined in a 100 mI 
round bottomed flask. This mixture was heated with stirring at 
200°C for 30 minutes. Then resublimed 2-aminophenol (1.80 g, 17 
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mmol) was added in one portion. The resulting mixture turned deep blue. A reflux condenser 
was attached and diethyl oxalate (1.0 ml, 7 mmol) was added dropwise. After a brief period 
the mixture bubbled vigorously. Heating and stirring was continued for 2 hours at 220°C, 
during which time the colour of the solution had changed to dark orange. The mixture was 
cooled to ca. 100°C and then poured onto ice/water (100 ml). An orange precipitate formed 
and was collected by fIltration and washed well with water. PurifIcation by column 
chromatography on silica gel with chloroform as the eluant gave pure 1. M.p. 255-256°C 
(lit.44 257-258°C); Yield 1.0 g (60%). 1H NMR (CDCh) 8: H4, 7.99; H5, 7.59; H6, 7.65; H7, 
7.88. 13C NMR (CDCh) 8: C2, unrecorded; C3A, 149.95; C4, 120.48; C5, 124.74; C6, 
126.51; C7, 110.44; C7A, 140.15. 
2,2'-Bibenzothiazole (2) 
P20 5 (12 g) and H3P04 (5 mI) were combined in a 100 ml ~S}---1:'N~ ~N s~ 
round bottomed flask. This mixture was heated with stirring at 
200°C for 30 minutes, and 2-aminothiophenol (3 ml, 28 mmol) was added in one portion. A 
reflux condenser was attached and diethyl oxalate (2.0 mI, 14 mmol) was added dropwise. 
Heating and stirring was continued for 2 hours at 220°C, during which time the colour of the 
solution had changed to orange. The mixture was cooled to ca. 100°C and then poured onto 
ice/water (l00 ml). A light yellow precipitate formed and was collected by fIltration and 
washed well with water. Recrystallisation from dioxane gave 2 as colourless crystals. M.p. 
300-301°C (lit.52 300-301°C); Yield 0.3 g (8%). 
2,2 '-Methylenebisbenzoxazole (3) 
P20 5 (12 g) and H3P04 (5 ml) were combined in a 100 mI nonon 
round bottomed flask. This mixture was heated with stirring at \d \d 
200°C for 30 minutes, and resublimed 2-aminophenol (1.75 g, 16 
mmol) was added in one portion. The resulting mixture turned deep blue. A reflux condenser 
was attached and diethyl malonate (1.2 mI, 7 mmol) was added dropwise. After a brief 
period, the mixture bubbled vigorously. Heating and stirring was continued for I hour at 
220°C, during which time the colour of the solution had changed to dark orange. The mixture 
was cooled to ca. 100°C and then poured onto ice/water (100 ml). A bright yellow precipitate 
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formed and was collected by filtration, washed well with H20, then recrystallised from 
ethanol/water. M.p. l12-l13 DC (lit.53 l15-ll6DC); yield 0.95 g (54%). 
2,2 '-Methylenebisbenzothiazole (4) 
Diethyl malonate (7.5 ml, 0.05 mol) and 2-aminothiophenol nsnSn 
(10.7 mI, 0.1 mol) were added to PPA (25 mI) at 70 DC with stirring. \d \.d 
Heating and stirring were continued for 2 hrs at l40DC, during 
which time the colour of the solution had changed to an orange. The mixture was cooled to 
ca. 100DC and then poured onto ice/water (200 ml). A canary-yellow precipitate formed and 
was collected by filtration, washed well with H20, then recrystallised from ethanol. M.p. 
230-240DC (lit.252 240DC); yield 2.5 g (17%). 
Attempted syntheses of 3,3'-bi-l,2-benzisoxazole viz. 5 
via Ni(O) coupling: 
In a 50 ml two-necked round bottomed flask was placed NiBr2(PPh3)2 (0.242 g, 0.33 
mmol) , zinc (0.098 g, 1.47 mmol), tetraethylammonium iodide (0.251 g, 0.98 mmol) and a 
magnetic spin vane. The flask was evacuated by oil pump and heated by heat gun to remove 
residual traces of water. This cycle was repeated three times, each time flushing the flask 
with argon. Under an argon atmosphere freshly distilled THF (6 ml) was added via syringe 
through a suba-seal and stirring started. The solution was left to stir for 50 minutes, at which 
time it was a deep red colour, before 3-chlorobenzisoxazole (0.15 g, 0.33 mmol) was added as 
a THF solution (2 ml). After ca. 5 minutes the solution had turned green. The solution was 
heated at 50DC and stirred for 20 hours under argon before being poured into 2 M ammonia 
solution (20 ml). A dark green precipitate was filtered away and a 1: 1 benzene/diethyl ether 
solution (20 ml) added. The organic layer was separated and one more extraction with 
another 20 ml of benzene/diethyl ether solution was performed. The combined organic 
extracts were washed with water (2 x 10 ml) and brine (2 x 10 mI) before being dried over 
Na2S04. The solvents were removed in vacuo and a dark brown oily residue was obtained. 
TLC and IH NMR spectra of this material gave no indication of any product that could be 
identified as 5. The material was chromatographed on silica gel and the only products that 
came offthe column were identified as PPh3 and PPh30. 
via tandem intramolecular cyclisation: 
Redistilled 2-methoxybenzaldehyde (5.0 g, 36 mmol) was added to a mixture of 
ethanol (6.5 ml) and water (5 ml) containing NaCN (0.5 g). The mixture was refluxed with 
stirring for 2 hrs. After cooling to room temperature the ethanol was removed in vacuo. The 
residue was suspended in ethyl acetate (ca. 100 ml), washed with water (3 x 40 ml) and dried 
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(NazS04)' Removal of the solvent in vacuo gave an orange coloured oil. The starting 
aldehyde was distilled away under reduced pressure and the red residue chromatographed on 
silica gel (2 x 20 cm) with 20% ethyl acetate:pet. ether as eluent. Combining the relevant 
fractions and removing the solvents in vacuo gave a yellow oil that crystallised on standing to 
give 2,2'-dimethoxybenzoin. M.p. 93-98°C (EtOH); yield 1.0 g (20%). Positive-ion EI mass 
spectrum: Calc. m/z for Cl6H1604 272.1049; found 272.1051. m/z 272.1 (M+, 11%), 137.1 
(MeO-C6H4-CHOH+, 92%), 135.0 (MeO-C6H4-CO+, 100%). IH NMR (CDCh) 8: 3.71, s, 
3H; 3.72, s, 3H; 4.47, d, (5.8Hz) 1H; 6.10, d, (5.4 Hz) 1H; 6.73-6.78, m, 2H; 6.83, t, lH; 6.92, 
t, 1H; 7.13-7.21, m, 2H; 7.36, t, 1H; 7.68, d, 1H. 
NH4N03 (0.38 g, 4.8 mmo}), Cu(OAch.2HzO (0.09 g, 0.5 mmol) and 2,2'-
dimethoxybenzoin (1.0 g, 3.6 mmol) were placed in a 20 ml round bottomed flask. An 80% 
solution of aqueous acetic acid (4 ml) was added to the solids and the mixture heated at reflux 
with stirring for 2.5 hrs then left to cool. The reaction mixture was taken up in ethyl acetate 
solution (80 ml) and washed with 10% aqueous NaOH (4 x 30 ml), HzO (1 x 20 ml) and dried 
(NazS04). Removal of the solvent in vacuo gave a light yellow solid that was recrystallised 
from ethanol to give pure 2,2'-dimethoxybenzil. M.p. 128-128.5°C; yield 0.94 (94%). 
Positive-ion EI mass spectrum: Calc. m/z for C16H1604 270.0892; found 270.0887. m/z 270.1 
(M+, 8%), 135.0 (MeO-C6~-CO+, 100%), IH NMR (CDCh) 8: 3.60, s, 3H; 6.96, d, 1H; 
7.12, t, 1H; 7.58, t, IH; 8.08, d, IH. 
2,2'-Dimethoxybenzil (0.5 g, 1.9 rnmol) was dissolved in dry CHzClz (35 ml) and 
cooled to -78°C. Boron tribromide (1.4 ml, 4.0 rnmol) was added in one portion to the stirred 
solution. hnmediately, the solution turned bright red and a suspension fonned. The stirred 
mixture was allowed to attain room temperature overnight. In the morning, ice was added to 
the now yellow solution, and the mixture stirred vigorously for 30 minutes before separating 
the organic layer, drying (NazS04), and removing the solvent in vacuo. The yellow oil was 
used immediately without further purification after a IH NMR spectrum showed no signal for 
a methoxy group. Hydroxylamine-O-sulfonic acid (0.52 g, 4.6 mmol) was dissolved in I: 1 
methanol/water (4 ml) and added to yellow oil dissolved in ethanol (10 ml). After 
approximately 10 minutes there was a slight precipitate and the mixture was gently heated at 
ca. 50°C for 30 minutes, at which time the solution was clear. The volume of the solution 
was reduced by removal of ca. % of the solvent in vacuo and more HzO (5 ml) was added. A 
saturated aqueous solution of NazC03 was added dropwise to the vigorously stirred solution 
until the pH was adjusted to 8-9 and dichloromethane (10 ml) was added and the biphasic 
solution left to stir overnight. In the morning the dichloromethane solution was separated, 
dried (NazS04), and the solvent removed in vacuo leaving a white solid. However the desired 
ligand could not be identified in this product. 
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3-(2-Pyridyl)-1,2-benzisoxazole (6) 
To an oven-dried, 25 ml, two-necked flask containing a magnetic stirring bar, was 
attached a suba-seal and a N2 gas supply/vacuum line. After flushing the system, 2-
bromopyridine (1.0 ml, 10.5 mmol) and dry THF (5 ml) were introduced through the seal and 
cooled to -78°C. n-Butyllithium (7.25 ml , 11.6 mmol) was added dropwise via syringe, and 
the deep red solution left to stir for 5 minutes. 2-Chlorobenzaldehyde (1.30 ml, 11.5 mmol) in 
dry THF (2 ml) was added dropwise with stirring at -78°C. The cooling bath was left to 
evaporate and the stirred solution attained room temperature overnight. In the morning, a 
saturated. solution of aqueous NH4Cl (ca. 10 ml) was added cautiously to the reaction mixture 
cooled in an ice-bath. This solution was poured into a separating funnel and CH2Clz (40 ml) 
added. The organic layer was separated, washed with brine (1 x 20 ml) and H20 (1 x 20 ml) 
before being dried over MgS04• Removal of the solvent in vacuo yielded a dark coloured oil. 
1H NMR (CDCh) 8: 8.57, d, lH; 7.60, t, 1H; 7.48 t, 2H; 7.30-7.20, m, 4H; 6.28, s, lH. 
To the brown oil thus obtained was added acetone (20 ml). Jones reagent, prepared 
from cr03 (1.59 g, mmol) in H20 (3 ml) and H2S04 (1 ml), was added dropwise with stining, 
and the solution left to stir for 30 minutes. Excess reagent was quenched by the addition of 
isopropyl alcohol and the solvent then removed in vacuo. The brown residue was extracted 
with ether (3 x 40 ml). The extracts were combined, dried (MgS04), and then solvent 
removed in vacuo to give a dark coloured oil. Positive-ion EI mass spectrum: Calc. mlz for 
C12HsN20C1216.02l6; found 216.0206. mlz 216.0 (M+, 2.27%),182.1 (M+-Cl, 100%),154.1 
(M+-COCl, 12%), 139.0 (M+- Py, 31 %), 111.0 (C6~Cl+, 22%). 1R NMR (CDCh) 8: 8.70, d, 
1H, H6; 8.14, d, lH, H3; 7.90, t, 1H, R4; 7.54-7.38, m, 5R. l3C NMR (CDCh) 8: 195.19; 
153.71; 149.26; 138.11; 13 7.08; 131.90; 131.55; 129.93; 129.89; 126.98; 126.55; 123.70. 
Hydroxy1ammonium chloride (0.32 g, 4.60 mmol) and NaOH 
(0.30 g, 7.50 mmol) were dissolved in 1:1 ethanol/water (2 ml) and added 
to the oil prepared above in a 10 ml round bottomed flask. This mixture 
was refluxed with stining for 5 hrs before removing the ethanol in vacuo, 
adding KOH (0.7 g, 12.5 mmol) and more H20 (1 ml) to the flask and 
6' 5' 
returning it to reflux. After 3 days the flask was cooled to room temperature and the white 
solid that had formed was filtered and washed with H20 before being recrystallised from 
ethanol/water. M.p. 60-62°C; yield 0.40 g (19%) (Found: C, 73.47; H, 4.04; N, 14.57. Calc. 
for C12HSN20: C, 73.46; H, 4.11; N, 14.27). Positive-ion EI mass spectrum: Calc. mlz for 
C12HgN20 196.0637; found 196.0642. mlz 196.1 (M+, 81%), 168.1 (M+- CO, 64%), 78.0 
(Py+, 100%). 1H NMR (CDCb) 8: 8.24, d, 1H, H3'; 7.83, t, 1H, H4'; 7.40, t, 1R, H5'; 8.81, d, 
1H, H6'; 8.58, d, 1H, R4; 7.41, t, 1R, R5; 7.59, t, 1H, H6; 7.62, d, lR, H7. l3C NMR (CDCh) 
8: C2', 156.48; C3', 122.61; C4', 136.76; C5', 124.49; C6', 149.79; C3 not found; C3a, 120.45; 
C4, 124.99; C5, 124.18; C6, 129.83; C7, 109.57; C7a, 164.06. 
1,1 '-Bibenzotriazole (23) 
Ligand 23 was prepared from the method of Harder et al.102 
IH NMR (CDCb) 8: H4, 8.27; H5, 7.58; H6, 7.65; H7, 7.33. l3C 
NMR (CDCb) 15: C3A, 144.28; C4, 121.08; C5, 125.82; C6, 130.28; 
C7, 108.57; C7A, 132.08. 
~N~N ~N 7 
1,1'-Metbylenebisbenzotriazole (24) 
Benzotriazole (2.55 g, 21.4 mmol) and CH2h (1.70 ml, 21.1 
mmol) were added along with a few drops of a saturated 5 
tetrabutylammonium hydroxide solution to 50 ml benzene and 40% 
aqueous NaOH (10 ml) in a 100 ml round bottomed flask. The 
NbA 6 tI ""..::: \\ I.-? 5 
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mixture was vigorously stirred and refluxed for 15 hrs. After cooling to room temperature, 25 
ml more benzene was added and the organic layer separated, washed with H20, dried 
(Na2S04), and the solvent removed in vacuo to give a white solid. IH NMR showed that there 
existed a 6:4: 1 ratio of isomers between 24, 1,2 '-methy1enebisbenzotriaz01e (25) and 2,2 '-
methylenebisbenzotriaz01e (26). Recrystallisation from toluene/hexane gave pure 24. M.p. 
185-188°C (lit. IOS 188°C); yield 0.79 g (30%). IHNMR (CD3CN) 15: H4, 8.05; H5, 7.46; H6, 
7.67; H7, 8.00; CH2, 7.43. 
1-(2-Pyridyl)benzotriazole (27) 
Ligand 27 was prepared following the method of Katritiky,106 
except that 2-chloropyridine was used in place of 2-bromopyridine. 
Benzotriaz01e (2.10 g, 17.5 mm01) and 2-chloropyridine (0.83 mI, 8.75 
mmol) were refluxed in dry toluene (2 ml) under an atmosphere ofN2 for 
19 hrs. The reaction mixture was then suspended in ca. 30 ml of ethyl acetate and washed 
with 5 % aqueous KOH to remove the unreacted benzotriazole. Evaporation under reduced 
pressure yielded 27 as a white solid. M.p. 107-108°C (lit.106 110-111 DC); yield 1.16 g (67%). 
1-[2-Pyridyl(metbyl)Jbenzotriazole (28) 
Benzotriazole (1.0 g, 8.4 mmol) and 2-picolyl chloride 
hydrochloride (1.0 g, 6.1 mmol) were added along with a few drops of a 
saturated tetra butyl ammonium hydroxide solution to benzene (25 ml) and 
40% aqueous NaOH (7 mI) in a 100 ml round bottomed flask. The 
mixture was vigorously stirred and refluxed for 15 hrs. After cooling to room temperature 25 
ml more benzene was added and the organic layer separated, washed with H20, dried 
(Na2S04), and the solvent removed in vacuo to give a white solid (0.79 g). IH NMR showed 
that there existed a 10: 1 ratio of isomers between 28 and 2-[2-pyridyl(methyl)]benzotriazole 
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(30). Recrystallisation from toluene gave pure 28. M.p. 101-102°C (lit.107 102-103°C); yield 
0.50 g (45%). 
l-(l-Isoquinolyl)benzotriazole (29) 
lsoquinoline (2.0 g, 15.5 mmol) was added to a solution of glacial acetic acid (10 m]) 
with 50% H20 2 (2 ml). This mixture was refluxed overnight at which time the solution was 
brown. The glacial acetic acid was removed in vacuo, and H20 (5 ml) was added to the 
residue. Solid K2C03 was added with gentle swirling until the pH = 8, when the solution 
turned to solid. The solid was filtered and washed with a small amount of cold H20. Upon 
standing more crystals fonned in the filtrate and these were again collected by filtration. M.p. 
80-85°C (lit. 103-105°C); yield 1.7 g (76%). 
The isoquinoline-N-oxide (1.7 g, 11.7 mmol) obtained was added in small portions 
with stirring to freshly distilled POCb (6 ml) at ice-bath temperature. This mixture was then 
refluxed for 3 hrs before cooling to room temperature and pouring onto ice (15 g). The 
resulting solution was made alkaline with 0.880 NH3 and extracted with CH2Ch (3 x 10 ml). 
The organic extracts were collected, dried (Na2S04) and evaporated in vacuo to give a brown 
residue. This was passed through a small column of silica gel to produce a yellow oil that 
gave white crystals on standing. Yield 0.98 g (50%). 
1-Chloroisoquinoline (0.42 g, 2.5 mmol) and benzotriazole (0.61 
g, 5.3 mmol) were refluxed in dry toluene (2 ml) under an atmosphere of 
N2 for 19 hrs. The reaction mixture was then suspended in ca. 30 ml of 
ethyl acetate and washed with 5% aqueous KOH to remove the unreacted 
benzotriazole. Evaporation of the solvent under reduced pressure yielded 
a white solid. Recrysta1lisation from methanol or benzene gave pure compound. M.p. 151-
152°C; yield 0.44 g (70%) (Found: C, 73.07; H, 3.92; N, 22.92. Calc. for C1sH10N4: C, 73.15; 
H, 4.09; N, 22.75). Positive-ion EI mass spectrum: Calc. mlz for C1sH10N4 246.0906; found 
246.0904. mlz 246.1 (M+, 23%), 218.1 (M+- N2, 100%), 128.1 (M+- Bt, 53%). IH NMR 
(CDCb) 8: H3', 8.58; H4', 7.80; H5', 7.99; H6', 7.81; HT, 7.71; H8', 8.60; H4, 8.21; H5, 7.49; 
H6, 7.61; H7, 8.08. 13C NMR (CDCb) 8: C1', 148.18; C3', 140.66; C4', 121.95; C4A', 138.87; 
C5', 126.95; C6', 131.14; CT, 128.78; C8', 126.25; C8A', 122.84; C3A, 145.93; C4, 119.87; 
C5, 124.88; C6, 128.86; C7, 112.89; C7A, 133.37. 
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Attempted synthesis of 5,5'-di(2-pyridyl)-3,3'-bi-l,2,4-oxadiazole viz. 60 
Picolinic acid (0.50 g, 4.1 mmol) was stirred in SOClz (5 ml) for three days at room 
temperature under an atmosphere of nitrogen. At this time the colour of the solution was a 
deep red. The excess SOClz was removed in vacuo and oxamidoxime (0.15 g, 1.2 mmol) 
dissolved in dry THF (28 ml) was added under nitrogen. After addition the solution was 
refluxed for a 1;2 hour and the resulting insoluble product was filtered off (0.47 g). IH NMR 
(d6-DMSO) 8: H3, 8.38; H4, 8.14; H5, 7.76; H6, 8.70; -NH2, 7.2 (2H). 
Polyphosphoric acid was prepared by adding P20 S (12 g) to H3P04 (5 ml) and heating 
at 200°C for 30 minutes. This solution was allowed to cool to 140°C, and the above material 
(0.47 g) was added as a solid. After 20 minutes the mixture was poured onto crushed ice (100 
g) and made alkaline with 40% aqueous NaOH (PH=8). The aqueous solution was extracted 
with chloroform (6 x 50 ml), and the combined extracts were dried over Na2S04. The solvent 
was removed under reduced pressure to yield an off-white solid (0.10 g), which was identified 
as the monocyclised product. IH NMR (~-DMSO) 8: H3, 8.26; H4, 8.09; H5, 7.70; H6, 8.80; 
N-OH, 10.60; -Nfu, 6.00. The F AB mass spectrum of this material showed the most intense 
ion at 206.0 a.m.u. (C9H7N50 2), with another weaker ion at 411.0 a.m.u., which was 
interpreted as the H-bonded dimer. 
Attempted synthesis of 5,5'-bi-l,2,4-oxadiazole viz. 61 
Formamidoxime (0.50 g, 0.83 mmol) and diethyl oxalate (0.65 ml, 0.42 mmol) were 
combined in a 10 ml round bottomed flask with a drop of boron trifluoride diethyl etherate. 
The flask was heated with stirring at 50°C for one hour. The colour of the mixture had 
changed to a yellow by this time. Ethanol (4 ml) was added to the syrup-like mixture, and by 
stirring a yellow solid was suspended. This was filtered off (0.22 g) and analysed by IH 
NMR spectroscopy and mass spectrometry. These only showed starting formamidoxime. 
The filtrate was reduced to an oily yellow residue and IH NMR showed that this was mainly 
diethyloxalate. This reaction was repeated in differing solvents (toluene and dry ethanol) and 
with or without catalysts (BF3 and NEt3) all with no success. 
3,3'-Di(2-pyridyl)-5,5'-bi-1,2,4-oxadiazole (62) 
Diethyl oxalate (0.50 ml, 3.7 mmo1) was heated with a 
couple of drops of boron trifluoride diethyl etherate to 160°C 
in a 5 ml round bottomed flask. 2-Picolylamidoxime (1.0 g, 
7.3 mmol) was then added in small portions to the stirred 
6' 
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solution. Heating and stirring was continued for 30 minutes at 160°C before the temperature 
was increased to 200°C. \¥hen a white solid started forming, the round bottomed flask was 
removed from the heat and allowed to cool to room temperature. The solid was rinsed onto a 
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filter with ethanol and then recrystallised from DMSO. M.p. 265-266°C; yield 0.28 g (26%) 
(Found: C, 57.80; H, 2.58; N, 28.96. Calc. for C14H8N602: C, 57.54; H, 2.76; N, 28.76). 
Positive-ion EI mass spectrum: Calc. for CI4H8N602 292.0709; found 292.0707. mlz 292.1 
(M+, 43%), 146.0 (C7HtN30+, 14.8%), 104.0 (PyCN+, 100%), 78.0 (Py+, 25%). IH NMR (~­
DMSO) 0: H3', 8.26; H41, 8.13; H51, 7.71; H6', 8.86. 
The ethanolic washings were evaporated to dryness in vacuo. The resulting solid was 
then suspended in ethyl acetate (ca. 20 ml), washed with 5% aqueous NaOH (2 x 10 m1), 
dried (Na2S04) then the solvent evaporated in vacuo to give 3,5-di(2-pyridyl)-1,2,4-
oxadiazo1e (0.25 g). 
2-(1,2,4-0xadiazol-3-yl)pyridine (63) 
2-Picolylamidoxime (0.50 g, 3.6 rnrnol) was refluxed in triethyl 
orthoformate (1 ml) with 1 drop boron trifluoride diethyl etherate for 30 
minutes. After cooling to room temperature the white crystalline solid 
was collected by filtration. Additional product was obtained after 
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concentration of the filtrate. M.p. 108°C (lit. IS3 109-110°C); yield 0.44 g (82%) (Found: C, 
57.31; H, 3.19; N, 28.71. Calc. for C7H5N30: C, 57.15; H, 3.43; N, 28.55). Positive-ion EI 
mass spectrum: Calc. mlz for C7H5N30 147.0433; found 147.0433. mlz 147.0 (M+, 23%), 
120.0 (PyCNO+, 13%), 104.0 (PyCN+, 100%). IH NMR (CDC13) 0: H5', 8.86; ill, 8.17; H4, 
7.88; H5, 7.46; H6, 8.83. l3C NMR (protonated carbons only) (CDCh) 0: C5', 165.29; C3, 
123.32; C4, 137.10; C5, 125.70; C6, 150.52. 
Attempted synthesis of 2-(1,2,4-oxadiazol-5-yl)pyridine viz. 64 
Pico1inamide (0.50 g, 4.1 mmol) and N,N1-dimethy1forrnamide dimethyl acetal(0.58 
ml, 4.3 rnrnol) were combined in a 10 ml round bottomed flask and heated at 50°C for thirty 
minutes. Hydroxylamine hydrochloride (0.43 g, 6.2 mmo1) and NaOH (0.25 g, 6.3 rnrnol) 
were dissolved in water (1 ml) and 70% aqueous acetic acid (3 ml), and this mixture added to 
the solution of the amide and stirred for 15 minutes at 50°C. The reaction mixture was then 
diluted with more water (3 ml) and left to cool in an ice-bath. The white solid that formed 
was collected by filtration and recrystallised from water. M.p. 154-155°C; yield 0.47 g 
(69%). Positive-ion EI mass spectrum: Calc. mlz for C7H5N302 165.0538; found 165.0539. 
mlz 165.1 (M+, 7%), 134.0 (M+- NOH, 56%), 106.0 (PyCO+, 14%), 78.0 (Py+, 100%). IH 
mvIR (CDCh) 0: H3, 8.25; H4, 7.92; H5, 7.44; H6, 8.66; 7.86, d, 1H; 10.7, s(br), IH. 
To the material prepared above (0.27 g, 1.6 mmol) was added acetic acid (1 ml) and 
dioxane (1 m1) and the mixture refluxed for 1 hour. Water (3 ml) was then added, and the 
mixture left to cool to room temperature overnight. In the morning, white crystals were 
filtered off and air-dried. The IH NMR spectrum of the crystals obtained was different from 
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that of the starting material and also was not consistent with that of the expected product. The 
EI mass spectrum was also different from that of the starting material. Elemental analysis of 
the crystals determined that the composition had not changed. M.p. 180-183°C; yield 0.14 g 
(51%) (Found: C, 50.66; H, 4.17; N, 25.51. Calc. for C7H7N30 2: C, 50.91; H, 4.27; N, 
25.44). Positive-ion EI mass spectrum: mlz 165.1 (M+, 10%), 149.0 (M+-16, 80%), 122.0 
(PyCONH2+, 65%), 106.0 (PyCO+, 78%), 78.0 (Py+, 100%). IH NMR (CDCh) 8: H3, 8.26; 
H4, 7.92; H5, 7.43; H6, 8.67; 10.0, s(br), 1H; 8.25, s(br), 1H; 5.5, s(br), 1H. 
2-(1,2,4-Thiadiazol-5-yl)pyridine (65) 
Thiopicolinamide (0.50 g, 3.6 mmo1) and dimethylformamide 
dimethyl acetal(0.48 ml, 3.6 mmo1) were combined and allowed to stand 
in a vial for 35 minutes. A solution made of hydroxy1amine-O-sulphonic 
acid (0.49 g, 4.3 mmo1) in methanol (3 ml) and pyridine (0.58 ml, 7.5 
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mmo1) in ethanol (5 m1) was then added. The solution was stirred magnetically at room 
temperature for 5 hrs. The solvents were then removed in vacuo and the residue taken up in 
ca. 25 ml CH2Clz, The CH2Ch solution was washed with H20 (1 x 10 ml), 0.1 N NaOH (1 x 
10 ml), and once more with H20 (1 x 10 ml), dried over Na2S04 then concentrated in vacuo. 
The residue was chromatographed on silica gel (1 x 18 cm) with 20% ethyl acetate:pet. ether 
and 65 (RfO.37) was obtained as a canary-yellow solid. M.p. 73-75°C (lit. l3O 68-69°C); yield 
0.44 g (75%) (Found: C, 51.56; H, 3.08; N, 25.57; S, 19,92. Calc. for C7HsN3S: C, 51.52; H, 
3.09; N, 25.75; S, 19.65). Positive-ion EI mass spectrum: Calc. mlz for C7HsN3S 163.0204; 
found 163.0200. mlz 163.0 (M+, 100%), 136.0 (M+- CNH, 43%), 104.0 (PyCN+, 53%), 78.0 
(Py+, 26%), 59 (SCNH+, 17%). IHNMR (CDCh) 8: H3', 8.75; H3, 8.18; H4, 7.88; H5, 7.43; 
H6, 8.66. l3C NMR (protonated carbons only) (CDCh) 8: C3', 163.50; C3, 120.38; C4, 
137.51; C5, 126.21; C6, 149.99. 
3,5-Di(2-pyridyl)-1,2,4-oxadiazole (66) 
2-Picolylamidoxime (0.28 g, 1.9 mmol) was heated at 210°C 
for 30 minutes. After cooling, the solid was dissolved in CHCh and 
washed with 5% aqueous NaOH, dried (Na2S04), and the solvent 
removed in vacuo to yield a white solid. Recrystallisation from 
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water gave pure white needles. M.p. 172-173°C (lit. IS7 173-175°C); yield 0.11 g (50%) 
(Found: C, 64.23; H, 3.48; N, 25.10. Calc. for C12H8N40: C, 64.28; H, 3.60; N, 24.99). 
Positive-ion EI mass spectrum: Calc. mlz for C12H8N40 224.0698; found 224.0696. mlz 224.1 
(M+, 100%), 194.1 (M+- NO, 37%), 120.0 (PyCNO+, 99%),104.0 (PyCN+, 15%),78.0 (Py+, 
83%). IH NMR (CDCh) 8: H3', 8.30; H4', 7.90; H5', 7.48; H6', 8.84; H3", 8.42; H4", 7.96; 
H5", 7.56; H6", 8.88. l3C NMR (CDCh) 8: C2', 146.19; C3', 123.43; C4', 137.08; C5', 
125.64; C6', 150.44; C2", 143.48, C3", 124.48; C4", 137.53; C5", 126.82; C6", 150.62; C3, 
168.91; C5, 174.98. 
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Attempted syntheses of 3,S-di(Z-pyridyl)-1,Z,4-thiadiazole viz. 67 
Via reaction of iodine with thiopicolinamide: 
Thiopicolinamide (0.25 g, 1.8 mmol) was dissolved in warm ethanol (9 ml) and added 
to 12 (1.37 g, 5.4 mmol) dissolved in ethanol (14 ml). The temperature of the solution rose 
from 20°C to 30°C immediately after addition. The solution was stirred for 10 minutes then 
left to stand overnight. The solution was then refluxed for 30 minutes and the hot solution 
filtered through a glass frit. The filtrate was reduced in volume by approximately one half, 
and treated with a solution of aqueous Na2S203 to destroy excess h The solution was taken 
to dryness in vacuo and the red residue chromatographed on silica gel (1 x 20 cm) with 50% 
ethyl acetate:pet. ether as the eluant. M.p. 155-160°C; yield 0.11 g (59%); Positive-ion E1 
mass spectrum: Calc. mlz for C18H14N6 314.1281; found 314.1280. IH NMR (CDCh) 8: 9.94, 
d, IH; 9.36, s(br) , lH; 8.64, m, 3H; 8.28, d, lH; 7.99, d, lH; 7.83, t, lH; 7.78, t, lH; 7.58, 
s(br), lH; 7.36, t, lH; 7.16, t, lH; 6.87, t, lH; 6.79, t, lH. 
Via reaction of hydrogen peroxide with thiopicolinamide in pyridine solution: 
Thiopicolinamide (0.52 g, 3.7 mmol) was dissolved in pyridine (3 ml) and a 50% 
solution of H20 2 (0.6 ml, 8.0 mmol) was added dropwise at such a rate to keep the solution 
from refluxing. The use of an ice-bath was necessary to cool the reaction flask at times 
during the addition. The reaction mixture was then stirred at ambient temperature for 24 
hours before the reaction mixture was poured into water (20 ml). The aqueous solution was 
extracted with chloroform (3 x 10 ml) and the combined extracts dried over Na2S04. TLC 
showed the presence of starting material and another component. After removing the solvent 
under reduced pressure, the yellow solid obtained was chromatographed on silica gel (1 x 20 
cm) with ethyl acetate as the eluant. Two fractions were obtained and analysed by IH NMR 
spectroscopy. The ftrst fraction was identifted as starting material, and the second as a 
molecule containing a single pyridine ring. F AB mass spectrometry of the second fraction 
identifted the molecular formula of C6HSN2SO for this product. (This was assumed to be the 
S-oxide product as the chemical shift of H4 changed little between starting thioamide and the 
resulting product.) 
Via reaction of nitrous acid with thiopicolinamide: 
Thiopicolinamide (0.25 g, 1.7 mmol) was dissolved in 2:1 acetic acid/water (6 ml) and 
NaN02 (0.17 g, 2.4 mmol) dissolved in water (2 ml) was added dropwise. The mixture turned 
green during the addition with the evolution of brown fumes. After the addition was complete 
the mixture was left to stand for thirty minutes before being poured onto 50 m1 ice/water. The 
precipitated material was collected by filtration (0.19 g). A IH NMR spectrum of this 
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material showed it was mostly starting thioamide. No signals were observed that were 
consistent with the desired product. 
Via [3 + 2] intermolecular cycloaddition: 
5-(2-Pyridyl)-1,3,4-oxathiazol-2-one 
Protected from atmospheric moisture by a CaCh guard tube, chlorocarbonyl sulfenyl 
chloride (5 g, 38 mmol) was added dropwise with stirring to picolinamide (4.66 g, 38 mmol) 
dissolved in dry CHCb (50 ml) at 40-50°C. The temperature was increased, and as the 
solution began to reflux a white solid appeared. After 1 hr, dry triethylamine (8 ml) was 
added dropwise, and the mixture refluxed for a further hour. The hot solution was filtered to 
remove picolinamide hydrochloride and the filtrate allowed to cool to room temperature. The 
filtrate was treated by stirring with 10% aqueous Na2C03 solution (100 ml), washing with 
H20 (1 x 50 ml), and drying with Na2S04. Removal of the solvent in vacuo gave a dark solid 
that was chromatographed on silica gel (2 x 30 cm) with 20% ethyl acetate:pet. ether as 
eluant. After recrystallisation from toluene the desired compound (Rf 0.18) was obtained as 
small colourless blocks. M.p .. 94-96°C; yield 0.80 g (12%) (Found: C, 46.79; H, 2.12; N, 
15.72; S, 18.04. Calc. for C7~J'h02S: C, 46.67; H, 2.24; N, 15.54; S, 17.79). Positive-ion 
FAB mass spectrum: Calc. for C7~N202S 179.9994; found 179.9993. mlz 180.0 (M+, 29%), 
152.0 (M+-CO, 24%), 106.0 (PyCO+, 56%), 78.0 (Py+, 100%). IH NMR (CDCb) 8: H3, 
8.02; H4, 7.88; H5, 7.49; H6, 8.77. 
5-(2-Pyridyl)-1,3,4-oxathiazol-2-one (0.20 g, 1.1 mmol) was added in small portions 
to redistilled 2-cyanopyridine (ca. 1 ml) heated to 200°C. The colour of the resulting solution 
changed to green during the addition, and heating was continued for about 10 minutes after 
the completion of addition. The reaction mixture was allowed to cool to room temperature. 
TLC showed the presence of a very small component and the whole mixture was 
chromatographed on silica gel (2 x 20 cm) with 40% ethyl acetate:pet. ether as eluant. 
However, the minor component was not isolated from the column. 
1-(Thiomethyl)-3-( dimethylamino )-imidazo [1,5-a ]pyridine (72) 
Thiopicolinamide (0.50 g, 3.6 mmol) and dimethylformamide 
dimethyl acetal (0.58 ml, 3.6 mmol) were combined in a 7 ml vial. The 
vial was capped and the mixture left to stand for 4 days. The methanol 
produced was removed in vacuo, and the residue chromatographed on 
cc's 7 8a 1 :/' 0.--6 ~ N-{~ 
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silica gel (2 x 20 cm) with 25% ethyl acetate:pet. ether as eluant, after combining the relevant 
fractions (Rf 0.18), the title compound was obtained. M.p. 34-37°C; yield 0040 g (54%) 
(Found: C, 57.72; H, 6041; N, 20.33; S, 15.72. Calc. for ClOH13N3S: C, 57.95; H, 6.22; N, 
20.26; S, 15.47). Positive-ion EI mass spectrum: Calc. mlz for ClOH13N3S 207.0830; found 
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207.0830. mlz 207.1 (M+, 100%), 192.0 (M+-CH2' 55%), 78.0 (Py+, 29%). IH NMR (CDCh) 
8: H5, 7.67; H6, 6.48; H7, 6.65; H8, 7.47; -SMe, 2.38; -1'\JMe2, 2.87. 13C NMR (CDCh) 8: C1, 
119.00; C3, 144.39; C5, 120.69; C6, 111.75; C7, 118.48; C8, 118.09; C8a, 129.94; -SMe, 
20.10; -NMe2, 42.18. 
3,6-Di(2-pyridyl)-1,4,2,5-dioxadiazine (87) 
Pyridine hydroximinoylchloride hydrochloride202 (0.51 g, 2.6 
mmol) was dissolved in ethanol (25 ml). Triethylamine (0.73 ml, 
5.3 mmol) and pyridine (0.64 ml, 7.9 mmol) were added and the 
3' 4' 
~60-N>fG>' ~ /; 0. '\ ~ /; 5' N-O 3 N 
6' 
solution swirled. The resultant solution changed to a yellow colour and a precipitate 
developed after ca. 1 minute. The reaction was left overnight. In the morning, the 
precipitated material was filtered off, and the filtrate taken to dryness in vacuo. The white 
solid from the filtrate was suspended in H20 (20 ml), filtered, and recrystallised from water. 
M.p. l54-l58°C; yield 0.18 g (59%) (Found: C, 60.05; H, 3.19; N, 23.47. Calc. for 
C12HSN402: C, 60.00; H, 3.36; N, 23.32). Positive-ion EI mass spectrum: Calc. mlz for 
C12HSN402 240.0647; found 240.0648. mlz 240.1 (M+, 1.8%), 120.0 (PyCNO+, 20%), 104.0 
(PyCN+, 100%), 78.0 (Py+, 62%). IH l'\JMR (CDCh) 8: H3', 7.94; H4', 7.80; H5', 7.44; H6', 
8.73. 13C NMR (CDCh) 8: C2', 144.66; C3', 123.26; C4', 136.99; C5', 126.69; C6', 150.30; 
C3/C6,160.63. 
Preliminary synthetic steps to 2-(1,2,5-oxadiazol-3-yl)pyridine (90) 
A solution of sodium ethoxide was prepared by adding sodium metal (0.22 g, 9.6 
mmol) to ethanol (25 ml). After all sodium had dissolved, 2-acetylpyridine (1 ml, 8.9 mmol) 
was added and the resultant solution left to stir for 5 minutes. Amyl nitrite (1.2 mI, 8.9 mmol) 
was added dropwise to the stirred mixture. After stirring for one hour the solution was 
refluxed for a further 4 hours. After cooling to room temperature, HCl was added to pH=5 
and the solvent removed in vacuo to give an oily residue. This material was used without 
purification for the next step. The residue was dissolved in ethanol (5 ml) and a solution 
made of hydroxylamine hydrochloride (0.65 g, 9.3 mmol) and sodium acetate (0.80 g, 9.7 
mmol) in water (3 ml) was added. The mixture was refluxed for four hours and was then 
allowed to cool. Evaporation of the solvent in vacuo left a white solid, which was identified 
as a mixture of the monoxime and glyoxime. Chromatography on silica gel (2 x 20 cm) with 
40% ethyl acetate:pet. ether gave pure dioxime as a colourless solid, 0.22 g (17%.) 
3,4-Di(2-pyridyl)-1,2,5-oxadiazole (91) 
2,2'-Pyridil (0.50 g, 2.4 mmol), hydroxylammonium chloride (0.65 g, 9.4 mmol) and 
NaOH (2 g) were contained in a 20 ml vial with a magnetic stirring bar. H20 (10 ml) was 
added and the solution stirred for 36 hrs. The solution was cooled in an ice-bath and 
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concentrated HCI was added dropwise until a flocculent precipitate developed. The solid was 
collected by filtration and washed with a small amount of cold water. M.p. 243-244°C; yield 
0.24 g (42%). Positive-ion EI mass spectrum: Calc. mlz for C12HlON402 240.0647; found 
240.0633; mlz 240.0 (M+, 2.61 %), 224.0 (M+- H20, 61%), 207.1 (M+- 2H20, 87%), 104.0 
(PyCN+, 100%), 78.0 (Py+, 62%). lH NMR (~-DMSO) 8: H3', 7.49; H4', 7.85; H5', 7.35; 
H6', 8.60; N-OH, 11.72. l3 C NMR (~-DMSO) 8: C2', 154.56; C3', 126.26; C4', 136.15; C5', 
124.77; C6', 149.14; Cl/C2, 152.04. 
The above dioxime (0.70 g, 2.89 mmol) and H20 (1 ml) were 
placed in a tube of dimensions; 33 mm LD., 41 mm O.D., vol. 85ml, and 
the tube sealed. This was placed in an oven and heated at 185°C for 7 hrs. 
The tube was then allowed to come to room temperature and the contents 
4' 
6' 
rinsed out with methanol. The washings were collected and the solvent removed in vacuo to 
give a red residue. Chromatography on silica gel successfully separated 91, which was then 
recrystallised from acetone/water. M.p. 121-125°C; yield 0.22 g (33%) (Found: C, 64.13; H, 
3.29; N, 25.10. Calc. for C12HsN40: C, 64.28; H, 3.60; N, 24.99). Positive-ion EI mass 
spectrum: Calc. mlz for C12HsN40 224.0698; found 224.0701. mlz 224.1 (M+, 23%), 104.0 
(PyCN+, 21 %),78.0 (Py+, 100%). IH NMR (CDCh) S: H3', 7.92; H4', 7.84; H5', 7.40; H6', 
8.60. 13C NMR (CDCh) 8: C2', 146.23; C3', 124.741124.67; C4', 136.76; C5', 124.671124.74; 
C6', 149.69; C3 and C4, 153.34. 
Attempted syntheses of 4,4'-di(2-pyridyl)-3,3'-bi-1,2,5-oxadiazole viz. 92 
Via tin reduction of bis(2-pyridoyl)furoxan: 
Bis(2-pyridoyl)furoxan204 (0.20 g, 0.68 mmol) and SnClz.2H20 (0.60, 2.68 mmol) 
were combined in a 10 m1 round bottomed flask. Acetic acid (2 ml) and concentrated 
aqueous HCI (5 drops) were added to the solids and the mixture heated at 30DC for one week. 
At this time there was a little solid on the bottom of the flask. This solid was filtered off and a 
lH NMR spectrum and melting point ofthis material was recorded. By comparison, this was 
assigned as picolinic acid. The filtrate was poured onto water (30 ml) and extracted with 
chloroform (3 x 30 m1). The combined extracts were dried (Na2S04) and the solvent removed 
under reduced pressure leaving a small residue. The aqueous solution was then adjusted to 
pH = 7 by the addition of a 40% aqueous solution of N aOH and again extracted with 
chloroform in the same manner as above. However, after treating the combined extracts as 
above nothing was obtained after removal ofthe solvent in vacuo. 
Via deoxygenation using triethylphoshite: 
All operations were performed under an atmosphere of nitrogen. Bis(2-
pyridoyl)furoxan (0.50 g, 1.7 mmo1) was placed in a 50 ml two-necked round bottomed flask 
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with a magnetic spin vane. Dry benzene (25 ml) was added via syringe and stirring was 
started. After all the solid had dissolved freshly distilled P(OEt)3 (0.30 ml, 1.8 mmol) was 
added and the mixture gradually turned dark. The mixture was stirred magnetically at room 
temperature overnight. In the morning, TLC still showed the presence of only the starting 
material, and so the mixture was set to reflux. However, after 5 hours TLC of the reaction 
mixture still showed no change. The experiment was repeated using the same quantities, this 
time with reflux started immediately. This did not seem to effect deoxygenation either as 
only starting material was recovered from the reaction. 
All operations were performed under an atmosphere of nitrogen. Bis(2-
pyridoyl)furoxan (0.44 g, 1.5 mmol) was placed in a 25 ml two-necked round bottomed flask 
with a magnetic spin vane. Freshly distilled P(OEt)3 was added (3 ml) and the mixture 
immediately turned dark. The mixture was stirred magnetically while being heated at reflux. 
After 20 hours the reaction mixture was poured into water (50 ml) containing a few drops of 
concentrated aqueous HCI. After a few days a brown powder had deposited and was 
collected by filtration. However, none of the desired product could be identified in IH NMR 
spectra or seen in TLC. 
2-(1,2,5-Thiadiazol-3-yl)pyridine (93) 
4 
2-Vinylpyridine (0.26 ml, 2.4 mmol) was dissolved in a mixture of 5 -....:::: 3 
4' dry toluene (3 ml) and dry pyridine (3 ml). Trithiazyl trichloride 6 -0 2 
N 3' \ ~N 
(S3N3Ch) (0.90 g, 3.5 mmol) dissolved in dry toluene (10 ml) was added N-s' 
dropwise with stirring at room temperature. The clear solution immediately turned dark red. 
The mixture was set to reflux with stirring for 4 hrs before being allowed to cool to room 
temperature. The solution was decanted into a separating funnel leaving a large dark solid. 
The solution was washed with saturated aqueous NaHC03 (3 x 20 ml), then with H20 (1 x 20 
ml). To the solid was added ca. 30 ml water, then solid NaHC03 with swirling until pH = 8. 
This solution was then extracted with CH2Cb (3 x 10 ml). The organic fractions were 
combined, dried (Na2S04), then the solvent removed in vacuo. Chromatography on silica gel 
(2 x 20 cm) with 30% ethyl acetate: pet. ether as the eluant separated the compounds. Pure 93 
(Rf 0.51) was obtained after recrystallisation from ethanol/water. M.p. 43-48°C; yield 0.17 g 
(43%) (Found: C, 51.22; H, 3.18; N, 25.90; S, 19.92. Calc. for C7HsN3S: C, 51.52; H, 3.09; 
N, 25.75; S, 19.65). IH NMR (CDCh) 8: H4', 9.32; H3, 8.17; H4, 7.84; H5, 7.36; H6, 8.70. 
l3C NMR (protonated carbons only) (CDCh) 8: C4', 149.691149.61; C3, 122.35; C4, 137.15; 
C5, 124.42; C6, 149.611149.69. 
3,4-Di(2-pyridyl)-1,2,5-thiadiazole (94) 
1,2-Di(2-pyridyl)ethene (0.59 g, 3.3 mmol) was dissolved in a 
mixture of dry toluene (5 ml) and dry pyridine (2 ml). Trithiazyl 
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trichloride (S3N3Ch) (0.83 g, 3.4 mmol) dissolved in dry toluene (15 ml) was added dropwise 
with stirring at room temperature. The clear solution became green and a precipitate 
developed. The mixture was set to reflux with stirring for 18 hrs. At this time the solution 
was a clear red with a small brown precipitate. After cooling, the solution was decanted into 
a separating funnel and more toluene (20 ml) added. The solution was washed with saturated 
aqueous NaHC03 (3 x 20 ml), then with H20 (1 x 20 ml). To the solid was added ca. 30 ml 
H20, then solid NaHC03 with swirling until pH = 8. This solution was then extracted with 
toluene (3 x 10 ml). The organic fractions were combined, dried (Na2S04), then the solvent 
removed in vacuo. Chromatography on silica gel (2 x 30 cm) with ethyl acetate as the eluant 
separated 94 (Rf 0.61), which was recrystallised from ethanol/water. M.p. 63-69°C; yield 
0.39 g (49%) (Found: C, 60.24; H, 3.38; N, 23.09; S, 13.06. Calc. for C12HgN4S: C, 59.99; H, 
3.36; N, 23.31; S, 13.34). Positive-ion EI mass spectrum: Calc. m/z for C12HsN4S 240.0470; 
found 240.0391. m/z 240.0 (M+, 89%). 1H NMR (CDCh) 8: H3', 7.78; H4', 7.78; H5', 7.30; 
H6', 8.50. l3C NMR (protonated carbons only) (CDCh) 8: C3', 124.20; C4', 136.45; C5', 
123.73; C6', 149.11. 
4,4 '-Di(2-pyridyl)-3,3 '-hi-l,2,5-thiadiazole (95) 
In freshly distilled acetone (20 ml) was placed a magnetic stirring bar, CuCl (75 mg) 
and TMEDA (0.10 ml). Stirring was started and O2 was introduced through a small fritted 
bubbler for 5 minutes before adding 2-ethynylpyridine (1 ml, 15 mmol). Bubbling and 
stirring was continued for 30 minutes. The acetone was then removed in vacuo, and the 
residue taken up in the minimum of CHCh, and passed through a small column of alumina. 
Removal of the CHCh in vacuo gave a tan solid, which was recrystallised from cyclohexane 
to give pure 1,4-di(2-pyridyl)buta-1,3-diyne. M.p. 121-122°C (lit.215 122-123); yield 1.0 g 
(66%). 
1,4-Di(2-pyridyl)buta-1,3-diyne (0.37 g, 1.8 mmol) was 
dissolved in dry toluene (3 ml) and dry pyridine (3 ml). Trithiazyl 
trichloride (S3N3Cb) (1.0 g, 4.1 mmol) dissolved in dry toluene (10 
ml) was added dropwise with stirring at room temperature. The 
clear solution became green and a precipitate developed. The mixture was set to reflux with 
stirring for 7 hrs. The mixture was then allowed to cool to room temperature and the solution 
was decanted into a separating funnel leaving a large dark solid. The solid was washed with 
more toluene (1 x 20 ml), and this was added to the decanted solution. The combined toluene 
solution was washed with saturated aqueous NaHC03 (3 x 20 ml), then with H20 (1 x 20 ml). 
To the solid was added ca. 30 ml H20, then solid NaHC03 with swirling until pH = 8. This 
solution was then extracted with CH2Clz (3 x 10 ml). The organic fractions were combined, 
dried (Na2S04), then the solvent removed in vacuo. Chromatography on silica gel (2 x 20 
cm) with 40% ethyl acetate:pet. ether as the eluent separated 95 CRf 0.41) which was 
recrystallised from ethanol/water to get canary-yellow needles. M.p. 128-129°C; yield 0.10 g 
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(17%) (Found: C, 51.92; H, 2.16; N, 25.94; S, 19.68. Calc. for C14HgN6S2: C, 51.85; H, 2.49; 
N, 25.90; S, 19.77). Positive-ion EI mass spectrum: Calc. mlz for C14HsN6S2 324.0252; found 
324.0257. mlz 324.0 (M+, 9%),246.0 (M+- Py, 100%). IH NMR (CDCh) 8: H3', 7.91; H4', 
7.58; H5', 7.02; H6', 8.07. l3C NMR (protonated carbons only) (CDCh) 8: C3', 123.58; C4', 
136.43; C5', 122.72; C6', 148.61. 
Synthesis of Complexes 
Bis(2,2 '-bipyridine )(2,2' -bibenzoxazolyl)chlororuthenium(II) hexafluorophosphate (8) 
and bis(2,2 '-bipyridine )(2,2 '-bibenzoxazolyl)ruthenium(II) bis(hexafluorophosphate) (7) 
Ligand 1 (14 mg, 0.06 mmo1) and RU(bPY)2Clz.2H20 (30 mg, 0.06 mmol) in 3:1 
EtOHIH20 (16 ml) were refluxed for 2 days. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the products precipitated out by the addition of an 
aqueous solution of N~PF6. Chromatography on alumina (1 x 7 em) with 100:1 
CH2ClzIMeOH as eluant, cleanly separated a dark red fraction then an orange fraction. IH 
NMR spectra and F AB mass spectrometry helped identify the fractions as the above 
mentioned complexes, respectively. 
Bis(2,2 '-bipyridine )(2,2 '-bibenzoxazolyl)chlororuthenium(ll)-(hexafluorophosphate) (8) 
Yield 10.3 mg (20%). IH NMR (CD3CN) 8:5.95, d, 1H, H4; 6.19, t, 1H; 6.25, d, 1H; 
6.60, d, 1H; 6.80, t, 1H; 7.18, t, 1H, bpy H5; 7.25, t, 1H, H5; 7.38, t, 1H, bpy H5; 7.48, m, 
2H, bpy H5 and; 7.55, d, 1H, H6; 7.62; 7.68, t, 1H, bpy H5; 7.75, t, 1H, bpy H4; 7.87, d, 1H, 
H7; 8.07, m, 2H, bpy H4's; 8.09, t, 1H, bpy H4; 8.11, d, 1H, bpy H3; 8.25, d, 2H, bpy H3 and 
bpy H6; 8.50, d, 1H, bpy H3; 8.53, d, 1H, bpy H3; 9.30, d, 1H, bpy H6. 
Bis(2,2 '-bipyridine )(2,2 '-bibenzoxazo1yl)ruthenium(ll) bis(hexafluorophosphate) (7) 
Yield 28.1 mg (50%) (Found: C, 43.68; H, 2.58; N, 8.85. Calc. for 
C34H24NgF1202P2Ru: C, 43.46; H, 2.57; N, 8.94). Positive-ion FAB mass spectrum: Calc. mlz 
for C34H24NsF602PRu+ ([(bpY)2Ru(1)](PF6)+) 795.0651; found 795.0646. Amax (CH3CN) 485 
nm, c 7300 M-1cm-1. EO (CH3CN) Ru2+lRu3+ 1.36 V, E1I2 60 mY; EOred -0.97 V, E1I2 60 mY; 
EOred -1.55 V, E1I2 60 mY; EOred -1.77 V, E1I2 60 mY. IH NMR (CD3CN) 8: 8.60, d, 2H, bpy 
H3; 8.25, t, 2H, bpy H4; 7.55, t, 2H, bpy H5; 8.00, d, 2H, bpy H6; 8.55, d, 2H, bpy H3'; 8.08, 
t, 2H, bpy H4'; 7.45, t, 2H, bpy H5'; 8.10, d, 2H bpy, H6'; 6.03, d, 2H, H4; 7.43, t, 2H, H5; 
7.75, t, 2H, H6; 8.01, d, 2H, H7. l3C NMR (CD3CN) 8: 113.79; 124.31; 124.63; 127.80; 
128.43; 130.62; 138.513; 139.02; 153.32; 154.49. 
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Alternatively, 7 was prepared via the silver method as follows: AgCI04 (20 mg, 0.09 
mmo1) and Ru(bpY)2Clz.2H20 (15 mg, 0.03 mmo1) were stirred in 1:1 deaerated 
acetone:ethanol (10 ml) for 2 hrs. The AgCl formed was filtered off and ligand 1 (10 mg, 
mmol) was added and the solution again dearated by N2 bubbling before refluxing for 4 hrs. 
After cooling, the reaction mixture was concentrated to dryness in vacuo. The resulting was 
suspended in water (10 ml) and a large excess of NMF6 added and stirred for 12 hours 
before the solid was collected by filtration and purified by chromatography. Yield 17 mg 
(64%). 
Bis(2,2' -bipyridine )(2,2' -bibenzothiazolyl)ruthenium(II) bis(hexafluorop ho sp hate) (9) 
RU(bPY)2Clz.2H20 (60 mg, 0.12 mmol) in 3:1 EtOHIH20 (24 ml) was refluxed for 1 
hr before the addition of ligand 2 (31 mg, 0.12 mmol) as a solid. Reflux was continued for 
another 3 days. After cooling, the reaction mixture was concentrated to dryness in vacuo. 
The residue was redissolved in the minimum of water, filtered to remove unreacted ligand, 
and the product precipitated out by the addition of an aqueous solution of~PF6. Yield 74 
mg (66%) (Found: C, 42.63; H, 2.71; N, 8.57. Calc. for C34H24N6F12P2RuS2: C, 42.03; H, 
2.49; N, 8.65). Positive-ion FAB mass spectrum: Calc. mlz for C3~24N6F6PRuS2+ 
([(bpY)2Ru(2)](PF6)+) 827.0214; found 827.0189. I~rnax (CH3CN) 516 nm, E 8500 M-Icm-1. EO 
(CH3CN) Ru2+lRu3+ 1.32 V, E1!2 60 mY; EOred -0.86 V, Elt2 60 mY; EOred -1.46 V, El/2 60 mY; 
EOred -1.73 V, ElI2 60 mY. IH NMR (CD3CN) <3: 8.60, d, 2H, bpy H3; 8.24, t, 2H, bpy H4; 
7.54, t, 2H, bpy H5; 7.92, d, 2H, bpy H6; 8.55, d, 2H, bpy H3'; 8.08, t, 2H, bpy H4'; 7.40, t, 
2H, bpy H5'; 7.82, d, 2H, bpy H6'; 6.28, d, 2H, H4; 7.36, t, 2H, H5; 7.68, t, 2H, H6; 8.32, d, 
2H, H7. l3C NMR (CD3CN) <3: bpy C2, 157.24; bpy C3, 125.04; bpy C4, 139.18; bpy C5, 
128.381128.33; bpy C6, 152.74; bpy C2', 158.47; bpy C3', 124.64; bpy C4', 138.45; bpy C5', 
128.33/128.38; bpy C6', 153.60; C2, not recorded; C3a, 151.87; C4, 120.45; C5, 129.55; C6, 
129.26; C7, 124.91; C7a, 135.87. 
Bis(2,2 '-bipyridine )(bis [2-benzoxazolyl] methine )ruthenium(II)-(hexafluorophosphate) 
(11) 
Ligand 3 (49 mg, 0.20 mmol) and RU(bPY)2Clz.2H20 (85 mg, 0.16 mmol) in 3:1 
EtOHIH20 (8 ml) were refluxed for 24 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of NH4PF6. Chromatography on alumina (1 x 10 cm) with 200:1 
CH2Ch:MeOH separated a small green head band that was identified as the title compound. 
Yield 15 mg (11%). Positive-ion FAB mass spectrum: Calc. mlz for C3sH2SN602Ru+ 
([(bpY)2Ru(3-H)]+) 663.1090; found 663.1083. I~max (CH3CN) 405 nm, E 17 600 M-1cm-1. EO 
(CH3CN) Ru2+;Ru3+ 1.39 V, EII2 60 mY; Bred -1.04 V (irreversible). IH NMR (CD3CN) <3: 
8.52, d, 2H, bpy H3; 8.09, t, 2H, bpy H4; 7.57, t, 2H, bpy H5; 8.83, d, 2H, bpy H6; 8.49, d, 
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2H, bpy H3'; 8.05, t, 2H, bpy H4'; 7.36, t, 2H, bpy H5'; 8.00, d, 2H, bpy H6'; 5.20, d, 2H, H4; 
6.65, t, 2H, H5; 6.96, t, 2H, H6; 7.28, d, 2H, H7; 5.20, s, 1H, -CH-. l3C NMR (CD3CN) 8: 
59.99; 109.13; 112.25; 120.99; 123.80; 124.30; 126.78; 127.10; 136.77; 136.95; 152.74; 
153.05. 
Alternatively, 11 (as the BF4 salt) was synthesised by the silver method as follows: 
RU(bPY)2Clz.2H20 (24.8 mg, 0.05 mmol) and AgBF4 (32.5 mg, 0.11 mmol) were stirred in 
de aerated 1: 1 acetone/EtOH (8 ml) at ambient temperature for 90 minutes. The solution was 
filtered to remove precipitated AgCI, and flushed with argon before ligand 3 (12 mg, 0.05 
mmol) was added as a solid. The reaction solution was heated at 40°C for two hours before 
being filtered and the solvent removed in vacuo. The residue was chromatographed on 
alumina (1 x 5 cm) and one green fraction was collected and identified as 11. Yield 20 mg 
(50%) 
Bis(2,2' -bipyridine )(3-[2-pyridyl]-1,2-benzisoxazolyl)ruthenium(II) 
bis(hexafluorophosphate) (13) 
Ligand 6 (18.8 mg, 0.10 mmol) and RU(bPY)2Clz.2H20 (50.0 mg, 0.10 mmol) in 3:1 
EtOHlH20 (8 ml) were refluxed for 15 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of NH4PF6. Yield 80 mg (94%) (Found: C, 42.92; H, 2.94; N, 9.15. Calc. 
for C32H24N6F120P2Ru: C, 42.73; H, 2.69; N, 9.34). Positive-ion FAB mass spectrum: Calc. 
mlz for C32H24N6F60PRu+ ([(bpY)2Ru(6)](PF6)+) 755.0668; found 755.0697. Amax (CH3CN) 
442 nm, e 18 200 M-1cm-1. EO (CH3CN) Ru2+lRu3+ 1.36 V, E1I2 60 mY; EOred -1.01 V 
(irreversible), EOred -1.72 V (irreversible), EOred -1.98 V (irreversible). IH NMR (CD3CN) 8: 
7.49, m, 3H, 3 x bpy H5's; 7.57, t, 1H, bpy H5; 7.59, t, 1H, H5'; 7.67, d, 1H, H7; 7.73, t, 1H, 
H5; 7.83, m, 3H, H6 and 2 x bpy H6's; 7.86, m, 2H, H6' and bpy H6; 8.02, d, 1H, bpy H6; 
8.14, m, 3H, 3 x bpy H4's; 8.21, t, 1H, bpy H4; 8.27, t, 1H, H4'; 8.42, d, 1H, H4; 8.58, m, 4H, 
4 x bpy H3's; 8.79, d, 1H, H3'. 
(2,2 '-Bibenzoxazolyl)dichloropalladium (14) 
A methanolic solution of 0.0904M Li2PdCl4 (2.5 ml, 0.23 mmol) was added to a 
stirred solution of ligand 1 (50 mg, 0.21 mmol) dissolved in boiling MeOH (25 ml). The tan 
precipitate that formed was collected by filtration and recrystallised from MeN02. M.p. 
>300°C; yield 74 mg (82%) (Found: C, 40.36; H, 2.02; N, 6.82; CI, 16.98. Calc. for 
C14HsN2Clz02Pd: C, 40.66; H, 1.95; N, 6.77; CI, 17.15). Positive-ion FAB mass spectrum: 
Calc. mlz for Cl~sN202Pd+ [(I)Pd+, 100%] 343.9619; found 343.9618. 
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(2,2 '-Methylenebisbenzoxazolyl)dichloropalladium.hemihydrate (15) 
A methanolic solution of 0.0363M Li2PdC14 (4.5 ml, 0.16 mmol) was added to a 
stirred solution of ligand 3 (38.8 mg, 0.16 mmol) in MeOH (3 ml). After a few seconds a 
precipitate developed and was filtered off (37.9 mg). The solution was then reduced in 
volume by removal of ca. half the solvent in vacuo and was then diluted with water (5 ml) 
and an orange precipitate formed and was again collected by filtration (15.4 mg). M.p. 288-
291°C; yield 53.3 mg (78%) (Found: C, 41.62; H, 2.23; N, 6.31; Cl, 16.32. Calc. for 
ClsHlON2Ch02Pd.Y2H20: C, 41.27; H, 2.54; N, 6.41; Cl, 16.24). Positive-ion FAB mass 
spectrum: Calc. mlz for ClsHlON2Cl02Pd+ [(3)PdCl+, 100%] 392.9464; found 392.9470. lH 
NMR (CDCh) 8: 8.56, d, 2H, H4; 7.49, t, 2H, H5; 7.53, t, 2H, H6; 7.58, d, 2H, H7; 5.16, s, 
2H, CH2. 
(2,2 '-Methylenebisbenzothiazolyl)dichloropalladium.hemihydrate (16) 
A methanolic solution of 0.0904M LhPdC14 (1.2 ml, 0.11 mmol) was added to a 
stirred solution of ligand 4 (30 mg, 0.11 mmol) in boiling MeOH (25 ml). After a few 
seconds small golden flakes fell out of solution. After cooling to room temperature, the flakes 
were collected by filtration. The solution was then reduced in volume by removal of ca. half 
the solvent in vacuo, and upon standing more golden flakes formed and were collected by 
filtration. M.p. 278-280°C; yield 40 mg (82%) (Found: C, 38.67; H, 2.31; N, 6.00; S, 15.10. 
Calc. for ClsHlON2ChS2Pd.V2H20: C, 38.44; H, 2.37; N, 5.97; S, 15.12). Positive-ion FAB 
mass spectrum: Calc. mlz for ClsHlON2ClS2Pd+ [(4)PdCl+, 100%] 424.9015; found 424.9013. 
lH NMR (d6-DMSO) 8: 8.65, d, 2H, H4; 7.65, t, 2H, H5; 7.58, t, 2H, H6; 7.18, d, 2H, H7; 
5.90, s, 2H, CH2. 
[3-(2-Pyridyl)-1,2-benzisoxazolyl]dichloropalladium (17) 
Ligand 6 (29.3 mg, 0.13 mmol) was dissolved in MeOH (2 ml) and added to a 
methanolic solution ofO.0363M Li2PdC14 (4.2 mIs, 0.15 mmol). The yellow precipitate that 
formed was collected by filtration and washed well with MeOH. M.p. >300°C; yield 52.4 mg 
(94%) (Found: C, 38.67; H, 2.20; N, 7.75; Cl, 19.22. Calc. for C12HgN20ChPd: C, 38.56; H, 
2.16; N, 7.50; Cl, 18.98). lH NMR (d6-DMSO) 8: 8.66, d, IH, H4; 7.73, t, lH, H5; 7.85, t, 
1H, H6; 8.11, d, lH, H7; 8.83, d, lH, H3'; 8.49, t, 1H, H4'; 7.95, t, lH, H5'; 9.11, d, lH, H6'. 
(2,2 '-Bibenzoxazolyl)dinitratodisilver (18) 
Ligand 1 (41 mg, 0.17 mmol) dissolved in chloroform (4 ml) was poured into a vial 
containing AgN03 (30 mg 0.18 mmol) dissolved in hot 2: 1 methanol/chloroform (6 ml). The 
solution immediately turned pink. The precipitated material was filtered after one day. M.p. 
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249-250°C; yield 43 mg (84%) (Found: C, 29.38; H, 0.94; N, 9.44. Calc for C14H8N406Ag2: 
C, 29.19; H, 1.40; N, 9.72). 
Reaction of 2,2'-methylenebisbenzoxazole with silver nitrate, viz 1,1',2,2'-
tetrabenzoxazol-2-yl ethene (19) 
Ligand 3 (46.5 mg, 0.186 mmol) dissolved in methanol (4 ml) was added to AgN03 
(33.4 mg, 0.196 mmol) dissolved in 1: 1 methanol/water (2 ml). The solution darkened upon 
the addition. After one day metallic silver had deposited around the sides of the vial and the 
solution was filtered to remove this everyday thereafter until no more precipitated (ca. 4 
days). The solution was then reduced to dryness in vacuo and the material analysed by lH 
NMR spectroscopy and TLC. The spectrum showed signals due to the starting material and 
another component. By GCMS this component was identified as 19. No attempt at 
separation of the components was made. 
(2,2'-Methylenebisbenzothiazolyl)nitratosilver (20) 
AgN03 (21 mg, 0.12 mmol) dissolved in hot MeOH (2 ml) was added to a stirred 
solution ofligand 4 (35 mg, 0.12 mmol) dissolved in boiling MeOH (20 ml). The solution 
darkened upon the addition. After evaporation of the solution, long crystals and some 
powdery material was left. The crystals were collected. M.p. 265-268°C; yield 30 mg (55%) 
(Found: C, 39.56; H, 2.28; N, 9.37; S, 14.00. Calc. for ClsHlON303S2Ag: C, 39.83; H, 2.23; 
N, 9.29; S, 14.20). 
Bis(N3-[2,2 '-bibenzoxazolyl])dichlorocopper (21) 
CuCb.2H20 (36 mg, 0.21 mmol) dissolved in MeOH (1/2 ml) was added to ligand 1 
(50 mg, 0.21 mmol) dissolved in CHCb (4 ml). The resulting solution turned dark purple. 
After complete evaporation of the solvent there remained purple cubes and blue needles. 
These were both collected and by washing with a small amount of ethanol the blue needles 
dissolved. M.p. 2l7-222°C; yield 30 mg (47%). Positive-ion FAB mass spectrum: Calc. mlz 
for C28H16N404CU+ [(1)2CU+, 100%] 535.0480; found 535.0470. 
Bis[3-(2-pyridyl)-1,2-benzisoxazolyl]dinitratocopper (22) 
Ligand 6 (23.0 mg, 0.117 mmol) in MeOH (2 ml) was added to CU(N03)2.3H20 (28.3 
mg, 0.117 mmol) in MeOH (1 ml) and left to stand. Large green crystals formed overnight 
and were collected by filtration. More green crystals grew upon more evaporation of the 
solution and these were also collected. M.p. 242-243°C; yield 26.0 mg (76%) (Found: C, 
49.71; H, 2.51; N, 14.22. Calc. for C24H16N608Cu: C, 49.71; H, 2.78; N, 14.49). Positive-ion 
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FAB mass spectrum: Calc. mlz for C24H16N402CU+ [(6)2CU+, 100%] 455.0584; found 
455.0571. 
Bis(2,2' -bipyridine) [N3-(1,1 ' -bibenzotriazolyl)] chlororuthenium(II)-
(hexafluorophosphate) (31) 
Ligand 23 (24.0 mg, 0.10 mmol) and Ru(bpY)2Cb.2H20 (52.9 mg, 0.10 mmol) were 
refluxed in 3: I EtOHlHzO (8 ml) for 48 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove umeacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofNH4PF6. Yield 69.6 mg (82%) (Found: C, 44.86; H, 3.05; N, 16.39. Cale. 
for C32HZ4NIOCIF6PRu.1 Y2H20: C, 44.84; H, 3.00; N, 16.33). Positive-ion FAB mass 
spectrum: Calc. mlz for C32H24N IOCIRu+ ([(bpY)2Ru(23)CI]+) 685.0908; found 685.0917. Amax 
(CH3CN) 479 nm, E 8650 M-1cm-1. 
IH NMR (CD3CN) 8: 
bpyH3, 8.35; bpyH4, 8.12; bpyH5, 7.80; bpyH6, 10.18. 
bpyH3, 8.21; bpyH4, 7.75; bpyH5, 7.08; bpy H6, 7.87 
bpyH3, 8.45; bpyH4, 7.80; bpyH5, 7.30; bpy H6, 7.77. 
bpy H3, 8.58; bpy H4, 8.16; bpy H5, 7.63; bpy H6, 9.04. 
Bt H4, 9.12; Bt H5, 7.65; Bt H6, 7.78; Bt H7, 7.57. 
Bt H4', 8.36; Bt H5', 7.70; Bt H6', 7.80; Bt H7', 7.53. 
Bis(2,2 '-bipyridine )[N3-(1,1 '-bisbenzotriazolyl)methane )]chlororuthenium(II)-
(hexafluorophosphate) (32) 
Ligand 24 (17.0 mg, 0.11 mmol) and RU(bPY)2Cb.2HzO (32.1 mg, 0.11 mmol) were 
refluxed in 3:1 EtOHlH20 (8 rol) for 6 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of~PF6. Yield 44.0 mg (82%) (Found: C, 45.90; H, 2.93; N, 15.93. Calc. 
for C33Hz6NlOC1F6PRu.H20: C, 45.98; H, 3.27; N, 16.24). Positive-ion FAB mass spectrum: 
Calc. m/z for C33H26NlOClRU+ ([(bpY)2Ru(24)Cl]+) 699.1056; found 699.1074. Amax (CH3CN) 
471 nm, E 7000 M-1cm-1. 
IH NMR (CD3CN) 8: 
bpyH3, 8.34; bpyH4, 8.04; bpyH5, 7.67; bpyH6, 10.07. 
bpy H3, 8.24; bpy H4, 7.84; bpy H5, 7.19; bpy, H6 7.86. 
bpyH3, 8.41; bpyH4, 7.88; bpyH5, 7.24; bpy, H6 7.71. 
bpyH3, 8.53; bpyH4, 8.10; bpyH5, 7.41; bpy, H6 8.67. 
Bt H4, 8.88; Bt H5, 7.46; Bt H6, 7.71; Bt H7, 8.07. 
Bt H4', 8.10; Bt H5', 7.68; Bt H6', 7.45; Bt H7', 7.78; CH2 7.57. 
Bis(2,2' -bipyridine) [N2,N2 '-(1,1 '-bisbenzotriazolyl)methane ]-ruthenium(H) 
bis(hexafluorophosphate) (34) 
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AgBF4 (34.1 mg, 0.175 mmol) and RU(bPY)2Ch.2H20 (45.1 mg, 0.087 mmo1) in 
deaerated 1: 1 ethanol/acetone (12 ml) was stirred at 35-40°C for 90 minutes. After filtering 
to remove precipitated AgCI, ligand 24 (25.0 mg, 0.10 mmol) was added as a solid, the 
solution was again deaerated by bubbling argon through the solution and the mixture stirred at 
40°C for 5 hrs. The resulting solution was concentrated to dryness in vacuo, and the residue 
was chromatographed on alumina. Yield 31 mg (47%) (Found: C, 47.63; H, 3.17; N, 16.56. 
Calc. for C33H26NlOB2F8Ru: C, 47.34; H, 3.13; N, 16.72). Positive-ion FAB mass spectrum: 
Calc. mlz for C33H26NlOBF4Ru+ ([(bpY)2Ru(24)](BF4)+) 751.1442; found 751.1415. Amax 
(CH3CN) 368 nm, 89 800 M-1cm- l . EO (CH2Ch) Ru2+lRu3+ 1.50 V, E1I2 60 mY; EOred -1.45 V, 
E1I2 60 mY; EOred -1.60 V; E1I2 70 mY. IH NMR (CD2Ch) 8: 8.48, d, 2H, bpy H3; 8.17, t, 2H, 
bpy H4; 7.57, t, 2H, bpy H5; 8.27, d, 2H, bpy H6; 8.43, d, 2H, bpy H3'; 8.12, t, 2H, bpy H4'; 
7.49, t, 2H, bpy H5'; 7.84, d, 2H, bpy H6'; 7.84, d, 2H, H4; 7.51, t, 2H, H5; 7.76, t, 2H, H6; 
8.04, d, 2H, H7; 7.31 7.43, dd, 2H, CH2. 
Bis(2,2'-bipyridine)(1-(2-pyridyl)benzotriazolyl)ruthenium(H) bis(hexafluorophosphate) 
(35) 
Ligand 27 (11.4 mg, 0.06 mmol) and RU(bPY)2Ch.2H20 (30.2 mg, 0.06 mmol) in 3:1 
EtOHlH20 (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofN~PF6. Yield 46.1 mg (88%) (Found: C, 41.30; H, 2.70; N, 12.40. Calc. 
for C31H24N8F12P2Ru: C, 41.39; H, 2.69; N, 12.46). Positive-ion FAB mass spectrum: Calc. 
mlz for C3IH24N8F6PRu+ ([(bpY)2Ru(27)](PF6)+) 755.0818; found 755.0809. Amax (CH3CN) 
423 nm, 8 16300 M-1cm-l . EO (CH3CN) Ru2+lRu3+ 1.53 V, E1I2 75 mY; EOred -1.39 V, E1I2 80 
mY; EOred -1.60 V; E1I2 95 mY. IH NMR (CD3CN) 8: 7.43, t, 1H, bpy H5; 7.48, m, 3H, H5' 
and 2 x bpy H5; 7.55, t, 1H, bpy H5; 7.71, t, 1H, H5; 7.83, m, 2H, H6' and bpy H6; 7.90, m, 
4H, H6 3 x bpy H6; 8.05, d, 1H, H4; 8.16, m, 3H, 3 x bpy H4; 8.21, t, 1H, bpy H4; 8.32, t, 
1H, H4'; 8.40, d, 1H, H7; 8.57, m, 3H, H3' and 2 x bpy H3; 8.59, d, 1H, bpy H3; 8.62, d, 1H, 
bpyH3. 
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Bis(2,2' -bipyridin e )(N3-(1-[(2-pyrid yl)methyl]b enzotriazolyl) )chlororu thenium(II)-
(hexafluorophosphate) (38) and bis(2,2'-bipyridine)(1-[(2-
pyridyl)methyl]benzotriazolyl)ruthenium(II) bis(hexafluorophosphate) (36) 
Ligand 28 (13.0 mgl 0.062 mmol) and RU(bPY)2Ch,2H20 (32.1 mgl 0.062 mmol) in 
3:1 EtOHlH20 (8 ml) were refluxed for 5 hrs. After coolingl the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of waterl 
filtered to remove unreacted ligandl and the product precipitated out by the addition of an 
aqueous solution of N~PF6. Chromatography on alumina (1 x 7 em) with 100: 1 
CH2Ch:MeOH as eluantl cleanly separated a small dark red fraction then a larger orange 
fraction. IH NMRl UV-visible spectroscoPYl FABMS and elemental analysis identified the 
fractions as the above mentioned complexes respectively. 
Bis(2l2l-bipyridine )(N3-( 1-[(2-pyridyl)methyl]benzotriazolyl) )chlororuthenium(II)-
(hexafluorophosphate) (38) 
Yield 7.2 mg (14%) (Found: Cl 47.97; Hl 3.21; Nl 14.04. Calc. for C32H26NsC1F6PRu: 
Cl 47.80; Hl 3.26; Nl 13.93). Positive-ion FAB mass spectrum: Calc. m/z for C32H26NsClRu+ 
([(bpY)2Ru(28)CI]+ 659.1028; found 659.1012. Amax (CH3CN) 494 lillll E 5600 M-1cm-1. 
IH NMR (CD3CN) 8: 
bpyH3l 8.28; bpyH4l 8.01; bpyH5l 7.71; bpyH6l 10.19. 
bpyH3l 8.14; bpyH4l 7.72; bpyH5l 7.11; bpyH6l 7.87. 
bpy H3 l 8.42; bpy H4l 7.86; bpy H5 l 7.23; bpy H6l 7.79. 
bpy H3l 8.53; bpy H4l 8.09; bpy H5 l 7.56; bpy H6l 8.90. 
bpyH3'l 6.97; bpyH4ll 7.72; bpyH5 ll 7.32; bpyH6 ll 8.42. 
Bt H4l 8.84; Bt H5 l 7.40; Bt H6l 7.57; Bt H7l 7.72; CH2l 5.72. 
Bis(2l2l-bipyridine)( 1-[ (2-pyridyl)methyl]benzotriazolyl )ruthenium(II) 
bis(hexafluorophosphate) (36) 
Yield 44 mg (77%) (Found: Cl 41.21; Hl 2.93; N, 12.09. Calc. for 
C32H26NsF12P2Ru.H20: C, 41.30; H, 3.03; N, 12.04). Positive-ion FAB mass spectrum: Calc. 
m/z for C32H26NsF6PRu+ ([(bpyhRu(28)](PF6)+) 769.0967; found 769.0957. Amax (CH3CN) 
426 nm, E 11 300 M,lcm-1• EO (CH3CN) Ru2+/Ru3+ 1.30 V, E1I2 75 mY; EOred -1.43 V, E1I2 70 
mY; EOred -1.64 V; E1I2 70 mY. 
IH NMR (CD3CN) 8: 
bpy H3, 8.50; bpy H4, 8.19; bpy H5 7.64; bpy H6, 8.58. 
bpy H3, 8.40; bpy H4, 8.05; bpy H5 7.43; bpy H6, 7.77. 
bpy H3, 8.66; bpy H4, 8.20; bpy H5 7.49; bpy H6, 7.96. 
bpyH3, 8.62; bpyH4, 8.13; bpyH5 7.46; bpyH6, 7.81. 
bpy H3', 8.00; bpy H4', 7.97; bpy H5', 7.25; bpy H6', 7.70. 
BtH4 7.80; BtH5, 7.51; BtH6, 7.71; BtH7, 8.00; CH2, Heq 6.13, Hax 5.91. 
Bis(2,2 ' -bipyridine )(l-[l-isoquinolyl]b enzotriazolyl)rutbenium(II) 
bis(bexafluoropbospbate) (37) 
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Ligand 29 (20.0 mg, 0.06 mmol) and RU(bPY)2Ch.2H20 (42.0 mg, 0.06 mmol) in 3:1 
BtOH!HzO (8 ml) were refluxed for 15 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofN~PF6. Yield 67.0 mg (87%) (Found: C, 44.12; H, 2.49; N, 11.59. Cale. 
for C35Hz6NgFIZPzRu: C, 44.27; H, 2.76; N, 11.80). Positive-ion FAB mass spectrum: Calc. 
mlz for C35Hz6N8F6PRu+ ([(bpy)zRu(29)](PF6)+) 805.0975; found 805.0966. Amax (CH3CN) 
429 run, E 16200 M-Icm-1• BO (CH3CN) Rif+/Ru3+ 1.47 V, BI/2 80 mY; BOred -1.34 V, BlIZ 80 
mY; BOred -1.72 V (irreversible); BOred -1.93 V (irreversible). l3 C NMR (CD3CN) 8: 113.90; 
119.42; 124.30; 124.67; 124.71; 124.96; 127.26; 127.56; 127.84; 128.20; 128.25; 129.88; 
130.24; 133.73; 138.90; 138.98; 139.16; 141.25; 152.31; 152.58; 152.87; 153.10. 
IH NMR (CD3CN) 8: 
bpyH3, 8.57; bpyH4, 8.12; bpyH5, 7.34; bpyH6, 7.90. 
bpy H3, 8.56; bpy H4, 8.10; bpy H5, 7.37; bpy H6, 8.03. 
bpy H3, 8.58; bpy H4, 8.19; bpy H5, 7.50; bpy H6, 7.82. 
bpy H3, 8.62; bpy H4, 8.22; bpy H5, 7.55; bpy H6, 7.88. 
isq H3', 7.60; isq H4', 7.94; isq H5', 8.25; isq H6', 8.10; isq H7', 8.08; isq H8', 8.58. 
Bt H4, 8.04; Bt H5, 7.70; Bt H6, 7.81; Bt H7, 8.07. 
(1,1 '-Bibenzotriazole)diaquadicblorocopper(39) 
Ligand 23 (30 mg, 0.13 mmol) in CHCh (3 ml) was added to CuCh.2HzO (22 mg, 
0.13 mmol) dissolved in 1: 1 MeOH/CHCb (1 ml). After several hours a light green solid had 
fonned and was collected by filtration. M.p. 240-244°C; yield 20 mg (47%) (Found: C, 
35.45; H, 2.16; N, 20.86. Calc, for CIzH8N6ChCu.2H20: C, 35.43; H, 2.97; N, 20.66). 
(1,1 '-Bibenzotriazolyl)tetrafluoroboratosilver (40) 
Ligand 23 (57 mg, 0.23 mmol) dissolved in CH2Ch (3 ml) was added to AgBF4 (47 
mg, 0.23 mmol) dissolved in 1:1 MeOH/CH2Ch (1 ml). A white solid fonned immediately 
and was collected by filtration. M.p. 245-246°C; yield 100 mg (97%) (Found: C, 33.63; H, 
1.60; N, 19.74. Calc, for C12HsN6BF4Ag: C, 33.45; H, 1.87; N, 19.50). 
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(l,l'-Bibenzotriazolyl)dichloropalladium (41) 
Ligand 23 (40 mg, 0.17 mmol) dissolved in warm MeOH (10 ml) was added to PdClz 
(30 mg, 0.1 7 mmol) dissolved in hot aqueous 2M HCI (2 ml). A yellow solid precipitated 
immediately and was collected by filtration. M.p. >300°C; yield 52.5 mg (75%) (Found: C, 
34.41; H, 1.97; N, 20.25; CI, 17.05. Calc. for C12H8N6ClzPd: C, 34.85; H, 1.95; N, 20.32; CI, 
17.15). 
[(l,l'-Methylenebisbenzotriazolyl)dichlorocopper]o (42) 
Ligand 24 (50 mg, 0.20 mmol) dissolved in warm MeOH (3 ml) was added to 
CuCh,2HzO (28 mg, 0.20 mmol) dissolved in MeOH (1 ml). Green crystals suitable for 
structure determination grew from slow evaporation of this solution. M.p. 240-250°C; yield 
60 mg (86%) (Found: C, 40.90; H, 2.52; N, 21.93; CI, 18.34. Calc. for C13H lON6ClzCu: C, 
40.59; H, 2.62; N, 21.84; CI, 18.43). 
[(N3-1,l'-Methylenebisbenzotriazolyl)nitratosilver. acetonitrile solvate]n (43) 
Ligand 24 (35 mg, 0.14 mmol) dissolved in warm MeOH (3 ml) was added to AgN03 
(24 mg, 0.14 mmo1) dissolved in warm MeOH (3 ml). A white solid formed immediately and 
was collected by filtration. Recrystallisation from acetonitrile gave colourless crystals 
suitable for structure detennination. M.p. 253-255°C; yield 48.4 mg (84%) (Found: C, 39.19; 
H, 2.57; N, 24.22. Calc. for C13HION70 3Ag.MeCN: C, 39.07; H, 2.84; N, 24.30). 
(l,l'-Methylenebisbenzotriazolyl)dichloropalladium (44) 
Ligand 24 (25 mg, 0.10 mmol) dissolved in 2 ml warm MeOH was added to PdClz (18 
mg, 0.10 mmol) dissolved in hot aqueous 2M HCI (1 ml). A yellow solid precipitated 
immediately and was collected by filtration. M.p. >300°C; yield 40 mg (93%) (Found: C, 
36.55; H, 2.74; N, 19.41. Calc. for C13HlON6ClzPd: C, 36.52; H, 2.36; N, 19.66). 
Bis [1-(2-pyridyl)benzotriazole]dinitratocopper .hydrate.methanol solvate (45) 
Ligand 27 (40 mg, 0.20 mmol) dissolved in MeOH (2 ml) was added to 
CU(N03)z.3HzO (49 mg, 0.20 mmol) dissolved in MeOH (1 ml). Green crystals suitable for 
structure detennination grew from slow evaporation of this solution. M.p. 223-225°C; yield 
65 mg (60%) (Found: C, 44.01; H, 3.38; N, 22.32. Calc. for CZZHI6NIO06Cu.MeOH.HzO: C, 
43.85; H, 3.52; N, 22.23). Positive-ion FAB mass spectrum: Calc. mlz for CZZHI6N8CU+ 
[(27)zCu+, 100%] 455.0802; found 455.0796. 
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,..-Bis[1-(2-pyridyl)benzotriazolyl] dinitratodisilver (46) 
Ligand 27 (40 mg, 0.20 mmol) dissolved in MeOH (3 ml) was added to AgN03 (35 
mg, 0.20 mmol) dissolved in hot MeOH (2 ml). Colourless crystals suitable for structure 
detelTI1ination grew from slow evaporation of this solution. M.p. 228-229°C; yield 57 mg 
(77%) (Found: C, 36.13; H, 1.99; N, 19.23. Calc. for C22H16NlO06Ag2: C, 36.09; H, 2.20; N, 
19.13). 
[1-(2-Pyridyl)benzotriazolyl]dichloropalladium.hemihydrate (47) 
Ligand 27 (40 mg, 0.20 mmol) dissolved in MeOH (2 ml) was added to PdCb (35 mg, 
0.20 mmol) dissolved in hot aqueous 2M HCI (2 ml). A yellow solid precipitated 
immediately and was collected by filtration and recrystallised from MeN02. M.p. >300°C; 
yield 70 mg (93%) (Found: C, 34.38; H, 2.47; N, 14.80. Calc. for ClIHsN4CbPdYili20: C, 
34.53; H, 2.11; N, 14.64). 
Bis [1-([2-pyridyl] methyl)benzotriazole] diperchloratocopper (48) 
Ligand 28 (57 mg, 0.27 mmol) dissolved in MeOH (2 ml) was added to 
Cu(CI04h.6H20 (100 mg, 0.27 mmol) dissolved in MeOH (1 ml). Blue plates grew from 
slow evaporation of this solution. M.p. 190°C; yield 80 mg (76%) (Found: C, 36.84; H, 2.42; 
N, 14.23. Calc. for C36H30N12Cl4016CU2.H20: C, 36.84; H, 2.75; N, 14.32). Positive-ion FAB 
mass spectrum: Calc. mlz for C24H2oNsCI04Cu2+ [(28)2Cu2(CI04)+, 50%], 646.9860; found 
646.9872. Calc. mlz for C24H2oNsCI04Cu+ [(28)2Cu(CI04)+, 50%] 582.0601; found 
582.0594. Fractional recrystallisation of this mixture from DMF afforded pure 48. 
,..-Bis[1-([2-pyridyl] methyl)benzotriazole] dinitratodisilver (49) 
Ligand 28 (48 mg, 0.23 mmol) dissolved in MeOH (2 ml) was added to AgN03 (39 
mg, 0.23 mmol) dissolved in hot MeOH (2 ml). A white solid precipitated immediately and 
was collected by filtration. Recrystallisation from MeCN gave colourless crystals suitable for 
structure determination. M.p. 225-227°C; yield 64 mg (73%) (Found: C, 38.10; H, 2.84; N, 
18.28. Calc. for C24H20NlO06Ag2: C, 37.91; H, 2.65; N, 18.42). 
,..-Bis[(1-[2-pyridyl]methyl)benzotriazolyl]tetrachlorodipalladium.methanol solvate (50) 
Ligand 28 (52 mg, 0.25 mmol) dissolved in MeOH (2 ml) was added to PdCb (44 mg, 
0.25 mmol) dissolved in hot aqueous 2M HCI (3 ml). A yellow solid precipitated 
immediately and was collected by filtration and recrystallised from MeN02. Crystals suitable 
for structure determination were grown from vapour diffusion ofMeOH into a DMF solution 
of the complex. M.p. 250-260°C; yield 94 mg (98%) (Found: C, 37.15; H, 3.29; N, 13.82; CI, 
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17.27. Calc. for C24H2oNgCI4Pd2.MeOH: C, 37.20; H, 3.00; N, 13.88; CI, 17.57). Positive-ion 
FAB mass spectrum: Calc. mlz for C24H2oNgChPd2+ [(28)2Pd2Ch+, 100%] 738.8965; found 
738.8947. 
Hexakis(J.1-2-chloro )(J.1-4-oxo )-tetrakis[1-(1-isoquinolyl)benzotriazole-copper(H)] (51) 
CuCh.2H20 (22.9 mg, 0.13 mmol) dissolved in 1: 1 chlorofonn!methanol (1 ml) was 
added to ligand 29 (33.0 mg, 0.13 mmo1) dissolved in chloroform (2 ml) and the resulting 
solution swirled. After 1 day a yellow solid had formed and this was filtered off. Vapour 
diffusion of ether into the filtrate precipitated more tan solid. Yield 45.4 mg (89%) (Found: 
C, 47.05; H, 2.58; N, 14.61; CI, 18.47. Calc. for C1sHlON4ChCu: C, 47.32; H, 2.65; N, 14.71; 
CI, 18.63). This material was recrystallised from nitromethane to give thin orange plate-like 
crystals of 51. 
[1-(1-Isoquinolyl) b enzotriazolyl ]tetrafluoro boratosilver .hemihydrate (52) 
AgBF4 (33.5 mg, 0.17 mmol) dissolved in 1:1 chlorofonn!methanol (1 ml) was added 
to 29 (41 mg, 0.17 mmol) dissolved in chloroform (2 ml). The reaction mixture was kept in 
the dark and a white solid developed over several days. The solid was filtered off and washed 
with chlorofonn. Yield 62 mg (83%) (Found: C, 39.93; H, 2.13; N, 12.43. Calc. for 
ClsHlON4BF4Ag.Y2H20: C, 40.04; H, 2.46; N, 12.44). 
J.1-Bis[1-(1-isoquinolYI)benzotriazole]tetrachlorodipalladium (53) 
A solution of 0.0363M Li2PdCl4 (5.70 ml, 0.21 mmol) in methanol was added to 29 
(50.3 mg, 0.21 mmol) dissolved in 25 ml refluxing MeOH. A yellow solid, which 
precipitated immediately, was collected by filtration and recrystallised from MeN02. M.p. 
255-260°C; yield 71.1 mg. Positive-ion FAB mass spectrum: Calc. mlz for C30H2oNgChPd2 
[(29)2Pd2CI/, 100%] 810.8956; found 810.8947. 
[N4,N4'-(3,3 '-Bi-1,2,4-oxadiazolyl) ]dichloropalladium (75) 
Ligand 57 (66 mg, 0.48 mmol) dissolved in MeOH (2.5 ml) was added to a 
methanolic solution of 0.0942M LhPdCl4 (5.2 ml, 0.49 mmol). After evaporation of ca. half 
the solution, orange plates had fonned and these were collected by filtration (35 mg). A 
yellow solid was obtained after more evaporation of the filtrate and this too was collected by 
filtration (60 mg). M.p. >300°C; yield 95 mg (63%) (Found: C, 15.15; H, 0.46; N, 17.96; C1, 
23.06. Calc. for C~2N4Ch02Pd: C, 15.23; H, 0.62; N, 17.76; CI, 22.48). 
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[N4-(3,3 '-Bi-l,2,4-oxadiazolyl)nitratosilver]n (76) 
Ligand 57 (20 mg, 0.15 mmol) dissolved in MeOH (1 ml) was added to AgN03 (31 
mg, 0.15 mmol) dissolved in MeOH (1 ml) and H20 (3-4 drops). A white solid formed 
immediately and was collected by filtration. Recrystallisation from acetonitrile produced 
crystals suitable for X-ray diffraction. M.p. 141-l45°C; yield 35 mg (69%) (Found: C, 15.70; 
H, 0.39; N, 22.69. Calc. for C4H2NsOsAg: C, 15.60; H, 0.65; N, 22.74). 
(5,5'-Dimethyl-3,3 '-bi-l,2,4-oxadiazolyl)dichloropalladium (77) 
PdClz (44 mg, 0.25 mmol) dissolved in hot aqueous 2M HCl (3 ml) was added to 
ligand 58 (40 mg, 0.25 mmol) dissolved in warm MeOH (4 ml). After standing for several 
days thin orange rods had formed and these were collected by filtration. M.p. >300°C; yield 
50 mg (60%) (Found: C, 21.05; H, 1.90; N, 16.20; Cl, 20.86. Calc. for C6Ht;N4Clz02Pd: C, 
20.98; H, 1.76; N, 16.31; Cl, 20.65). 
[2-(1,2,4-0xadiazol-3-yl)pyridine]dichloropalladium (78) 
A methanolic solution of 0.0942M LizPdCG (3 ml, 0.28 mmol) was added to a stirred 
solution of ligand 63 (40 mg, 0.27 mmol) dissolved in MeOH (3 ml). The yellow precipitate 
that formed was collected by filtration and recrystallised from MeN02. M.p. >300°C; yield 
84 mg (95%) (Found: C, 26.04; H, 1.31; N, 12.95; Cl, 21.56. Calc. for C7HsN3ClzOPd: C, 
25.95; H, 1.55; N, 12.95; Cl, 21.85). IH NMR (d6-DMSO) 8: 8,41, d, 1H, H3; 8.41, t, 1H, 
H4; 7.96, t, lH, H5; 9.08, d, lH, H6; 10.73, s, IH, H5'. 
Bis [methyl picolinimidate] dinitratodiaquacopper (79) 
Ligand 63 (35.0 mg, 0.238 mmol) dissolved in methanol (3 ml) was added to 
CU(N03)2.3H20 (31.1 mg, 0.129 mmol) dissolved in methanol (2 ml). After several days sky 
blue crystals had formed and these were collected by filtration. M.p. 185-187°C; yield 39.2 
mg (61 %) (Found: C, 34.1 1; H, 4.05; N, 16.86. Calc for C14H20N60lOCU: C, 33.91; H, 4.07; 
N,16.94). 
[2-(1,2,4-0xadiazol-3-yl)pyridine]dichlorocopper (80) 
Ligand 63 (46.3 mg, 0.31 mmol) dissolved in MeOH (2 ml) was added to CuClz.2H20 
(54.0 mg, 0.32 mmol) dissolved in MeOH (1 ml). The lime precipitate that formed was 
collected by filtration. M.p. >300°C; yield 88 mg (99%) (Found: C, 29.98; H, 1.59; N, 14.83; 
Cl, 25.08. Calc for C7HSN3ChOCu: C, 29.86; H, 1.79; N, 14.92; CI, 25.18). 
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[N1,N4 '-2-(1,2,4-Thiadiazol-5-yl)pyridine] dichloropalladium (81) 
Ligand 65 (53 mg, 0.33 mmol) dissolved in MeOH (3 ml) was added to a methanolic 
solution of 0.0363M Li2PdCl4 (9 ml, 0.33 mmol) and the resulting solution swirled. The 
voluminous yellow precipitate that formed was collected by filtration and recrystallised from 
MeN02. M.p. >300°C; yield 94 mg (85%) (Found: C, 24.80; H, 1.48; N, 12.53; CI, 20.90. 
Calc. for C7HsN3ChSPd: C, 24.69; H, 1.48; N, 12.34; CI, 20.82). lH NMR (dt;-DMSO) 8: 
8.78, d, 1H, H3; 8.43, t, 1H, H4; 7.95, t, 1H, H5; 9.03, d, 1H, H6; 9.14, s, 1H, H3'. 
[N1,N 4 '-2-(1,2,4-Thiadiazol-5-yl)pyridine] dichlorocopper (82) 
Ligand 65 (55 mg, 0.34 mmol) dissolved in MeOH (3 ml) was added to CuClz.2HzO 
(53 mg, 0.34 mmol) dissolved in MeOH (1 ml) and the resulting solution swirled. The light 
lime precipitate that formed was collected by filtration. M.p. >300°C; yield 94 mg (98%) 
(Found: C, 28.31; H, 1.67; N, 14.00; CI, 23.83. Calc. for C7HsN3ClzSCu: C, 28.25; H, 1.69; 
N, 14.11; CI, 23.82). Positive-ion FAB mass spectrum: Calc. mlz for C7HsN3CISCu+ 
[(65)CuCI+, 100%] 260.9192; found 260.9191. 
Bis( 4,4 '-dimethyl-2,2 '-bipyridine )(N1,N 4 '-[2-(1,2,4-thiadiazol-5-
yl)pyridine ])ruthenium(II) bis(hexafluorophosphate) (83) 
Ligand 65 (12.0 mg, 0.074 mmol) and Ru(dmb)zCh.2H20 (40.0 mg, 0.069 mmol) in 
3:1 EtOHlH20 (8 ml) were refluxed for 15 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofN&PF6. Yield 61 mg (96%) (Found: C, 40.10; H, 3.06; N, 10.59. Calc. 
for C31H29N7F12PzRuS: C, 40.35; H, 3.17; N, 10.63). Positive-ion FAB mass spectrum: Calc. 
mlz for C31Hz9N7F6PRuS+ ([(dmb)2Ru(65)](PF6)+) 778.0910; found 778.0891. ""max (CH3CN) 
487 nm, E 9400 M-1cm-1• EO (CH3CN) Ru2+lRu3+ 1.18 V, E11Z 75 mY; EOred -1.08 V, E1I2 60 
mY; EOred -1.69 V, EII2 80 mY; EOred -1.88 V, E11Z 60 mY. IH NMR (CD3CN) 8: 2.59, s, 
12H, dmb4-CH3's; 7.29, m, 4H, dmb H5's; 7.56, m, 3H, H5 and 2 x dmb H6's; 7.65, m, 2H, 2 
x dmb H6's; 7.85, d, 1H, H6; 8.15, t, 1H, H4; 8.28, s, 1H, H3'; 8.39, m, 4H, dmb H3's; 8.59, d, 
1H,H3. 
Bis(2,2 '-bipyridine )(N1,N 4' -[2-(1,2,4-thiadi azol-5-yl)pyridine ])rutheni um(U) 
bis(hexafluorophosphate) (84) 
Ligand 65 (16.0 mg, 0.098 mmol) and Ru(bpY)zCh.2H20 (51.0 mg, 0.098 mmol) in 
3:1 EtOHlHzO (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
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aqueous solution ofNH4PF6. Yield 65.1 mg (77%) (Found: C, 37.64; H, 2.57; N, 11.04. Calc. 
for C27H21N7F12P2RuS: C, 37.42; H, 2.44; N, 11.31). Positive-ion FAB mass spectrum: Calc. 
mlz for C27H21N7F6PRuS+ ([(bPY)2Ru(L)J(PF6)+) 722.0280; found 722.0265. !-max (CH3CN) 
487 nm, E 9400 M-1cm-1. EO (CH3CN) Ru2+lRu3+ 1.29 V, El/2 60 mY; EOred -1.02 V, E1I2 60 
mY; EOred -1.58 V, Ell2 60 mY; EOred -1.92 V, El/2 70 mY. IH NMR (CD3CN) 8: 7.48, m, 4H, 
H5 and 3 x bpy H5; 7.58, t, IH, bpy H5; 7.75, d, IH, bpy H6; 7.79, d, IH, bpy H6; 7.86, m, 
3H, 3 x bpy H6; 8.15, m, 5H, H4 and 4 x bpy H4; 8.31, s, IH, H3'; 8.56, m, 4H, H3 and 3 x 
bpyH3; 8.62, d, 1H, bpyH3. 
[3,6-Di(2-pyridyl)-1,4,2,5-dioxadiazine]nitratosilver (88) 
AgN03 (22.4 mg, 0.13 mmol) dissolved in hot MeOH (3 ml) was added to ligand 87 
(31.3 mg, 0.13 mmol) in warm MeOH (2 ml). A colourless precipitate formed immediately 
and was collected by filtration. Yield 51.4 mg (96%) (Found: C, 34.94; H, 1.79; N, 16.80. 
Calc. for C12HgNsOsAg: C, 35.15; H, 1.97; N, 17.07). 
[1,4-Bis(2-pyridyl)buta-1,3-diyne]nitratosilver (104) 
AgN03 (46 mg, 0.27 mmo1) dissolved in hot MeOH (2 ml) was added to 103 (50 mg, 
0.24 mmol) dissolved in MeOH (1 ml). The fawn precipitate that formed was collected by 
filtration. Crystals suitable for X-ray analysis were grown from slow evaporation of a 
CH3CN solution ofthe complex. M.p. >179°C; yield 83 mg (86%) (Found: C, 44.60; H, 2.05; 
N, 11.13. Calc. for C1JIsN303Ag: C, 44.95; H, 2.16; N, 11.23). 
Bis(2,2 ' -bipyridine )(2-[N 5-1 ,2,5-thiadiazol-3-yl]pyridine )chlo roruthenium(II)-
hexatluorophosphate (107) and bis(2,2 '-bipyridine )(2-[N2-1,2,5-thiadiazol-3-
yl]pyridine )ruthenium(IT) bis(hexafluorophosphate) (108) 
RU(bPY)2Clz.2H20 (64.0 mg, 0.122 mmol) in 3:1 EtOH!H20 (8 ml) was refluxed for 1 
hr before the addition ofligand 93 (20.0 mg, 0.123 mmol) as a solid. Reflux was continued 
for another 2 hrs. After cooling, the reaction mixture was concentrated to dryness in vacuo. 
The residue was redissolved in the minimum of water, filtered to remove unreacted ligand, 
and the product precipitated out by the addition of an aqueous solution of N14PF6• 
Chromatography on alumina (1 x 7 cm) with 100:1 CH2ClzIMeOH as eluent, cleanly 
separated a small dark red fraction, then a larger orange fraction. IH ]'Th1R, LTV-visible 
spectroscopy, FAB mass spectrometry and elemental analysis identified the fractions as the 
above mentioned complexes respectively. 
Bis(2,2'-bipyridine)(2-[N5-1,2,5-thiadiazol-3-ylJpyridine)chlororuthenium(II)-
hexafluorophosphate (107) 
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Yield 5.5 mg (8%). Positive-ion FAB mass spectrum: Calc. mlz for C27H21N7ClRUS+ 
([(bpY)2Ru(93)Cl]+) 612.0321; found 612.0311. 
Bis(2,2'-bipyridine)(N1,N2'-[2-(1,2,5-thiadiazol-3-yl)pyridineJ)ruthenium(II) 
bis(hexafluorophosphate) (108) 
Yield 77.7 mg (73%) (Found: C, 37.70; H, 2.23; N, 11.14. Calc. for 
C27H21N7F12P2RuS: C, 37.42; H, 2.44; N, 11.31). Positive-ion FAB mass spectrum: Calc. mlz 
for C27H21N7F6PRuS+ ([(bpY)2Ru(93)](PF6)+) 722.0278; found 722.0265. A.max (CH3CN) 450 
nm, E 11 600 M-1cm-l • EO (CH3CN) Ru2+lRu3+ +1.36 V, El/2 65 mY; EOred -1.19 V, EII2 70 
mY; EOred -1.55 V (irreversible). lH NMR (CD3CN) 8: 7.55, m, 5H, H5 and 4 x bpy H5's; 
7.64, d, lH, bpy H6; 7.80, m, 3H, 3 x bpy H6's; 7.86, d, 1H, bpy H6; 8.18, m, 5H, H4 and 4 x 
bpy H4's; 8.60, 5H, H6 and 4 x bpy H6; 9.55, s, 1H, H4'. 
Bis(2,2 '-bipyridine )(N2 ,N1' - [3,4-di(2-pyridyl)-1,2,S-oxadiazolyl])ruthenium(II) 
bis(hexafluoropbospbate) (109) 
Ligand 91 (15.0 mg, 0.067 mmol) and Ru(bPY)2Clz,2H20 (34.8 mg, 0.067 mmol) in 
3: 1 EtOHIH20 (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofNfuPF6. Yield 56.0 mg (92%) (Found: C, 41.50; H, 2.48; N, 12.06. Calc. 
for C32H24NgF120P2Ru: C, 41.44; H, 2.61; N, 12.08). Positive-ion FAB mass spectrum: Calc. 
mlz for C32H24NgF60PRu+ ([(bpY)2Ru(91)](PF6)+) 783.0773; found 783.0758. A.max (CH3CN) 
435 nm, E 13 400 M-1cm-1. EO (CH3CN) Ru2+lRu3+ 1.51 V, EII2 60 mY; EOred -0.97 V 
(irreversible). 
IH NMR (CD3CN) 8: 
bpyH3, 8.59; bpyH4, 8.18; bpyH5, 7.53; bpyH6, 8.03. 
bpy H3, 8.56; bpy H4, 8.17; bpy H5, 7.50; bpy H6, 7.86. 
bpy H3, 8.58; bpy H4, 8.16; bpy H5, 7.54; bpy H6, 7.74. 
bpy H3, 8.63; bpy H4, 8.23; bpy H5, 7.57; bpy H6, 7.79. 
H3, 9.86; H4, 8.22; H5, 7.59; H6, 7.88. 
H3', 8.27; H4', 8.16; H5', 7.77; H6', 9.03. 
Bis( 4,4'-dimetbyl-2,2 '-bipyridine )(N2,N1 '-[3,4-di(2-pyridyl)-1,2,S-
oxadiazoly]])ruthenium(ll) bis(bexafluoropbosphate) (110) 
Ligand 91 (10.0 mg, 0.045 mmol) and Ru(dmb)2Clz,2H20 (25.8 mg, 0.045 mmol) in 
3: 1 EtOHlH20 (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
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filtered to remove unreacted ligand and the product precipitated out by the addition of an 
aqueous solution ofNRtPF6. Yield 19.1 mg (89%) (Found: C, 43.77; H, 3.41; N, 11.12. Calc. 
for C36H32N8F120P2Ru: C, 43.96; H, 3.28; N, 11.39). Positive-ion FAB mass spectrum: Calc. 
mlz for C32H24N8F60PRu+ ([(dmb)2Ru(91)](PF6)+) 778.0910 found 778.0891. Amax (CH3CN) 
441nm, E 23 500 M-1cm-1. EO (CH3CN) Ru2+/Ru3+ +1.40 V, E1I2 60 mY; EOred -1.08 V 
(irreversible). IH NMR (CD3CN) 8: 2.60, s, 3H, dmb4-CH3; 2.62, s, 6H, dmb4-CH3; 2.64, s, 
3H, dmb4-CH3; 7.35, m, 3H, 3 x dmb H5; 7.40, d, 1H, dmb H5; 7.52, d, 1H, dmb H6; 7.56, t, 
1H, H5; 7.59, d, 1H, dmb H6; 7.67, d, 1H, dmb H6; 7.76, t, 1H, H5'; 7.82, d, 1H, dmb H6; 
7.85, d, 1H, H6; 8.17, t, 1H, H5; 8.18, t, 1H, H5'; 8.25, d, 1H, H3'; 8.42, s, 1H, dmb H3; 8.43, 
s, 2H, 2 x dmb H3; 8.48, s, 1H, dmb H3; 9.02, d, 1H, H6'; 9.80, d, 1H, H3. 
Bis(2,2 '-bipyridine )(N2,N1 '-[3,4-di(2-pyridyl)-1,2,S-thiadiazolyl])ruthenium(II) 
bis(hexafluorophosphate) (111) 
Ligand 94 (45 mg, 0.19 mmo1) and RU(bPY)2Cb.2H20 (l05 mg, 0.20 mmo1) in 3:1 
EtOHlH20 (8 ml) were refluxed for 5 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of N~PF6. Chromatography on alumina separated a small amount of the 
dinuclear complex from the desired mononuclear complex. Yield 153 mg (87%) (Found: C, 
40.45; H, 2.46; N, 11.62. Calc. for C32H24N8F12P2RuS: C, 40.73; H, 2.56; N, 11.87). Positive-
ion FAB mass spectrum: Calc. mlz for C32H24N8F6PRuS+ ([(bpY)2Ru(94)](PF6)+) 759.0540; 
found 759.0537. Amax (CH3CN) 454 nm, E 15 000 M-1cm-1. EO (CH3CN) Ru2+lRu3+ +1.37 V, 
E1I2 65 mY; EOred -1.18 V, E1I2 65 mY; EOred - 1.53 V (irreversible). 
IHNMR (CD3CN) 8: 
bpyH3, 8.59; bpyH4, 8.16; bpyH5, 7.51; bpyH6, 7.92. 
bpyH3, 8.61; bpyH4, 8.18; bpyH5, 7.52; bpyH6, 7.81. 
bpyH3, 8.59; bpyH4, 8.18; bpyH5, 7.52; bpyH6, 7.77. 
bpyH3, 8.60; bpyH4, 8.20; bpyH5, 7.50; bpyH6, 7.88. 
H3, 9.02; H4, 8.03; H5, 7.49; H6, 7.86. 
H3', 8.09; H4', 8.12; H5', 7.74; H6', 8.90. 
Tris(N2,N1 '-[3,4-di(2-pyridyl)-1,2,S-thiadiazolyl])ruthenium(II) 
bis(hexafluorophosphate) (112) 
Ligand 94 (0.1056 g, 0.44 mmol) and Ru(DMSO)4Cb (0.0630 g, 0.13 mmol) in 3:1 
ethanol/water (8 ml) were refluxed for 24 hours. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of NRtPF6 and purified by chromatography on alumina (1 x 5 cm) with 
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200:1 dichloromethane/methanol. Yield 113 mg (78%) (Found: C, 38.44; H, 2.36; N, 14.56; 
S, 8.58. Calc. for C36H24NI2FI2P2RuS3.H20: C, 38.27; H, 2.32; N, 14.87; S, 8.51). Positive-
ion FAB mass spectrum: Calc. mlz for C36H24N12F6PRuS3+ ([(94)3RuJ(PF6)+) ; found. Amax 
(CH3CN) 435 run, E 18900 M-1cm-1. EOred (CH3CN) - 0.73 V (irreversible). 
Tris(N2,N1 ' -[3,4-di(2-pyridyl)-1,2,5-oxadiazolyl])rutbenium(U) 
bis(bexafluoropbospbate) (113) 
Ligand 91 (31.6 mg, 0.14 mmol) and Ru(DMSO)4Ch (19.5 mg, 0.04 mmol) in 3:1 
ethanol/water (6 ml) were refluxed for 5 hours. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of NH4PF6 and purified by chromatography on alumina (1 x 4 em) with 
200:1 dichloromethane/methanol. Yield 19 mg (45%). Positive-ion FAB mass spectrum: 
Calc. mlz for C36H24N12F603PRu+ ([(91)3RuJ(PF6)+) 919.0810; found 919.0780. A.max 
(CH3CN) 401 run, E 16900 M-1cm-1• EOred (CH3CN) - 0.41 V (irreversible). 
Bis(2,2 '-bipyridine) [2-(2-pyridyl)-3-nitro-pyrazolo [1,5-a ]pyridine]-rutbenium(U) 
bis(bexafluoropbospbate) (115) 
Ligand 99 (17.0 mg, 0.058 mmo1) and RU(bPY)2Ch.2H20 (30.0 mg, 0.058 mmol) in 
3: 1 EtOHIH20 (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofN"B4PF6. Yield 59.1 mg (90%) (Found: C, 40.97; H, 2.31; N, 11.68. Calc. 
for C31H24NsF12P2Ru: C, 40.74; H, 2.56; N, 11.87). Positive-ion FAB mass spectrum: Calc. 
mlz for C31H24NsF6PRu+ ([(bpY)2Ru(L)](PF6)+) 799.0722; found 799.0708. Amax (CH3CN) 
443 nm, E 15900 M-1cm-1. EO (CH3CN) Ru2+/Ru3+ +1.28 V, E1I2 65 mY; EOred -0.97 V, E1I2 
65mV. 
IH NMR (CD3CN) 8: 
bpyH3, 8.53; bpyH4, 8.10; bpyH5, 7.47; bpyH6, 7.70. 
bpy H3, 8.56; bpy H4, 8.15; bpy H5, 7.45; bpy H6, 7.60. 
bpy H3, 8.58; bpy H4, 8.14; bpy H5, 7.42; bpy H6, 7.97. 
bpyH3, 8.59; bpyH4, 8.18; bpyH5, 7.54; bpyH6, 7.96. 
H3, 9.55; H4, 8.23; H5, 7.50; H6, 7.84. 
H4', 8.57; H5', 7.91; H6', 7.16; H7', 7.34. 
Bis( 4,4'-dimethyl-2,2 '-bipyridine) [2-(2-pyridyl)-3-nitro-pyrazolo [1,5-a ]pyridine]-
ruthenium(II) bis(hexafluorophosphate) (116) 
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Ligand 99 (14.6 mg, 0.061 mmol) and Ru(dmb)2Ch,2H20 (35.1 mg, 0.061 mmol) in 
3:1 EtOHlH20 (8 ml) were refluxed for 4 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of N~PF6. The dark red salt was recrystallised by vapour diffusion of 
diethylether into an acetonitrile solution of the complex. Yield 55.0 mg (90%) (Found: C, 
43.75; H, 3.10; N, 11.64. Calc. for C36H32NgF1202P2Ru.YzCH3CN: C, 43.56; H, 3.30; N, 
11.66). Positive-ion FAB mass spectrum: Calc. mlz for C36H32NgF602PRu+ 
([(dmb)2Ru(L)J(PF6)+) 855.1340; found 855.1334. Amnx (CH3CN) 438 nm, c: 15500 M-1cm-1. 
EO (CH3CN) Ru2+lRu3+ 1.18 V, E1I2 70 mY; EOred -1.00 V, El/2 60 mY. IH NIVIR (CD3CN) 8: 
2.56, s, 3H, dmb4-CH3; 2.58, s, 3H, dmb4-CH3; 2.59, 3H, dmb4-CH3; 2.62, 3H, dmb4-CH3; 
7.18, t, IH, H6'; 7.23, t, 1H, dmb H5; 7.29, m, 2H, dmb H5's; 7.37, d, 2H, H7' and dmb H5; 
7.40, d, lH, dmb H6; 7.48, t, 1H, H5; 7.50, d, lH, dmb H6, 7.76, d, 2H, dmb H6's; 7.83, d, 
lH, H6; 7.91, t, 1H, H5'; 8.20, t, 1H, H4; 8.37, s, lH, dmb H3; 8.41, s, 2H, dmb H3; 8.44, s, 
1H, dmb H3; 8.57, d, lH, H4'; 9.53, d, lH, H3. 
[N1 ',N1 "-3 ,4-Di(2-pyridyl)-1,2,5-oxadiazolyl-2-oxide] dichloropalladium (117) 
A methanolic solution of 0.0363M LizPdC4 (2.1 ml, 0.075 nunol) was added to a 
stirred solution of ligand 99 (18.2 mg, 0.075 mm01) dissolved in MeOH (2 ml). After a few 
seconds a yellow precipitate formed and was then collected by filtration. M.p. >300°C; yield 
30 mg (97%) (Found: C, 34.65; H, 1.79; N, 13.45; Cl, 16.93. Calc for C12HgN4C}z02Pd: C, 
34.52; H, 1.93; N, 13.41; Cl, 16.98). Positive-ion FAB mass spectrum: Calc. mlz for 
C12HgN4Cl02Pd+ [(99)PdCl+, 100%J 380.9361; found 380.9368. IH NMR (~-DMSO) 8: 
8.03, d, 1H, H3; 8.27, t, lH, H4; 7.82, t, 1H, H5; 9.14, d, 1H, H6; 8.07, d, lh, H3', 8.28, t, 1H, 
H4'; 7.90, t, IH, H5'; 9.18, d, 1H, H6'. 
Bis [N1 ',N1" -3,4-di(2-pyridyl)-1,2,5-oxadiazolyl-2-oxide ]tetrachlorodicopper (118) 
Ligand 99 (15.8 mg, 0.09 nunol) dissolved in MeOH (2 ml) was added with stirring to 
CuClz.2H20 (22.2 mg, 0.09 mmol) dissolved in MeOH (1 ml). Green crystals started forming 
after several minutes. The solution was left to stand overnight and the crystals were then 
collected by filtration. M.p. 284-287°C; yield 32 mg (92%) (Found: C, 38.67; H, 1.95; N, 
15.05; Cl, 18.97. Calc for C24H16N8C1404CU2: C, 38.47; H, 2.15; N, 14.95; Cl, 18.93). 
[3 ,4-Di(2-pyridyl)-1,2,5-oxadiazolyl-2-oxide ]ni tratosilver (119) 
Ligand 99 (21 mg, 0.09 nunol) dissolved in MeOH (2 ml) was added with stirring to 
AgN03 (15 mg, 0.09 mmol) dissolved in MeOH (1 ml). A white precipitate developed and 
was collected by filtration. Yield 31 mg (86%) (Found: C, 35.18; H, 1.74; N, 17.28. Calc. for 
C12HsN505Ag: C, 35.23; H, 1.97; N, 17.11). 
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[N1,N2'-2-(l,2,S-thiadiazol-3-yl)pyridine]dichloropaUadiurn (120) 
A methanolic solution of 0.0904M LizPdC4 (2.5 m1, 0.23 mmo1) was added to ligand 
93 (34.3 mg, 0.21 mmol) dissolved in methanol (2 ml). The yellow precipitate that fonned 
was collected by filtration. M.p. >300°C; yield 65.1 mg (91%) (Found: C, 24.71; H, 1.39; N, 
12.50; S, 9.18. Calc. for C7HsN3SClzPd: C, 24.69; H, 1.48; N 12.34; S, 9.42). IH NMR (d6-
DMSO) 8: 8.57, d, 1H, H3; 8.44, t, 1H, H4; 7.88, t, 1H, H5; 8.93, d, 1H, H6; 9.76, s, 1H, H4'. 
[N1 ',N1 "-3,4-di(2-pyridyl)-1,2,S-oxadiazolyl]dichloropaUadiurn (121) 
An excess of 0.0904M LizPdC4 was added to ligand 91 (6.5 mg, 0.029 mmol) 
dissolved in methanol (1 ml). The fme yellow precipitate that developed was collected by 
filtration. M.p. >300°C; yield 11.1 mg (95%) (Found: C, 35.71; H, 2.04; N, 13.38; CI, 17.43. 
Calc. for C12HsN4ClzOPd: C, 35.88; H, 2.01; N, 13.95; Cl, 17.66). 1H NMR (~-DMSO) 8: 
8.05, d, 2H, H3; 8.26, t, 2H, H4; 7.86, t, 2H, H5; 9.15, d, 2H, H6. 
[N1,N1 "-3,4-di(2-pyridyl)-1,2,S-thiadiazolyl]dichloropaUadiurn (122) 
An excess of 0.0904M LizPdCl4 was added to ligand 94 (19.4 mg, 0.081 mmol) 
dissolved in methanol (2 ml). The yellow precipitate that fonned was collected by filtration 
and washed with methanoL M.p. >300°C; yield 30.3 mg (90%) (Found: C, 34.55; H, 2.02; N, 
13.04; S, 7.68. Calc. for CI2HsN4ChPdS: C, 34.52; H, 1.93; N, 13.41; S, 7.68). IH NMR (d6-
DMSO) 8: 8.93, d, 2H, H3; 8.19, t, 2H, H4; 7.79, t, 2H, H5; 9.08, d, 2H, H6. 
[3,4-Di(2-pyridyl)-1 ,2,S-thiadiazolyl] dichloroplatinurn (123) 
Ligand 94 (37.5 mg, 0.155 mmol) dissolved in nitromethane (2 ml) was added to 
(DMSO)2PtClz (66.5 mg, 0.158 mmol) dissolved in nitromethane (3 ml), and the clear 
solution left overnight. In the morning the resulting yellow microcrystals were filtered off. 
M.p. >300°C; yield 71.2 mg (91%) (Found: C, 28.49; H, 1.67; N, 10.85; CI, 13.91; S, 6.13. 
Calc. for C12HsN4ClzPtS: C, 28.45; H, 1.60; N, 10.77; CI, 13.99; S, 6.19). E1ectrospray MS: 
Calc. for C12HsN4ClPtS+: 469.9806; found 469.9788. 
[N1,N1"-3,4-di(2-pyridyl)-1,2,S-thiadiazolyl]dinitratocopper (124) 
Ligand 94 (39.5 mg, 0.160 mmol) dissolved in methanol (2.5 ml) was added to 
Cu(N03)2.3H20 (85.0 mg, 0.350 mmol) dissolved in methanol (2.5 ml). After several days 
the sky blue crystals that had fonned were collected by filtration. M.p. 190-200°C; yield 41.1 
mg (58%) (Found: C, 33.80; H, 1.84; N, 19.32. Calc. for CI2HsN606CUS: C, 33.69; H, 1.88; 
N,19.64). 
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[Nl,Nl" -3,4-di(2-pyridyl)-1,2,5-thiadiazole silver nitrate]lI (125) 
AgN03 (26.3 mg 0.154 mmol) dissolved in hot methanol (2.5 ml) was added to ligand 
94 (37.9 mg, 0.158 mmol) dissolved in methanol (3 ml). After several days a powder had 
formed, and the methanolic solution was withdrawn. The remaining solid was recrystallised 
from acetonitrile. Yield 56 mg (88%) (Found: C, 35.23; H, 1.85; N, 17.20. Calc. for 
C12H8N403AgS: C, 35.14; H, 1.97; N, 17.07). 
Tetrakis( 4,4' -dim ethyl-2,2' -bipyridine )-1-1-[3 ,4-di(2-pyridyl)-1,2 ,5-oxadiazolyl]-
diruthenium(II)-tetrakis(hexafluorophosphate) (126) 
Ligand 91 (15.5 mg, 0.069 nunol) and Ru(dmbhCh.2H20 (80 mg, 0.138 mmol) in 
3:1 EtOHlH20 (16 ml) were refluxed for 24 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of ~BF 4. Additional product was obtained by extraction of the aqueous 
solution with dichloromethane. Chromatography on alumina separated the mononuclear 
complex from the dinuclear complex. The lH NMR spectrum of 126 showed the presence of 
two diastereoisomers in a ratio of 5:6. The isomers were not assigned to the meso or the 
racemic forms. Yield 42 mg (35%) (Found: C, 44.55; H, 3.71; N, 9.01. Calc. for 
C6oH56N12F240P~U2: C, 41.35; H, 3.24; N, 9.64). Positive-ion FAB mass spectrum: Calc. 
mlz for C6oH56N12Fl80P3Ru2+ ([(dmb)2Ru(91)Ru(dmb)2] (PF6)3+) 1599.1727; found 
1599.1713. Ivrnax (CH3CN) 497 nm, E 15000 M-1cm-l. EOoxl (CH3CN) + 1.42 V, E1I2 60 mY; 
EOox2 +1.80 V, EI/2 60 mY; EOredl -0.58 V (irreversible). lH NMR (CD3CN) 8: 2.54, .6H, 
dmb4-CH3; 2.56, 6H, dmb4-CH3; 2.57, 6H, dmb4-CH3; 2.61, 6H, dmb4-CH3; 2.62, 12H, 
dmb4-CH3; 2.64, 6H, dmb4-CH3; 2.71, 6H, dmb4-CH3; 6.96, m, 4H, dmb H5's; 7.14, m, 6H, 
dmb H5's; 7.26, d, 2H, dmb H6; 7.30, d, 2H, dmb H6; 7.42, m, 2H, dmb H5; 7.45, d, 4H, dmb 
H6's; 7.53, m, 4H, dmb H6 and dmb H5; 7.66, m, 4H, H5's; 7.73, d, 2H, dmb H6; 7.90, d, 2H, 
H6; 7.98, d, 2H, H6; 8.04, d, 2H, dmb H6; 8.19, s, 2H, dmb H3; 8.22, s, 2H, dmb H3; 8.24, s, 
2H, dmb H3; 8.33, t, 4H, H4's; 8.39, s, 4H, dmb H3's; 8.44, s, 4H, dmb H3's; 8.47, s, 4H, dmb 
H3's; 8.96, d, 4H, H3's. 
Tetrakis(2,2 '-bipyridin e )-1-1-[3,4-di(2-pyridyl)-1,2,5-oxadiazolyl ]-diruthenium(II)-
tetrakis(tetrafluoroborate) (127) 
Ligand 91 (36.6 mg, 0.16 mmol) and RU(bPY)2Ch.2H20 (144.1 mg, 0.27 nunol) in 3:1 
EtOHIH20 (16 ml) were refluxed for 24 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of N~BF 4. Chromatography on alumina separated the mononuclear 
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complex from the dinuc1ear complex. The IH NMR spectrum of 127 showed the presence of 
two diastereoisomers, in a ratio of 5:6. The isomers could not be assigned to either the meso 
or the racemic forms. Yield 53.7 mg (31%) (Found: C, 44.06; H, 2.94; N, 11.93. Calc. for 
CS2H4oNI2B4FI60Ru2.H20: C, 44.10; H, 2.99; N, 11.86). Positive-ion FAB mass spectrum: 
Calc. mlz for CS2HwN12F120B3Ru2+ ([(bpY)2Ru(91)Ru(bpY)2] (BF4)3+) 1312.1631; found 
1312.1635. "'max (CH3CN) 497 nm, E 11 600 M-1cm-l. EOox1 (CH3CN) + 1.48 V, El/2 60 mY; 
EOox2 + 1.82 V, EII2 60 mY; EOredl -0.53 V (irreversible); EOred2 -1.70 V (2e-), E1I2 80 mY. 
Tetralds(2,2'-bipyridine)-p.a.-[3,4-di(2-pyridyl)-1,2,S-thiadiazolyl]-diruthenium(II)-
tetrakis(hexafluorophosphate) (128) 
Ligand 94 (30 mg, 0.125 mmol) and RU(bPY)2Ch.2H20 (130 mg, 0.250 mmol) in 3:1 
EtOHlH20 (16 ml) were refluxed for 24 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
filtered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of ~PF6. Chromatography on alumina separated the mononuclear 
complex from the dinuclear complex. The lH NMR spectrum of 128 showed the presence of 
two diastereoisomers, 128a and 128b, in a ratio of 3: 1. The isomers could not be assigned to 
the meso or the racemic forms. However, because of the large diastereoisomeric excess, they 
could be assigned to the major component (128a) or the minor component (128b). Yield 97 
mg (47%) (Found: C, 37.63; H, 2.35; N, 10.06. Calc. for CS2H4oNI2F2~~U2S: C, 37.92; H, 
2.45; N, 10.20). Positive-ion FAB mass spectrum: Calc. mlz for CS2H4oNI2FlSP3Ru2S+ 
([(bpY)2Ru(94)Ru(bpY)2]~F6)3+) 1503.0272; found 1503.0253. Am8X (CH3CN) 531 nm, E 16 
000 M-1cm-l. Eoxl (CH3CN) + 1.41 V, EII2 60 mY; Eox2 + 1.67 V, EI/2 60 mY; Eredl -0. 62V; 
EI/2 60 mY; Ered2 -1.08 V (irreversible); Ered3 -1.60 V (2e-); Ered4 -1.86 V (2e-). 
IH NMR (128a) (CD3CN) 8: 
bpyH3, 8.42; bpyH4, 8.10; bpyH5, 7.41; bpyH6, 7.53. 
bpyH3, 8.42; bpyH4, 8.05; bpyH5, 7.37; bpyH6, 7.71. 
bpy H3, 8.62; bpy H4, 8.19; bpy H5, 7.49; bpy H6, 7.60. 
bpy H3, 8.62; bpy H4, 8.24; bpy H5, 7.66; bpy H6, 8.08. 
H3, 9.00; H4, 8.30; H5, 7.66; H6, 7.95. 
IHNMR (128b) (CD3CN) 8: 
bpyH3, 8.59; bpyH4,; bpy H5,; bpyH6, 7.69. 
bpyH3, 8.49; bpyH4, 8.05; bpyH5, 7.32; bpyH6, 7.55. 
bpy H3, 8.56; bpy H4, 8.14; bpy H5, 7.24; bpy H6, 7.32. 
bpy H3, 8.60; bpy H4, 8.31; bpy H5, 7.65; bpy H6, 8.03. 
H3, 8.98; H4, 8.27; H5, 7.62; H6, 7.92. 
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Tetrakis( 4,4 '-dimethyl-2,2' -bipyridine )-11-[ 4,4'-di(2-pyridyl)-3,3 '-bi-1,2,5-thiadiazolyl]-
dirutheninm(II)-tetrakis(hexafluorophosphate) (129) 
Ligand 95 (8.1 mg, 0.025 mmol) and Ru(dmb)2Cb.2H20 (37.8 mg, 0.066 mmol) in 
3:1 EtOH!H20 (8 ml) were refluxed for 42 hrs. After cooling, the reaction mixture was 
concentrated to dryness in va(:uo. The residue was redissolved in the minimum of water, 
fIltered to remove unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution of NH4PF6. Chromatography on alumina separated a small amount of the 
mononuclear complex from the dinuclear complex. Yield 43.2 mg (95%) (Found: C, 41.32; 
H, 3.04; N, 10.41. Calc. for C62H56N14F24P4Ru2S: C, 40.40; H, 3.06; N, 10.63). Positive-ion 
FAB mass spectrum: Calc. mlz for C62H56N14F18P3Ru2S+ ([(bpyhRu(9S)Ru(bpY)2J(PF6)3+) 
1699.1292; found 1699.1266. Amax (CH3CN) 481 nm, E 24 800 M-1cm-l. EOox1 (CH3CN) 
+1.31 V (2e-), E1/2 70 mY; EOmll -1.02 V, Ell2 65 mY; EOred2 -1.14 V, E1/2 65 mY. IH NMR 
(CD3CN) 8: 2.60, s, 6H, dmb4-CH3; 2.61, s, 6H, dmb4-CH3; 2.63, s, 24H, dmb4-CH3; 2.64, 
s, 12H, dmb4-CH3; 7.35, m, 16H, dmb H5; 7.51, m, 6H, H5 and dmb H6; 7.57, d, 6H, dmb 
H6; 7.71, m, 4H, dmb H6; 7.79, d, 4H, dmb H6; 7.86, d, 4H, H6; 7.91, t, 4H, H4; 8.12, d, 4H, 
H3; 8.45, s, 4H, dmb H3; 8.48, s, 12H, dmb H3. 
Tetrakis(2,2'-bipyridine)-11-[4,4'-di(2-pyridyl)-3,3'-bi-1,2,S-thiadiazolyl]-
diruthenium(II)-tetrakis(hexafluorophosphate) (130) 
Ligand 95 (16.5 mg, 0.051 mmol) and RU(bPY)2Ch.2H20 (68.0 mg, 0.l30 mmol) in 
3: 1 EtOHffi20 (16 ml) were refluxed for 24 hrs. After cooling, the reaction mixture was 
concentrated to dryness in vacuo. The residue was redissolved in the minimum of water, 
fIltered to remove any unreacted ligand, and the product precipitated out by the addition of an 
aqueous solution ofNRtPF6. Yield 86 mg (96%) (Found: C, 37.16; H, 2.45; N, 11.61. Calc. 
for C52~N I2F24P ~U2S2: C, 37.47; H, 2.33; N, 11.32). Positive-ion F AB mass spectrum: 
Calc. mlz for C52RtoNI2FISP3Ru2S2+ ([(bpY)2Ru(9S)Ru(bpYhJ(PF6)3+) 1587.0058; found 
1587.0014. Amax (CH3CN) 471 nm, E 25 500 M-1cm-l. EOoxl (CH3CN) +1.41 V (2e-), E1I2 70 
mY; EOredl -0.98 V, E1I2 60 mY; EOred2 -1.10 V, E112 60 mY. IH NMR (CD3CN) 0: 7.49-7.58, 
m, 20H, H5's; 7.74-7.82, m, 6H, H6's; 7.86-8.02, m, 14H, H6's; 8.12-8.26, m, 20H, H4's; 
8.58-8.68, m, 20H, H3 'so 
Bis(2,2'-bipyridine)(dichloropaUadium(II)-11-[3,4-di(2-pyridyl)-1,2,S-thiadiazolyl]-
ruthenium(II) bis(chloride) (131) 
A methanolic solution of 0.1140M LhPdC14 (0.45 ml, 0.051 mmol) was added to 111 
(44.0 mg, 0.047 mrnol) dissolved in refluxing 3:1 ethanol/acetone (8 m1). A precipitate 
formed immediately. Refluxing was continued for 5 minutes and then the reaction mixture 
allowed to cool to room temperature and the dark red precipitate collected by filtration and 
washed with ethanol. Yield 44.7 mg (100%). Amax (CH3CN) 456 nm, E 12 000 M-Icm-I. IH 
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NMR (CD3CN) 6: 7.51, m, 5H, H5 and 4 x bpy H5; 7.68, d, IH, H3; 7.86, m, 7H, H4, H6, 
H3', H5' and 3 x bpy H6; 8.17, m, 5H, H4'; 8.38, d, 1H, bpy H6; 8.60, m, 4H, 4 x bpy H3; 
9.35, d, 1H, H6'. 
Bis( 4,4' -dimethyl-2,2' -bipyridine)( dichlo ropaUadium(II)-J.l-[3,4-di(2-pyridyl)-1,2,5-
oxadiazolyl]-ruthenium(lI) bis(chloride) (132) 
A methanolic solution of 0.0904M Li2PdCl4 (0.5 ml, 0.057 mm01) was added to 110 
(22.3 mg, 0.024 nuno1) dissolved in refluxing 3: 1 ethanol/acetone (8 ml). A precipitate 
fonned immediately. Refluxing was continued for 5 minutes and then the reaction mixture 
allowed to cool to room temperature and the orange precipitate collected by filtration and 
washed with ethanol. Yield 22.8 mg (100%). IHNMR (CD3CN) 6: 2.56, s, 3H, dmb4-CH3; 
2.60, s, 3H, dmb4-CH3; 2.61, s, 3H, dmb4-CH3; 2.63, s, 3H, dmb4-CH3; 7.38, m, 4H, 4 x 
dmb H5; 7.52, t, 1H, H5; 7.56, m, 1H; 7.61, d, 1H, dmb H6; 7.69, d, 1H, dmb H6; 7.71, d, 
1H, dmb H6; 7.85, m, 3H, H3, H5'and dmb H6; 7.93, t, 1H, H4; 8.06, d, 1H, H3'; 8.26, t, IH; 
H4'; 8.40, s, 1H, dmb H3; 8.45, s, 3H, 3 x dmb H3; 9.33, d, IH, H6'. 
Dichloro(benzonitrile)-palladium(II)-bis(2,2'-bipyridine)-J.l-[3,4-di(2-pyridyl)-1,2,5-
thiadiazolyl]-ruthenium(II) bis(hexafluorophosph ate) (133) 
(PhCNhPdCh (12.7 mg, 0.034 mmol) dissolved in CHCb (0.5 ml) was added to 111 
(32.2 mg, 0.034 mmol) dissolved in CH2Ch (l ml). A precipitate fonned immediately and 
was collected by filtration and washed with CHCb. Yield 37.8 mg (9] %). Positive-ion FAB 
mass spectrum: Calc. mlz for C39H30N9CIF6PPdRuS+ ([(bpyhRu(94)PdCI(NCPh)](PF6)+) 
] 045.9730; found 1045.9758. A.max (CH3CN) 455 nm, E ] 3 700 M-1cm-1• 
Bis(2,2' -bipyridine)( dichloropalladium(II)-J.l-[3,4-di(2-pyridyl)-1,2,5-thiadiazolyl]-
ruthenium(II) bis(hexafluorophosphate) (134) 
(Found: C, 34.22; H, 1.97; N, 9.74. Calc. for C32H24NgChF12P2PdRUS: C, 34.29; H, 2.16; N, 
9.99). 
(Dimethyl sulfoxide)(dichloroplatinum(II)-J.l-[3,4-di(2-pyridyl)-1,2,5-thiadiazolyl]-
bis(2,2' -bipyridine )ruthenium(II) bis(hexafluorophosphate) (136) 
Complex 111 (42.3 mg, 0.045 mmol) dissolved in 1:] acetone/ethanol (2 ml) was 
added to (DMSO)2PtCh (19.5 mg, 0.046 mmol) dissolved in nitromethane (V2 ml), and the 
resultant solution left overnight. The reaction mixture was then concentrated to dryness in 
vacuo. The residue was redissolved in acetone (ca. 1 ml) and was filtered through a small 
plug of celite into a small vial. Vapour diffusion of diethyl ether into this solution 
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precipitated a red powder (53 mg). A sample was examined by positive-ion FAB mass 
spectrometry: Calc. mlz for C39H30N9C1F6PPdRuS+ ([(bPY)2RU(94)PtCh(DMSO)] (PF6)+) 
1142.9693; found 1142.9696. All the remaining material was redissolved in 1:1 
ethanollnitromethane (4 m1) and refluxed for 8 hours. After cooling the same workup 
procedure was followed. Yield 51 mg (88%) (Found: C, 31.85; H, 2.24; N, 8.87. Calc. for 
C52~oN12F24P4Ru2S2: C, 31.71; H, 2.35; N, 8.70). Amax (CH3CN) 514 nm, E 7000 M-1cm-l, A2 
458 nm, E 11 300 M"lcm-l; A3 423 nm, E 11 500 M-lcm-I. EOoxl (CH3CN) + 1.41 V (2e-), E1I2 
65 mY; EOox2 +1.67 V, E1I2 70 mY; EOredl -0.60 V (irreversible). IH NMR (CD3CN) 0: 2.61, 
s, 6H, DMSO; 7.50, m, 4H, 4 x bpyH6; 7.62, t, IH, H5; 7.71, d, IH, bpy H6; 7.74, d, IH, bpy 
H6; 7.86, m, 3H, ; 7.95, d, IH, H6; 8.19, m, 5H, 4 x bpy H4 + H4; 8.50, t, IH, H4'; 8.60, m, 
4H, 4 x bpy H6; 8.76, d, IH, H3'; 8.86, d, IH, H3; 9.07, d, IH, H6'. 
223 
Crystallography 
Tables CI-C5 list crystal data and X-ray experimental details for the structures 
detemuned. Selected bond lengths and angles are listed in the discussion of the structures and 
the remaining distances and angles, as well as atom coordinates, anisotropic displacement 
parameters and hydrogen atom coordinates, are available from the Chemistry Department, 
University of Canterbury. 
Intensity data were collected with: 
(I) a Siemens P4s four-circle diffractometer using monochromatised Mo Ka radiation. 
Cell parameters were determined by least-squares refinement of at least 25 accurately centred 
reflections (28 > 20°). Throughout the data collections the intensities of three standard 
reflections were monitored at regular intervals, and this showed no significant crystal 
decomposition. 
(II) a Siemens SMART CCD area detector using monochromatised Mo Ka radiation, 
and the standard software SMART and SAINT. Intensities were corrected for Lorentz, 
polarisation and absorption effects. 
The structures were solved by direct methods using SHELXS253 and refined, using 
SHELXL,254 on F2 using all data. The functions minimised were I.w(Fo2 - Fl.?)' with w = 
[c1(Fo2) + aP2 + bPr1 where P = [max(Fo2 + 2Fc2)J/3. The hydrogens were included in 
calculated positions and assigned isotropic displacement parameters 1.3 times the isotropic 
equivalent of their carrier atoms. In all cases the final Fourier synthesis did not show any 
significant residual electron density in chemically sensible locations. 
7 
N 
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Table Cl Crystal Data and X-ray Experimental Details for 1,2, 7, 21 and 22. 
Compound 1 2 7 21· 22 
Data collection device P4s P4s CCD CCD CCD 
Empirical fonnula C14HsN202 CI4H8N2S2 C35H26C12F 12N602P2Ru C28H 16CU ,N4C140 4 C24H16CuN60g 
Formula weight 236.22 268.34 1024.53 606.88 289.99 
Temperature (K) 163(2) 163(2) 168(2) 153(2) 168(2) 
Crystal system Monoclinic Monoclinic Tric1inic Monoclinic Triclinic 
Space group P21/n P2 j /c P-I P21/c P-I 
Unit cell dimensions: a (A) 4.627(1) 8.993(1) 10.724(3) 9.980(1) 7.031(2) 
b (A) 16.480(2) 5.998(1) 11.124(4) 14.426(2) 9.060(2) 
c (A) 7.004(1) 11.445(2) 18.866(6) 9.472(1) 9.894(3) 
11 (0) 90 90 101.652(4) 90 77.568(3) 
P CO) 94.34(1 ) 110.870(10) 91.649(4) 117.422(3) 76.300(4) 
'Y CO) 90 90 110.354(4) 90 68.521(3) 
Volume (N) 535.5(2) 575.9(2) 2054.7(12) 1210.5(3) 564.0(3) 
Z 2 2 2 2 1 
Density (calculated) (Mglm3) 1.473 1.548 1.656 1.665 1.708 
Absorption coefficient (mm-I) 0.101 0.441 0.685 1.169 1.036 
F(OOO) 244 276 1020 614 295 
Crystal size (mm3) 0.34 X 0.22 x 0.18 0.77xO.21 xO.13 0.38 x 0.19 x 0.04 0.23 x 0.19 x 0.17 0.80 x OAO x 0.37 
Theta range for data collection CO) 2.47 to 26.00 2.42 to 26.99 2.06 to 22.50 2.30 to 23.22 2.14 to 27.73 
Reflections collected 1733 1619 19597 1549 7402 
Independent reflections [R(int)] 1044 [0.0354] 1262 [0.0265] 5373 [0.0968] 1197 [0.0275] 2415 [0.0311] 
Observed reflections [I>2a(I)] 741 964 3444 1024 2233 
Data / restraints / parameters 1044/0/82 1261 /0/82 5373/0/541 1197 J 0/178 2415/0/178 
Goodness-of-fit on Fl 0.920 0.931 .. 1.024 1.071 1.081 
RJ 1.1>20-(1)] 0.0413 0.0342 0.0509 0.0497 0.0324 
WR2 (all data) 0.1127 0.1068 0.1248 0.1884 0.0899 
If) 
N 
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Table C5 Crystal data and X-ray Experimental Details for 104,115,118,124 and 125. 
Compound 104 115 118 124 125 
Data collection device CCD CCD CCD CCD CCD 
Empirical fonnula Cl4HsAgN303 C32.50H25CIF 12Ns02.5oP2Ru C12HsChCuN40 2 C12HsCuN60 6S C12HgAgNs0 3S 
Formula weight 374.10 994.07 374.66 427.84 410.16 
Temperature eX) 158(2) 168(2) 168(2) 168(2) 168(2) 
Crystal system Triclinic Monoclinic Monoclinic Triclink Monoclinic 
Space group P-1 C2/c P2 1/n P-1 P2 1/n 
Unit cell dimensions: a (A) 8.6182(8) 21.86(8) 9.711(4) 7.737(2) 7.054(2) 
b (A) 9.3085(9) 13.81(5) 9.571(4) 8.108(2) 14.793(4) 
c (A) 9.7959(9) 24.70(7) 15.080(6) 12.933(3) 13.249(4) 
a. (0) 90.059(1) 90 90 96.838(3) 90 
~n 112.297(1) 96.16 92.877(6) 100.565(3) 101.286(3) 
Y (0) 115.467(1) 90 90 102.623(3) 90 
Volume (A3) 643.64(10) 7415(42) 1399.9(9) 767.5(3) 1355.7(7) 
Z 2 8 4 2 4 
Density (calculated) (Mg/m3) 1.930 1.781 1.778 1.851 2.010 
Absorption coefficient (mm-I) 1.579 0.698 1.949 1.607 1.661 
F(OOO) 368 3960 748 430 808 
Crystal size (mm3) 0.62 x 0.44 x 0.10 0.16 x 0.13 x 0.08 0.35 x 0.13 x 0.06 0.56 x 0.46 x 0.07 0.45 x 0.41 x 0.21 
Theta range for data collection CO) 2.79 to 26.35 2.34 to 24.00 2.44 to 26.40 2.61 to 26.43 2.09 to 26.40 
Reflections collected 7309 13551 9273 9879 17123 
Independent reflections [R(int)] 2462 [0.0189] 5558 [0.2323] 2830 [0.0513] 3113 [0.0202] 2764 [0.0374] 
o bserved reflections [1> 2a(I) ] 2285 1561 1603 2799 2584 
Data / restraints / parameters 2462/0/190 5558/0/543 2830/ 1/200 3113/0/235 2764/0/199 
Goodness-of-fit on F2 1.030 0.801 0.801 1.059 1.169 
Rl [1>2a(L)] 0.0205 0.0742 0.0337 0.0247 0.0318 
wR2 (all data) 0.0559 0.2006 0.0550 0.0654 0.0778 
\.D 
N 
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Tahle C4 Crystal Data and X-ray Experimental Details for 75,76,79,82 and 95. 
Compound 75 76 79 82 95 
Data collection device CCD P4s CCD CCD CCD 
Empirical formula CJi2ChN40 2Pd C4H2AgN50 5 ClJi20CuN601O C7HsCbCuN300.258 CJ4HSN682 
Formula weight 315.40 307.98 495.90 301.64 324.38 
Temperature (K) 153(2) 153(2) 168(2) 168(2) 168(2) 
Crystal system Orthorhombic Orthorhombic Triclinic Monoclinic Triclinic 
Space group Pbca Pnma P-l C2/c P-l 
Unit cell dimensions: a (A) 7.7176(4) 10.0248(10) 7.525(2) 17.652(7) 6.354(2) 
b (A) 13.1725(6) 14.7795(11) 8.121(2) 17.215(7) 9.030(3) 
c (A) 16.5280(8) 5.3288(5) 8.146(2) 7.149(3) 12.241(4) 
ue) 90 90 84.167(4) 90 84.602(5) 
~ (0) 90 90 78.256(3) 91.172(5) 85.788(5) 
Y CO) 90 90 84.969(4) 90 78.885(4) 
Volume (N) 1680.24(14) 789.52(12) 483.7(2) 2171.9(15) 685.1(4) 
Z 8 4 1 8 2 
Density (calculated) (Mg/m3) 2.494 2.591 1.703 1.845 1.573 
Absorption coefficient (mm·1) 2.812 2.567 1.198 2.659 0.393 
F(OOO) 1200 592 255 1192 332 
Crystal size (mm3) 0.40 x 0.21 x 0.04 0.78 x 0.42 x 0.21 0.47 x 0.25 x 0.07 0.34 x 0.11 x 0.08 0.55 x 0.25 x 0.15 
Theta range for data collection CO) 2.46 to 23.32 2.76 to 27.00 2.53 to 26.39 2.31 to 26.32 2.31 to 23.00 
Reflections collected 4956 1198 5934 13724 6864 
Independent reflections [R(int)] 1212 [0.0491] 895 [0.0458] 1952 [0.0363] 2205 [0.0818] 1890 [0.0638] 
Observed reflections [1> 2a(I)] 4129 854 1843 1691 1707 
Data 1 restraints 1 parameters 1212/0/120 89510/77 1952/01146 2205/0/170 189010/199 
Goodness-of-fit on F2 0.991 1.064 1.120 1.220 1.312 
RJ [1>20'(1)] 0.0245 0.0262 0.0350 0.0854 0.1052 
wR2 (all data) 0.0492 0.0684 0.0887 0.1670 0.2240 
l:-
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Table C3 Crystal Data and X-ray Experimental Details for 48,49,50, 51and 59. 
Compound 48 49 50 51 59 
Data collection device P4s P4s P4s CCD CCD 
Empirical fomlu1a C30H36ChCuNlOO C12H IOAgNs03 C 12.soHI2ChN4Oo.soPd C40~CI8C~16()1 C1JIlON4()2 
Formula weight 431.56 380.12 403.56 1298.64 290.28 
Temperature (K) 163(2) 168(2) 153(2) 168(2) 150(2) 
Crystal system Triclinic Monoclinic Monoclinic Monoclinic Monoclinic 
Space group P-l C2/c P2dc C2/c P21/c 
Unit cell dimensions: a (A) 8.277 16.252(2) 10.820(2) 42.568(11) 8.5243(5) 
b (A) 10.216 11.020(2) 15.273(2) 13.657(3) 5.6457(3) 
c (A) 12.594 14.709(2) 17.715(3) 24.603(7) 13.7393(8) 
(lea) 99.11(1) 90 90 90 90 
~ CO) 108.43(1) 96.98(1) 97.21(1) 109.474(4) 91.742(2) 
Y (0) 108.96(1) 90 90 90 90 
Volume (A3) 914.15 2614.8(7) 29043(8) 13484(6) 660.91(6) 
Z 2 8 8 8 2 
Density (calculated) (Mglm3) 1.568 1.931 1.846 1.279 1.459 
Absorption coefficient (rum-I) 0.821 1.560 1.642 1.600 0.101 
F(OOO) 445 1504 1592 5216 300 
Crystal size (111m3) 0.54 x 0.30 x 0.27 0.55 x 0.34 x 0.25 0.69 x 0.05 x 0.03 0.40 x 0.21 x 0.06 0.52 x 0.26 x 0.15 
Theta range for data collection (0) 2.20 to 25.00 2.24 to 27.00 2.32 to 25.03 2.03 to 22.50 2.97 to 25.99 
Reflections collected 4835 2963 5828 62461 2201 
Independent reflections [R(int)] 3186 [0.0382] 2865 [0.0209] 5115 [0.2082] 8814 [0.2038] 1027 [0.0706] 
()bserved reflections [1>20(1)] 2791 2365 2193 6267 871 
Data I restraints / parameters 3186/0/254 2865/0/190 5115/0/361 8814/25/792 1027/0/100 
Goodness-of-fit on 1',2 1.350 0.981 0.662 1.217 1.170 
Rl [1>20(1)] 0.0769 0.0250 0.0462 0.1367 0.0495 
wRz (all data) 0.2124 0.0609 0.0826 0.3202 0.1l60 
= C·" C'~ 
Table C2 Crystal Data and X-ray Experimental Details for 23,42,43,45 and 46. 
Compound 23 42 43 45 46 
Data collection device CCD P4s P4s P4s CCD 
Empirical formula C12HsN6 C 13HlOChCuN6 ClsH13AgNg03 C24H2~CuN 1008 CIlHgAgNsO} 
Formula weight 236.24 384.71 461.20 644.07 366.09 
Temperature (K) 168(2) 163(2) 163(2) 153(2) 168(2) 
Crystal system Orthorhombic Triclinic Triclinic Monoclinic Triclinic 
Space grouP. P212121 P-l P-I P2 1/u P-l 
Unit cell dimensions: a (A) 7.277(3) 8.554(1) 9.212(1) 7.720(1) 8.308(2) 
b(A) 7.639(3) 9.250(1) 9307(1) 12.016(1) 8.675(2) 
c (A) 19.940(8) 10.322(1) 11.849(1) 14.921(2) 9.664(3) 
a (0) 90 88.79(1) 92.28(1) 90 102377(4) 
~ (0) 90 72.78(1) 105.92(1) 103.14(1) 109.288(3) 
Y CO) 90 65.83 115.69(1) 90 107.132(3) 
Volume (N) 1108.5(7) 707.01(13) 865.5(2) 1347.9(3) 589.5(3) 
Z 4 2 2 4 2 
Density (calculated) (Mglm3) 1,416 l.807 1.770 1.587 2.063 
Absorption coefficient (mm·1) 0.094 1.926 1.0~2 0.879 1.726 
F(OOO) 488 386 460 662 360 
Crystal size (nun3) 0.51 x 0.25 x 0.16 0,41 x 0.33 x 0.14 0.74 x 0.27 x 0.11 0.62 x 0,44 x 0.31 0.55 x 0.25 x 0.11 
Theta range for data collection CO) 2.86 to 23.00 2.08 to 26.00 2,47 to 28.00 2.20 to 27.00 2.36 to 26,48 
Reflections collected 11015 3558 4400 3157 7588 
Independent reflections [R(int) J 1544 [0.0809] 2719 [0.0209] 4150 [0.0171] 2941 [0.0240] 2387 [0.0245] 
Observed reflections [1>20(l)] 1248 2010 3561 2007 2206 
Data / restraints 1 parameters 1544/0/163 2719/0/199 415010/245 2941/0/200 87/01181 
Goodness-of-fit on F2 1.103 0.899 1.003 0.919 1.052 
Rl [[>20(1)] 0.0509 0.0330 0.0281 0.0373 0.0222 
wRz (all data) 0.1184 0.0770 0.0693 0.0893 0.0562 
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